[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"global":3,"strapi:https://cms.sensus.org/api/news-articles?populate%5BcardImage%5D=true&sort=date%3Adesc&pagination%5BpageSize%5D=200":142},{"id":4,"documentId":5,"contactEmail":6,"donationUrl":7,"currentYear":8,"createdAt":9,"updatedAt":9,"publishedAt":10,"navigation":11,"socialLinks":104,"addresses":123,"legalLinks":130,"seo":138},2,"wax4le714pamz1q6degpmuah","contact@sensus.org","https://donorbox.org/donation-to-sensus",2026,"2026-07-28T11:13:22.092Z","2026-07-28T11:13:22.085Z",[12,20,45,85,91,97],{"id":13,"label":14,"to":15,"icon":16,"external":17,"badge":18,"children":19},7,"Home","/","i-heroicons-home",false,null,[],{"id":21,"label":22,"to":18,"icon":23,"external":17,"badge":18,"children":24},11,"About","i-heroicons-information-circle",[25,30,35,40],{"id":26,"label":27,"to":28,"icon":29,"external":17,"badge":18},12,"Who Are We?","/about/who-are-we","i-heroicons-question-mark-circle",{"id":31,"label":32,"to":33,"icon":34,"external":17,"badge":18},13,"Timeline","/about/timeline","i-heroicons-clock",{"id":36,"label":37,"to":38,"icon":39,"external":17,"badge":18},14,"SensUs People","/about/people","i-heroicons-users",{"id":41,"label":42,"to":43,"icon":44,"external":17,"badge":18},15,"Partners","/partners","i-heroicons-briefcase",{"id":26,"label":46,"to":18,"icon":47,"external":17,"badge":18,"children":48},"Competition","i-heroicons-trophy",[49,54,59,64,69,74,80],{"id":50,"label":51,"to":52,"icon":53,"external":17,"badge":18},16,"Theme 2026","/competition/theme-2026","i-heroicons-sparkles",{"id":55,"label":56,"to":57,"icon":58,"external":17,"badge":18},17,"Participating Teams","/competition/teams","i-heroicons-user-group",{"id":60,"label":61,"to":62,"icon":63,"external":17,"badge":18},18,"Jury","/competition/jury","i-heroicons-scale",{"id":65,"label":66,"to":67,"icon":68,"external":17,"badge":18},19,"High Schools","/competition/high-schools","i-heroicons-academic-cap",{"id":70,"label":71,"to":72,"icon":73,"external":17,"badge":18},20,"Archive","/competition/archive","i-heroicons-archive-box",{"id":75,"label":76,"to":77,"icon":78,"external":79,"badge":18},21,"Photos","https://photos.sensus.org/","i-heroicons-camera",true,{"id":81,"label":82,"to":83,"icon":84,"external":17,"badge":18},22,"Regulations","/regulations","i-heroicons-document-text",{"id":86,"label":87,"to":88,"icon":89,"external":17,"badge":18,"children":90},8,"News","/news","i-heroicons-newspaper",[],{"id":92,"label":93,"to":94,"icon":95,"external":17,"badge":18,"children":96},9,"Contact","/contact","i-heroicons-envelope",[],{"id":98,"label":99,"to":100,"icon":101,"external":17,"badge":102,"children":103},10,"Symposium","/symposium","i-heroicons-microphone","Aug 25",[],[105,110,115,119],{"id":106,"icon":107,"href":108,"label":109},5,"youtube","https://www.youtube.com/@sensuscompetition","YouTube",{"id":111,"icon":112,"href":113,"label":114},6,"linkedin","https://www.linkedin.com/company/sensus-organization","LinkedIn",{"id":13,"icon":116,"href":117,"label":118},"instagram","https://www.instagram.com/sensuscompetition/","Instagram",{"id":86,"icon":120,"href":121,"label":122},"tiktok","https://www.tiktok.com/@sensusorganization","TikTok",[124,127],{"id":13,"label":125,"lines":126},"Organization","Technische Universiteit Eindhoven\nMatrix Building, Room 1.239\nGroene Loper 3\n5612 AE Eindhoven, The Netherlands",{"id":86,"label":128,"lines":129},"Shipping","Matrix - SensUs Organization\nDe Rondom 70\n5612 AP Eindhoven\nThe Netherlands",[131,134],{"id":132,"label":133,"url":83},123,"Regulations & Privacy Policy",{"id":135,"label":136,"url":137},124,"Third Party Licenses","/assets/docs/third-party-licenses.txt",{"id":139,"metaTitle":140,"metaDescription":141},41,"SensUs | The Global Competition for Biosensors","SensUs is the annual international student competition on sensors for health. Join students, industry, and healthcare professionals accelerating biosensor innovation.",[143,221,312,371,428,480,527,576,623,674,727,774,820,866,970,1065,1107,1194,1285,1333,1389,1437,1522,1563,1617,1679,1756,1913,1974,2071,2151,2247,2311,2382,2422,2503,2556,2622,2674,2719,2781,2876,2922,3018,3113,3171,3317,3422,3510,3557,3642,3829,3917,3969,4071,4147,4188,4246,4313,4381,4488,4544,4653,4745,4841,4888,4952,5030,5134,5203,5357,5415,5531,5630,5751,5811,5909,5980,6050,6118,6186,6248,6332,6412,6528,6670,6773,6873,6923,6992,7041,7121,7172,7228,7291,7363,7420,7487,7548,7657,7711,7763,7810,7930,8029,8094,8199,8306,8367,8417,8487,8546,8621,8730,8816,8864,8943,9061,9130,9183,9270,9351],{"id":144,"documentId":145,"title":146,"slug":147,"date":148,"cardTitle":18,"excerpt":149,"body":150,"createdAt":173,"updatedAt":173,"publishedAt":174,"cardImage":175},245,"av5aumw2bxq2aak7h9zwa8jp","Navigating Life with Kidney Disease","navigating-life-kidney-disease","2025-03-30","Learn more about Harold de Bie and his story",[151,157,161,165,169],{"type":152,"children":153},"paragraph",[154],{"text":155,"type":156},"Sometimes in life, we get confronted with unexpected challenges: hurdles that force you to transform your way of living and adapt in ways you never imagined. For Harold van de Bie, a 56 years old former entrepreneur, this became a reality: in 2009, he was diagnosed with Nephrotic Syndrome, caused by the rare condition Membranoproliferative glomerulonephritis (MPGN).","text",{"type":152,"children":158},[159],{"text":160,"type":156},"“When I got the diagnosis, the condition wasn’t even on google,” Harold told us in an interview. His condition, MPGN, accounts for approximately 7 percent of causes of nephrotic syndrome in adults. It causes the kidney’s glomeruli – tiny kidney filters - to become damaged and inflamed. This leads to problems with the kidneys' ability to filter blood properly. When Harold got this diagnosis, the doctors outlined three possibilities: the condition might clear up on its own, become life-threatening, or lead to a future where he’d depend on dialysis or a kidney transplant.",{"type":152,"children":162},[163],{"text":164,"type":156},"The outcome was the latter, leading to a series of hardships that Harold had to overcome. The first few years were spent enduring constant medication, followed by an immune-system affecting virus that made him so vulnerable he had to get a kidney transplant. Though the transplant was successful, Harold had to sell his company, which added financial stress on an already overwhelming situation. “In hindsight: if there is something that gets hit the hardest, it is your mental health,” he reflected. “It’s a combination of all factors: financial strain, the endless hospital visits, and how the entire situation impacts your surroundings.”",{"type":152,"children":166},[167],{"text":168,"type":156},"How Harold views the idea of continuous monitoring with biosensors? While it might feel like a concept for the future, Harold sees how it could be valuable for maintaining his health. He explains that while salt is harmful to kidney function, completely avoiding it isn't the solution either. \"I had to go salt-free for a while, but I’ve learned that you need a certain amount of salt for your body to function properly,” he says. With a wearable biosensor, he could track how salt affects his kidney condition in real-time, allowing him and other kidney patients to find the right balance in diet.",{"type":152,"children":170},[171],{"text":172,"type":156},"Harold is one of the millions of people suffering from kidney disease. Over 2 million people worldwide currently receive treatment with dialysis or a kidney transplant to stay alive, and this number represents only a small fraction of the people who can benefit from better care. That's why the international student teams in SensUs are developing continuous biosensors that may help patients to take control of their health. Wearable sensors that monitor critical biomarkers could give real time data, reduce guesswork in diet and treatment, and hopefully provide patients with peace of mind and a better quality of life.","2026-07-28T11:13:32.307Z","2026-07-28T11:13:32.306Z",{"id":176,"documentId":177,"name":178,"alternativeText":18,"caption":18,"focalPoint":18,"width":179,"height":180,"formats":181,"hash":216,"ext":183,"mime":186,"size":217,"url":218,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":220,"updatedAt":220,"publishedAt":220},1127,"cgntcvzql6ivlq7vtf3t5927","1414-2000-max_1.png",1414,2000,{"large":182,"small":192,"medium":200,"thumbnail":208},{"ext":183,"url":184,"hash":185,"mime":186,"name":187,"path":18,"size":188,"width":189,"height":190,"sizeInBytes":191},".png","/uploads/large_1414_2000_max_1_6edd1b68bd.png","large_1414_2000_max_1_6edd1b68bd","image/png","large_1414-2000-max_1.png",543.63,707,1000,543631,{"ext":183,"url":193,"hash":194,"mime":186,"name":195,"path":18,"size":196,"width":197,"height":198,"sizeInBytes":199},"/uploads/small_1414_2000_max_1_6edd1b68bd.png","small_1414_2000_max_1_6edd1b68bd","small_1414-2000-max_1.png",198.83,354,500,198827,{"ext":183,"url":201,"hash":202,"mime":186,"name":203,"path":18,"size":204,"width":205,"height":206,"sizeInBytes":207},"/uploads/medium_1414_2000_max_1_6edd1b68bd.png","medium_1414_2000_max_1_6edd1b68bd","medium_1414-2000-max_1.png",365.31,530,750,365311,{"ext":183,"url":209,"hash":210,"mime":186,"name":211,"path":18,"size":212,"width":213,"height":214,"sizeInBytes":215},"/uploads/thumbnail_1414_2000_max_1_6edd1b68bd.png","thumbnail_1414_2000_max_1_6edd1b68bd","thumbnail_1414-2000-max_1.png",29.19,110,156,29188,"1414_2000_max_1_6edd1b68bd",265.66,"/uploads/1414_2000_max_1_6edd1b68bd.png","local","2026-07-28T11:13:32.304Z",{"id":222,"documentId":223,"title":224,"slug":225,"date":226,"cardTitle":18,"excerpt":18,"body":227,"createdAt":270,"updatedAt":270,"publishedAt":271,"cardImage":272},246,"sovhg2gnz29bt6quc1i1r04d","Article | Biosensors in the Spotlight","article-biosensors-spotlight","2024-03-11",[228,232,242,246,250,254,262],{"type":152,"children":229},[230],{"text":231,"type":156},"The SensUs student competition is an international competition in which students take on the challenge of developing rapid biosensors for monitoring critical medical conditions. The competition is organized annually by students from Eindhoven University of Technology (TU/e) with the aim of stimulating technology development for healthcare. This article was written for Nederlands Tijdschrift voor Natuurkunde by Noah Olmeijer.",{"type":152,"children":233},[234,240],{"url":235,"type":236,"children":237},"/uploads/Student_december_2023_def_1_51bb3303ea.pdf","link",[238],{"text":239,"type":156},"Link",{"text":241,"type":156}," (Dutch)",{"type":152,"children":243},[244],{"text":245,"type":156},"Title: Biosensoren in de schijnwerpers: de SensUs-studentencompetitie",{"type":152,"children":247},[248],{"text":249,"type":156},"Author: Noah Olmeijer",{"type":152,"children":251},[252],{"text":253,"type":156},"December 2023",{"type":152,"children":255},[256,258,260],{"text":257,"type":156},"Olmeijer, N. (2023). Biosensoren in de schijnwerpers: de SensUs-studentencompetitie. ",{"text":259,"type":156,"italic":79},"Nederlands Tijdschrift voor Natuurkunde. 89",{"text":261,"type":156},"(12) 52-55",{"type":152,"children":263},[264,266],{"text":265,"type":156},"NTvN Website: ",{"url":267,"type":236,"children":268},"https://www.ntvn.nl/",[269],{"text":267,"type":156},"2026-07-28T11:13:32.637Z","2026-07-28T11:13:32.636Z",{"id":273,"documentId":274,"name":275,"alternativeText":18,"caption":18,"focalPoint":18,"width":276,"height":277,"formats":278,"hash":308,"ext":280,"mime":283,"size":309,"url":310,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":311,"updatedAt":311,"publishedAt":311},1129,"tr7yo0mxp0q61z1rgdxy98wo","DSC06429.jpg",4922,3281,{"large":279,"small":288,"medium":295,"thumbnail":301},{"ext":280,"url":281,"hash":282,"mime":283,"name":284,"path":18,"size":285,"width":190,"height":286,"sizeInBytes":287},".jpg","/uploads/large_DSC_06429_1a139b81ac.jpg","large_DSC_06429_1a139b81ac","image/jpeg","large_DSC06429.jpg",105.1,666,105099,{"ext":280,"url":289,"hash":290,"mime":283,"name":291,"path":18,"size":292,"width":198,"height":293,"sizeInBytes":294},"/uploads/small_DSC_06429_1a139b81ac.jpg","small_DSC_06429_1a139b81ac","small_DSC06429.jpg",35.84,333,35842,{"ext":280,"url":296,"hash":297,"mime":283,"name":298,"path":18,"size":299,"width":206,"height":198,"sizeInBytes":300},"/uploads/medium_DSC_06429_1a139b81ac.jpg","medium_DSC_06429_1a139b81ac","medium_DSC06429.jpg",67.65,67652,{"ext":280,"url":302,"hash":303,"mime":283,"name":304,"path":18,"size":305,"width":306,"height":214,"sizeInBytes":307},"/uploads/thumbnail_DSC_06429_1a139b81ac.jpg","thumbnail_DSC_06429_1a139b81ac","thumbnail_DSC06429.jpg",11.42,234,11421,"DSC_06429_1a139b81ac",932.04,"/uploads/DSC_06429_1a139b81ac.jpg","2026-07-28T11:13:32.634Z",{"id":313,"documentId":314,"title":315,"slug":316,"date":317,"cardTitle":18,"excerpt":18,"body":318,"createdAt":331,"updatedAt":331,"publishedAt":332,"cardImage":333},247,"mfkfeuqiwfdbdzfiued66mer","Article | NEOSENS, a SensUs Startup","article-neosens-sensus-startup","2023-10-11",[319,323,327],{"type":152,"children":320},[321],{"text":322,"type":156},"NEOSENS, a startup brought into life by three young innovators—Mateo Hamel, Marco Fumagalli, and Karim Zahra—aims to tackle a pressing global health concern head-on. In low and middle-income countries, an alarming 12% of newborns undergo unnecessary antibiotic treatment each year due to false sepsis diagnosis. In this interview with the founders, we explore their inspiring journey and groundbreaking solution to this critical issue, which finds its roots in the SensUs Competition.",{"type":152,"children":324},[325],{"text":326,"type":156},"Sepsis, a life-threatening condition triggered by an uncontrolled response to infection, poses a formidable challenge in healthcare. Quick and accurate diagnosis is of utmost importance, yet current laboratory techniques can take up to a week to yield results, exposing patients to enormous risks. Furthermore, sepsis is a complex condition involving multiple factors beyond the infectious agent itself, further complicating the diagnostic process.",{"type":152,"children":328},[329],{"text":330,"type":156},"The idea for starting NEOSENS started with participation in the SensUs Competition of 2022, where the trio, along with their team LAU’SENS from École Polytechnique Fédérale de Lausanne secured first place in the categories of analytical performance as well as translation potential. They not only demonstrated their talent but also shared their ambition to transform their biosensor prototype into a full-fledged startup.","2026-07-28T11:13:33.415Z","2026-07-28T11:13:33.413Z",{"id":334,"documentId":335,"name":336,"alternativeText":18,"caption":18,"focalPoint":18,"width":337,"height":338,"formats":339,"hash":367,"ext":280,"mime":283,"size":368,"url":369,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":370,"updatedAt":370,"publishedAt":370},1131,"t1ohlvvfp6v4r1f1tovtxtja","goodworking.jpg",7652,5104,{"large":340,"small":347,"medium":354,"thumbnail":361},{"ext":280,"url":341,"hash":342,"mime":283,"name":343,"path":18,"size":344,"width":190,"height":345,"sizeInBytes":346},"/uploads/large_goodworking_13b3d22739.jpg","large_goodworking_13b3d22739","large_goodworking.jpg",99.56,667,99563,{"ext":280,"url":348,"hash":349,"mime":283,"name":350,"path":18,"size":351,"width":198,"height":352,"sizeInBytes":353},"/uploads/small_goodworking_13b3d22739.jpg","small_goodworking_13b3d22739","small_goodworking.jpg",33.28,334,33277,{"ext":280,"url":355,"hash":356,"mime":283,"name":357,"path":18,"size":358,"width":206,"height":359,"sizeInBytes":360},"/uploads/medium_goodworking_13b3d22739.jpg","medium_goodworking_13b3d22739","medium_goodworking.jpg",62.31,501,62314,{"ext":280,"url":362,"hash":363,"mime":283,"name":364,"path":18,"size":365,"width":306,"height":214,"sizeInBytes":366},"/uploads/thumbnail_goodworking_13b3d22739.jpg","thumbnail_goodworking_13b3d22739","thumbnail_goodworking.jpg",10.25,10251,"goodworking_13b3d22739",2648.87,"/uploads/goodworking_13b3d22739.jpg","2026-07-28T11:13:33.348Z",{"id":372,"documentId":373,"title":374,"slug":375,"date":376,"cardTitle":18,"excerpt":18,"body":377,"createdAt":392,"updatedAt":392,"publishedAt":393,"cardImage":394},248,"vx8o95e9wgb886ur5xryg4uu","From academic spinoff to attractive value proposition","academic-spinoff-attractive-value-proposition","2023-09-29",[378,388],{"type":379,"level":380,"children":381},"heading",3,[382,384,386],{"bold":79,"text":383,"type":156},"Problem exploration for creating value propositions when developing",{"text":385,"type":156}," ",{"bold":79,"text":387,"type":156},"point-of-care solutions",{"type":152,"children":389},[390],{"bold":79,"text":391,"type":156,"italic":79},"Annelies Bobelyn, Rene Unteregger, Johanna I. Höffken, Isabelle Reymen","2026-07-28T11:13:39.026Z","2026-07-28T11:13:39.024Z",{"id":395,"documentId":396,"name":397,"alternativeText":18,"caption":18,"focalPoint":18,"width":398,"height":398,"formats":399,"hash":424,"ext":183,"mime":186,"size":425,"url":426,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":427,"updatedAt":427,"publishedAt":427},1134,"z602ll2ayp9kc198iic770bs","Article_Annelies_Bobelyn_0.png",4500,{"large":400,"small":406,"medium":412,"thumbnail":418},{"ext":183,"url":401,"hash":402,"mime":186,"name":403,"path":18,"size":404,"width":190,"height":190,"sizeInBytes":405},"/uploads/large_Article_Annelies_Bobelyn_0_5fdcb20937.png","large_Article_Annelies_Bobelyn_0_5fdcb20937","large_Article_Annelies_Bobelyn_0.png",1053.39,1053385,{"ext":183,"url":407,"hash":408,"mime":186,"name":409,"path":18,"size":410,"width":198,"height":198,"sizeInBytes":411},"/uploads/small_Article_Annelies_Bobelyn_0_5fdcb20937.png","small_Article_Annelies_Bobelyn_0_5fdcb20937","small_Article_Annelies_Bobelyn_0.png",299.7,299695,{"ext":183,"url":413,"hash":414,"mime":186,"name":415,"path":18,"size":416,"width":206,"height":206,"sizeInBytes":417},"/uploads/medium_Article_Annelies_Bobelyn_0_5fdcb20937.png","medium_Article_Annelies_Bobelyn_0_5fdcb20937","medium_Article_Annelies_Bobelyn_0.png",621.01,621012,{"ext":183,"url":419,"hash":420,"mime":186,"name":421,"path":18,"size":422,"width":214,"height":214,"sizeInBytes":423},"/uploads/thumbnail_Article_Annelies_Bobelyn_0_5fdcb20937.png","thumbnail_Article_Annelies_Bobelyn_0_5fdcb20937","thumbnail_Article_Annelies_Bobelyn_0.png",38.58,38578,"Article_Annelies_Bobelyn_0_5fdcb20937",3635.79,"/uploads/Article_Annelies_Bobelyn_0_5fdcb20937.png","2026-07-28T11:13:39.022Z",{"id":429,"documentId":430,"title":431,"slug":432,"date":433,"cardTitle":18,"excerpt":18,"body":434,"createdAt":443,"updatedAt":443,"publishedAt":444,"cardImage":445},249,"yzs8pctkf961515uj2ar4nxr","SensUs Interview: Niels de Laat","sensus-interview-niels-de-laat","2023-05-30",[435,439],{"type":152,"children":436},[437],{"text":438,"type":156,"italic":79},"‘It was a head-on collision. My head smashed into the dashboard of my scooter and - sorry, I have to be a bit graphic here - I broke basically every bone of my face.’",{"type":152,"children":440},[441],{"text":442,"type":156},"This is the story of Niels de Laat. At a young age he was involved in a serious scooter accident. Now, 26 years later, he still experiences the effects of his TBI. It changed his life entirely.","2026-07-28T11:13:39.958Z","2026-07-28T11:13:39.955Z",{"id":446,"documentId":447,"name":448,"alternativeText":18,"caption":18,"focalPoint":18,"width":449,"height":450,"formats":451,"hash":476,"ext":280,"mime":283,"size":477,"url":478,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":479,"updatedAt":479,"publishedAt":479},1136,"vdfzwm2d59ry0rbma2zltjc8","52635601085_f484636d04_o.jpg",7873,5249,{"large":452,"small":458,"medium":464,"thumbnail":470},{"ext":280,"url":453,"hash":454,"mime":283,"name":455,"path":18,"size":456,"width":190,"height":345,"sizeInBytes":457},"/uploads/large_52635601085_f484636d04_o_8b663b4719.jpg","large_52635601085_f484636d04_o_8b663b4719","large_52635601085_f484636d04_o.jpg",75.32,75319,{"ext":280,"url":459,"hash":460,"mime":283,"name":461,"path":18,"size":462,"width":198,"height":293,"sizeInBytes":463},"/uploads/small_52635601085_f484636d04_o_8b663b4719.jpg","small_52635601085_f484636d04_o_8b663b4719","small_52635601085_f484636d04_o.jpg",26.24,26235,{"ext":280,"url":465,"hash":466,"mime":283,"name":467,"path":18,"size":468,"width":206,"height":198,"sizeInBytes":469},"/uploads/medium_52635601085_f484636d04_o_8b663b4719.jpg","medium_52635601085_f484636d04_o_8b663b4719","medium_52635601085_f484636d04_o.jpg",47.94,47943,{"ext":280,"url":471,"hash":472,"mime":283,"name":473,"path":18,"size":474,"width":306,"height":214,"sizeInBytes":475},"/uploads/thumbnail_52635601085_f484636d04_o_8b663b4719.jpg","thumbnail_52635601085_f484636d04_o_8b663b4719","thumbnail_52635601085_f484636d04_o.jpg",8.58,8576,"52635601085_f484636d04_o_8b663b4719",3265.47,"/uploads/52635601085_f484636d04_o_8b663b4719.jpg","2026-07-28T11:13:39.953Z",{"id":481,"documentId":482,"title":483,"slug":484,"date":485,"cardTitle":18,"excerpt":18,"body":486,"createdAt":491,"updatedAt":491,"publishedAt":492,"cardImage":493},250,"qgjn5a8naqtjjatyqn32fg0i","SensUs Interview: Sebastian & Anna","sensus-interview-sebastian-anna","2023-04-19",[487],{"type":152,"children":488},[489],{"text":490,"type":156},"Continuous sensing is a new development in the field of biosensing. Commercial sensors for continuous monitoring exist for glucose, but not yet for other substances and biomarkers. How does continuous monitoring work and what will the sensors of the future look like? This is the focus of the CONSENSE research consortium. Members of CONSENSE are Sebastian and Anna, both PhD students at Eindhoven University of Technology. Who are they and what do they study in the field of biosensing?","2026-07-28T11:13:40.839Z","2026-07-28T11:13:40.835Z",{"id":494,"documentId":495,"name":496,"alternativeText":18,"caption":18,"focalPoint":18,"width":497,"height":497,"formats":498,"hash":523,"ext":183,"mime":186,"size":524,"url":525,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":526,"updatedAt":526,"publishedAt":526},1138,"txi8jckpwph77vyvvrpantmy","Overview_news_website_0.png",1200,{"large":499,"small":505,"medium":511,"thumbnail":517},{"ext":183,"url":500,"hash":501,"mime":186,"name":502,"path":18,"size":503,"width":190,"height":190,"sizeInBytes":504},"/uploads/large_Overview_news_website_0_985750fec5.png","large_Overview_news_website_0_985750fec5","large_Overview_news_website_0.png",988.43,988433,{"ext":183,"url":506,"hash":507,"mime":186,"name":508,"path":18,"size":509,"width":198,"height":198,"sizeInBytes":510},"/uploads/small_Overview_news_website_0_985750fec5.png","small_Overview_news_website_0_985750fec5","small_Overview_news_website_0.png",266.98,266982,{"ext":183,"url":512,"hash":513,"mime":186,"name":514,"path":18,"size":515,"width":206,"height":206,"sizeInBytes":516},"/uploads/medium_Overview_news_website_0_985750fec5.png","medium_Overview_news_website_0_985750fec5","medium_Overview_news_website_0.png",574.01,574012,{"ext":183,"url":518,"hash":519,"mime":186,"name":520,"path":18,"size":521,"width":214,"height":214,"sizeInBytes":522},"/uploads/thumbnail_Overview_news_website_0_985750fec5.png","thumbnail_Overview_news_website_0_985750fec5","thumbnail_Overview_news_website_0.png",31.48,31481,"Overview_news_website_0_985750fec5",289.48,"/uploads/Overview_news_website_0_985750fec5.png","2026-07-28T11:13:40.833Z",{"id":528,"documentId":529,"title":530,"slug":531,"date":532,"cardTitle":18,"excerpt":18,"body":533,"createdAt":538,"updatedAt":538,"publishedAt":539,"cardImage":540},251,"f4tsdatoo1u7z47hjhgr2ohg","Recap of the SensUs Event 2022","recap-sensus-event-2022","2022-10-07",[534],{"type":152,"children":535},[536],{"text":537,"type":156},"A few weeks ago, the SensUs Innovation Days took place at Eindhoven University of Technology. Fourteen Student Teams from eleven countries from all over the world came to Eindhoven to compete in the SensUs Student Competition. This year they were asked to create the best possible biosensor for acute inflammation, with a focus on sepsis. With more than 900 visitors, both physical and online, it was a week full of creativity, innovation and biosensing!","2026-07-28T11:13:41.133Z","2026-07-28T11:13:41.130Z",{"id":541,"documentId":542,"name":543,"alternativeText":18,"caption":18,"focalPoint":18,"width":544,"height":545,"formats":546,"hash":572,"ext":280,"mime":283,"size":573,"url":574,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":575,"updatedAt":575,"publishedAt":575},1140,"fg7mtopctgmy6ag3qhxw8fw7","RL402136.jpg",1707,2560,{"large":547,"small":553,"medium":559,"thumbnail":565},{"ext":280,"url":548,"hash":549,"mime":283,"name":550,"path":18,"size":551,"width":345,"height":190,"sizeInBytes":552},"/uploads/large_RL_402136_d9f86cccba.jpg","large_RL_402136_d9f86cccba","large_RL402136.jpg",73.13,73126,{"ext":280,"url":554,"hash":555,"mime":283,"name":556,"path":18,"size":557,"width":293,"height":198,"sizeInBytes":558},"/uploads/small_RL_402136_d9f86cccba.jpg","small_RL_402136_d9f86cccba","small_RL402136.jpg",23.85,23848,{"ext":280,"url":560,"hash":561,"mime":283,"name":562,"path":18,"size":563,"width":198,"height":206,"sizeInBytes":564},"/uploads/medium_RL_402136_d9f86cccba.jpg","medium_RL_402136_d9f86cccba","medium_RL402136.jpg",44.7,44702,{"ext":280,"url":566,"hash":567,"mime":283,"name":568,"path":18,"size":569,"width":570,"height":214,"sizeInBytes":571},"/uploads/thumbnail_RL_402136_d9f86cccba.jpg","thumbnail_RL_402136_d9f86cccba","thumbnail_RL402136.jpg",4.56,104,4557,"RL_402136_d9f86cccba",536.16,"/uploads/RL_402136_d9f86cccba.jpg","2026-07-28T11:13:41.067Z",{"id":577,"documentId":578,"title":579,"slug":580,"date":581,"cardTitle":582,"excerpt":18,"body":583,"createdAt":588,"updatedAt":588,"publishedAt":589,"cardImage":590},252,"x7vcsw7h8jqb2crmpg08g7i4","Sepsis patient representative and coordinator of 'Sepsis en daarna': Idelette Nutma","sensus-interview-idelette-nutma","2022-08-30","SensUs Interview: Idelette Nutma",[584],{"type":152,"children":585},[586],{"text":587,"type":156},"“I went to the ER, was admitted to the hospital with pneumonia and two hours later, I suddenly felt very dizzy. I was going into shock”, Idelette Nutma tells us. She was quickly transferred to the ICU. ‘That rapid response was crucial, it saved my life’. Sepsis is very dangerous and a lot of people aren’t aware of that, including professionals. Yearly, fifty million people worldwide develop sepsis and twenty percent do not survive. But what is sepsis and why is there so little known about it? In this article, we speak with Idelette Nutma, former sepsis patient, patient representative, and coordinator of ‘Sepsis en daarna’.","2026-07-28T11:13:41.189Z","2026-07-28T11:13:41.186Z",{"id":591,"documentId":592,"name":593,"alternativeText":18,"caption":18,"focalPoint":18,"width":594,"height":595,"formats":596,"hash":619,"ext":598,"mime":283,"size":620,"url":621,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":622,"updatedAt":622,"publishedAt":622},1143,"cznfcflngp30hntn6uaxke9k","idelette_foto_meer_pixels.jpeg",891,590,{"small":597,"medium":605,"thumbnail":612},{"ext":598,"url":599,"hash":600,"mime":283,"name":601,"path":18,"size":602,"width":198,"height":603,"sizeInBytes":604},".jpeg","/uploads/small_idelette_foto_meer_pixels_4ab72bd461.jpeg","small_idelette_foto_meer_pixels_4ab72bd461","small_idelette_foto_meer_pixels.jpeg",21.12,331,21121,{"ext":598,"url":606,"hash":607,"mime":283,"name":608,"path":18,"size":609,"width":206,"height":610,"sizeInBytes":611},"/uploads/medium_idelette_foto_meer_pixels_4ab72bd461.jpeg","medium_idelette_foto_meer_pixels_4ab72bd461","medium_idelette_foto_meer_pixels.jpeg",37.54,497,37540,{"ext":598,"url":613,"hash":614,"mime":283,"name":615,"path":18,"size":616,"width":617,"height":214,"sizeInBytes":618},"/uploads/thumbnail_idelette_foto_meer_pixels_4ab72bd461.jpeg","thumbnail_idelette_foto_meer_pixels_4ab72bd461","thumbnail_idelette_foto_meer_pixels.jpeg",7.15,235,7154,"idelette_foto_meer_pixels_4ab72bd461",46.32,"/uploads/idelette_foto_meer_pixels_4ab72bd461.jpeg","2026-07-28T11:13:41.185Z",{"id":624,"documentId":625,"title":626,"slug":627,"date":628,"cardTitle":18,"excerpt":18,"body":629,"createdAt":634,"updatedAt":634,"publishedAt":635,"cardImage":636},253,"gqlmfwjrvfv58a8cb54m9i4p","From SensUs Participant to Demcon’s business community!","sensus-participant-demcons-business-community","2022-08-22",[630],{"type":152,"children":631},[632],{"text":633,"type":156},"Maaike Kraamer works at Demcon, one of the partner companies of SensUs. Unique about Maaike is that she knows SensUs inside out, because she participated as a student in the 2017 edition of SensUs. In this article Maaike tells us about her experiences as a student in SensUs and as a professional in Demcon!","2026-07-28T11:13:41.564Z","2026-07-28T11:13:41.555Z",{"id":637,"documentId":638,"name":639,"alternativeText":18,"caption":18,"focalPoint":18,"width":640,"height":641,"formats":642,"hash":670,"ext":280,"mime":283,"size":671,"url":672,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":673,"updatedAt":673,"publishedAt":673},1145,"l0fql3q2kmhkg599m65bil0f","demcon.1.jpg",3024,4032,{"large":643,"small":649,"medium":656,"thumbnail":663},{"ext":280,"url":644,"hash":645,"mime":283,"name":646,"path":18,"size":647,"width":206,"height":190,"sizeInBytes":648},"/uploads/large_demcon_1_6a84c237ff.jpg","large_demcon_1_6a84c237ff","large_demcon.1.jpg",116.6,116596,{"ext":280,"url":650,"hash":651,"mime":283,"name":652,"path":18,"size":653,"width":654,"height":198,"sizeInBytes":655},"/uploads/small_demcon_1_6a84c237ff.jpg","small_demcon_1_6a84c237ff","small_demcon.1.jpg",33.81,375,33809,{"ext":280,"url":657,"hash":658,"mime":283,"name":659,"path":18,"size":660,"width":661,"height":206,"sizeInBytes":662},"/uploads/medium_demcon_1_6a84c237ff.jpg","medium_demcon_1_6a84c237ff","medium_demcon.1.jpg",68.56,563,68556,{"ext":280,"url":664,"hash":665,"mime":283,"name":666,"path":18,"size":667,"width":668,"height":214,"sizeInBytes":669},"/uploads/thumbnail_demcon_1_6a84c237ff.jpg","thumbnail_demcon_1_6a84c237ff","thumbnail_demcon.1.jpg",4.92,117,4916,"demcon_1_6a84c237ff",1645.15,"/uploads/demcon_1_6a84c237ff.jpg","2026-07-28T11:13:41.550Z",{"id":675,"documentId":676,"title":677,"slug":678,"date":679,"cardTitle":18,"excerpt":18,"body":680,"createdAt":689,"updatedAt":689,"publishedAt":690,"cardImage":691},254,"ycnovfs3wvc0ghrv483rdixz","Meet the chairs of 2022!","meet-chairs-2022","2022-03-01",[681,685],{"type":152,"children":682},[683],{"bold":79,"text":684,"type":156},"Who are the chairs of the SensUs Organization 2022?",{"type":152,"children":686},[687],{"text":688,"type":156},"Meet the chairs of SensUs 2022: Vera Teurlinx and Hans Douben. Vera and Hans are both Biomedical Engineering students at the Eindhoven University of Technology. Chair Vera and Vice-Chair Hans are 20 and 22 years old respectively. Fun fact: they consider themselves already really old.","2026-07-28T11:13:41.993Z","2026-07-28T11:13:41.989Z",{"id":692,"documentId":693,"name":694,"alternativeText":18,"caption":18,"focalPoint":18,"width":695,"height":696,"formats":697,"hash":722,"ext":598,"mime":283,"size":723,"url":724,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":725,"updatedAt":725,"publishedAt":726},1147,"h1qtdktzycrxwuqo7f2z0ns3","Vera_and_Hans.jpeg",1536,2048,{"large":698,"small":704,"medium":710,"thumbnail":716},{"ext":598,"url":699,"hash":700,"mime":283,"name":701,"path":18,"size":702,"width":206,"height":190,"sizeInBytes":703},"/uploads/large_Vera_and_Hans_afe2a362db.jpeg","large_Vera_and_Hans_afe2a362db","large_Vera_and_Hans.jpeg",54.99,54994,{"ext":598,"url":705,"hash":706,"mime":283,"name":707,"path":18,"size":708,"width":654,"height":198,"sizeInBytes":709},"/uploads/small_Vera_and_Hans_afe2a362db.jpeg","small_Vera_and_Hans_afe2a362db","small_Vera_and_Hans.jpeg",17.57,17569,{"ext":598,"url":711,"hash":712,"mime":283,"name":713,"path":18,"size":714,"width":661,"height":206,"sizeInBytes":715},"/uploads/medium_Vera_and_Hans_afe2a362db.jpeg","medium_Vera_and_Hans_afe2a362db","medium_Vera_and_Hans.jpeg",34.39,34386,{"ext":598,"url":717,"hash":718,"mime":283,"name":719,"path":18,"size":720,"width":668,"height":214,"sizeInBytes":721},"/uploads/thumbnail_Vera_and_Hans_afe2a362db.jpeg","thumbnail_Vera_and_Hans_afe2a362db","thumbnail_Vera_and_Hans.jpeg",3.16,3158,"Vera_and_Hans_afe2a362db",190.85,"/uploads/Vera_and_Hans_afe2a362db.jpeg","2026-07-28T11:13:41.917Z","2026-07-28T11:13:41.918Z",{"id":728,"documentId":729,"title":730,"slug":731,"date":732,"cardTitle":18,"excerpt":18,"body":733,"createdAt":738,"updatedAt":738,"publishedAt":739,"cardImage":740},255,"zvl175a0bgza823rjylrwj4i","SensUs | Newsletter December","sensus-newsletter-december-2","2021-12-25",[734],{"type":152,"children":735},[736],{"bold":79,"text":737,"type":156},"The SensUs Organization is working hard towards the Christmas holidays! Due to the pandemic the very first Kick-off Event of the SensUs Competition will be held a little differently than planned, but it will definitely be as great and fun! Make sure to keep an eye out for the 12th of January, because something special is coming your way!","2026-07-28T11:13:42.119Z","2026-07-28T11:13:42.117Z",{"id":741,"documentId":742,"name":743,"alternativeText":18,"caption":18,"focalPoint":18,"width":696,"height":744,"formats":745,"hash":770,"ext":280,"mime":283,"size":771,"url":772,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":773,"updatedAt":773,"publishedAt":773},1150,"mjs68rb0qb0gn21hw2pu3j37","51528066945_b39cf3fdcf_k.jpg",1365,{"large":746,"small":752,"medium":758,"thumbnail":764},{"ext":280,"url":747,"hash":748,"mime":283,"name":749,"path":18,"size":750,"width":190,"height":345,"sizeInBytes":751},"/uploads/large_51528066945_b39cf3fdcf_k_87620771aa.jpg","large_51528066945_b39cf3fdcf_k_87620771aa","large_51528066945_b39cf3fdcf_k.jpg",95.25,95253,{"ext":280,"url":753,"hash":754,"mime":283,"name":755,"path":18,"size":756,"width":198,"height":293,"sizeInBytes":757},"/uploads/small_51528066945_b39cf3fdcf_k_87620771aa.jpg","small_51528066945_b39cf3fdcf_k_87620771aa","small_51528066945_b39cf3fdcf_k.jpg",34.7,34703,{"ext":280,"url":759,"hash":760,"mime":283,"name":761,"path":18,"size":762,"width":206,"height":198,"sizeInBytes":763},"/uploads/medium_51528066945_b39cf3fdcf_k_87620771aa.jpg","medium_51528066945_b39cf3fdcf_k_87620771aa","medium_51528066945_b39cf3fdcf_k.jpg",62.4,62403,{"ext":280,"url":765,"hash":766,"mime":283,"name":767,"path":18,"size":768,"width":306,"height":214,"sizeInBytes":769},"/uploads/thumbnail_51528066945_b39cf3fdcf_k_87620771aa.jpg","thumbnail_51528066945_b39cf3fdcf_k_87620771aa","thumbnail_51528066945_b39cf3fdcf_k.jpg",11.56,11556,"51528066945_b39cf3fdcf_k_87620771aa",333.89,"/uploads/51528066945_b39cf3fdcf_k_87620771aa.jpg","2026-07-28T11:13:42.115Z",{"id":775,"documentId":776,"title":777,"slug":778,"date":779,"cardTitle":18,"excerpt":18,"body":780,"createdAt":785,"updatedAt":785,"publishedAt":786,"cardImage":787},256,"xctmxal596150dzadgwrnjfi","Career tips from the Panel Talk of SensUs 2021","career-tips-panel-talk-sensus-2021","2021-12-02",[781],{"type":152,"children":782},[783],{"bold":79,"text":784,"type":156},"The speakers in the Panel Talk of SensUs 2021 explained the hurdles they had to overcome in their career paths and how they tackled the challenging situations. This article summarizes their tips and tricks, which may help in designing your own career!","2026-07-28T11:13:42.277Z","2026-07-28T11:13:42.276Z",{"id":788,"documentId":789,"name":790,"alternativeText":18,"caption":18,"focalPoint":18,"width":696,"height":744,"formats":791,"hash":816,"ext":280,"mime":283,"size":817,"url":818,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":819,"updatedAt":819,"publishedAt":819},1152,"ftgcg609melkantk3orjnai5","51501756037_eecc048200_k.jpg",{"large":792,"small":798,"medium":804,"thumbnail":810},{"ext":280,"url":793,"hash":794,"mime":283,"name":795,"path":18,"size":796,"width":190,"height":345,"sizeInBytes":797},"/uploads/large_51501756037_eecc048200_k_eafe223bd3.jpg","large_51501756037_eecc048200_k_eafe223bd3","large_51501756037_eecc048200_k.jpg",66.7,66702,{"ext":280,"url":799,"hash":800,"mime":283,"name":801,"path":18,"size":802,"width":198,"height":293,"sizeInBytes":803},"/uploads/small_51501756037_eecc048200_k_eafe223bd3.jpg","small_51501756037_eecc048200_k_eafe223bd3","small_51501756037_eecc048200_k.jpg",22.27,22267,{"ext":280,"url":805,"hash":806,"mime":283,"name":807,"path":18,"size":808,"width":206,"height":198,"sizeInBytes":809},"/uploads/medium_51501756037_eecc048200_k_eafe223bd3.jpg","medium_51501756037_eecc048200_k_eafe223bd3","medium_51501756037_eecc048200_k.jpg",42.29,42293,{"ext":280,"url":811,"hash":812,"mime":283,"name":813,"path":18,"size":814,"width":306,"height":214,"sizeInBytes":815},"/uploads/thumbnail_51501756037_eecc048200_k_eafe223bd3.jpg","thumbnail_51501756037_eecc048200_k_eafe223bd3","thumbnail_51501756037_eecc048200_k.jpg",7.35,7350,"51501756037_eecc048200_k_eafe223bd3",230.58,"/uploads/51501756037_eecc048200_k_eafe223bd3.jpg","2026-07-28T11:13:42.271Z",{"id":821,"documentId":822,"title":823,"slug":824,"date":825,"cardTitle":18,"excerpt":18,"body":826,"createdAt":831,"updatedAt":831,"publishedAt":832,"cardImage":833},257,"attt354tgqvh5upvgta7zqpj","Summary of the SensUs Event 2021","summary-sensus-event-2021","2021-10-04",[827],{"type":152,"children":828},[829],{"text":830,"type":156},"On Friday, September 3rd, the SensUs 2021 Event took place at Eindhoven University of Technology. In this international event, fourteen student teams from thirteen countries competed to win awards for the best and most innovative biosensor to detect Influenza A, better known as the flu, to prevent the next pandemic. The biosensors were judged on four categories: public inspiration, creativity, translation potential, and analytical performance.","2026-07-28T11:13:42.525Z","2026-07-28T11:13:42.522Z",{"id":834,"documentId":835,"name":836,"alternativeText":18,"caption":18,"focalPoint":18,"width":696,"height":744,"formats":837,"hash":862,"ext":280,"mime":283,"size":863,"url":864,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":865,"updatedAt":865,"publishedAt":865},1154,"le8stchxagfmtd8app2zuora","51527819974_4186a7e70c_k.jpg",{"large":838,"small":844,"medium":850,"thumbnail":856},{"ext":280,"url":839,"hash":840,"mime":283,"name":841,"path":18,"size":842,"width":190,"height":345,"sizeInBytes":843},"/uploads/large_51527819974_4186a7e70c_k_71f3b2dea2.jpg","large_51527819974_4186a7e70c_k_71f3b2dea2","large_51527819974_4186a7e70c_k.jpg",84.22,84224,{"ext":280,"url":845,"hash":846,"mime":283,"name":847,"path":18,"size":848,"width":198,"height":293,"sizeInBytes":849},"/uploads/small_51527819974_4186a7e70c_k_71f3b2dea2.jpg","small_51527819974_4186a7e70c_k_71f3b2dea2","small_51527819974_4186a7e70c_k.jpg",27.13,27131,{"ext":280,"url":851,"hash":852,"mime":283,"name":853,"path":18,"size":854,"width":206,"height":198,"sizeInBytes":855},"/uploads/medium_51527819974_4186a7e70c_k_71f3b2dea2.jpg","medium_51527819974_4186a7e70c_k_71f3b2dea2","medium_51527819974_4186a7e70c_k.jpg",52,51998,{"ext":280,"url":857,"hash":858,"mime":283,"name":859,"path":18,"size":860,"width":306,"height":214,"sizeInBytes":861},"/uploads/thumbnail_51527819974_4186a7e70c_k_71f3b2dea2.jpg","thumbnail_51527819974_4186a7e70c_k_71f3b2dea2","thumbnail_51527819974_4186a7e70c_k.jpg",8.51,8507,"51527819974_4186a7e70c_k_71f3b2dea2",345.29,"/uploads/51527819974_4186a7e70c_k_71f3b2dea2.jpg","2026-07-28T11:13:42.439Z",{"id":867,"documentId":868,"title":869,"slug":870,"date":871,"cardTitle":18,"excerpt":18,"body":872,"createdAt":931,"updatedAt":931,"publishedAt":932,"cardImage":933},258,"asshqg2e8ug7clirq8o0a2uo","The SensUs Event is coming near!","sensus-event-coming-near","2021-09-01",[873,888,892,899,909,913,917,924],{"type":152,"children":874},[875,877,879,881,886],{"text":876,"type":156},"In two days, the SensUs Event, the day we have all been waiting for, will take place on ",{"bold":79,"text":878,"type":156},"Friday, September 3rd",{"text":880,"type":156},"! We as the SensUs Organization have been working toward this Event the whole year and could not be more excited. Of course, you can make this day even better by joining our ",{"url":882,"type":236,"children":883},"https://digital.sensus.org/",[884],{"bold":79,"text":885,"type":156},"online SensUs Event 2021",{"bold":79,"text":887,"type":156},".",{"type":152,"children":889},[890],{"text":891,"type":156},"This year, the whole Event revolves around inventing a rapid, accurate, and creative biosensor to detect influenza in saliva. In the future, these biosensors can help overcome the next flu pandemic. The Teams have been very busy with this assignment and we are looking forward to seeing their results. On Friday the Teams will give pitches explaining their biosensor innovations.",{"type":152,"children":893},[894,896],{"text":895,"type":156},"Even though this year we are having an online edition, the Teams will be able to test their biosensor thanks to the Distributed Testing Event taking place Wednesday. The Teams will then test their biosensors at the labs at their own university. The best performing Teams will be rewarded with an award from one of the following categories: Analytical Performance, Creativity, Translation Potential and Public Inspiration. For the Public Inspiration award, you can cast your vote for the Team which inspires you the most: ",{"url":882,"type":236,"children":897},[898],{"text":882,"type":156},{"type":152,"children":900},[901,903,907],{"text":902,"type":156},"On Friday, it will get really interesting for all of you: a day filled with pitches of the Teams, an interesting Keynote lecture from Bart van Meerbergen, a festive award ceremony, and a connecting network drink. An elaborate Program Booklet of the Event can be found here: ",{"url":904,"type":236,"children":905},"https://www.sensus2021.com/",[906],{"text":904,"type":156},{"text":908,"type":156},". The Program Booklet provides you with information about the official program, influenza and the story behind SensUs 2021!",{"type":152,"children":910},[911],{"text":912,"type":156},"Make sure to join us Friday, support your favorite team and learn something new about biosensors for influenza! Hope to see you there!",{"type":152,"children":914},[915],{"bold":79,"text":916,"type":156},"Links:",{"type":152,"children":918},[919,921],{"text":920,"type":156,"italic":79},"Program Booklet of the SensUs Event: ",{"url":904,"type":236,"children":922},[923],{"text":904,"type":156,"italic":79},{"type":152,"children":925},[926,928],{"text":927,"type":156,"italic":79},"Follow the livestream and cast your vote here: ",{"url":882,"type":236,"children":929},[930],{"text":882,"type":156,"italic":79},"2026-07-28T11:13:42.991Z","2026-07-28T11:13:42.989Z",{"id":934,"documentId":935,"name":936,"alternativeText":18,"caption":18,"focalPoint":18,"width":937,"height":938,"formats":939,"hash":966,"ext":941,"mime":283,"size":967,"url":968,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":969,"updatedAt":969,"publishedAt":969},1157,"qou4ovkmbrk8xqxzgh802f1a","GES_3956.JPG",6016,4016,{"large":940,"small":948,"medium":954,"thumbnail":960},{"ext":941,"url":942,"hash":943,"mime":283,"name":944,"path":18,"size":945,"width":190,"height":946,"sizeInBytes":947},".JPG","/uploads/large_GES_3956_af2da00274.JPG","large_GES_3956_af2da00274","large_GES_3956.JPG",108.88,668,108875,{"ext":941,"url":949,"hash":950,"mime":283,"name":951,"path":18,"size":952,"width":198,"height":352,"sizeInBytes":953},"/uploads/small_GES_3956_af2da00274.JPG","small_GES_3956_af2da00274","small_GES_3956.JPG",36.71,36713,{"ext":941,"url":955,"hash":956,"mime":283,"name":957,"path":18,"size":958,"width":206,"height":359,"sizeInBytes":959},"/uploads/medium_GES_3956_af2da00274.JPG","medium_GES_3956_af2da00274","medium_GES_3956.JPG",70.07,70068,{"ext":941,"url":961,"hash":962,"mime":283,"name":963,"path":18,"size":964,"width":306,"height":214,"sizeInBytes":965},"/uploads/thumbnail_GES_3956_af2da00274.JPG","thumbnail_GES_3956_af2da00274","thumbnail_GES_3956.JPG",11.19,11193,"GES_3956_af2da00274",2425.78,"/uploads/GES_3956_af2da00274.JPG","2026-07-28T11:13:42.905Z",{"id":971,"documentId":972,"title":973,"slug":974,"date":975,"cardTitle":18,"excerpt":976,"body":977,"createdAt":1028,"updatedAt":1028,"publishedAt":1029,"cardImage":1030},259,"qg8uva4crs305jqniehwnhx7","Meet the Jury: dr. Marko Blom","meet-jury-dr-marko-blom","2021-08-11","Chair of the Translation Potential award: dr. Blom",[978,981,985,989,993,1004,1008,1012,1016,1020,1024],{"type":379,"level":4,"children":979},[980],{"text":973,"type":156},{"type":152,"children":982},[983],{"text":984,"type":156},"The SensUs Student Competition wouldn’t be complete without our very own Jury. The Jury looks at every biosensor, reads all the Team Result Documents, and assesses them on certain criteria. The jury of this year consists of 28 experts in the field of medical technologies.",{"type":152,"children":986},[987],{"text":988,"type":156},"The Teams have the possibility to win two jury-based awards: the Creativity and Translation Potential award. Today we introduce you to the chair of the Translation Potential award: dr. Marko Blom!",{"type":152,"children":990},[991],{"text":992,"type":156,"italic":79},"Why are you in contact with the SensUs Student Competition?",{"type":152,"children":994},[995,997,1002],{"text":996,"type":156},"As a company (",{"url":998,"type":236,"children":999},"https://www.micronit.com/",[1000],{"text":1001,"type":156},"Micronit BV",{"text":1003,"type":156},") active in the development and manufacturing of lab-on-a-chip devices, SensUs provides us with a perfect combination. First of all, it gives us an opportunity to meet with students, who are our future co-workers but also our future customers, and with other partners in the field. Secondly, we get a feel for the practical difficulties Teams are struggling with, but also for the inventive ideas they come up with.",{"type":152,"children":1005},[1006],{"text":1007,"type":156,"italic":79},"Why did you accept the invitation to be chair of the Creativity award this year?",{"type":152,"children":1009},[1010],{"text":1011,"type":156},"Being the chair of the Creativity jury is a nice bonus but the important element is the jury duty itself, being in a position to see the Team’s creative new concepts.",{"type":152,"children":1013},[1014],{"text":1015,"type":156,"italic":79},"What does the Creativity award mean?",{"type":152,"children":1017},[1018],{"text":1019,"type":156},"For me, the Creativity award is not only about novelty and inventiveness, but also takes into account the applicability. This means finding the right balance between doing something new and showing or motivating that the solution can work well in practice.",{"type":152,"children":1021},[1022],{"text":1023,"type":156,"italic":79},"In your earlier years as a Jury member, what is the most interesting or fun thing you remember?",{"type":152,"children":1025},[1026],{"text":1027,"type":156},"In earlier years, I clearly remember the buzz during the actual Testing Event, with all Teams rushing and improvising to get their measurements done. Also, the interaction during the meetings with the students, who showed a clear interest in the matter, was a motivating element for me and my colleagues running the workshop.","2026-07-28T11:13:43.780Z","2026-07-28T11:13:43.779Z",{"id":1031,"documentId":1032,"name":1033,"alternativeText":18,"caption":18,"focalPoint":18,"width":1034,"height":1035,"formats":1036,"hash":1061,"ext":280,"mime":283,"size":1062,"url":1063,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":1064,"updatedAt":1064,"publishedAt":1064},1160,"e9qgtehtxf72pkwxtigerd7b","Marko_Blom_0.jpg",8256,5504,{"large":1037,"small":1043,"medium":1049,"thumbnail":1055},{"ext":280,"url":1038,"hash":1039,"mime":283,"name":1040,"path":18,"size":1041,"width":190,"height":345,"sizeInBytes":1042},"/uploads/large_Marko_Blom_0_c3d1c0652b.jpg","large_Marko_Blom_0_c3d1c0652b","large_Marko_Blom_0.jpg",57.71,57705,{"ext":280,"url":1044,"hash":1045,"mime":283,"name":1046,"path":18,"size":1047,"width":198,"height":293,"sizeInBytes":1048},"/uploads/small_Marko_Blom_0_c3d1c0652b.jpg","small_Marko_Blom_0_c3d1c0652b","small_Marko_Blom_0.jpg",20.35,20354,{"ext":280,"url":1050,"hash":1051,"mime":283,"name":1052,"path":18,"size":1053,"width":206,"height":198,"sizeInBytes":1054},"/uploads/medium_Marko_Blom_0_c3d1c0652b.jpg","medium_Marko_Blom_0_c3d1c0652b","medium_Marko_Blom_0.jpg",36.95,36947,{"ext":280,"url":1056,"hash":1057,"mime":283,"name":1058,"path":18,"size":1059,"width":306,"height":214,"sizeInBytes":1060},"/uploads/thumbnail_Marko_Blom_0_c3d1c0652b.jpg","thumbnail_Marko_Blom_0_c3d1c0652b","thumbnail_Marko_Blom_0.jpg",7.02,7019,"Marko_Blom_0_c3d1c0652b",4831.98,"/uploads/Marko_Blom_0_c3d1c0652b.jpg","2026-07-28T11:13:43.777Z",{"id":1066,"documentId":1067,"title":1068,"slug":1069,"date":1070,"cardTitle":1071,"excerpt":18,"body":1072,"createdAt":1081,"updatedAt":1081,"publishedAt":1082,"cardImage":1083},260,"oy4uarzoxgsc6jksoeulx795","Dr. Annelies Bobelyn - The chair of the Translation Potential award","dr-annelies-bobelyn-translation-potential-award","2021-08-05","Dr. Annelies Bobelyn - Translation Potential award",[1073,1077],{"type":152,"children":1074},[1075],{"bold":79,"text":1076,"type":156},"The SensUs Student Competition wouldn’t be complete without our very own jury. The jury looks at every biosensor, reads all the Team Result Documents, and assesses them on certain criteria. The jury of this year consists of 28 experts in the field of medical technologies.",{"type":152,"children":1078},[1079],{"bold":79,"text":1080,"type":156},"The Teams have the possibility to win two jury-based awards: the Creativity award and the Translation Potential award. Today we introduce you to the chair of the Translation Potential award: dr. Annelies Bobelyn!","2026-07-28T11:13:49.476Z","2026-07-28T11:13:49.474Z",{"id":1084,"documentId":1085,"name":1086,"alternativeText":18,"caption":18,"focalPoint":18,"width":398,"height":398,"formats":1087,"hash":1104,"ext":183,"mime":186,"size":425,"url":1105,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":1106,"updatedAt":1106,"publishedAt":1106},1162,"jabyrs1in46sgitpaennsxdl","Article_Annelies_Bobelyn.png",{"large":1088,"small":1092,"medium":1096,"thumbnail":1100},{"ext":183,"url":1089,"hash":1090,"mime":186,"name":1091,"path":18,"size":404,"width":190,"height":190,"sizeInBytes":405},"/uploads/large_Article_Annelies_Bobelyn_3eda69cc9f.png","large_Article_Annelies_Bobelyn_3eda69cc9f","large_Article_Annelies_Bobelyn.png",{"ext":183,"url":1093,"hash":1094,"mime":186,"name":1095,"path":18,"size":410,"width":198,"height":198,"sizeInBytes":411},"/uploads/small_Article_Annelies_Bobelyn_3eda69cc9f.png","small_Article_Annelies_Bobelyn_3eda69cc9f","small_Article_Annelies_Bobelyn.png",{"ext":183,"url":1097,"hash":1098,"mime":186,"name":1099,"path":18,"size":416,"width":206,"height":206,"sizeInBytes":417},"/uploads/medium_Article_Annelies_Bobelyn_3eda69cc9f.png","medium_Article_Annelies_Bobelyn_3eda69cc9f","medium_Article_Annelies_Bobelyn.png",{"ext":183,"url":1101,"hash":1102,"mime":186,"name":1103,"path":18,"size":422,"width":214,"height":214,"sizeInBytes":423},"/uploads/thumbnail_Article_Annelies_Bobelyn_3eda69cc9f.png","thumbnail_Article_Annelies_Bobelyn_3eda69cc9f","thumbnail_Article_Annelies_Bobelyn.png","Article_Annelies_Bobelyn_3eda69cc9f","/uploads/Article_Annelies_Bobelyn_3eda69cc9f.png","2026-07-28T11:13:49.471Z",{"id":1108,"documentId":1109,"title":1110,"slug":1111,"date":1112,"cardTitle":18,"excerpt":18,"body":1113,"createdAt":1158,"updatedAt":1158,"publishedAt":1159,"cardImage":1160},261,"beshlqp8hxmtz5x77z35x6h4","The need of rapid testing - dr. Annelies Riezebos-Brilman","need-rapid-testing-dr-annelies-riezebos-brilman","2021-06-30",[1114,1118,1122,1126,1130,1134,1138,1142,1146,1150,1154],{"type":152,"children":1115},[1116],{"text":1117,"type":156},"Many were caught by surprise when COVID-19 took over the world in record time. However, experts have been warning us of a situation like this for years. Shall we listen to them and prepare ourselves for the next pandemic? Influenza can be seen as a likely candidate to cause the next one. In this series of articles, we explore influenza and the possibility of it becoming the next pandemic by consulting experts from various fields.",{"type":152,"children":1119},[1120],{"text":1121,"type":156},"For this article, we interviewed Annelies Riezebos-Brilman, clinical microbiologist/virologist LabMicTA, in Hengelo, the Netherlands.",{"type":152,"children":1123},[1124],{"text":1125,"type":156,"italic":79},"How does your work relate to influenza?",{"type":152,"children":1127},[1128],{"text":1129,"type":156},"As a clinical microbiologist, I am responsible for the diagnostics, antimicrobial stewardship, and infection prevention of infectious diseases in patients. We perform diagnostics for general practitioners, nursing homes, hospitals, and intensive care. In case of influenza, this is mostly done by using PCR tests because it gives the most reliable result. If there would be a biosensor that could rapidly and accurately test influenza, that could be very interesting.",{"type":152,"children":1131},[1132],{"text":1133,"type":156,"italic":79},"Could influenza cause a huge pandemic like the COVID-19 pandemic?",{"type":152,"children":1135},[1136],{"text":1137,"type":156},"In theory, influenza can cause a pandemic of the same size as the current COVID-19 pandemic. Clinicians and scientists have actually always been very wary of this. The focus was always more on influenza viruses rather than coronaviruses, which is why we were surprised by the COVID-19 pandemic. Of course, there have already been some very serious influenza pandemics. Best known is the Spanish flu during the First World War, which resulted in many deaths.",{"type":152,"children":1139},[1140],{"text":1141,"type":156},"However, you can never be sure which virus will result in a pandemic. Viruses that are easily transferable between humans but do not immediately kill someone, could spread quickly and may form good candidates for a pandemic. Crucial for a pandemic is a newly formed virus, often with a reservoir in animals, that can be transferred to humans. In 2009, a new influenza virus, H1N2pdm09 caused a pandemic. Because this was a new virus created by reassortment, mainly in pigs, the immune system of humans did not recognize it. The lack of pre-existing immunity is what makes it dangerous since many people can become infected and subsequently become ill.",{"type":152,"children":1143},[1144],{"text":1145,"type":156,"italic":79},"Why could it be important to have rapid tests for influenza?",{"type":152,"children":1147},[1148],{"text":1149,"type":156},"This is important for two reasons: to be able to identify the virus and act accordingly. When you know you are infected, you can adjust your behavior, for example, by going in quarantine if necessary or get early treatment in case you are a patient within a high-risk group. In the case of a pandemic, rapid tests are crucial in keeping the spread of the virus under control in the community as well as inside institutions.",{"type":152,"children":1151},[1152],{"text":1153,"type":156,"italic":79},"How could we prevent a pandemic in the future?",{"type":152,"children":1155},[1156],{"text":1157,"type":156},"Pandemics happen, viruses have been on this earth longer than we have. The power we have is to recognize and contain the virus as quickly as possible. The sooner a virus is identified, the better we can prepare. We would need a test that can tell us if it is a virus we know or if it is a new one. Viruses we do not know yet could be the most dangerous ones.","2026-07-28T11:13:50.006Z","2026-07-28T11:13:50.004Z",{"id":1161,"documentId":1162,"name":1163,"alternativeText":18,"caption":18,"focalPoint":18,"width":1164,"height":1164,"formats":1165,"hash":1190,"ext":183,"mime":186,"size":1191,"url":1192,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":1193,"updatedAt":1193,"publishedAt":1193},1164,"cvua3tes2endmcjmb3dtbc9b","Annelies.png",1080,{"large":1166,"small":1172,"medium":1178,"thumbnail":1184},{"ext":183,"url":1167,"hash":1168,"mime":186,"name":1169,"path":18,"size":1170,"width":190,"height":190,"sizeInBytes":1171},"/uploads/large_Annelies_e54bc7480f.png","large_Annelies_e54bc7480f","large_Annelies.png",1049.28,1049281,{"ext":183,"url":1173,"hash":1174,"mime":186,"name":1175,"path":18,"size":1176,"width":198,"height":198,"sizeInBytes":1177},"/uploads/small_Annelies_e54bc7480f.png","small_Annelies_e54bc7480f","small_Annelies.png",307.2,307197,{"ext":183,"url":1179,"hash":1180,"mime":186,"name":1181,"path":18,"size":1182,"width":206,"height":206,"sizeInBytes":1183},"/uploads/medium_Annelies_e54bc7480f.png","medium_Annelies_e54bc7480f","medium_Annelies.png",635.49,635493,{"ext":183,"url":1185,"hash":1186,"mime":186,"name":1187,"path":18,"size":1188,"width":214,"height":214,"sizeInBytes":1189},"/uploads/thumbnail_Annelies_e54bc7480f.png","thumbnail_Annelies_e54bc7480f","thumbnail_Annelies.png",40.08,40081,"Annelies_e54bc7480f",296.66,"/uploads/Annelies_e54bc7480f.png","2026-07-28T11:13:50.002Z",{"id":1195,"documentId":1196,"title":1197,"slug":1198,"date":1112,"cardTitle":18,"excerpt":1199,"body":1200,"createdAt":1247,"updatedAt":1247,"publishedAt":1248,"cardImage":1249},262,"pcuopmyin6wy4b0sm814bktc","The impact of plant viruses on human health - dr. Richard Kormelink","impact-plant-viruses-human-health-dr-richard-kormelink","Shared features of human and plant viruses",[1201,1204,1208,1211,1215,1219,1223,1227,1231,1235,1239,1243],{"type":152,"children":1202},[1203],{"text":1117,"type":156},{"type":152,"children":1205},[1206],{"text":1207,"type":156},"In this article, we talk with dr. Richard Kormelink, a virologist specialized in plant viruses from Wageningen University and Research.",{"type":152,"children":1209},[1210],{"text":1125,"type":156,"italic":79},{"type":152,"children":1212},[1213],{"text":1214,"type":156},"I am a virologist with a keen interest in fundamental processes. Although my primary targets of investigation involve plant viruses, the model virus we are studying is from a family of viruses that primarily infect animals and humans. In other words, these viruses, irrespective of whether infecting plants or animals as a host, share many features. This may sound somewhat confusing, but if you look more into the biology of animals and plants many fundamental processes do not differ that much between these species. On this point, I am quite interested in how these viruses, ending up infecting different hosts, evolved from one common ancestor. But it is clear that being embedded in one family, being so much alike, many of the host cellular processes these viruses rely on are likely the same. One of the questions I am investigating is how our plant virus initiates the transcription of its own RNA genome into messenger molecules that are translated into viral proteins. This initiation process is a highly conserved process and very unique for a certain group of viruses to which also influenza belongs. Typical for this process is that the virus steals the “letter head” from host cellular messengers, to transform their own viral RNA molecules into messengers that can be recognized and translated by the host cell machinery into viral proteins.",{"type":152,"children":1216},[1217],{"text":1218,"type":156,"italic":79},"What will be your focus of your next research?",{"type":152,"children":1220},[1221],{"text":1222,"type":156},"During our studies on a plant virus, we discovered specific features that we hypothesized to be generic for all viruses that employ this “letter head” stealing. Among those is also the influenza virus. So our next step was to test our findings on the influenza virus. Those studies showed that the influenza virus seems to act exactly the same as our plant virus. Our aim is now to investigate whether we can exploit this knowledge into antiviral drug design concepts that interfere in this process of “letter head” stealing, not limited to influenza virus only, but also to other viruses that use this mechanism and for which no vaccines are available yet.",{"type":152,"children":1224},[1225],{"text":1226,"type":156,"italic":79},"What can we learn about viruses and pandemics from your research concerning viruses in plants, animals and humans?",{"type":152,"children":1228},[1229],{"text":1230,"type":156},"Viruses are amongst, against and with us. We know many of them by the diseases they cause, sometimes leading to epidemics or even pandemics. However, many viruses we also don’t know because they remain in a kind of stealth mode, sometimes even being beneficial to their host. Still, we know so little about them and their impact on evolution, and by studying all of them, not only the medically important ones, we may not only learn from them but also identify targets and ways to interfere in their multiplication. The studies on the process of “letter head” stealing present a beautiful example on how fundamental knowledge generated on a plant virus can even initiate and support translational research activities that aim to develop new antiviral strategies against animal or human viruses.",{"type":379,"level":380,"children":1232},[1233],{"text":1234,"type":156,"italic":79},"“We should not only focus on medically important viruses that affect humans: the impact of some plant viruses on human health is sometimes much bigger compared to human-infecting viruses”",{"type":152,"children":1236},[1237],{"text":1238,"type":156,"italic":79},"What is something you think our society should learn from the current pandemic to prepare for the next pandemic?",{"type":152,"children":1240},[1241],{"text":1242,"type":156},"Future pandemics will keep coming, and we cannot prevent that from happening, we can only better prepare. But we should not only focus on medically important viruses that affect humans: the impact of some plant viruses on human health is sometimes much bigger compared to human-infecting viruses. A major cause of famine in developing countries is often caused by enormous crop losses resulting from plant diseases, in which nearly 50% of all newly emerging plant diseases involve viruses.",{"type":152,"children":1244},[1245],{"text":1246,"type":156},"Considering the likeliness of future pandemics involving viruses, and the huge financial investments now going into research on COVID-19, the international community should make efforts to strive towards more joint collaborative efforts and investments to tackle future pandemics.","2026-07-28T11:13:50.520Z","2026-07-28T11:13:50.519Z",{"id":1250,"documentId":1251,"name":1252,"alternativeText":18,"caption":18,"focalPoint":18,"width":1253,"height":1254,"formats":1255,"hash":1281,"ext":280,"mime":283,"size":1282,"url":1283,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":1284,"updatedAt":1284,"publishedAt":1284},1166,"puswgd5g74m36otbatjjao1f","cdc-rHCNMH9Vlmw-unsplash.jpg",2760,2070,{"large":1256,"small":1262,"medium":1268,"thumbnail":1274},{"ext":280,"url":1257,"hash":1258,"mime":283,"name":1259,"path":18,"size":1260,"width":190,"height":206,"sizeInBytes":1261},"/uploads/large_cdc_r_HCNMH_9_Vlmw_unsplash_d7158a0fc7.jpg","large_cdc_r_HCNMH_9_Vlmw_unsplash_d7158a0fc7","large_cdc-rHCNMH9Vlmw-unsplash.jpg",89.6,89599,{"ext":280,"url":1263,"hash":1264,"mime":283,"name":1265,"path":18,"size":1266,"width":198,"height":654,"sizeInBytes":1267},"/uploads/small_cdc_r_HCNMH_9_Vlmw_unsplash_d7158a0fc7.jpg","small_cdc_r_HCNMH_9_Vlmw_unsplash_d7158a0fc7","small_cdc-rHCNMH9Vlmw-unsplash.jpg",26.52,26522,{"ext":280,"url":1269,"hash":1270,"mime":283,"name":1271,"path":18,"size":1272,"width":206,"height":661,"sizeInBytes":1273},"/uploads/medium_cdc_r_HCNMH_9_Vlmw_unsplash_d7158a0fc7.jpg","medium_cdc_r_HCNMH_9_Vlmw_unsplash_d7158a0fc7","medium_cdc-rHCNMH9Vlmw-unsplash.jpg",52.77,52770,{"ext":280,"url":1275,"hash":1276,"mime":283,"name":1277,"path":18,"size":1278,"width":1279,"height":214,"sizeInBytes":1280},"/uploads/thumbnail_cdc_r_HCNMH_9_Vlmw_unsplash_d7158a0fc7.jpg","thumbnail_cdc_r_HCNMH_9_Vlmw_unsplash_d7158a0fc7","thumbnail_cdc-rHCNMH9Vlmw-unsplash.jpg",7.12,209,7120,"cdc_r_HCNMH_9_Vlmw_unsplash_d7158a0fc7",1042.11,"/uploads/cdc_r_HCNMH_9_Vlmw_unsplash_d7158a0fc7.jpg","2026-07-28T11:13:50.517Z",{"id":1286,"documentId":1287,"title":1288,"slug":1289,"date":1290,"cardTitle":18,"excerpt":18,"body":1291,"createdAt":1296,"updatedAt":1296,"publishedAt":1297,"cardImage":1298},263,"r151pg85youkuho82svbc8jq","SensUs | Newsletter June","sensus-newsletter-june-0","2021-06-19",[1292],{"type":152,"children":1293},[1294],{"text":1295,"type":156},"The SensUs Event is getting closer and closer and the SensUs Organization is working hard to organize the hybrid Event.","2026-07-28T11:13:51.204Z","2026-07-28T11:13:51.199Z",{"id":1299,"documentId":1300,"name":1301,"alternativeText":18,"caption":18,"focalPoint":18,"width":1302,"height":1303,"formats":1304,"hash":1330,"ext":280,"mime":283,"size":313,"url":1331,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":1332,"updatedAt":1332,"publishedAt":1332},1168,"w3nuk93kr9bzu1zf947neo26","header_image.jpg",2047,1356,{"large":1305,"small":1312,"medium":1318,"thumbnail":1324},{"ext":280,"url":1306,"hash":1307,"mime":283,"name":1308,"path":18,"size":1309,"width":190,"height":1310,"sizeInBytes":1311},"/uploads/large_header_image_6a7e4d1d05.jpg","large_header_image_6a7e4d1d05","large_header_image.jpg",75.95,662,75954,{"ext":280,"url":1313,"hash":1314,"mime":283,"name":1315,"path":18,"size":1316,"width":198,"height":603,"sizeInBytes":1317},"/uploads/small_header_image_6a7e4d1d05.jpg","small_header_image_6a7e4d1d05","small_header_image.jpg",26.71,26711,{"ext":280,"url":1319,"hash":1320,"mime":283,"name":1321,"path":18,"size":1322,"width":206,"height":610,"sizeInBytes":1323},"/uploads/medium_header_image_6a7e4d1d05.jpg","medium_header_image_6a7e4d1d05","medium_header_image.jpg",49.2,49200,{"ext":280,"url":1325,"hash":1326,"mime":283,"name":1327,"path":18,"size":1328,"width":617,"height":214,"sizeInBytes":1329},"/uploads/thumbnail_header_image_6a7e4d1d05.jpg","thumbnail_header_image_6a7e4d1d05","thumbnail_header_image.jpg",8.56,8557,"header_image_6a7e4d1d05","/uploads/header_image_6a7e4d1d05.jpg","2026-07-28T11:13:50.629Z",{"id":1334,"documentId":1335,"title":1336,"slug":1337,"date":1338,"cardTitle":1339,"excerpt":1340,"body":1341,"createdAt":1349,"updatedAt":1349,"publishedAt":1350,"cardImage":1351},264,"vzhk9v65ylg8lq1ummmry4jr","Subscribe now for the Venture Building Program of 2021","venture-building-program","2021-06-14","Venture Building Program","The subscriptions are open right now!",[1342],{"type":152,"children":1343},[1344],{"url":1345,"type":236,"children":1346},"https://docs.google.com/forms/d/e/1FAIpQLSeTluQBLBGGSckUiq9yomZti4kM_eV_CA8vqK4wmVkIDqNcnA/viewform",[1347],{"text":1348,"type":156},"Register here","2026-07-28T11:13:53.964Z","2026-07-28T11:13:53.962Z",{"id":1352,"documentId":1353,"name":1354,"alternativeText":18,"caption":18,"focalPoint":18,"width":1355,"height":1356,"formats":1357,"hash":1385,"ext":183,"mime":186,"size":1386,"url":1387,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":1388,"updatedAt":1388,"publishedAt":1388},1173,"yawyrm30ljyv2s1w8lpfm7wp","VBP_brochure_2.3_short_version.png",9921,4671,{"large":1358,"small":1365,"medium":1371,"thumbnail":1378},{"ext":183,"url":1359,"hash":1360,"mime":186,"name":1361,"path":18,"size":1362,"width":190,"height":1363,"sizeInBytes":1364},"/uploads/large_VBP_brochure_2_3_short_version_415bee5bba.png","large_VBP_brochure_2_3_short_version_415bee5bba","large_VBP_brochure_2.3_short_version.png",323.1,471,323097,{"ext":183,"url":1366,"hash":1367,"mime":186,"name":1368,"path":18,"size":1369,"width":198,"height":617,"sizeInBytes":1370},"/uploads/small_VBP_brochure_2_3_short_version_415bee5bba.png","small_VBP_brochure_2_3_short_version_415bee5bba","small_VBP_brochure_2.3_short_version.png",115.48,115477,{"ext":183,"url":1372,"hash":1373,"mime":186,"name":1374,"path":18,"size":1375,"width":206,"height":1376,"sizeInBytes":1377},"/uploads/medium_VBP_brochure_2_3_short_version_415bee5bba.png","medium_VBP_brochure_2_3_short_version_415bee5bba","medium_VBP_brochure_2.3_short_version.png",211.21,353,211207,{"ext":183,"url":1379,"hash":1380,"mime":186,"name":1381,"path":18,"size":1382,"width":144,"height":1383,"sizeInBytes":1384},"/uploads/thumbnail_VBP_brochure_2_3_short_version_415bee5bba.png","thumbnail_VBP_brochure_2_3_short_version_415bee5bba","thumbnail_VBP_brochure_2.3_short_version.png",39.69,115,39694,"VBP_brochure_2_3_short_version_415bee5bba",3280.42,"/uploads/VBP_brochure_2_3_short_version_415bee5bba.png","2026-07-28T11:13:53.369Z",{"id":1390,"documentId":1391,"title":1392,"slug":1393,"date":1394,"cardTitle":1395,"excerpt":18,"body":1396,"createdAt":1401,"updatedAt":1401,"publishedAt":1402,"cardImage":1403},265,"sq72bjipf7frl6v8mojbyqek","A Studium Generale Lecture with Anja Schreijer","how-contain-next-pandemic","2021-06-12","How to contain the Next Pandemic",[1397],{"type":152,"children":1398},[1399],{"text":1400,"type":156},"After good consideration of who could be an interesting speaker about the danger of viruses for a Studium Generale lecture, we came up with Anja Schreijer and we could not have made a better choice! Dr. Anja Schreijer, part of the Outbreak Management Team and Head of Infectious Disease Control at the GGD in Amsterdam has given us a very interesting and exceptional lecture about virus outbreaks.","2026-07-28T11:13:55.967Z","2026-07-28T11:13:55.964Z",{"id":1404,"documentId":1405,"name":1406,"alternativeText":18,"caption":18,"focalPoint":18,"width":1407,"height":1407,"formats":1408,"hash":1433,"ext":183,"mime":186,"size":1434,"url":1435,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":1436,"updatedAt":1436,"publishedAt":1436},1176,"m2qb3erevec256asbhujlzl5","Design_Anja_Schreijer_V2.png",1500,{"large":1409,"small":1415,"medium":1421,"thumbnail":1427},{"ext":183,"url":1410,"hash":1411,"mime":186,"name":1412,"path":18,"size":1413,"width":190,"height":190,"sizeInBytes":1414},"/uploads/large_Design_Anja_Schreijer_V2_070cfdc180.png","large_Design_Anja_Schreijer_V2_070cfdc180","large_Design_Anja_Schreijer_V2.png",1955.64,1955643,{"ext":183,"url":1416,"hash":1417,"mime":186,"name":1418,"path":18,"size":1419,"width":198,"height":198,"sizeInBytes":1420},"/uploads/small_Design_Anja_Schreijer_V2_070cfdc180.png","small_Design_Anja_Schreijer_V2_070cfdc180","small_Design_Anja_Schreijer_V2.png",541.43,541432,{"ext":183,"url":1422,"hash":1423,"mime":186,"name":1424,"path":18,"size":1425,"width":206,"height":206,"sizeInBytes":1426},"/uploads/medium_Design_Anja_Schreijer_V2_070cfdc180.png","medium_Design_Anja_Schreijer_V2_070cfdc180","medium_Design_Anja_Schreijer_V2.png",1134.9,1134895,{"ext":183,"url":1428,"hash":1429,"mime":186,"name":1430,"path":18,"size":1431,"width":214,"height":214,"sizeInBytes":1432},"/uploads/thumbnail_Design_Anja_Schreijer_V2_070cfdc180.png","thumbnail_Design_Anja_Schreijer_V2_070cfdc180","thumbnail_Design_Anja_Schreijer_V2.png",63.78,63775,"Design_Anja_Schreijer_V2_070cfdc180",743.04,"/uploads/Design_Anja_Schreijer_V2_070cfdc180.png","2026-07-28T11:13:55.519Z",{"id":1438,"documentId":1439,"title":1440,"slug":1441,"date":1442,"cardTitle":18,"excerpt":18,"body":1443,"createdAt":1481,"updatedAt":1481,"publishedAt":1482,"cardImage":1483},266,"ev2gmn4uls711l6tkyh41rl8","Influenza: the next pandemic? Janette Ramahat-Langendoen","influenza-next-pandemic-janette-ramahat-langendoen","2021-05-02",[1444,1447,1451,1454,1458,1462,1466,1470,1474,1477],{"type":152,"children":1445},[1446],{"text":1117,"type":156},{"type":152,"children":1448},[1449],{"text":1450,"type":156},"In this article, we talk with dr. Janette Ramahat-Langendoen, a microbiologist from the RadboudUMC in Nijmegen, the Netherlands.",{"type":379,"level":106,"children":1452},[1453],{"text":1125,"type":156,"italic":79},{"type":152,"children":1455},[1456],{"text":1457,"type":156},"Since October 2013, I've been working at the Radboud university medical center as a clinical microbiologist with a focus on virology. So the influenza virus is one of the more important parts of my job! Every year, when the influenza season is approaching, we prepare our laboratory to perform proper diagnostics, both timely and accurate. And of course, we anticipate more materials coming in from patients who are suspected of having an influenza virus infection. For the hospital I work at, the influenza season is a yearly returning substantial burden. Before the start of the epidemic, we had large vaccination campaigns for health care workers, to avoid infection in this very important group of employees. During an influenza epidemic, depending on the severity, a lot of patients will be admitted for whom enough hospital beds should be available. This is quite a task for us, as every patient suspected of or confirmed with the influenza virus infection should be placed in isolation: a one-person room, with personal protective equipment for health care workers who come in contact with the patient.",{"type":379,"level":106,"children":1459},[1460],{"text":1461,"type":156,"italic":79},"What do you think is the greatest risk of the influenza A virus?",{"type":152,"children":1463},[1464],{"text":1465,"type":156},"The biggest risk is the ability of influenza A virus to mutate. We have these yearly epidemics because of the relative ease of influenza virus to mutate into variants to which we have less immunity based on previous infections. Besides, the influenza virus is also very frequently found in animals, especially birds. Avian influenza virus strains can mingle with the human influenza virus, either via a so-called ‘mixing vessel’ (e.g. pigs) or, sporadically, directly from birds to humans. These animal influenza viruses are totally new for humans, no immunity exists, so a pandemic could occur. We have seen those influenza pandemics in the past, the most famous is of course the ‘Spanish flu’ in 1918, but we also experienced one rather recently (Mexican flu, 2009). So this is a real risk of these viruses.",{"type":379,"level":106,"children":1467},[1468],{"text":1469,"type":156,"italic":79},"What do you think of the initiative of SensUs to stimulate the development of rapid tests for influenza?",{"type":152,"children":1471},[1472],{"text":1473,"type":156},"I think it’s a very good initiative. In order to be able to act on the infection and transmission of the influenza A virus, either within patient care or infection control and public health, you need to diagnose the virus first. Not only in high-income countries with well-equipped laboratories but also in middle and low-income countries, where you have to deal with different circumstances. So in my opinion, developing a device that is easy to handle, gives an adequate result in a timely manner, and uses material that is easy to get from a patient is crucial.",{"type":379,"level":106,"children":1475},[1476],{"text":1238,"type":156,"italic":79},{"type":152,"children":1478},[1479],{"text":1480,"type":156},"The current pandemic shows us (again) that we are living in a small world, where the transmission of virus infections is facilitated by people able to travel around the world with relative ease. So to be prepared, we also need to take into account the situation in other parts of the world. It may seem far away and not of great concern for our way of living, but as we experience in this COVID pandemic, the world is our backyard. Preventing pathogens from jumping from animals to humans is a key factor. Additional efforts besides current ones will be necessary focusing on several important domains: from basic research into virus evolution and transmission patterns to contributing socio-economic factors in less fortunate countries around the world. Because in the end, prevention is far more important than reacting to the next pandemic.","2026-07-28T11:13:56.121Z","2026-07-28T11:13:56.120Z",{"id":1484,"documentId":1485,"name":1486,"alternativeText":18,"caption":18,"focalPoint":18,"width":1487,"height":1488,"formats":1489,"hash":1517,"ext":183,"mime":186,"size":1518,"url":1519,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":1520,"updatedAt":1520,"publishedAt":1521},1180,"x16gsc1rhom0b28qfieka2x4","Radboud_umc.png",2362,1562,{"large":1490,"small":1497,"medium":1503,"thumbnail":1510},{"ext":183,"url":1491,"hash":1492,"mime":186,"name":1493,"path":18,"size":1494,"width":190,"height":1495,"sizeInBytes":1496},"/uploads/large_Radboud_umc_fe3183a91f.png","large_Radboud_umc_fe3183a91f","large_Radboud_umc.png",112.18,661,112175,{"ext":183,"url":1498,"hash":1499,"mime":186,"name":1500,"path":18,"size":1501,"width":198,"height":603,"sizeInBytes":1502},"/uploads/small_Radboud_umc_fe3183a91f.png","small_Radboud_umc_fe3183a91f","small_Radboud_umc.png",34.63,34633,{"ext":183,"url":1504,"hash":1505,"mime":186,"name":1506,"path":18,"size":1507,"width":206,"height":1508,"sizeInBytes":1509},"/uploads/medium_Radboud_umc_fe3183a91f.png","medium_Radboud_umc_fe3183a91f","medium_Radboud_umc.png",67.81,496,67806,{"ext":183,"url":1511,"hash":1512,"mime":186,"name":1513,"path":18,"size":1514,"width":1515,"height":214,"sizeInBytes":1516},"/uploads/thumbnail_Radboud_umc_fe3183a91f.png","thumbnail_Radboud_umc_fe3183a91f","thumbnail_Radboud_umc.png",9.6,236,9600,"Radboud_umc_fe3183a91f",463.17,"/uploads/Radboud_umc_fe3183a91f.png","2026-07-28T11:13:56.118Z","2026-07-28T11:13:56.119Z",{"id":1523,"documentId":1524,"title":1525,"slug":1526,"date":1527,"cardTitle":18,"excerpt":18,"body":1528,"createdAt":1537,"updatedAt":1537,"publishedAt":1538,"cardImage":1539},267,"tawcut0th8wc6p2aaijk8rfk","SensUs | Newsletter March","sensus-newsletter-march","2021-03-01",[1529,1533],{"type":152,"children":1530},[1531],{"text":1532,"type":156},"Now that spring has arrived in the Netherlands, the sun is shining brighter than ever before! The SensUs Organization is very motivated and continuously working to arrange an unforgettable SensUs Event for all!",{"type":152,"children":1534},[1535],{"text":1536,"type":156},"The Innovation Days of SensUs 2021 will take place from the 30th of August until the 3rd of September. On the last day of this week, the official SensUs Event will take place where the 15 participating Teams present their biosensors to the world!","2026-07-28T11:13:56.728Z","2026-07-28T11:13:56.724Z",{"id":1540,"documentId":1541,"name":1542,"alternativeText":18,"caption":18,"focalPoint":18,"width":1543,"height":595,"formats":1544,"hash":1559,"ext":183,"mime":186,"size":1560,"url":1561,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":1562,"updatedAt":1562,"publishedAt":1562},1182,"cwc4oaoz7hujq8xgpxagnusl","Newsletter_March_2.png",710,{"small":1545,"thumbnail":1552},{"ext":183,"url":1546,"hash":1547,"mime":186,"name":1548,"path":18,"size":1549,"width":198,"height":1550,"sizeInBytes":1551},"/uploads/small_Newsletter_March_2_c2fd61fc64.png","small_Newsletter_March_2_c2fd61fc64","small_Newsletter_March_2.png",239.69,415,239688,{"ext":183,"url":1553,"hash":1554,"mime":186,"name":1555,"path":18,"size":1556,"width":1557,"height":214,"sizeInBytes":1558},"/uploads/thumbnail_Newsletter_March_2_c2fd61fc64.png","thumbnail_Newsletter_March_2_c2fd61fc64","thumbnail_Newsletter_March_2.png",44.81,188,44809,"Newsletter_March_2_c2fd61fc64",112.43,"/uploads/Newsletter_March_2_c2fd61fc64.png","2026-07-28T11:13:56.482Z",{"id":1564,"documentId":1565,"title":730,"slug":1566,"date":1567,"cardTitle":18,"excerpt":18,"body":1568,"createdAt":1577,"updatedAt":1577,"publishedAt":1578,"cardImage":1579},268,"bhmvyuo06umsyr9hycwfhzwo","sensus-newsletter-december-1","2020-12-17",[1569,1573],{"type":152,"children":1570},[1571],{"bold":79,"text":1572,"type":156},"4 months into the new SensUs year, the SensUs Organization is done wrapping up SensUs 2020 and all focus is on SensUs 2021. Curious about what the SensUs 2021 Organization is up to right now? Check out the SensUs Instagram, where our 5 Departments take you on a one week journey.",{"type":152,"children":1574},[1575],{"bold":79,"text":1576,"type":156},"SensUs 2021 will take place from the 30th of August till the 3rd of September. On the last day of this week, the official Event will take place where the 15 participating Teams present their biosensor to the world.","2026-07-28T11:13:57.529Z","2026-07-28T11:13:57.526Z",{"id":1580,"documentId":1581,"name":1582,"alternativeText":18,"caption":18,"focalPoint":18,"width":934,"height":1583,"formats":1584,"hash":1613,"ext":598,"mime":283,"size":1614,"url":1615,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":1616,"updatedAt":1616,"publishedAt":1616},1188,"upy6jb8hg9kr3gdz2194xutz","WhatsApp_Image_2020-12-14_at_18.24.11_V2.jpeg",647,{"large":1585,"small":1592,"medium":1599,"thumbnail":1606},{"ext":598,"url":1586,"hash":1587,"mime":283,"name":1588,"path":18,"size":1589,"width":190,"height":1590,"sizeInBytes":1591},"/uploads/large_Whats_App_Image_2020_12_14_at_18_24_11_V2_eb119dec6f.jpeg","large_Whats_App_Image_2020_12_14_at_18_24_11_V2_eb119dec6f","large_WhatsApp_Image_2020-12-14_at_18.24.11_V2.jpeg",109.12,559,109116,{"ext":598,"url":1593,"hash":1594,"mime":283,"name":1595,"path":18,"size":1596,"width":198,"height":1597,"sizeInBytes":1598},"/uploads/small_Whats_App_Image_2020_12_14_at_18_24_11_V2_eb119dec6f.jpeg","small_Whats_App_Image_2020_12_14_at_18_24_11_V2_eb119dec6f","small_WhatsApp_Image_2020-12-14_at_18.24.11_V2.jpeg",39.02,280,39017,{"ext":598,"url":1600,"hash":1601,"mime":283,"name":1602,"path":18,"size":1603,"width":206,"height":1604,"sizeInBytes":1605},"/uploads/medium_Whats_App_Image_2020_12_14_at_18_24_11_V2_eb119dec6f.jpeg","medium_Whats_App_Image_2020_12_14_at_18_24_11_V2_eb119dec6f","medium_WhatsApp_Image_2020-12-14_at_18.24.11_V2.jpeg",71.75,419,71747,{"ext":598,"url":1607,"hash":1608,"mime":283,"name":1609,"path":18,"size":1610,"width":144,"height":1611,"sizeInBytes":1612},"/uploads/thumbnail_Whats_App_Image_2020_12_14_at_18_24_11_V2_eb119dec6f.jpeg","thumbnail_Whats_App_Image_2020_12_14_at_18_24_11_V2_eb119dec6f","thumbnail_WhatsApp_Image_2020-12-14_at_18.24.11_V2.jpeg",12.66,137,12663,"Whats_App_Image_2020_12_14_at_18_24_11_V2_eb119dec6f",137.43,"/uploads/Whats_App_Image_2020_12_14_at_18_24_11_V2_eb119dec6f.jpeg","2026-07-28T11:13:56.794Z",{"id":1618,"documentId":1619,"title":1620,"slug":1621,"date":1622,"cardTitle":18,"excerpt":1623,"body":1624,"createdAt":1637,"updatedAt":1637,"publishedAt":1638,"cardImage":1639},269,"ol0mrjqi5m8o3x60zjlul2y8","Influenza - the theme of SensUs 2021","influenza","2020-12-12","Learn more about the theme of 2021",[1625,1629,1633],{"type":152,"children":1626},[1627],{"bold":79,"text":1628,"type":156},"Pandemics: Corona and influenza",{"type":152,"children":1630},[1631],{"text":1632,"type":156},"The corona virus pandemic of 2020 caught the world off guard. Millions of people worldwide have got infected by this virus and it has a significant impact on society. However, this is not the first respiratory pandemic the world has seen. The influenza virus has caused four major pandemics over the last 100 years. Starting with the H1N1 Spanish flu in 1918, which resulted in approximately 40-50 million deaths. After that, the H2N2 Asian flu caused around 2 million deaths in 1957 and the H3N2 Hong Kong flu was the reason for at least 500 thousand deaths between 1968 and 1970. The most recent influenza pandemic was in 2009, where the H1N1 swine flu caused up to 575 thousand deaths. [1]",{"type":152,"children":1634},[1635],{"text":1636,"type":156},"Even though there has not been an influenza pandemic since 2009, local epidemics of influenza cause 290,000 to 650,000 deaths each year according to the WHO [2].","2026-07-28T11:13:58.810Z","2026-07-28T11:13:58.807Z",{"id":1640,"documentId":1641,"name":1642,"alternativeText":18,"caption":18,"focalPoint":18,"width":1643,"height":1644,"formats":1645,"hash":1674,"ext":183,"mime":186,"size":1675,"url":1676,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":1677,"updatedAt":1677,"publishedAt":1678},1195,"xitzr8s6h2v8h3aq1vjou3bo","Influenza_article_banner_0.png",1024,780,{"large":1646,"small":1653,"medium":1660,"thumbnail":1667},{"ext":183,"url":1647,"hash":1648,"mime":186,"name":1649,"path":18,"size":1650,"width":190,"height":1651,"sizeInBytes":1652},"/uploads/large_Influenza_article_banner_0_06191d20b4.png","large_Influenza_article_banner_0_06191d20b4","large_Influenza_article_banner_0.png",1354.18,762,1354176,{"ext":183,"url":1654,"hash":1655,"mime":186,"name":1656,"path":18,"size":1657,"width":198,"height":1658,"sizeInBytes":1659},"/uploads/small_Influenza_article_banner_0_06191d20b4.png","small_Influenza_article_banner_0_06191d20b4","small_Influenza_article_banner_0.png",368.34,381,368343,{"ext":183,"url":1661,"hash":1662,"mime":186,"name":1663,"path":18,"size":1664,"width":206,"height":1665,"sizeInBytes":1666},"/uploads/medium_Influenza_article_banner_0_06191d20b4.png","medium_Influenza_article_banner_0_06191d20b4","medium_Influenza_article_banner_0.png",813.04,571,813036,{"ext":183,"url":1668,"hash":1669,"mime":186,"name":1670,"path":18,"size":1671,"width":1672,"height":214,"sizeInBytes":1673},"/uploads/thumbnail_Influenza_article_banner_0_06191d20b4.png","thumbnail_Influenza_article_banner_0_06191d20b4","thumbnail_Influenza_article_banner_0.png",70.13,205,70132,"Influenza_article_banner_0_06191d20b4",256.9,"/uploads/Influenza_article_banner_0_06191d20b4.png","2026-07-28T11:13:58.766Z","2026-07-28T11:13:58.767Z",{"id":1680,"documentId":1681,"title":1682,"slug":1683,"date":1684,"cardTitle":18,"excerpt":18,"body":1685,"createdAt":1722,"updatedAt":1722,"publishedAt":1722,"cardImage":1723},270,"pbec1izoxjjm1rmudkw8c29a","Meet the Chairs of SensUs 2021","meet-chairs-sensus-2021","2020-11-14",[1686,1690,1694,1698,1702,1706,1710,1714,1718],{"type":152,"children":1687},[1688],{"bold":79,"text":1689,"type":156,"italic":79},"A new year of SensUs means a new SensUs Organization. The SensUs Organization 2021 is up and running and currently busy organizing the SensUs Competition 2021 with all its initiatives to create an even closer network in the field of biosensing. Another year also means a new duo of Chairs for the Organization. This year, Iris Schilthuis and Remco Aalsbersberg have taken up this challenge.",{"type":152,"children":1691},[1692],{"text":1693,"type":156},"Both chairs are currently bachelor students in Biomedical Engineering. Their interest in SensUs is not only because of its mission of innovating the development of sensors for health, but also because of the possibility SensUs has given them to grow personally and as a team with the rest of the Organization.",{"type":152,"children":1695},[1696],{"text":1697,"type":156,"italic":79},"“Stimulating the innovation of biosensors in a friendly competitive way is still the goal, even in changing times.” ~ Iris",{"type":152,"children":1699},[1700],{"text":1701,"type":156},"The mission and vision of SensUs are the most important guide in these changing times. Being mostly online takes its toll on the Organization, but Iris and Remco have faith in the motivation of all Organization members. This is because everyone is still working towards the SensUs Event with the same mission in the back of their heads: stimulating the innovation of biosensors. The Event has different scenarios, based on the number of regulations from the governments in each of the participating countries. No one knows exactly what they are working towards and this uncertainty makes it difficult to organize and plan far ahead. However, even being online for most of the time is not a limitation, according to Iris and Remco, it is a challenge; SensUs always has been about innovation and accepting new challenges to work on.",{"type":152,"children":1703},[1704],{"text":1705,"type":156},"Adapting is one of the strong suits of the new duo. Iris and Remco describe their role as chairs as keeping the overview of the Organization and doing a constant risk analysis: What can go wrong, what can we do to prevent it, and when do we take action? This risk analysis is based fully on their own Department meetings as a Chairs&Co, together with the secretary, treasurer and HR-manager, and all the meetings they have with the Department chairs, who update them on their progress of the 4 other Departments (Events, External Relations, Public Relations, and Technology). The goal of these meetings is to see where the Departments stand and where collaborations can be formed between Departments so that everything goes smoothly. This team spirit approach also improves the motivation of all members.",{"type":152,"children":1707},[1708],{"text":1709,"type":156},"When asked about their hope for SensUs 2021, the answer is a direct one. Thinking so far ahead is difficult within this pandemic and so they don’t actually know. Iris and Remco take inspiration from the 2019 and 2020 Events. They strive towards a similar spirit as the one achieved during those Events. The weeks working towards the SensUs Event 2020 were not only inspiring but also a lot of fun. Even with all the measurements against the novel coronavirus and the stress of organizing, all members were constantly working together and having a very good time. Looking back at 2019, Iris mentions that she really enjoyed being in close contact with the Teams, and hearing their SensUs experiences. She and Remco both agree that they hope to hear a lot from the competing Teams this year.",{"type":152,"children":1711},[1712],{"text":1713,"type":156,"italic":79},"“We are still just a student-run competition, with mostly bachelor students. It is quite inspiring!” ~ Remco",{"type":152,"children":1715},[1716],{"text":1717,"type":156},"Next to their ambitions for the SensUs Event 2021, Remco and Iris were both drawn to SensUs because of the potential for personal growth. Personal growth is important for all members. One thing they both love about the Organization is its willingness to help others grow and develop new skills. Iris wants to improve her conversation skills. Furthermore, due to her previous year at SensUs, her presentation skills have already improved because of the support and feedback of other members. Remco’s goal is to learn how to be a good leader of a team, a leader who can keep a good overview. He believes that you need feedback from the people you work with to improve your skills.",{"type":152,"children":1719},[1720],{"text":1721,"type":156},"Overall, Iris and Remco are both very motivated to be the Chairs of the SensUs Organization 2021. They mostly want to emphasize that all of SensUs is a team effort. Their role is to keep an overview and help all members with their problems or challenges on the way. They support the personal growth of members by giving feedback and they highly value the feedback they receive themselves as well. The team effort is what makes the SensUs Organization special and the Chairs are not the only ones that deserve the spotlight. So keep our social media in the loop, because the other Departments will present themselves too in the following months!","2026-07-28T11:13:58.873Z",{"id":1724,"documentId":1725,"name":1726,"alternativeText":18,"caption":18,"focalPoint":18,"width":1643,"height":1644,"formats":1727,"hash":1752,"ext":280,"mime":283,"size":1753,"url":1754,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":1755,"updatedAt":1755,"publishedAt":1755},1198,"csvziks5a1hwv1u2y38a0m9h","Chairs_article_6.jpg",{"large":1728,"small":1734,"medium":1740,"thumbnail":1746},{"ext":280,"url":1729,"hash":1730,"mime":283,"name":1731,"path":18,"size":1732,"width":190,"height":1651,"sizeInBytes":1733},"/uploads/large_Chairs_article_6_55031e0998.jpg","large_Chairs_article_6_55031e0998","large_Chairs_article_6.jpg",75.71,75707,{"ext":280,"url":1735,"hash":1736,"mime":283,"name":1737,"path":18,"size":1738,"width":198,"height":1658,"sizeInBytes":1739},"/uploads/small_Chairs_article_6_55031e0998.jpg","small_Chairs_article_6_55031e0998","small_Chairs_article_6.jpg",26.13,26128,{"ext":280,"url":1741,"hash":1742,"mime":283,"name":1743,"path":18,"size":1744,"width":206,"height":1665,"sizeInBytes":1745},"/uploads/medium_Chairs_article_6_55031e0998.jpg","medium_Chairs_article_6_55031e0998","medium_Chairs_article_6.jpg",48.79,48787,{"ext":280,"url":1747,"hash":1748,"mime":283,"name":1749,"path":18,"size":1750,"width":1672,"height":214,"sizeInBytes":1751},"/uploads/thumbnail_Chairs_article_6_55031e0998.jpg","thumbnail_Chairs_article_6_55031e0998","thumbnail_Chairs_article_6.jpg",6.62,6622,"Chairs_article_6_55031e0998",79.64,"/uploads/Chairs_article_6_55031e0998.jpg","2026-07-28T11:13:58.871Z",{"id":1757,"documentId":1758,"title":1759,"slug":1760,"date":1761,"cardTitle":18,"excerpt":18,"body":1762,"createdAt":1879,"updatedAt":1879,"publishedAt":1880,"cardImage":1881},271,"xv7n8r24fvdaupgjay2gu743","SensUs Newsletter September","sensus-newsletter-september-3","2020-10-02",[1763,1767,1771,1775,1779,1783,1829,1833,1844,1848,1856,1860],{"type":379,"level":380,"children":1764},[1765],{"text":1766,"type":156},"SensUs 2020",{"type":152,"children":1768},[1769],{"text":1770,"type":156},"With 8,000 people voting and 15,000 website- and live stream users from all over the world, the SensUs Organization 2020 is proud to announce that the first online SensUs Event has been a success.",{"type":152,"children":1772},[1773],{"text":1774,"type":156},"The switch to a fully digital event required a lot of adjustments so that the 15 participating Teams with 150 students were able to present their innovative conceptual biosensors to the experts and the public. Every year, SensUs challenges international Teams to create an innovative biosensor for a socially impactful disease. The challenge of SensUs 2020 is to develop biosensors for measuring an anti-epileptic drug in order to control epileptic seizures.",{"type":152,"children":1776},[1777],{"text":1778,"type":156},"Due to COVID-19, this year’s Event was organized in a fully digital manner. Nevertheless, visitors from all over the world were able to join the Event from home and contribute by voting for their favorite Teams. The Teams demonstrated their biosensors and pitches through Microsoft Teams. Accordingly, they were judged by an international, multidisciplinary jury, on Translation Potential (the probability that the concepts will make it into society) and Creativity (the novelty of approach and used techniques). A third award was given to the Team that received the most votes and appreciation from the public: the Public Inspiration Award.",{"type":152,"children":1780},[1781],{"bold":79,"text":1782,"type":156},"The awards",{"type":152,"children":1784},[1785,1787,1792,1794,1799,1801,1806,1808,1813,1815,1820,1822,1827],{"text":1786,"type":156},"With a nerve-racking photo finish, ",{"url":1788,"type":236,"children":1789},"https://old.sensus.org/2020/teams/China",[1790],{"text":1791,"type":156},"Trusense",{"text":1793,"type":156}," from Zhejiang University China won the Public Inspiration award 2020. With only 14 votes removed from the winning Team, ",{"url":1795,"type":236,"children":1796},"https://old.sensus.org/2020/teams/Egypt",[1797],{"text":1798,"type":156},"AUsense",{"text":1800,"type":156}," (Egypt) is the well-deserved runner-up. Team ",{"url":1802,"type":236,"children":1803},"https://old.sensus.org/2020/teams/Belgium",[1804],{"text":1805,"type":156},"EpiSense",{"text":1807,"type":156}," (Belgium) won the Translation Potential award. Team ",{"url":1809,"type":236,"children":1810},"https://old.sensus.org/2020/teams/Portugal",[1811],{"text":1812,"type":156},"LxUs",{"text":1814,"type":156}," from Portugal became runner-up in this category. Furthermore, Team ",{"url":1816,"type":236,"children":1817},"https://old.sensus.org/2020/teams/Netherlands",[1818],{"text":1819,"type":156},"T.E.S.T.",{"text":1821,"type":156}," from Eindhoven received first place in the Creativity award and ",{"url":1823,"type":236,"children":1824},"https://old.sensus.org/2020/teams/Sweden",[1825],{"text":1826,"type":156},"UppSense",{"text":1828,"type":156}," (Sweden) was the proud number two.",{"type":152,"children":1830},[1831],{"text":1832,"type":156},"To give the Teams and Partners of SensUs 2020 an opportunity to meet, network, and learn, an online Meet the Partners Event was organized. Each participating Partner prepared a case study for the students to learn about the challenges their company faces. Afterwards, the network drink was a perfect way to discuss the case studies and learn more about the Partners.",{"type":152,"children":1834},[1835,1837,1839,1841,1842],{"text":1836,"type":156},"A whole new concept this year is the ",{"text":1838,"type":156,"italic":79},"express ",{"text":1840,"type":156},"Venture Building Program (VBP) powered by HighTechXL. This week-long program on how to build a start-up was filled with online workshops, feedback sessions, and contact with biomedical experts. The participants were all very positive about this first edition of the ",{"text":1838,"type":156,"italic":79},{"text":1843,"type":156},"VBP and presented their ideas to our Partners and Teams during the Meet the Partners Event!",{"type":379,"level":380,"children":1845},[1846],{"text":1847,"type":156},"SensUs 2021",{"type":152,"children":1849},[1850,1852,1854],{"text":1851,"type":156},"Now we are preparing for SensUs 2021 where we will focus on viral pandemics. The challenge of the international teams will be to develop biosensors for the rapid ",{"bold":79,"text":1853,"type":156},"measurement of influenza virus in saliva",{"text":1855,"type":156},". SensUs 2021 will take place from August 30 until September 3.",{"type":152,"children":1857},[1858],{"text":1859,"type":156},"Thanks to all universities, partners, healthcare professionals, and the public from all over the world for making SensUs 2020 a success, and we look forward to seeing you in SensUs 2021!",{"type":152,"children":1861},[1862,1864,1868,1870,1875],{"text":1863,"type":156},"Photos of the SensUs Event 2020 can be found via the following ",{"url":1865,"type":236,"children":1866},"https://www.flickr.com/photos/158504404@N02/albums/72157716111965988/with/50381851578/",[1867],{"text":236,"type":156},{"text":1869,"type":156}," and the summary of the live stream can be found via this ",{"url":1871,"type":236,"children":1872},"https://www.youtube.com/watch?v=65GrV8VPjsM&t=6s",[1873],{"text":1874,"type":156},"l",{"url":1871,"type":236,"children":1876},[1877],{"text":1878,"type":156},"ink","2026-07-28T11:13:58.992Z","2026-07-28T11:13:58.990Z",{"id":497,"documentId":1882,"name":1883,"alternativeText":18,"caption":18,"focalPoint":18,"width":1302,"height":1303,"formats":1884,"hash":1909,"ext":280,"mime":283,"size":1910,"url":1911,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":1912,"updatedAt":1912,"publishedAt":1912},"wfnglsiqow23xteaj30v2rsv","50382586511_cc772e16a0_k.jpg",{"large":1885,"small":1891,"medium":1897,"thumbnail":1903},{"ext":280,"url":1886,"hash":1887,"mime":283,"name":1888,"path":18,"size":1889,"width":190,"height":1310,"sizeInBytes":1890},"/uploads/large_50382586511_cc772e16a0_k_4a674895b0.jpg","large_50382586511_cc772e16a0_k_4a674895b0","large_50382586511_cc772e16a0_k.jpg",83.96,83964,{"ext":280,"url":1892,"hash":1893,"mime":283,"name":1894,"path":18,"size":1895,"width":198,"height":603,"sizeInBytes":1896},"/uploads/small_50382586511_cc772e16a0_k_4a674895b0.jpg","small_50382586511_cc772e16a0_k_4a674895b0","small_50382586511_cc772e16a0_k.jpg",28.07,28072,{"ext":280,"url":1898,"hash":1899,"mime":283,"name":1900,"path":18,"size":1901,"width":206,"height":610,"sizeInBytes":1902},"/uploads/medium_50382586511_cc772e16a0_k_4a674895b0.jpg","medium_50382586511_cc772e16a0_k_4a674895b0","medium_50382586511_cc772e16a0_k.jpg",52.82,52820,{"ext":280,"url":1904,"hash":1905,"mime":283,"name":1906,"path":18,"size":1907,"width":617,"height":214,"sizeInBytes":1908},"/uploads/thumbnail_50382586511_cc772e16a0_k_4a674895b0.jpg","thumbnail_50382586511_cc772e16a0_k_4a674895b0","thumbnail_50382586511_cc772e16a0_k.jpg",8.72,8718,"50382586511_cc772e16a0_k_4a674895b0",303.42,"/uploads/50382586511_cc772e16a0_k_4a674895b0.jpg","2026-07-28T11:13:58.988Z",{"id":1914,"documentId":1915,"title":1916,"slug":1917,"date":1918,"cardTitle":18,"excerpt":1919,"body":1920,"createdAt":1945,"updatedAt":1945,"publishedAt":1946,"cardImage":1947},272,"ozk9wm4tupt3qm8beyqp74hh","SensUs interviews Else","sensus-interviews-else","2020-09-15","Read about how Else deals with epilepsy",[1921,1925,1929,1933,1937,1941],{"type":152,"children":1922},[1923],{"bold":79,"text":1924,"type":156},"‘Measuring with ease to manage epileptic disease’ is the theme of SensUs 2020. SensUs 2020 challenges Teams to develop biosensors for the detection of valproate, an important drug for patients with epilepsy. We spoke with Else about her experiences with this disease.",{"type":152,"children":1926},[1927],{"text":1928,"type":156},"My name is Else, I’m 55 years old. I was officially diagnosed with epilepsy when I was in my twenties. However, before my diagnosis, I passed out multiple times. Nevertheless, the doctor said that it was common for my age category and that I should not worry too much. Therefore, I didn't expect to get the diagnosis. It had always happened when I was alone. When I was 18, it was the first time another person saw me during a seizure and they noticed directly that it was not the same thing as fainting. A few years later, when I was at work at the general practice, I had an epileptic seizure and my colleagues recognized it as epilepsy. On the EEG was no activity visible, so a clear diagnosis stayed out.",{"type":152,"children":1930},[1931],{"text":1932,"type":156},"I have not had an epileptic seizure in the last 21 years, which is quite special. I am still using anti-epileptics and I’m afraid to quit. I am afraid because, after a seizure, you are not allowed to drive for a certain time or go on a flight, and I do not want to risk not being able to do those activities. Driving my car represents my freedom and my self-reliance, I need my car to go to work or to visit my family up in the north.",{"type":152,"children":1934},[1935],{"text":1936,"type":156},"Having children has always been a dream for me, despite the restrictions my disease imposes on my body. I am a proud mother of two sons. Unfortunately, they have both inherited the disease. I have been using valproate, depakine, for 35 years now. I detest the medicine, one of the biggest side-effects of valproate is that it can slow down metabolism which makes you gain weight. Other known side-effects are declining sight, declining memory capacity, anemia, and hair loss. It is also not known what the long term effects are after taking this medicine for years in a row. These were the main reasons I definitely did not want my sons to use the same medication, even if the doctor would advise valproate. I consider myself an experiential expert, that’s what you are a mom for, protecting your children. I do not want my kids to experience what I have endured.",{"type":152,"children":1938},[1939],{"text":1940,"type":156},"It has taken me 15 years to find the right treatment, so I am not keen to switch to another form of medication or another method. This also includes alternative treatment with electrical shocks etc. A biosensor to measure the dose of medicine is not my biggest need, I am past that phase. There are many new developments in the healthcare sector. For me personally, I would prefer an easy method to measure iron deficiency. Like a glucose meter can measure glucose levels, I would like to be able to better monitor my anemia. Another thing that could be improved is the administration of medication. It is really important to take your medication consistently and on time, however, I tend to forget my medicines sometimes. My son is younger and is all over the place with his medication. A system that could do this automatically, would take it off your mind to constantly having to remember to take your pills.",{"type":152,"children":1942},[1943],{"text":1944,"type":156},"What I think is a problem with epilepsy is the stigma. People do not understand what is happening during a seizure and think it is weird or crazy. People tend to associate the disease with mental defects. Recently, I had a situation when the light was bothering me. Since the light could trigger my epilepsy, I asked to dim the light. People thought I was joking and did not react well. I hope this international competition will make young people more familiar with the disease and reduce its stigma.","2026-07-28T11:13:59.155Z","2026-07-28T11:13:59.154Z",{"id":1948,"documentId":1949,"name":1950,"alternativeText":18,"caption":18,"focalPoint":18,"width":190,"height":190,"formats":1951,"hash":1970,"ext":183,"mime":186,"size":1971,"url":1972,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":1973,"updatedAt":1973,"publishedAt":1973},1202,"hwmr9q5lnforkiop40ao5ipw","Interview_Else_V2.png",{"small":1952,"medium":1958,"thumbnail":1964},{"ext":183,"url":1953,"hash":1954,"mime":186,"name":1955,"path":18,"size":1956,"width":198,"height":198,"sizeInBytes":1957},"/uploads/small_Interview_Else_V2_eb6e3cbbba.png","small_Interview_Else_V2_eb6e3cbbba","small_Interview_Else_V2.png",236.57,236568,{"ext":183,"url":1959,"hash":1960,"mime":186,"name":1961,"path":18,"size":1962,"width":206,"height":206,"sizeInBytes":1963},"/uploads/medium_Interview_Else_V2_eb6e3cbbba.png","medium_Interview_Else_V2_eb6e3cbbba","medium_Interview_Else_V2.png",528.27,528273,{"ext":183,"url":1965,"hash":1966,"mime":186,"name":1967,"path":18,"size":1968,"width":214,"height":214,"sizeInBytes":1969},"/uploads/thumbnail_Interview_Else_V2_eb6e3cbbba.png","thumbnail_Interview_Else_V2_eb6e3cbbba","thumbnail_Interview_Else_V2.png",35.34,35344,"Interview_Else_V2_eb6e3cbbba",165.46,"/uploads/Interview_Else_V2_eb6e3cbbba.png","2026-07-28T11:13:59.152Z",{"id":1975,"documentId":1976,"title":1977,"slug":1978,"date":1979,"cardTitle":18,"excerpt":18,"body":1980,"createdAt":2037,"updatedAt":2037,"publishedAt":2038,"cardImage":2039},273,"vs1ene5u1o4b99ixlrm5hxnq","SensUs interview: Erwin","sensus-interview-erwin","2020-08-24",[1981,1985,1993,1997,2001,2005,2009,2013,2017,2021,2025,2029,2033],{"type":152,"children":1982},[1983],{"bold":79,"text":1984,"type":156},"Can you tell something about yourself and about your daily activities?",{"type":152,"children":1986},[1987,1989,1991],{"text":1988,"type":156},"My name is Erwin Lont and I’m 25 years old. Currently, I am working in green landscaping",{"text":1990,"type":156,"italic":79},". ",{"text":1992,"type":156},"Furthermore, I really enjoy sports and hanging out with friends. In my youth, I experienced a substantial amount of epileptic seizures. Because of the high number, I sometimes did not notice them anymore. One time I got a seizure while I was driving; luckily someone was sitting next to me and was able to help me out. Now, I take medicine and have a more regular sleeping pattern, which helps to suppress epileptic seizures.",{"type":152,"children":1994},[1995],{"bold":79,"text":1996,"type":156},"How did you find out that you had epilepsy?",{"type":152,"children":1998},[1999],{"text":2000,"type":156},"In the year 2009, I got a brain infection that put me in a coma for a week. During the coma, I started having seizures, and the doctors quickly stated that I had epilepsy. From that moment on, I am using anti-epileptic medication. My medication pattern is adapted depending on the seriousness and amount of epileptic seizures.",{"type":152,"children":2002},[2003],{"bold":79,"text":2004,"type":156},"Can you tell something about epilepsy and how it affects you as a person?",{"type":152,"children":2006},[2007],{"text":2008,"type":156},"The best way to describe an epileptic attack is that it starts as a strange feeling which rises up inside your body. Physical work, long days, and an irregular sleeping pattern are not beneficial, because these worsen my epilepsy. I can do most daily activities, but for example sports like soccer and tennis are not possible, due to my epilepsy and my left leg that is paralyzed. These are things that I will never recover from. Soccer is too intensive for me and I would risk getting an epileptic attack. The sports I still can do are fitness and mountain biking.",{"type":152,"children":2010},[2011],{"bold":79,"text":2012,"type":156},"What does a normal day look like for you?",{"type":152,"children":2014},[2015],{"text":2016,"type":156},"Because I am not allowed to drive myself, my parents have to bring me to work. In general, I find my workdays really exhausting, and I usually spend my weekends watching sports, gaming, and going out with friends.",{"type":152,"children":2018},[2019],{"bold":79,"text":2020,"type":156},"The SensUs competition works with the medicine Valproate. Are you familiar with this medicine?",{"type":152,"children":2022},[2023],{"text":2024,"type":156},"No, I use different medications. My medication causes me to be tired very easily and it decreases my concentration and vocabulary. Recently, I had surgery in my brain and since then, it has gotten a little bit better. During the operation, they removed scar tissue, which may or may not help with my epilepsy. This is something I will find out later. For now, it is too early to say.",{"type":152,"children":2026},[2027],{"bold":79,"text":2028,"type":156},"The theme of SensUs 2020 is: “Measuring epilepsy with ease to manage epileptic disease”. What do you think of this theme?",{"type":152,"children":2030},[2031],{"text":2032,"type":156},"I think it is very good that the focus of this year’s theme is epilepsy. Epilepsy is underestimated because it is an invisible disease that many people suffer from. We face difficulties every day and are very limited in our daily life. It is good that people are doing research on it because it can help so many people. I sometimes participate in experiments myself, because I like to help with finding new solutions to treat epilepsy.",{"type":152,"children":2034},[2035],{"text":2036,"type":156},"For the future, it would be really helpful if there would be a way to predict epilepsy seizures, so I could be prepared.","2026-07-28T11:13:59.268Z","2026-07-28T11:13:59.267Z",{"id":2040,"documentId":2041,"name":2042,"alternativeText":18,"caption":18,"focalPoint":18,"width":2043,"height":2044,"formats":2045,"hash":2067,"ext":280,"mime":283,"size":2068,"url":2069,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":2070,"updatedAt":2070,"publishedAt":2070},1204,"mbfrdd259jph6mfvk39domse","article_erwin.jpg",783,610,{"small":2046,"medium":2053,"thumbnail":2060},{"ext":280,"url":2047,"hash":2048,"mime":283,"name":2049,"path":18,"size":2050,"width":198,"height":2051,"sizeInBytes":2052},"/uploads/small_article_erwin_8471fbc2bb.jpg","small_article_erwin_8471fbc2bb","small_article_erwin.jpg",45.04,390,45036,{"ext":280,"url":2054,"hash":2055,"mime":283,"name":2056,"path":18,"size":2057,"width":206,"height":2058,"sizeInBytes":2059},"/uploads/medium_article_erwin_8471fbc2bb.jpg","medium_article_erwin_8471fbc2bb","medium_article_erwin.jpg",84.62,584,84623,{"ext":280,"url":2061,"hash":2062,"mime":283,"name":2063,"path":18,"size":2064,"width":2065,"height":214,"sizeInBytes":2066},"/uploads/thumbnail_article_erwin_8471fbc2bb.jpg","thumbnail_article_erwin_8471fbc2bb","thumbnail_article_erwin.jpg",9.34,200,9341,"article_erwin_8471fbc2bb",90.61,"/uploads/article_erwin_8471fbc2bb.jpg","2026-07-28T11:13:59.266Z",{"id":2072,"documentId":2073,"title":2074,"slug":2075,"date":2076,"cardTitle":2077,"excerpt":2074,"body":2078,"createdAt":2110,"updatedAt":2110,"publishedAt":2111,"cardImage":2112},274,"arz3hq7z7tj17ejbxdjssghl","SensUs interviews: Prof. Dr. Alain van Gool","sensus-interviews-prof-dr-alain-van-gool","2020-08-21","SensUs interviews Prof. Dr. Alain van Gool",[2079,2083,2087,2091,2095,2099,2103],{"type":379,"level":106,"children":2080},[2081],{"text":2082,"type":156},"We’d like to give you a sneak peek into the talk of our keynote speaker Alain van Gool.",{"type":152,"children":2084},[2085],{"text":2086,"type":156},"This year’s keynote speaker of the SensUs Event is prof. dr. Alain van Gool from the Radboud University Medical Centre. He is a professor Personalized in Healthcare and the head of the Translational Metabolic Laboratory, with a strong passion for the application of biomarkers in translational medicine and personalized healthcare.",{"type":152,"children":2088},[2089],{"text":2090,"type":156},"Prof. van Gool’s professional background is a mix of academia, pharmaceutical industry, applied research institutes and university medical centres. He has been leading technology-based biomarker laboratories, cross-functional expert teams, therapeutic project teams and public-private consortia, many of which were focused on the discovery, development and implementation of translational biomarkers in a variety of therapeutic areas. His technical expertise resides most strongly in molecular profiling, analytical biomarker development, and applications in translational scientific research.",{"type":152,"children":2092},[2093],{"text":2094,"type":156},"Prof. van Gool is a strong believer in open innovation networks and thrives to work with specialists to translate basic research to applied science which perfectly combines with the vision of SensUs. Recently, he published a comprehensive ‘Handbook of Biomarkers and Precision Medicine’ detailing many lessons-learned from translational biomarker experts in pharma and academia.",{"type":152,"children":2096},[2097],{"text":2098,"type":156},"Alain is positive about the current academic state of biomedical science:",{"type":152,"children":2100},[2101],{"text":2102,"type":156,"italic":79},"“We have reached a fantastic period in biomedical science. Exponential developments in molecular technologies such as next-generation sequencing and mass spectrometry have enabled us to obtain increasing insights into the molecular components of human biology and their interactions. Novel personalized diagnostics and high precision therapies that modulate selected disease mechanisms are now driving the new paradigm of precision medicine. The parallel strong developments in digital biomarker platforms like wearables and apps further drive the personalized aspect of health management, even towards prevention of un-health. To innovate to the next level, we need to be fully aware of the many lessons learned thus far and use these to translate novel molecular technologies to clinical practice.”",{"type":152,"children":2104},[2105,2107],{"text":2106,"type":156},"We are looking forward to the lecture of Alain, his expertise and enthusiasm are evident. Tune in on the 28th to join his lecture about the usage of biosensors for personalized healthcare via ",{"url":882,"type":236,"children":2108},[2109],{"text":882,"type":156},"2026-07-28T11:13:59.370Z","2026-07-28T11:13:59.369Z",{"id":2113,"documentId":2114,"name":2115,"alternativeText":18,"caption":18,"focalPoint":18,"width":2116,"height":2117,"formats":2118,"hash":2147,"ext":280,"mime":283,"size":2148,"url":2149,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":2150,"updatedAt":2150,"publishedAt":2150},1206,"r4047w0s4ormrxe8q2zjz9fa","Alain_van_Gool_0.jpg",2104,1263,{"large":2119,"small":2126,"medium":2133,"thumbnail":2140},{"ext":280,"url":2120,"hash":2121,"mime":283,"name":2122,"path":18,"size":2123,"width":190,"height":2124,"sizeInBytes":2125},"/uploads/large_Alain_van_Gool_0_6a6ce822e2.jpg","large_Alain_van_Gool_0_6a6ce822e2","large_Alain_van_Gool_0.jpg",52.62,600,52615,{"ext":280,"url":2127,"hash":2128,"mime":283,"name":2129,"path":18,"size":2130,"width":198,"height":2131,"sizeInBytes":2132},"/uploads/small_Alain_van_Gool_0_6a6ce822e2.jpg","small_Alain_van_Gool_0_6a6ce822e2","small_Alain_van_Gool_0.jpg",15.58,300,15582,{"ext":280,"url":2134,"hash":2135,"mime":283,"name":2136,"path":18,"size":2137,"width":206,"height":2138,"sizeInBytes":2139},"/uploads/medium_Alain_van_Gool_0_6a6ce822e2.jpg","medium_Alain_van_Gool_0_6a6ce822e2","medium_Alain_van_Gool_0.jpg",31.89,450,31892,{"ext":280,"url":2141,"hash":2142,"mime":283,"name":2143,"path":18,"size":2144,"width":144,"height":2145,"sizeInBytes":2146},"/uploads/thumbnail_Alain_van_Gool_0_6a6ce822e2.jpg","thumbnail_Alain_van_Gool_0_6a6ce822e2","thumbnail_Alain_van_Gool_0.jpg",5.08,147,5077,"Alain_van_Gool_0_6a6ce822e2",191.74,"/uploads/Alain_van_Gool_0_6a6ce822e2.jpg","2026-07-28T11:13:59.367Z",{"id":2152,"documentId":2153,"title":2154,"slug":2155,"date":2156,"cardTitle":18,"excerpt":18,"body":2157,"createdAt":2214,"updatedAt":2214,"publishedAt":2215,"cardImage":2216},275,"lnrar7r273s58uw0xpsmfauf","SensUs interview: Het Epilepsiefonds","sensus-interview-het-epilepsiefonds-1","2020-08-20",[2158,2162,2166,2170,2174,2178,2182,2186,2190,2194,2198,2202,2206,2210],{"type":152,"children":2159},[2160],{"text":2161,"type":156},"The Dutch Epilepsy Foundation (‘Het Epilepsiefonds’) helps patients by financing scientific research and promoting educational activities. They are a partner of SensUs and we spoke with them about their activities, vision, and goals.",{"type":152,"children":2163},[2164],{"bold":79,"text":2165,"type":156},"What is Het Epilepsiefonds and what are your main goals?",{"type":152,"children":2167},[2168],{"text":2169,"type":156},"Het Epilepsiefonds is an organization for everyone who is involved with epilepsy. Our dream is to create solutions for an epilepsy free world. We aim to create ways to control epilepsy and improve the lives of patients. In order to reach this, we financially support research, we promote the interests of people with epilepsy, provide information, and support other educational activities.",{"type":152,"children":2171},[2172],{"text":2173,"type":156},"The majority of our pursuits are focussed on people with epilepsy. We organize adapted trips that enable patients with epilepsy to travel and enjoy normal holidays. We also bring people together who are coping with a similar situation, for example, via the epilepsy café, a physical meeting place where people with epilepsy can meet and have a drink together.",{"type":152,"children":2175},[2176],{"bold":79,"text":2177,"type":156},"How do you view the SensUs Student Competition?",{"type":152,"children":2179},[2180],{"text":2181,"type":156},"We are excited that so many students from all over the world are focusing on this theme! We hope that the ideas generated in this Competition can provide better solutions to control or prevent epileptic attacks. In addition, we hope that this Competition could be an eye-opener for people to improve the understanding of how difficult life with epilepsy can be, and to show the importance of additional research into this disease.",{"type":152,"children":2183},[2184],{"bold":79,"text":2185,"type":156},"What are the most important changes in the treatment of epilepsy that will occur in the upcoming years?",{"type":152,"children":2187},[2188],{"text":2189,"type":156},"Treatment options for patients with epilepsy are rapidly expanding. This trend also holds for patients with refractory epilepsy, who have ongoing seizures without response to traditional medication. Several new neuromodulation and surgical techniques are being introduced. Furthermore, genetic testing can yield more and more possibilities to finetune treatments to the individual patient, to further enhance personalized care.",{"type":152,"children":2191},[2192],{"bold":79,"text":2193,"type":156},"This year, SensUs challenges students from all over the world to develop biosensors that can measure an anti-epileptic drug. How do you think these sensors can help patients with epilepsy?",{"type":152,"children":2195},[2196],{"text":2197,"type":156},"Sensors can be imagined to monitor treatment (blood levels) as well as brain activity. This can help patients to adapt rapidly to the situation and perhaps prevent imminent seizures.",{"type":152,"children":2199},[2200],{"bold":79,"text":2201,"type":156},"In what way do treatments of epilepsy differ around the world?",{"type":152,"children":2203},[2204],{"text":2205,"type":156},"Treatments around the world mainly differ based on available resources. Not all medication types are available everywhere, not all surgical techniques are available everywhere, and so on. This is one of the global challenges the world is facing: the distribution of resources, also concerning treatment.",{"type":152,"children":2207},[2208],{"bold":79,"text":2209,"type":156},"Finally, what is your advice for the participating Teams?",{"type":152,"children":2211},[2212],{"text":2213,"type":156},"No idea is too crazy, how crazy that may sound. Support each other in this Competition because the more knowledge we can spread, the greater the impact that can be made! Do not forget to enjoy this amazing experience.","2026-07-28T11:13:59.510Z","2026-07-28T11:13:59.509Z",{"id":2217,"documentId":2218,"name":2219,"alternativeText":18,"caption":18,"focalPoint":18,"width":2220,"height":1543,"formats":2221,"hash":2243,"ext":183,"mime":186,"size":2244,"url":2245,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":2246,"updatedAt":2246,"publishedAt":2246},1208,"fet1k6v9htamysw649t198f7","Epilepsy_Fonds_1.png",790,{"small":2222,"medium":2229,"thumbnail":2236},{"ext":183,"url":2223,"hash":2224,"mime":186,"name":2225,"path":18,"size":2226,"width":198,"height":2227,"sizeInBytes":2228},"/uploads/small_Epilepsy_Fonds_1_2a701122f7.png","small_Epilepsy_Fonds_1_2a701122f7","small_Epilepsy_Fonds_1.png",41.67,449,41667,{"ext":183,"url":2230,"hash":2231,"mime":186,"name":2232,"path":18,"size":2233,"width":206,"height":2234,"sizeInBytes":2235},"/uploads/medium_Epilepsy_Fonds_1_2a701122f7.png","medium_Epilepsy_Fonds_1_2a701122f7","medium_Epilepsy_Fonds_1.png",77.28,674,77276,{"ext":183,"url":2237,"hash":2238,"mime":186,"name":2239,"path":18,"size":2240,"width":2241,"height":214,"sizeInBytes":2242},"/uploads/thumbnail_Epilepsy_Fonds_1_2a701122f7.png","thumbnail_Epilepsy_Fonds_1_2a701122f7","thumbnail_Epilepsy_Fonds_1.png",9.07,174,9070,"Epilepsy_Fonds_1_2a701122f7",22.14,"/uploads/Epilepsy_Fonds_1_2a701122f7.png","2026-07-28T11:13:59.508Z",{"id":2248,"documentId":2249,"title":2250,"slug":2251,"date":2252,"cardTitle":2253,"excerpt":2250,"body":2254,"createdAt":2273,"updatedAt":2273,"publishedAt":2274,"cardImage":2275},276,"hddg8oirq3amv1ldtmnm6xxx","SensUs newsletter August","sensus-newsletter-august","2020-08-18","SensUs Newsletter August",[2255,2259,2269],{"type":379,"level":106,"children":2256},[2257],{"text":2258,"type":156},"The Digital Event",{"type":152,"children":2260},[2261,2263,2267],{"text":2262,"type":156},"Due to COVID-19, the SensUs Event of 2020 is going to be held online instead of a physical Event in Eindhoven. The SensUs Organization is currently working hard on providing you with the best possible experience during the Digital Event on Friday, 28th of August. The Teams and Partners are going to be invited to join the Event through Microsoft Teams, with multiple channels for the Creativity and Translational Potential pitches of the Teams. The whole Event will be live-streamed on YouTube for the whole world to see. The links can be found on the SensUs Digital website: ",{"url":882,"type":236,"children":2264},[2265],{"text":2266,"type":156},"digital.sensus.org",{"text":2268,"type":156},". Within the SensUs Digital website, you can also vote for your favorite Team.",{"type":152,"children":2270},[2271],{"text":2272,"type":156},"We hope to see you all at the SensUs Event!","2026-07-28T11:13:59.933Z","2026-07-28T11:13:59.929Z",{"id":2276,"documentId":2277,"name":2278,"alternativeText":18,"caption":18,"focalPoint":18,"width":2279,"height":2280,"formats":2281,"hash":2307,"ext":280,"mime":283,"size":2308,"url":2309,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":2310,"updatedAt":2310,"publishedAt":2310},1210,"lt4hqq6vy3dj8c1xxmpolt7t","Flyer_28_aug.jpg",3508,2480,{"large":2282,"small":2288,"medium":2294,"thumbnail":2300},{"ext":280,"url":2283,"hash":2284,"mime":283,"name":2285,"path":18,"size":2286,"width":190,"height":189,"sizeInBytes":2287},"/uploads/large_Flyer_28_aug_cff59ccd3e.jpg","large_Flyer_28_aug_cff59ccd3e","large_Flyer_28_aug.jpg",138.75,138750,{"ext":280,"url":2289,"hash":2290,"mime":283,"name":2291,"path":18,"size":2292,"width":198,"height":1376,"sizeInBytes":2293},"/uploads/small_Flyer_28_aug_cff59ccd3e.jpg","small_Flyer_28_aug_cff59ccd3e","small_Flyer_28_aug.jpg",42.01,42014,{"ext":280,"url":2295,"hash":2296,"mime":283,"name":2297,"path":18,"size":2298,"width":206,"height":205,"sizeInBytes":2299},"/uploads/medium_Flyer_28_aug_cff59ccd3e.jpg","medium_Flyer_28_aug_cff59ccd3e","medium_Flyer_28_aug.jpg",86.05,86048,{"ext":280,"url":2301,"hash":2302,"mime":283,"name":2303,"path":18,"size":2304,"width":2305,"height":214,"sizeInBytes":2306},"/uploads/thumbnail_Flyer_28_aug_cff59ccd3e.jpg","thumbnail_Flyer_28_aug_cff59ccd3e","thumbnail_Flyer_28_aug.jpg",9.91,220,9911,"Flyer_28_aug_cff59ccd3e",947.49,"/uploads/Flyer_28_aug_cff59ccd3e.jpg","2026-07-28T11:13:59.737Z",{"id":2312,"documentId":2313,"title":2314,"slug":2315,"date":2316,"cardTitle":18,"excerpt":18,"body":2317,"createdAt":2354,"updatedAt":2354,"publishedAt":2355,"cardImage":2356},277,"f0xov5vkxueb137e974245fe","Interview Marianne","interview-marianne","2020-08-16",[2318,2322,2330,2334,2338,2342,2346,2350],{"type":152,"children":2319},[2320],{"bold":79,"text":2321,"type":156},"SensUs 2020 challenges Teams to develop biosensors for the detection of valproate, an important drug in the treatment of patients with epilepsy. We spoke with Marianne about her experiences with epilepsy.",{"type":152,"children":2323},[2324,2326,2328],{"text":2325,"type":156},"When I was a child, I had a dizzy feeling in my head and it was very hard for me to concentrate. My mother, who also had epilepsy, decided to take me to a neurologist. The neurologist said that after 5 minutes of talking to me, she saw 20 absences, which resulted in a fast diagnosis: Epilepsy. Back in the days, there was very little knowledge about the disease. It was quite a taboo in society and people would think that you are stupid. Over the years, the knowledge of epilepsy has grown and I got two medicines. During my pregnancy and a year after, I did not have any attacks. However, it came back more intense. I started to get clonic attacks. When this happens, I am conscious but all my muscles contract at once. I call it ‘",{"text":2327,"type":156,"italic":79},"the ‘hell on earth",{"text":2329,"type":156},"’.",{"type":152,"children":2331},[2332],{"text":2333,"type":156},"As an epileptic patient, I cannot drive, go on high hikes, or go to a country where I do not speak the language. However, I try to live a normal life. For an epileptic patient, my hobbies and work are quite unusual: I am a swimming teacher for children who already have their first swimming diploma. It is important that the children already know the basics of swimming because when I have an epileptic attack, the children need to be able to swim on their own. Even though I enjoy doing my work, it comes with its own terms and conditions. For example, I need to be able to cancel a class at any time when I am not feeling well, I have to wear special swimming glasses so that I do not see light reflections from the water. I also like to swim indoors and outdoors but with a restriction. I will not go swimming in a river or a sea since this is too dangerous for me. Swimming is my passion and I do not want to give it up; it is not in my nature to sit around and do nothing all day.",{"type":152,"children":2335},[2336],{"text":2337,"type":156},"Living with epilepsy brings many restrictions. For example, when there is a large change in air pressure, I will notice this. When it is going to storm, it is also going to storm in my head. As a result, I will get a lot of absences. For me, absences mean that I miss parts of sentences. You can see this as trying to read a newspaper but in every sentence, a few words are missing. When this happens, it is very difficult to understand the text when you are reading something. I always try to find out where I got lost. This is quite demanding and it can be exhausting. For me, it differs how often I have these absences and how long they last. It can differ from 10 times to 100 times a day. Little absences happen very often, that nowadays it is normal for me.",{"type":152,"children":2339},[2340],{"text":2341,"type":156},"Over the years, I have had a lot of different medications. I have tried around 60% of all the antiepileptics that are currently available on the market. Most of them have side effects that influence your mood; you can become depressed. In the past, I have also used valproate, which worked but also caused many side effects for me. I got stomach problems for which I needed to take antacids and I needed a special diet. I eventually stopped with valproate due to these side effects. Another big side effect was the greater need for food, which eventually affects your self-image.",{"type":152,"children":2343},[2344],{"text":2345,"type":156},"For the future, I hope that the next generation of medicines will have fewer side effects and that the impact of switching between medication has less impact on your body. In addition, the availability of anti-epileptic medication in the Netherlands is unstable. Every three months it is unsure whether you will receive your medication.",{"type":152,"children":2347},[2348],{"text":2349,"type":156},"Neurologists talk about new treatments and a change from chemical treatment to deep brain stimulation. An example is a kind of shock therapy, where they put something in your brain that is going to deliver pulses. This is something that really scares me because I already have a lot of brain damage, so this does not seem appealing to me.",{"type":152,"children":2351},[2352],{"text":2353,"type":156},"I think that SensUs is an amazing initiative. SensUs informs a broad audience about the disease, which I find very important. Unfortunately, epilepsy cannot be cured, but I hope that new ways will be found to improve the lives of patients with epilepsy!","2026-07-28T11:14:00.057Z","2026-07-28T11:14:00.056Z",{"id":2357,"documentId":2358,"name":2359,"alternativeText":18,"caption":18,"focalPoint":18,"width":2220,"height":1543,"formats":2360,"hash":2378,"ext":183,"mime":186,"size":2379,"url":2380,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":2381,"updatedAt":2381,"publishedAt":2381},1215,"wwzofjk8uvwawtef3cb5vpp1","Interview_marianne.png",{"small":2361,"medium":2367,"thumbnail":2373},{"ext":183,"url":2362,"hash":2363,"mime":186,"name":2364,"path":18,"size":2365,"width":198,"height":2227,"sizeInBytes":2366},"/uploads/small_Interview_marianne_3b9a535f58.png","small_Interview_marianne_3b9a535f58","small_Interview_marianne.png",39.66,39656,{"ext":183,"url":2368,"hash":2369,"mime":186,"name":2370,"path":18,"size":2371,"width":206,"height":2234,"sizeInBytes":2372},"/uploads/medium_Interview_marianne_3b9a535f58.png","medium_Interview_marianne_3b9a535f58","medium_Interview_marianne.png",66.31,66313,{"ext":183,"url":2374,"hash":2375,"mime":186,"name":2376,"path":18,"size":768,"width":2241,"height":214,"sizeInBytes":2377},"/uploads/thumbnail_Interview_marianne_3b9a535f58.png","thumbnail_Interview_marianne_3b9a535f58","thumbnail_Interview_marianne.png",11560,"Interview_marianne_3b9a535f58",9.93,"/uploads/Interview_marianne_3b9a535f58.png","2026-07-28T11:14:00.054Z",{"id":2383,"documentId":2384,"title":2385,"slug":2386,"date":2387,"cardTitle":18,"excerpt":2385,"body":2388,"createdAt":2393,"updatedAt":2393,"publishedAt":2394,"cardImage":2395},278,"wi3d7ck9ot306ocew70d0lj8","New Members 2021","new-members-2021","2020-06-24",[2389],{"type":379,"level":380,"children":2390},[2391],{"bold":79,"text":2392,"type":156},"We are happy to introduce twenty new members that will continue the great work of SensUs in 2021!","2026-07-28T11:14:00.125Z","2026-07-28T11:14:00.123Z",{"id":2396,"documentId":2397,"name":2398,"alternativeText":18,"caption":18,"focalPoint":18,"width":2220,"height":1543,"formats":2399,"hash":2418,"ext":280,"mime":283,"size":2419,"url":2420,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":2421,"updatedAt":2421,"publishedAt":2421},1217,"hb0tjckni7ktt1tmypjj16df","Overview_image_website.jpg",{"small":2400,"medium":2406,"thumbnail":2412},{"ext":280,"url":2401,"hash":2402,"mime":283,"name":2403,"path":18,"size":2404,"width":198,"height":2227,"sizeInBytes":2405},"/uploads/small_Overview_image_website_ae477bdb9d.jpg","small_Overview_image_website_ae477bdb9d","small_Overview_image_website.jpg",39.89,39889,{"ext":280,"url":2407,"hash":2408,"mime":283,"name":2409,"path":18,"size":2410,"width":206,"height":2234,"sizeInBytes":2411},"/uploads/medium_Overview_image_website_ae477bdb9d.jpg","medium_Overview_image_website_ae477bdb9d","medium_Overview_image_website.jpg",71.33,71326,{"ext":280,"url":2413,"hash":2414,"mime":283,"name":2415,"path":18,"size":2416,"width":2241,"height":214,"sizeInBytes":2417},"/uploads/thumbnail_Overview_image_website_ae477bdb9d.jpg","thumbnail_Overview_image_website_ae477bdb9d","thumbnail_Overview_image_website.jpg",7.65,7651,"Overview_image_website_ae477bdb9d",73.14,"/uploads/Overview_image_website_ae477bdb9d.jpg","2026-07-28T11:14:00.122Z",{"id":2423,"documentId":2424,"title":2425,"slug":2426,"date":2427,"cardTitle":18,"excerpt":2425,"body":2428,"createdAt":2473,"updatedAt":2473,"publishedAt":2474,"cardImage":2475},279,"crgr3qoypvzu5ff4jjsgnbgs","SensUs interviews Dr Richard Lazeron","sensus-interviews-dr-richard-lazeron","2020-06-08",[2429,2433,2437,2441,2445,2449,2453,2457,2461,2465,2469],{"type":379,"level":111,"children":2430},[2431],{"text":2432,"type":156},"Dr Richard Lazeron is a neurologist and chief medical officer at Kempenhaeghe Epilepsy Center. His expertise in the field of neurology and his focus on epilepsy have been of great value for SensUs. He had an important role in the choice of the theme of SensUs 2020. SensUs spoke with him about his daily activities, his opinion about SensUs and the future of biosensing.",{"type":152,"children":2434},[2435],{"bold":79,"text":2436,"type":156},"Can you tell something about yourself and your job as a neurologist? What are your daily activities?",{"type":152,"children":2438},[2439],{"text":2440,"type":156},"I am a neurologist currently working at Kempenhaeghe, an epilepsy expertise center in the Netherlands. When seizures of a patient are not controlled, or the diagnosis is not clear, the patients are referred to our center. My fields of expertises are seizure detection, e-health and epilepsy, and psychogenic nonepileptic seizures. In my daily routine I see patients for diagnosis and treatment and I do scientific work. In addition I am a University Researcher at the Eindhoven University of Technology, in the department of Electrical Engineering.",{"type":152,"children":2442},[2443],{"bold":79,"text":2444,"type":156},"What do you think are the main challenges in the treatment of epilepsy? How do you think that the treatment of epilepsy patients will evolve in the future?",{"type":152,"children":2446},[2447],{"text":2448,"type":156},"The main challenge within the treatment of epilepsy is that there is no cure, however the disorder can be managed with medications and other strategies. Currently patients are treated with anti-epileptic drugs that aim to control seizures with minimal side effects. Epilepsy has many different causes and the mechanisms behind these causes are still unclear. I hope that in the future we will understand the mechanisms and will be able to tackle these causes.",{"type":152,"children":2450},[2451],{"bold":79,"text":2452,"type":156},"In SensUs 2020 students will develop biosensors for an anti-epileptic drug. Can you tell something about anti-epileptic drugs? What are the clinical problems?",{"type":152,"children":2454},[2455],{"text":2456,"type":156},"The challenge when treating patiënts with anti-epileptic drugs is to find the right drug and the right amount of medication. Sometimes the drug treatment gives major side effects, and it isn’t always possible to fully control and prevent seizures. When treating patients it is difficult to strike the right balance.",{"type":152,"children":2458},[2459],{"bold":79,"text":2460,"type":156},"How could biosensors for measuring anti-epileptic drugs be useful for doctors and patients?",{"type":152,"children":2462},[2463],{"text":2464,"type":156},"A biosensor can measure the medication level faster than standard methods. When patients are treated with epileptic drugs, it is always a challenge to find the right balance between seizure prevention and living without side effects. A biosensor could help to ensure that the patient has a correct and stable drug concentration in the blood, to achieve a low seizure probability and minimal side effects. SensUs is a nice initiative to boost the development of this kind of technology and make new things possible.",{"type":152,"children":2466},[2467],{"bold":79,"text":2468,"type":156},"Finally, do you have advice for the participating teams?",{"type":152,"children":2470},[2471],{"text":2472,"type":156},"It will be great if biosensors become available to easily measure the level of medication in a drop of blood. As a next question: How can the measurement data be combined with data from non-invasive sensors, e.g. sensors that monitor electrical signals from the patients? And could it be possible to measure drug levels without taking a drop of blood? I would love to see creative solutions in this area, to achieve the best possible monitoring of patients.","2026-07-28T11:14:00.184Z","2026-07-28T11:14:00.183Z",{"id":2476,"documentId":2477,"name":2478,"alternativeText":18,"caption":18,"focalPoint":18,"width":2220,"height":1543,"formats":2479,"hash":2498,"ext":280,"mime":283,"size":2499,"url":2500,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":2501,"updatedAt":2501,"publishedAt":2502},1219,"frgt3wzvcf8hsve3xodczmoe","lazaron.jpg",{"small":2480,"medium":2486,"thumbnail":2492},{"ext":280,"url":2481,"hash":2482,"mime":283,"name":2483,"path":18,"size":2484,"width":198,"height":2227,"sizeInBytes":2485},"/uploads/small_lazaron_b23106537d.jpg","small_lazaron_b23106537d","small_lazaron.jpg",16.99,16988,{"ext":280,"url":2487,"hash":2488,"mime":283,"name":2489,"path":18,"size":2490,"width":206,"height":2234,"sizeInBytes":2491},"/uploads/medium_lazaron_b23106537d.jpg","medium_lazaron_b23106537d","medium_lazaron.jpg",31.26,31261,{"ext":280,"url":2493,"hash":2494,"mime":283,"name":2495,"path":18,"size":2496,"width":2241,"height":214,"sizeInBytes":2497},"/uploads/thumbnail_lazaron_b23106537d.jpg","thumbnail_lazaron_b23106537d","thumbnail_lazaron.jpg",4.01,4007,"lazaron_b23106537d",31.83,"/uploads/lazaron_b23106537d.jpg","2026-07-28T11:14:00.181Z","2026-07-28T11:14:00.182Z",{"id":1597,"documentId":2504,"title":2505,"slug":2506,"date":2507,"cardTitle":18,"excerpt":18,"body":2508,"createdAt":2520,"updatedAt":2520,"publishedAt":2521,"cardImage":2522},"jyfsvlzuakdftbvtfi8a5j8x","SensUs Newsletter May","sensus-newsletter-may-0","2020-06-04",[2509,2512,2516],{"type":152,"children":2510},[2511],{"bold":79,"text":2505,"type":156},{"type":152,"children":2513},[2514],{"text":2515,"type":156},"Over the last few months, a lot has happened. The world is in a lockdown, schools are closed, and many, many more things have happened under these bizarre circumstances.",{"type":152,"children":2517},[2518],{"text":2519,"type":156},"Through this newsletter, we would like to inform you about the things that we have been working on, and the new initiatives that we are taking on. One of these new initiatives is the Venture Building program (VBP).","2026-07-28T11:14:00.318Z","2026-07-28T11:14:00.316Z",{"id":2523,"documentId":2524,"name":2525,"alternativeText":18,"caption":18,"focalPoint":18,"width":1302,"height":744,"formats":2526,"hash":2551,"ext":280,"mime":283,"size":2552,"url":2553,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":2554,"updatedAt":2554,"publishedAt":2555},1221,"wfa36psuy8p638ud33gpfzox","48708209277_b62c835c37_k_0.jpg",{"large":2527,"small":2533,"medium":2539,"thumbnail":2545},{"ext":280,"url":2528,"hash":2529,"mime":283,"name":2530,"path":18,"size":2531,"width":190,"height":345,"sizeInBytes":2532},"/uploads/large_48708209277_b62c835c37_k_0_100944c609.jpg","large_48708209277_b62c835c37_k_0_100944c609","large_48708209277_b62c835c37_k_0.jpg",72.45,72450,{"ext":280,"url":2534,"hash":2535,"mime":283,"name":2536,"path":18,"size":2537,"width":198,"height":293,"sizeInBytes":2538},"/uploads/small_48708209277_b62c835c37_k_0_100944c609.jpg","small_48708209277_b62c835c37_k_0_100944c609","small_48708209277_b62c835c37_k_0.jpg",27.36,27355,{"ext":280,"url":2540,"hash":2541,"mime":283,"name":2542,"path":18,"size":2543,"width":206,"height":198,"sizeInBytes":2544},"/uploads/medium_48708209277_b62c835c37_k_0_100944c609.jpg","medium_48708209277_b62c835c37_k_0_100944c609","medium_48708209277_b62c835c37_k_0.jpg",47.69,47690,{"ext":280,"url":2546,"hash":2547,"mime":283,"name":2548,"path":18,"size":2549,"width":306,"height":214,"sizeInBytes":2550},"/uploads/thumbnail_48708209277_b62c835c37_k_0_100944c609.jpg","thumbnail_48708209277_b62c835c37_k_0_100944c609","thumbnail_48708209277_b62c835c37_k_0.jpg",9.44,9440,"48708209277_b62c835c37_k_0_100944c609",251.12,"/uploads/48708209277_b62c835c37_k_0_100944c609.jpg","2026-07-28T11:14:00.285Z","2026-07-28T11:14:00.286Z",{"id":2557,"documentId":2558,"title":2559,"slug":2560,"date":2561,"cardTitle":18,"excerpt":18,"body":2562,"createdAt":2599,"updatedAt":2599,"publishedAt":2600,"cardImage":2601},281,"k7kgeo5fngtb293jrlastf2t","COVID-19 update","covid-19-update-0","2020-05-06",[2563,2567,2571,2575,2579,2587,2591,2595],{"type":152,"children":2564},[2565],{"text":2566,"type":156},"During the last months, our normal life has radically changed due to the COVID-19 pandemic. Our university has been closed and in a short time, everything had to be switched to an online environment. Our Organization will continue with the journey towards the SensUs Event facing new challenges. We now have all meetings over Skype, including the weekly plenary meeting. We have noticed that Skype meetings can be chaotic and we miss the social interactions and our weekly dinner together, but at least our work can continue.",{"type":152,"children":2568},[2569],{"text":2570,"type":156},"To stay visible, social media activity has been upgraded and new online initiatives have been introduced. For example, we have started an Instagram take-over by the organization to show our followers what we are up to. A SensUs quiz was launched, a Q&A session was hosted by our Chairs and even the honors program pitch has been recorded and published online! Furthermore, the recruitment of new members is in full swing; we have to get creative since we cannot contact the students by talking to them face to face.",{"type":152,"children":2572},[2573],{"text":2574,"type":156},"Nobody knows how the Corona pandemic will develop in August, so the Organization is looking at alternative scenarios for the SensUs Innovations Days. The advice and opinions of our competing Teams are valuable to SensUs when making decisions. By means of questionnaires, the communication between the Teams and the SensUs Organization has been intensified to gain input and decide on new ways forward.",{"type":152,"children":2576},[2577],{"text":2578,"type":156},"All international Teams have informed us that they will continue working on SensUs, but in a different way than before. Since most universities have closed their labs, the Teams now focus on the Creativity and Translation Potential award. For these awards, no lab work is needed. The contact with professionals and experts is even harder than before. However, our Teams are innovative and creative and have found new ways to remotely work as a group.",{"type":152,"children":2580},[2581,2583,2585],{"text":2582,"type":156},"The event date is coming closer and closer, and our excitement is still rising. Every edition of SensUs is different, and this edition will certainly be unlike previous years. After the press conference of the Dutch prime minister, we were recently informed that a physical SensUs event at Eindhoven University will not be allowed in August. So now it is certain that the SensUs Innovation Days will be organized ",{"bold":79,"text":2584,"type":156},"fully online",{"text":2586,"type":156},". This also means that the SensUs projects that run parallel to the SensUs Innovation Days (e.g. the Venture Building Program and the High School project) will go digital. Right now we are looking at the available options and how the switch can be managed best! There are a lot of things to be looked into, for example, what digital platform are we going to use and how the program will change, but we will keep you updated as soon as we know more. Tips and feedback are always welcome!",{"type":152,"children":2588},[2589],{"text":2590,"type":156},"Currently, we are looking at how we can help Teams to come in contact with our partners to get a high-value network. We already have had our Kick-off Meet the Partners which turned out to be quite successful over Skype. Now that universities are slowly opening their labs again so the work can restart, our Organization is looking into new ways to show the biosensors of the Teams to the public via a digital platform. Our aim is to make it possible for every team to share their findings.",{"type":152,"children":2592},[2593],{"text":2594,"type":156},"We are all part of challenging times. In the coming weeks, we expect that it will become more clear what the digital SensUs Event will look like. We wish all our Teams the best in their SensUs work and we will keep you updated through our channels! Stay safe and let’s compete for quality of life!",{"type":152,"children":2596},[2597],{"text":2598,"type":156},"Follow us on Facebook, Instagram, and LinkedIn for more updates.","2026-07-28T11:14:00.373Z","2026-07-28T11:14:00.372Z",{"id":2602,"documentId":2603,"name":2604,"alternativeText":18,"caption":18,"focalPoint":18,"width":1543,"height":595,"formats":2605,"hash":2618,"ext":280,"mime":283,"size":2619,"url":2620,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":2621,"updatedAt":2621,"publishedAt":2621},1224,"a4xiz31n8u6n7i5h04pbr48v","corona_article.jpg",{"small":2606,"thumbnail":2612},{"ext":280,"url":2607,"hash":2608,"mime":283,"name":2609,"path":18,"size":2610,"width":198,"height":1550,"sizeInBytes":2611},"/uploads/small_corona_article_b8d39571da.jpg","small_corona_article_b8d39571da","small_corona_article.jpg",29.01,29014,{"ext":280,"url":2613,"hash":2614,"mime":283,"name":2615,"path":18,"size":2616,"width":1557,"height":214,"sizeInBytes":2617},"/uploads/thumbnail_corona_article_b8d39571da.jpg","thumbnail_corona_article_b8d39571da","thumbnail_corona_article.jpg",6.75,6750,"corona_article_b8d39571da",45.24,"/uploads/corona_article_b8d39571da.jpg","2026-07-28T11:14:00.371Z",{"id":2623,"documentId":2624,"title":2625,"slug":2626,"date":2627,"cardTitle":18,"excerpt":18,"body":2628,"createdAt":2639,"updatedAt":2639,"publishedAt":2640,"cardImage":2641},282,"i9b0ubw3ibusfvwoiojbxks4","SensUs Newsletter December","sensus-newsletter-december-0","2020-01-23",[2629],{"type":152,"children":2630},[2631,2633,2638],{"bold":79,"text":2632,"type":156},"The Organization of SensUs 2020 is at full blast to create another fantastic edition of the SensUs Student Competition. If you want to relive last year's success, you can watch the aftermovie ",{"url":2634,"type":236,"children":2635},"https://www.youtube.com/watch?v=wEu4I60QPkg&t=1s",[2636],{"bold":79,"text":2637,"type":156},"here",{"bold":79,"text":887,"type":156},"2026-07-28T11:14:01.462Z","2026-07-28T11:14:01.457Z",{"id":2642,"documentId":2643,"name":2644,"alternativeText":18,"caption":18,"focalPoint":18,"width":640,"height":641,"formats":2645,"hash":2670,"ext":280,"mime":283,"size":2671,"url":2672,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":2673,"updatedAt":2673,"publishedAt":2673},1226,"wxc8qe9xnq3b7od5bbi8t9w3","Kerstkaart_foto.jpg",{"large":2646,"small":2652,"medium":2658,"thumbnail":2664},{"ext":280,"url":2647,"hash":2648,"mime":283,"name":2649,"path":18,"size":2650,"width":206,"height":190,"sizeInBytes":2651},"/uploads/large_Kerstkaart_foto_509e492a24.jpg","large_Kerstkaart_foto_509e492a24","large_Kerstkaart_foto.jpg",107.13,107130,{"ext":280,"url":2653,"hash":2654,"mime":283,"name":2655,"path":18,"size":2656,"width":654,"height":198,"sizeInBytes":2657},"/uploads/small_Kerstkaart_foto_509e492a24.jpg","small_Kerstkaart_foto_509e492a24","small_Kerstkaart_foto.jpg",35.94,35943,{"ext":280,"url":2659,"hash":2660,"mime":283,"name":2661,"path":18,"size":2662,"width":661,"height":206,"sizeInBytes":2663},"/uploads/medium_Kerstkaart_foto_509e492a24.jpg","medium_Kerstkaart_foto_509e492a24","medium_Kerstkaart_foto.jpg",67.52,67521,{"ext":280,"url":2665,"hash":2666,"mime":283,"name":2667,"path":18,"size":2668,"width":668,"height":214,"sizeInBytes":2669},"/uploads/thumbnail_Kerstkaart_foto_509e492a24.jpg","thumbnail_Kerstkaart_foto_509e492a24","thumbnail_Kerstkaart_foto.jpg",5.47,5465,"Kerstkaart_foto_509e492a24",976.85,"/uploads/Kerstkaart_foto_509e492a24.jpg","2026-07-28T11:14:00.601Z",{"id":2675,"documentId":2676,"title":1759,"slug":2677,"date":2678,"cardTitle":18,"excerpt":1759,"body":2679,"createdAt":2684,"updatedAt":2684,"publishedAt":2685,"cardImage":2686},283,"ppspfjqrzhuun72kdhze7ckc","sensus-newsletter-september-1","2019-09-24",[2680],{"type":152,"children":2681},[2682],{"bold":79,"text":2683,"type":156},"The final contest of SensUs 2019 took place on the 30th of August at Eindhoven University of Technology. It was a vibrant event with fourteen teams from North-America, Africa, Asia and Europe competing for the four awards. More than 10.000 people voted and the cumulative visitor count online was 22.000, from over 80 countries.","2026-07-28T11:14:01.726Z","2026-07-28T11:14:01.722Z",{"id":2687,"documentId":2688,"name":2689,"alternativeText":18,"caption":18,"focalPoint":18,"width":1302,"height":744,"formats":2690,"hash":2715,"ext":280,"mime":283,"size":2716,"url":2717,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":2718,"updatedAt":2718,"publishedAt":2718},1233,"zehvh5aigyx4ry4d6xreds5u","kleiner_0.jpg",{"large":2691,"small":2697,"medium":2703,"thumbnail":2709},{"ext":280,"url":2692,"hash":2693,"mime":283,"name":2694,"path":18,"size":2695,"width":190,"height":345,"sizeInBytes":2696},"/uploads/large_kleiner_0_da0317193a.jpg","large_kleiner_0_da0317193a","large_kleiner_0.jpg",153.68,153675,{"ext":280,"url":2698,"hash":2699,"mime":283,"name":2700,"path":18,"size":2701,"width":198,"height":293,"sizeInBytes":2702},"/uploads/small_kleiner_0_da0317193a.jpg","small_kleiner_0_da0317193a","small_kleiner_0.jpg",47.91,47910,{"ext":280,"url":2704,"hash":2705,"mime":283,"name":2706,"path":18,"size":2707,"width":206,"height":198,"sizeInBytes":2708},"/uploads/medium_kleiner_0_da0317193a.jpg","medium_kleiner_0_da0317193a","medium_kleiner_0.jpg",94.81,94813,{"ext":280,"url":2710,"hash":2711,"mime":283,"name":2712,"path":18,"size":2713,"width":306,"height":214,"sizeInBytes":2714},"/uploads/thumbnail_kleiner_0_da0317193a.jpg","thumbnail_kleiner_0_da0317193a","thumbnail_kleiner_0.jpg",13.62,13622,"kleiner_0_da0317193a",561.19,"/uploads/kleiner_0_da0317193a.jpg","2026-07-28T11:14:01.601Z",{"id":2720,"documentId":2721,"title":2722,"slug":2723,"date":2724,"cardTitle":18,"excerpt":18,"body":2725,"createdAt":2747,"updatedAt":2747,"publishedAt":2748,"cardImage":2749},284,"k2am9aw9mzlx37x8z81h72m7","DEMCON HandScan","demcon-handscan","2019-08-29",[2726,2730,2738],{"type":152,"children":2727},[2728],{"text":2729,"type":156},"DEMCON is a high-end technology supplier of innovative products and systems. Our focus areas are high-tech, medical, optomechatronic, robotic and industrial systems & vision. DEMCON has matching interests with SensUs when it comes to the development of biomedical healthcare innovations.",{"type":152,"children":2731},[2732,2734,2736],{"text":2733,"type":156},"This year’s theme: Managing rheumatic disease, by measuring with ease is particularly interesting as DEMCON already is active in the field of rheumatology. Our ",{"bold":79,"text":2735,"type":156},"HandScan",{"text":2737,"type":156}," is the first optical imaging device that supports the rheumatologist in objective monitoring of rheumatoid arthritis inflammation. The patented technology uses optical imaging hemodynamic changes to visualize joint inflammation.",{"type":152,"children":2739},[2740,2742,2746],{"text":2741,"type":156},"The images the scanner produces display joint inflammation in the patient's hands and wrists. The device is non-invasive, easy to work with and safe. Furthermore, it reduces the costly time burden on the rheumatologist as nonmedical staff can work with the scanner as well. More information can be found ",{"url":2743,"type":236,"children":2744},"https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.demcon.nl%2Fshowcase%2Fhandscan%2F&data=02%7C01%7Cj.geschiere%40student.tue.nl%7C2b5f0950bcd048562a8808d72c69299b%7Ccc7df24760ce4a0f9d75704cf60efc64%7C1%7C0%7C637026702524959314&sdata=2JmUMTE4SXTJ9XsWjDKU09qLZxt9oBf%2FRFd3UmfWM0A%3D&reserved=0",[2745],{"text":2637,"type":156},{"text":887,"type":156},"2026-07-28T11:14:02.243Z","2026-07-28T11:14:02.242Z",{"id":2750,"documentId":2751,"name":2752,"alternativeText":18,"caption":18,"focalPoint":18,"width":2753,"height":2754,"formats":2755,"hash":2777,"ext":183,"mime":186,"size":2778,"url":2779,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":2780,"updatedAt":2780,"publishedAt":2780},1240,"k7mzn0wvdjarrqx8cuhqqdhl","Scanner_meerdere_pics.png",932,693,{"small":2756,"medium":2763,"thumbnail":2770},{"ext":183,"url":2757,"hash":2758,"mime":186,"name":2759,"path":18,"size":2760,"width":198,"height":2761,"sizeInBytes":2762},"/uploads/small_Scanner_meerdere_pics_19314d09cc.png","small_Scanner_meerdere_pics_19314d09cc","small_Scanner_meerdere_pics.png",365.34,372,365337,{"ext":183,"url":2764,"hash":2765,"mime":186,"name":2766,"path":18,"size":2767,"width":206,"height":2768,"sizeInBytes":2769},"/uploads/medium_Scanner_meerdere_pics_19314d09cc.png","medium_Scanner_meerdere_pics_19314d09cc","medium_Scanner_meerdere_pics.png",772.17,558,772166,{"ext":183,"url":2771,"hash":2772,"mime":186,"name":2773,"path":18,"size":2774,"width":2775,"height":214,"sizeInBytes":2776},"/uploads/thumbnail_Scanner_meerdere_pics_19314d09cc.png","thumbnail_Scanner_meerdere_pics_19314d09cc","thumbnail_Scanner_meerdere_pics.png",74.79,210,74789,"Scanner_meerdere_pics_19314d09cc",238.24,"/uploads/Scanner_meerdere_pics_19314d09cc.png","2026-07-28T11:14:02.227Z",{"id":2782,"documentId":2783,"title":2784,"slug":2785,"date":2724,"cardTitle":18,"excerpt":18,"body":2786,"createdAt":2837,"updatedAt":2837,"publishedAt":2838,"cardImage":2839},285,"bq13kjqjtptqi6j3uryaxjxz","Preview Event","preview-event",[2787,2791,2795,2799,2803,2807,2811,2815,2819,2823,2833],{"type":379,"level":111,"children":2788},[2789],{"bold":79,"text":2790,"type":156},"Introduction",{"type":152,"children":2792},[2793],{"text":2794,"type":156},"Sensus 2019 is only a few days away. On the 30th of August the SensUs contest day will take place. 14 participating teams from all over the world will show their innovative biosensor prototypes to the world. The SensUs event is a unique chance to listen to inspiring talks, explore innovations and expand your network.",{"type":379,"level":111,"children":2796},[2797],{"bold":79,"text":2798,"type":156},"Theme 2019",{"type":152,"children":2800},[2801],{"text":2802,"type":156},"The theme of SensUs 2019 is Managing rheumatic disease by measuring with ease. SensUs 2019 has challenged teams to develop innovative biosensing systems for the detection of the anti-inflammatory drug adalimumab. Adalimumab is used for treating rheumatoid arthritis. Rheumatoid arthritis is a chronic inflammatory disease with a worldwide prevalence of 1%. Patients suffering from rheumatoid arthritis experience constant pain and difficulty with everyday chores. Adalimumab relieves the symptoms of rheumatoid arthritis by suppressing the body’s defence system and inhibiting inflammation. Adalimumab is not an adequate treatment for every patient. Patients may not have benefits or may even lose treatment benefits over time. A biosensor that can precisely measure the level of adalimumab in a patient will therefore be of great value in managing rheumatic diseases.",{"type":379,"level":111,"children":2804},[2805],{"bold":79,"text":2806,"type":156},"Awards",{"type":152,"children":2808},[2809],{"text":2810,"type":156},"During the SensUs contest day, the teams will be assessed for several awards: the analytical performance award, the creativity award, the translation potential award and the public inspiration award. The analytical performance award is won by the team with the best performing biosensor, this performance is calculated via an algorithm. The juries of the translation potential award and the creativity award consist of medical experts, patients and technical experts.The translation potential award will be presented to the team with the most suitable and thoughtful future applications in healthcare and towards industrialization. The creativity award will be presented to the team that has the most surprising results and has thereby set a new standard for the upcoming years. The winner of the public inspiration award will be determined by all visitors and viewers of SensUs 2019.",{"type":379,"level":111,"children":2812},[2813],{"bold":79,"text":2814,"type":156},"Workshops",{"type":152,"children":2816},[2817],{"text":2818,"type":156},"There will be three workshops given during the contest day. The workshops will be suitable for the general audience. The first workshop will be given by ReumaZorg Nederland on how it is like to live with rheumatoid arthritis. Another workshop is by SlimmerLeven on design thinking. The last workshop is given by Peter Joosten, a biohacker and a DIY-futurist, this workshop will focus on the impact of biohacking, human enhancement and transhumanism.",{"type":379,"level":111,"children":2820},[2821],{"bold":79,"text":2822,"type":156},"Symposium and Professional course",{"type":152,"children":2824},[2825,2827,2832],{"text":2826,"type":156},"Visitors will also be able to visit a scientific symposium and professional course, course organized by Dr. Bart van den Bemt, Prof. Mart van de Laar and Prof. Menno Prins. The program contains lectures on upcoming technologies for clinical immunology in the fields of therapy, monitoring and clinical data. The lectures will be followed by discussions on the translation to the clinic and impact on patients. For more information see ",{"url":2828,"type":236,"children":2829},"https://old.sensus.org",[2830],{"text":2831,"type":156},"www.sensus.org",{"text":887,"type":156},{"type":152,"children":2834},[2835],{"text":2836,"type":156,"italic":79},"The event can be watched live via digital.sensus.org","2026-07-28T11:14:02.606Z","2026-07-28T11:14:02.605Z",{"id":2840,"documentId":2841,"name":2842,"alternativeText":18,"caption":18,"focalPoint":18,"width":2843,"height":2844,"formats":2845,"hash":2872,"ext":280,"mime":283,"size":2873,"url":2874,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":2875,"updatedAt":2875,"publishedAt":2875},1242,"xrjtpvr5iuyoo0zyagy92pwp","3.jpg",4999,2812,{"large":2846,"small":2852,"medium":2858,"thumbnail":2865},{"ext":280,"url":2847,"hash":2848,"mime":283,"name":2849,"path":18,"size":2850,"width":190,"height":661,"sizeInBytes":2851},"/uploads/large_3_c6e30080b3.jpg","large_3_c6e30080b3","large_3.jpg",121.17,121166,{"ext":280,"url":2853,"hash":2854,"mime":283,"name":2855,"path":18,"size":2856,"width":198,"height":2557,"sizeInBytes":2857},"/uploads/small_3_c6e30080b3.jpg","small_3_c6e30080b3","small_3.jpg",39.05,39045,{"ext":280,"url":2859,"hash":2860,"mime":283,"name":2861,"path":18,"size":2862,"width":206,"height":2863,"sizeInBytes":2864},"/uploads/medium_3_c6e30080b3.jpg","medium_3_c6e30080b3","medium_3.jpg",75.68,422,75683,{"ext":280,"url":2866,"hash":2867,"mime":283,"name":2868,"path":18,"size":2869,"width":144,"height":2870,"sizeInBytes":2871},"/uploads/thumbnail_3_c6e30080b3.jpg","thumbnail_3_c6e30080b3","thumbnail_3.jpg",12.53,138,12533,"3_c6e30080b3",1768.21,"/uploads/3_c6e30080b3.jpg","2026-07-28T11:14:02.603Z",{"id":2877,"documentId":2878,"title":2879,"slug":2880,"date":2881,"cardTitle":18,"excerpt":18,"body":2882,"createdAt":2920,"updatedAt":2920,"publishedAt":2921,"cardImage":18},286,"n14xeag1hq0rgzh8l5j0hbjh","SensUs 2019: Perspective from an RA patient","sensus-2019-perspective-ra-patient","2019-08-28",[2883,2887,2891,2895,2899,2903,2907,2911],{"type":152,"children":2884},[2885],{"bold":79,"text":2886,"type":156},"ReumaNederland is the main patient organization in the Netherlands for rheumatic disease and the most important funder of research in the field of inflammatory arthritis. ReumaNederland has become a partner of SensUs because of the opportunities biosensing can give for a better quality of life for rheumatoid arthritis (RA) patients. Mariëlle Kersten (32) is a patient and will be ambassador for ReumaNederland at the SensUs 2019 event. We spoke with her about her experiences and expectations of living with rheumatoid arthritis.",{"type":152,"children":2888},[2889],{"text":2890,"type":156},"My name is Mariëlle Kersten, I am 32 years old and I live in Deventer. I am a rheumatoid arthritis patient and will attend the SensUs event 2019. In my daily life, I teach students in the field of Travel, Leisure and Hospitality at the Deltion College in Zwolle. I really like my job, because I am very interested in tourism myself.",{"type":152,"children":2892},[2893],{"text":2894,"type":156},"Besides my job, I like to play sports in several disciplines. It’s really a way in which I can stop worrying about certain things and clear my mind. In the beginning of my RA, I had difficulties with stopping at the right time, not noticing when I felt my RA. I was used to muscle strains, but a thick knee from RA was new to me. I had to find a new balance. By now, I am used to this and it all happens on ‘automatic pilot’.",{"type":152,"children":2896},[2897],{"text":2898,"type":156},"In my social circle, everybody knows about my disease. However, sometimes other people do not see that I suffer from RA which can lead to incomprehension. People do not understand that I can’t stand up for elderly when travelling by train if my knee starts to hurt for instance. People often want to see proof, but it’s not always visible. I once had to pay for a dentist’s appointment when I couldn’t go because my knees started to hurt. They couldn’t relate to that and I just called that morning, so I had to pay for the appointment.",{"type":152,"children":2900},[2901],{"text":2902,"type":156},"I first noticed the inconveniences of RA in 2009 and I was diagnosed with it one year later. I felt several things, for instance a tingling in my knee, which got thick and warm. Later, I suffered from my wrists. This was very annoying and also exhausting for me. During a skiing trip, I was in too much pain to continue skiing, so I went to a hospital and the doctors thought it was bursa inflammation. Eventually, I went to a general practitioner back home and it turned out to be RA all the time.",{"type":152,"children":2904},[2905],{"text":2906,"type":156},"Throughout the years, I’ve used a list of different medicines in my treatment. Some of them worked, others didn’t. Some brought along too many side effects, which was why I had to stop taking those. Adalimumab as a medicine worked for me. I felt fitter than before and was less exhausted. This was also the time when I picked up exercising again, and I gained more and more trust in my body. Sadly, my skin irritated at the injection spots, which later resulted in swellings. I turned out to be allergic to a component in the biologicals. Now my rheumatologist and I are facing a new challenge: finding a way on how to treat my RA.",{"type":152,"children":2908},[2909],{"text":2910,"type":156},"This is why I am very enthusiastic about biosensing and what it could contribute in the treatment of RA. At the moment, the treatment consists of some trial and error medicines and hoping that it will catch on. This differs for every patient and it takes months to see the effect of the medicine on the patient. A biosensor can accelerate this whole process, full of inconveniences. I hope the development of biosensors will lead to a more comfortable treatment with more freedom of movement.",{"type":152,"children":2912},[2913,2915],{"text":2914,"type":156},"If you want to know more about rheumatic disease and the things ReumaNederland does to improve the quality of patients’ lives, visit ",{"url":2916,"type":236,"children":2917},"http://www.reumanederland.nl",[2918],{"text":2919,"type":156},"www.reumanederland.nl","2026-07-28T11:14:02.608Z","2026-07-28T11:14:02.607Z",{"id":2923,"documentId":2924,"title":2925,"slug":2926,"date":2927,"cardTitle":18,"excerpt":18,"body":2928,"createdAt":2981,"updatedAt":2981,"publishedAt":2982,"cardImage":2983},288,"sjet9i9rnrrhp6njlj62phk9","SensUs Interview: Steven Staal","sensus-interview-steven-staal","2019-08-26",[2929,2933,2937,2941,2945,2949,2953,2957,2961,2965,2969,2973,2977],{"type":379,"level":111,"children":2930},[2931],{"text":2932,"type":156},"Steven Staal is the chair of the Creativity jury of SensUs 2019. Under his supervision, the creativity award will be presented to the team that has the most surprising results and thereby sets a new standard for the upcoming years. SensUs spoke with him about his daily activities, his motivation to join the jury of SensUs 2019 and the future of point of care testing.",{"type":152,"children":2934},[2935],{"text":2936,"type":156,"italic":79},"Thanks for joining the jury of SensUs 2019. Can you tell us who you are and what are your daily activities?",{"type":152,"children":2938},[2939],{"text":2940,"type":156},"My name is Steven Staal and I have an electrical engineering background with specialization in Lab on a Chip systems. I graduated as MSc in the Lab-on-a-Chip group from Albert van den Berg from the University of Twente in 2004. After my graduation I continued the PhD research results of Elwin Vrouwe and started a new company with the vision to create a new self test based on electrophoresis. With our company, and 14 years of experience later, we now have a self test in the market that can measure multiple parameters at once like Sodium, Potassium, Lithium and Creatinine from one droplet, in urine, plasma or fingerstick whole blood.",{"type":152,"children":2942},[2943],{"text":2944,"type":156,"italic":79},"What is your passion and/or your mission?",{"type":152,"children":2946},[2947],{"text":2948,"type":156},"My passion is to create new technologies and to successfully place them in the market. I like the combined challenge of technology development while covering all other business aspects at the same time. I am driven by a combination of strong motivation, strive for success and embracing and finishing challenges. With this mindset, together with our team, we developed the first electrophoresis based self test for the medical market to be used by patients with bipolar disorder by measuring lithium, creatinine and the kidney function. The system is now used by multiple health care clinics in the Netherlands.",{"type":152,"children":2950},[2951],{"text":2952,"type":156,"italic":79},"You have joined the jury of SensUs 2019. What do you expect from being on the SensUs jury? What has been your motivation?",{"type":152,"children":2954},[2955],{"text":2956,"type":156},"The development activities are generally much underestimated. I know how many challenges are ahead and how long it takes to actually successfully go through each phase from idea to market. Not only with the technology itself, but also with the organization. I am looking forward to see how other teams are preparing themselves and I hope to be able to share some of my experiences with the teams.",{"type":152,"children":2958},[2959],{"text":2960,"type":156,"italic":79},"The theme of SensUs 2019 is “Managing rheumatic disease, by measuring with ease”. How do you view this theme? What does it mean to you and/or to society?",{"type":152,"children":2962},[2963],{"text":2964,"type":156},"A friend of mine did his PhD in characterizing the degree of Rheumatoid Arthritis from images of the hand. This is how far I came with this specific disease, so regretfully my understanding of this illness itself is very little. But I do have experience with technology development for self tests use including validation studies and legislation requirements. I am looking forward to hear about the expected activities by the other teams and see similarities and/or differences in the product development.",{"type":152,"children":2966},[2967],{"text":2968,"type":156,"italic":79},"The student teams have worked to make biosensors and business models for the measurement of adalimumab, an antirheumatic biological drug. How do you view the relevance of measuring biological drugs, for patients, doctors, and/or society?",{"type":152,"children":2970},[2971],{"text":2972,"type":156},"I cannot estimate the relevance of measuring adalimumab as a self test myself, but I know the relevance for measuring other drugs like for instance lithium for patients with bipolar disorder. These advantages are expected to be really significant. Having quickly available measurement results at any location improves health care at multiple points. First, the patients will gain more patient empowerment, therapy loyalty and will experience a better treatment itself. Secondly, the specialist will be able to measure at once with the outcome directly obtained. As a consequence, treatments will be induced directly and follow up due to ill treatment or delayed treatment will be reduced. This reduces the complexity of the treatment process from the view of the specialist and improves patient treatment. Thirdly having more self tests available, treatments become more efficient with better care which reduces the tension to the health care system and thus improves the quality of life of patients and/or reduces the health care costs.",{"type":152,"children":2974},[2975],{"text":2976,"type":156,"italic":79},"More in general, how do you see the future for point-of-care testing and biosensors for patient monitoring? Where can biosensors have impact, and what do you think are the main challenges in realizing and applying such biosensors?",{"type":152,"children":2978},[2979],{"text":2980,"type":156},"I expect that the medical relevance of biosensors can become very significant. Creating new information at the location we desire ourselves gives the possibility to directly act on the outcome, make the right decision and have immediate follow up. Communicating the obtained information with the specialist will make it possible to make more complex follow up possible.Outside the medical market we already measure many parameters on site, like length, weight, temperature and more. Just imagine how difficult it will be to build a house if the length and angle measurements are done in a laboratory… we just forget that this is still often the case in daily medicine. So, I expect that on site biosensors are for sure an important part of the future for better patient treatment and health care. Currently self test measurements are still available in limited numbers. With the new emerging technologies we are just at the beginning of creating the possibility to measure many more parameters on site. In the next decades I expect that more technologies will become available. However, the first medical acceptance will not go quickly as the new information needs to be analyzed on relevance, impact and it should be accepted by all different medical parties involved, this is a time consuming process.","2026-07-28T11:14:04.080Z","2026-07-28T11:14:04.078Z",{"id":2984,"documentId":2985,"name":2986,"alternativeText":18,"caption":18,"focalPoint":18,"width":2987,"height":2988,"formats":2989,"hash":3014,"ext":280,"mime":283,"size":3015,"url":3016,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":3017,"updatedAt":3017,"publishedAt":3017},1246,"duausb9rf5uj9lg770sjski7","43745281975_c43676075a_o.jpg",5000,3333,{"large":2990,"small":2996,"medium":3002,"thumbnail":3008},{"ext":280,"url":2991,"hash":2992,"mime":283,"name":2993,"path":18,"size":2994,"width":190,"height":286,"sizeInBytes":2995},"/uploads/large_43745281975_c43676075a_o_2fe0170303.jpg","large_43745281975_c43676075a_o_2fe0170303","large_43745281975_c43676075a_o.jpg",49.12,49124,{"ext":280,"url":2997,"hash":2998,"mime":283,"name":2999,"path":18,"size":3000,"width":198,"height":293,"sizeInBytes":3001},"/uploads/small_43745281975_c43676075a_o_2fe0170303.jpg","small_43745281975_c43676075a_o_2fe0170303","small_43745281975_c43676075a_o.jpg",18.4,18403,{"ext":280,"url":3003,"hash":3004,"mime":283,"name":3005,"path":18,"size":3006,"width":206,"height":198,"sizeInBytes":3007},"/uploads/medium_43745281975_c43676075a_o_2fe0170303.jpg","medium_43745281975_c43676075a_o_2fe0170303","medium_43745281975_c43676075a_o.jpg",33.01,33012,{"ext":280,"url":3009,"hash":3010,"mime":283,"name":3011,"path":18,"size":3012,"width":306,"height":214,"sizeInBytes":3013},"/uploads/thumbnail_43745281975_c43676075a_o_2fe0170303.jpg","thumbnail_43745281975_c43676075a_o_2fe0170303","thumbnail_43745281975_c43676075a_o.jpg",6.37,6369,"43745281975_c43676075a_o_2fe0170303",1390.8,"/uploads/43745281975_c43676075a_o_2fe0170303.jpg","2026-07-28T11:14:04.052Z",{"id":3019,"documentId":3020,"title":3021,"slug":3022,"date":2927,"cardTitle":18,"excerpt":18,"body":3023,"createdAt":3076,"updatedAt":3076,"publishedAt":3077,"cardImage":3078},287,"k0wfybllybkl8txixm8wy7ja","SensUs Interview: Luc Derijks","sensus-interview-luc-derijks",[3024,3028,3032,3036,3040,3044,3048,3052,3056,3060,3064,3068,3072],{"type":379,"level":111,"children":3025},[3026],{"text":3027,"type":156},"Introduction of clinical pharmacologist",{"type":152,"children":3029},[3030],{"text":3031,"type":156},"My name is Luc Derijks, I am a hospital pharmacist and clinical pharmacologist at Maxima Medical Center in the Netherlands. I got my PhD in medicine for clinical research I conducted with inflammatory bowel disease (IBD) patients treated with thiopurines.",{"type":152,"children":3033},[3034],{"text":3035,"type":156},"Since then, I have a passion for applying personalized medicine in clinical practice. Too often we see that treatments are still applied by the ‘one dose fits all’ principle, while for many drugs this is not ideal. Choosing the right drug and the right dose can be very challenging, tools like therapeutic drug monitoring (TDM) can help us in doing so. At the moment, I’m working on personalized medicine in IBD and rheumatoid arthritis (RA). Both are autoimmune diseases in which the immune system works too hard and attacks cells of the human body.",{"type":152,"children":3037},[3038],{"text":3039,"type":156,"italic":79},"‘Personalized medicine for immunological treatments is emerging.’",{"type":379,"level":111,"children":3041},[3042],{"bold":79,"text":3043,"type":156},"The role of biologicals",{"type":152,"children":3045},[3046],{"text":3047,"type":156},"During the treatment of RA, an autoimmune disease where the immune system attacks the joints, we use different types of medication. In Europe, we usually follow the EULAR-guidelines, these are evidence-based guidelines for many rheumatologic diseases. For most part, RA-patients are being treated by the ‘step-up’ approach, which refers to a sequential treatment strategy that begins with less potent and usually less toxic drugs, with escalation to more effective but potentially more toxic agents, such as immunosuppressives or biologicals. Currently, a subset of patients with the prediction of a more severe and refractory disease course may qualify for a ‘top-down’ strategy, in which biologicals (often in combination with immunosuppressives) are introduced at an early stage, to prevent disease progression and disability.",{"type":152,"children":3049},[3050],{"text":3051,"type":156},"‘The top-down approach has been a paradigm shift in the treatment of RA, to prevent irreversible joint damage in patients with severe disease.’",{"type":152,"children":3053},[3054],{"text":3055,"type":156},"Biologicals are very expensive compared to the other drugs used. We want to give patients the most cost-effective treatment: we want the drug to be effective, but we can’t afford to give everybody a biological, and it is not necessary either. Adalimumab was the best selling drug worldwide until last year, when a biosimilar entered the market. Biosimilars are as effective as the original biological, but substantially cheaper. Because of this, adalimumab drug costs dropped significantly. TDM is also a helpful tool to accompany a switch of originator drugs to biosimilars and objectify clinical outcomes.",{"type":379,"level":111,"children":3057},[3058],{"text":3059,"type":156},"SensUs and point-of-care testing",{"type":152,"children":3061},[3062],{"text":3063,"type":156},"The theme ‘managing rheumatic disease, by measuring with ease’ of SensUs this year is like music to my ears! Anti-rheumatic drugs are still very expensive, so it’s challenging to give the right dose to the right patient for minimal costs so we can treat every patient in need. We therefore perform TDM. Until now, we have to do this in our clinic.",{"type":152,"children":3065},[3066],{"text":3067,"type":156,"italic":79},"‘Point-of-care testing will substantially contribute to self-management of (chronic) diseases.’",{"type":152,"children":3069},[3070],{"text":3071,"type":156},"Easy access to TDM will make it easier to apply personalized medicine in this group of patients, which I think is really interesting. With a biosensor, patients can measure their adalimumab concentrations at home at a moment that suits them. In general, I see a great future in biosensing for all kinds of treatments. What I really like about the SensUs competition is that it competitive but stimulates collaboration. I really hope that RA patients in the near future will benefit from this initiative. Do I have any tips for the teams? Well, it is important to keep in mind that rheumatic patients can have rigid fingers, so the sensor should be manageable for these patients. It would also be great if teams add communicating tools to the biosensor, so the outcome can also be sent to the physician immediately.",{"type":152,"children":3073},[3074],{"text":3075,"type":156,"italic":79},"‘Therapeutic drug monitoring is not only measuring drug concentrations in blood, but also the dosing advice as a result of it.’","2026-07-28T11:14:03.345Z","2026-07-28T11:14:03.344Z",{"id":3079,"documentId":3080,"name":3081,"alternativeText":18,"caption":18,"focalPoint":18,"width":3082,"height":2987,"formats":3083,"hash":3109,"ext":280,"mime":283,"size":3110,"url":3111,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":3112,"updatedAt":3112,"publishedAt":3112},1244,"mo6o3wxr4who18x6l575cqh8","Untitled-1.jpg",6667,{"large":3084,"small":3090,"medium":3096,"thumbnail":3102},{"ext":280,"url":3085,"hash":3086,"mime":283,"name":3087,"path":18,"size":3088,"width":190,"height":206,"sizeInBytes":3089},"/uploads/large_Untitled_1_56d8b4ecf3.jpg","large_Untitled_1_56d8b4ecf3","large_Untitled-1.jpg",40.66,40663,{"ext":280,"url":3091,"hash":3092,"mime":283,"name":3093,"path":18,"size":3094,"width":198,"height":654,"sizeInBytes":3095},"/uploads/small_Untitled_1_56d8b4ecf3.jpg","small_Untitled_1_56d8b4ecf3","small_Untitled-1.jpg",13.06,13060,{"ext":280,"url":3097,"hash":3098,"mime":283,"name":3099,"path":18,"size":3100,"width":206,"height":661,"sizeInBytes":3101},"/uploads/medium_Untitled_1_56d8b4ecf3.jpg","medium_Untitled_1_56d8b4ecf3","medium_Untitled-1.jpg",25.44,25435,{"ext":280,"url":3103,"hash":3104,"mime":283,"name":3105,"path":18,"size":3106,"width":3107,"height":214,"sizeInBytes":3108},"/uploads/thumbnail_Untitled_1_56d8b4ecf3.jpg","thumbnail_Untitled_1_56d8b4ecf3","thumbnail_Untitled-1.jpg",3.69,208,3688,"Untitled_1_56d8b4ecf3",814.77,"/uploads/Untitled_1_56d8b4ecf3.jpg","2026-07-28T11:14:03.342Z",{"id":3114,"documentId":3115,"title":3116,"slug":3117,"date":3118,"cardTitle":18,"excerpt":18,"body":3119,"createdAt":3136,"updatedAt":3136,"publishedAt":3137,"cardImage":3138},289,"mjygchf4swqqhhhgogd97u8l","SensUs High Schools Project","sensus-high-schools-project-0","2019-08-22",[3120,3124,3128,3132],{"type":152,"children":3121},[3122],{"text":3123,"type":156},"SensUs 2019 is not only a day for the student teams to showcase their work on biosensors for healthcare of the past year. There will also be 11 high school teams to present their projects.",{"type":152,"children":3125},[3126],{"text":3127,"type":156},"In Februari the SensUs High Schools Project started with a kick-off lectures for all participating high schools groups. They learned about their assignment: making a concept for a biosensor, with emphasize on the societal impact of such a biosensor. To relate this to the student teams, the high school team had also the theme \"rheumatoid arthritis\" and focused on anti-CCP, an antibody that is related to the presence of reuma. In the Kick-off lecture they also learned about the innovative TRIZ-model and about how to do literature research.",{"type":152,"children":3129},[3130],{"text":3131,"type":156},"Throughout the year they worked on the project themselves at school. They cover all kind of subjects, as target group, financial feasibility, and technical aspects of a biosensor. Additionally, We organised an excursion to Diagnostiek Voor U, where the practical importance of measuring markers in blood was clearly illustrated. The high school teams got lessons about how to make a scientific poster en good pitch, which are what they will show 30 Augustus at SensUs 2019.",{"type":152,"children":3133},[3134],{"text":3135,"type":156},"All the groups will give a one minute pitch on the same podium the student teams also pitch. Their posters will be showcased and visitors can view their findings and hard work. We as SensUs are very proud of the work these high schools students have put into the project and what they will show everyone at the SensUs event!","2026-07-28T11:14:04.800Z","2026-07-28T11:14:04.799Z",{"id":3139,"documentId":3140,"name":3141,"alternativeText":18,"caption":18,"focalPoint":18,"width":2987,"height":2988,"formats":3142,"hash":3167,"ext":280,"mime":283,"size":3168,"url":3169,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":3170,"updatedAt":3170,"publishedAt":3170},1249,"mqcm47vacdzyfi0ap9fyaf42","44654582861_87b11fab18_o.jpg",{"large":3143,"small":3149,"medium":3155,"thumbnail":3161},{"ext":280,"url":3144,"hash":3145,"mime":283,"name":3146,"path":18,"size":3147,"width":190,"height":286,"sizeInBytes":3148},"/uploads/large_44654582861_87b11fab18_o_7b444172fb.jpg","large_44654582861_87b11fab18_o_7b444172fb","large_44654582861_87b11fab18_o.jpg",146.76,146761,{"ext":280,"url":3150,"hash":3151,"mime":283,"name":3152,"path":18,"size":3153,"width":198,"height":293,"sizeInBytes":3154},"/uploads/small_44654582861_87b11fab18_o_7b444172fb.jpg","small_44654582861_87b11fab18_o_7b444172fb","small_44654582861_87b11fab18_o.jpg",45.76,45757,{"ext":280,"url":3156,"hash":3157,"mime":283,"name":3158,"path":18,"size":3159,"width":206,"height":198,"sizeInBytes":3160},"/uploads/medium_44654582861_87b11fab18_o_7b444172fb.jpg","medium_44654582861_87b11fab18_o_7b444172fb","medium_44654582861_87b11fab18_o.jpg",91.22,91217,{"ext":280,"url":3162,"hash":3163,"mime":283,"name":3164,"path":18,"size":3165,"width":306,"height":214,"sizeInBytes":3166},"/uploads/thumbnail_44654582861_87b11fab18_o_7b444172fb.jpg","thumbnail_44654582861_87b11fab18_o_7b444172fb","thumbnail_44654582861_87b11fab18_o.jpg",13.28,13279,"44654582861_87b11fab18_o_7b444172fb",2469.81,"/uploads/44654582861_87b11fab18_o_7b444172fb.jpg","2026-07-28T11:14:04.734Z",{"id":3172,"documentId":3173,"title":3174,"slug":3175,"date":3118,"cardTitle":18,"excerpt":18,"body":3176,"createdAt":3280,"updatedAt":3280,"publishedAt":3281,"cardImage":3282},290,"nqziwxh24wfn2xfpguexsarv","SensUs Interview: Bert-Jan Woertman","sensus-interview-bert-jan-woertman",[3177,3181,3185,3196,3200,3204,3208,3212,3216,3220,3224,3228,3232,3236],{"type":379,"level":111,"children":3178},[3179],{"text":3180,"type":156},"Bert-Jan Woertman is a social innovator and Dutch Startup Changemaker. We had the chance to speak with him about the role of students in innovation, the value of the SensUs competition and open innovation, and the current startup scene that the SensUs teams will enter into.",{"type":152,"children":3182},[3183],{"text":3184,"type":156},"My name is Bert-Jan Woertman. I am an innovation ecosystem builder, a venture humanist, and an occasional speaker and moderator. After graduating in Eindhoven, I started my journey at Philips NatLab. NatLab was the place of birth of many brilliant new Philips products, which is why I enjoyed my time there. NatLab also formed the basis of what we now know as High Tech Campus Eindhoven. After various HR Management roles, I joined High Tech Campus Eindhoven Site Management Team. I was responsible for developing The Strip, the beating heart of the Campus, a 400-metre-long building designed to connect people and stimulate sharing of knowledge and cooperation. During the eleven years I worked for the Campus, I was able to develop myself in the field of marketing, communication and business development. I love startups and have been actively involved as co-founder in building the world's best accelerator for high-tech start- and scale-ups, HightechXL & HighTechXL Plaza. After my time at the High Tech Campus, I worked as commercial director of the campus of Eindhoven University Technology, the homeplace of SensUs, and kickstarted the Brainport Industry Campus as director.",{"type":152,"children":3186},[3187,3189,3194],{"text":3188,"type":156},"Now, I work for myself within my company ‘Social Machines’ where I am able to pursue my passion, which is bringing people together. With ‘Social Machines’, I build ecosystems that really work. Currently, I am working at",{"url":3190,"type":236,"children":3191},"https://www.tue.nl/en/tue-campus/tue-innovation-space/",[3192],{"text":3193,"type":156}," Innovation Space at Eindhoven University of Technology (TU/e)",{"text":3195,"type":156},", which is a community and facility that supports interdisciplinary hands-on education, engineering design and entrepreneurship. In an ecosystem the people make the difference, how these people are connected to each other and the environment, and how the environment again is connected to a bigger region, like Innovation Space in the Brainport region. One can read all books in the world or build a specific object, but that will not make the difference, it is always the dynamics between people that makes the difference, people that work together. In an ecosystem that works, people undertake the right actions together and make it happen.",{"type":152,"children":3197},[3198],{"text":3199,"type":156},"“People always make the difference”",{"type":152,"children":3201},[3202],{"text":3203,"type":156},"The ingredients needed for innovation to happen, and thus economic growth, are talent and technology. Talent and technology are found at a university. Here at the TU/e, we have a huge network of companies connected to the university. We´re the world number one in cooperation with innovative companies. These companies provide the students routes through the world of innovation. The students work together and stand on the shoulders of giants like Philips, ASML and NXP. In today’s world, innovation is a team effort.",{"type":152,"children":3205},[3206],{"text":3207,"type":156},"What is so nice about working with students, is that no one, not even the most experienced Philips VP or serial entrepreneur, really knows how everything works. Therefore, students look at problems in their own unique manner and do not really care about how problems were solved in the past. We have huge problems in the world which we can technically solve, but this does not happen. Students I work with at the TU/e take action and get to work. They understand that the future depends on what you do today.",{"type":152,"children":3209},[3210],{"text":3211,"type":156},"“Students show it is possible.”",{"type":152,"children":3213},[3214],{"text":3215,"type":156},"What I find so interesting about SensUs is that SensUs has a different approach on innovating healthcare than current companies in the medical industry. When it comes to innovation, companies are very protective of their own investments and research and development. Even though we are talking about diseases of which people suffer daily together with their families around them. SensUs shows it can be done differently. The competition addresses a new disease each year with teams working on it in an open atmosphere, sharing knowledge. Biomarker by biomarker, SensUs tries to make the dream of personalized medicine come true and bring it closer to reality. SensUs is only in its fourth edition and already some teams are setting up startup companies. SensUs sets an example and shows that it is possible to work differently in the medical field..",{"type":152,"children":3217},[3218],{"text":3219,"type":156},"“SensUs brings 14 teams to Eindhoven, that work together in an open atmosphere, share all knowledge. 150 excellent student working together. This already provides serious solutions.”",{"type":152,"children":3221},[3222],{"text":3223,"type":156},"“Biomarker by biomarker, SensUs tries to make the dream of personalized medicine come true and bring it closer to reality. SensUs sets an example and shows that it is possible to do work differently in the medical field”",{"type":152,"children":3225},[3226],{"text":3227,"type":156},"I love the startup scene, as you are constantly in control of your own learning experience. I also have a lot of respect for it as it takes a lot of courage to become a startup company. The teams trying to become a startup company will encounter problems and challenges which need to be solved with limited resources, long hours and no one knows what will happen. You start, you undertake action, make lots of mistakes and keep going. The point is that the idea, the technology and the prototype are simple. That does not make the difference. Here again, you come back to the person, the people, the team that needs to make the startup work together. The difference between success and failure will be the team that works together, and trust within the team. You need to make it work together over and over again.",{"type":152,"children":3229},[3230],{"text":3231,"type":156},"“It is really nice to be part of a startup as your are constantly in charge of your own learning process.”",{"type":152,"children":3233},[3234],{"text":3235,"type":156},"My advice to the teams that want to become a startup company would be to start working and talk to people with the right expertise. Of course, you have to be careful with what you say, because you need to apply for patents, but you cannot reach your goals alone. Five people will say five different things, so develop your own view on their opinions and act on this view. Never immediately say yes, give yourself the chance to gather further input and maybe say no. Use the knowledge and expertise of others to your advantage.",{"type":152,"children":3237},[3238,3240,3245,3247,3252,3254,3258,3260,3265,3267,3272,3274,3279],{"text":3239,"type":156},"If you want to learn more about the startup community in Eindhoven, Bert-Jan organizes",{"url":3241,"type":236,"children":3242},"https://www.hightechcampus.nl/connect",[3243],{"text":3244,"type":156}," Demo’s & Drinks",{"text":3246,"type":156}," every first Wednesday of the month, you can search for the",{"url":3248,"type":236,"children":3249},"https://www.hightechxl.com/",[3250],{"text":3251,"type":156}," High Tech Campus startup community",{"text":3253,"type":156},",",{"url":3190,"type":236,"children":3255},[3256],{"text":3257,"type":156}," TU/e Innovation Space",{"text":3259,"type":156}," or",{"url":3261,"type":236,"children":3262},"https://www.tue.nl/tue-campus/tue-innovation-lab/",[3263],{"text":3264,"type":156}," TU/e Innovation Lab",{"text":3266,"type":156}," or the",{"url":3268,"type":236,"children":3269},"https://www.eindhovenstartupalliance.com/",[3270],{"text":3271,"type":156}," Eindhoven Startup Alliance",{"text":3273,"type":156}," or directly contact Bert-Jan: ",{"url":3275,"type":236,"children":3276},"mailto:bertjanwoertman@gmail.com",[3277],{"text":3278,"type":156},"bertjanwoertman@gmail.com",{"text":887,"type":156},"2026-07-28T11:14:05.642Z","2026-07-28T11:14:05.640Z",{"id":3283,"documentId":3284,"name":3285,"alternativeText":18,"caption":18,"focalPoint":18,"width":3286,"height":3287,"formats":3288,"hash":3313,"ext":941,"mime":283,"size":3314,"url":3315,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":3316,"updatedAt":3316,"publishedAt":3316},1252,"xlq4qy1bc22s4aljjmaac9lx","IMG_1347_(002)[1891]_0.JPG",3648,5472,{"large":3289,"small":3295,"medium":3301,"thumbnail":3307},{"ext":941,"url":3290,"hash":3291,"mime":283,"name":3292,"path":18,"size":3293,"width":345,"height":190,"sizeInBytes":3294},"/uploads/large_IMG_1347_002_1891_0_dac65d945c.JPG","large_IMG_1347_002_1891_0_dac65d945c","large_IMG_1347_(002)[1891]_0.JPG",63.12,63118,{"ext":941,"url":3296,"hash":3297,"mime":283,"name":3298,"path":18,"size":3299,"width":293,"height":198,"sizeInBytes":3300},"/uploads/small_IMG_1347_002_1891_0_dac65d945c.JPG","small_IMG_1347_002_1891_0_dac65d945c","small_IMG_1347_(002)[1891]_0.JPG",22.09,22086,{"ext":941,"url":3302,"hash":3303,"mime":283,"name":3304,"path":18,"size":3305,"width":198,"height":206,"sizeInBytes":3306},"/uploads/medium_IMG_1347_002_1891_0_dac65d945c.JPG","medium_IMG_1347_002_1891_0_dac65d945c","medium_IMG_1347_(002)[1891]_0.JPG",40.81,40812,{"ext":941,"url":3308,"hash":3309,"mime":283,"name":3310,"path":18,"size":3311,"width":570,"height":214,"sizeInBytes":3312},"/uploads/thumbnail_IMG_1347_002_1891_0_dac65d945c.JPG","thumbnail_IMG_1347_002_1891_0_dac65d945c","thumbnail_IMG_1347_(002)[1891]_0.JPG",4.15,4148,"IMG_1347_002_1891_0_dac65d945c",1850.25,"/uploads/IMG_1347_002_1891_0_dac65d945c.JPG","2026-07-28T11:14:05.638Z",{"id":3318,"documentId":3319,"title":3320,"slug":3321,"date":3322,"cardTitle":18,"excerpt":18,"body":3323,"createdAt":3381,"updatedAt":3381,"publishedAt":3382,"cardImage":3383},291,"dfe3jmdidmyypwy5mwlftcte","Personal Story: Gerda Geven","personal-story-gerda-geven","2019-07-06",[3324,3328,3332,3336,3340,3344,3348,3352,3356,3360,3364],{"type":152,"children":3325},[3326],{"text":3327,"type":156},"The theme of SensUs 2019 is ‘Managing rheumatic disease by measuring with ease’. SensUs 2019 challenges teams to develop biosensors for the detection of adalimumab, an important drug for patients with rheumatoid arthritis. We spoke with Gerda Geven about her experiences as a rheumatoid arthritis patient.",{"type":152,"children":3329},[3330],{"text":3331,"type":156},"My name is Gerda, I am 59 years old. At this moment I work at a shared service center for public libraries in the marketing and communication department. In addition, I run two small companies, a marketing and communication company, ROOTime, and I have a small publishing agency. Furthermore, I write my own regional novels with a friend of mine. In my spare time I like to cook and do some wine tasting. I am also a patient partner for the National Association ReumaZorg Nederland, which is the Dutch patient organization for all people in the Netherlands with rheumatism.",{"type":152,"children":3333},[3334],{"text":3335,"type":156},"I was diagnosed with rheumatoid arthritis (RA) when I was 16 years old. I remember the first symptoms when I was about 10 years old. When the pain was unbearable, I went to see the doctor, but at first they thought it was nothing severe. At that time, in the 70s, a RA diagnosis was not common among children. Directly after my diagnosis, a doctor recommended me to keep moving despite the pain. Looking back, I am very grateful for this. A friend of mine was also diagnosed with RA, she was given bed rest for a long time and this made her very stiff in her movements and this is not reversible.",{"type":152,"children":3337},[3338],{"text":3339,"type":156},"In 2000, TNF-alpha inhibitors were introduced for the treatment of RA, which I also started to use then. The first biological I used was not effective enough. I had to go to the hospital for injections once every eight weeks, but after six weeks I already needed a new shot due to the pain. Then I started using another biological, etanercept. However, I suffered from blood sedimentation, therefore, the doctor suggested to try adalimumab. Adalimumab alone was not effective enough, so it was combined with methotrexate (MTX). MTX works as a trigger for adalimumab. The combination of adalimumab and MTX did not stop the blood-sedimentation, but is was effective against the pain. Unfortunately, at the end of 2018, I started getting allergic reactions to MTX. Now, I am using MTX tablets together with tocilizumab which seems to work quite well. I used these tablets 22 years ago as well.",{"type":152,"children":3341},[3342],{"text":3343,"type":156,"italic":79},"‘Without biologicals, I would not be so mobile right now.’",{"type":152,"children":3345},[3346],{"text":3347,"type":156},"The transition from etanercept to adalimumab went very smoothly. I did not experience any discomfort during that time. The only burden was the painful adalimumab injections. I had to inject myself every two weeks. The pain was unbearable, but for me it was an acceptable price to pay, as it did relief me from the joint inflammation pain. Trying to make the injections more comfortable, I tried to use the injection pen, but this was no improvement. At this time, my partner started to inject the adalimumab, as it was quite hard to do yourself when it is so painful. One day, when my partner gave the injection, the gruesome pain was suddenly gone. I still do not know how, I suspect it had something to do with the substances in the injection.",{"type":152,"children":3349},[3350],{"text":3351,"type":156},"With the current medication for RA, my future perspective is good. I know it is a progressive disease, and it will only get worse with the years, but I believe with the current innovative treatments and technologies, I will not experience a lot of discomfort. For example, I currently use a speak monitor for my writing, as typing is no longer possible. My new kitchen also contains a lot of adjustments that make cooking much more comfortable, as this is very important to me.",{"type":152,"children":3353},[3354],{"text":3355,"type":156},"‘I have never seen RA as a burden.’",{"type":152,"children":3357},[3358],{"text":3359,"type":156},"A biosensor can make the use of medication more effective and will help for financial reasons. Such a sensor can be applicable for many treatments, as it is an objective measuring tool which tells the doctor and patients what steps need to be taken in the treatment. However, it should be considered in which phases of the treatment process the sensor should be applied and how certain information is shared with the patient. As sometimes, the results might be confronting for a patient at a certain phase in treatment. A patient might feel fine, but a biosensor might show that a treatment is not working at all. I think that biosensors will be very useful in various fields of healthcare. Innovation is only achieved by trying a lot of things in a lot of different ways. SensUs stimulates innovation in healthcare by bringing together students with a lot of different backgrounds. So keep up the good work!",{"type":152,"children":3361},[3362],{"text":3363,"type":156},"‘A competition suggests there is a winner, but in this field, losers are winners as well, because many different solutions should be tried.’",{"type":152,"children":3365},[3366,3368,3373,3375,3380],{"text":3367,"type":156},"This interview was conducted in association with the National Association ReumaZorg Nederland. The National Association ReumaZorg Nederland is the Dutch patient organization for all people in the Netherlands with rheumatism. They give rheumatism a face and a voice in their patient advocacy activities as well as in research and education. Would you like to know more about their activities? Feel free to contact them: ",{"url":3369,"type":236,"children":3370},"mailto:info@reumazorgnederland.nl",[3371],{"text":3372,"type":156},"info@reumazorgnederland.nl",{"text":3374,"type":156}," or have a look on their website:",{"url":3376,"type":236,"children":3377},"http://www.reumazorgnederland.nl",[3378],{"text":3379,"type":156}," www.reumazorgnederland.nl",{"text":887,"type":156},"2026-07-28T11:14:06.422Z","2026-07-28T11:14:06.421Z",{"id":3384,"documentId":3385,"name":3386,"alternativeText":18,"caption":18,"focalPoint":18,"width":3387,"height":3388,"formats":3389,"hash":3418,"ext":280,"mime":283,"size":3419,"url":3420,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":3421,"updatedAt":3421,"publishedAt":3421},1254,"piuwmshujz6c80lsgrltpa0m","gerda-023_(002).jpg",6113,4724,{"large":3390,"small":3397,"medium":3404,"thumbnail":3411},{"ext":280,"url":3391,"hash":3392,"mime":283,"name":3393,"path":18,"size":3394,"width":190,"height":3395,"sizeInBytes":3396},"/uploads/large_gerda_023_002_7ddcbb7b70.jpg","large_gerda_023_002_7ddcbb7b70","large_gerda-023_(002).jpg",77.72,773,77715,{"ext":280,"url":3398,"hash":3399,"mime":283,"name":3400,"path":18,"size":3401,"width":198,"height":3402,"sizeInBytes":3403},"/uploads/small_gerda_023_002_7ddcbb7b70.jpg","small_gerda_023_002_7ddcbb7b70","small_gerda-023_(002).jpg",19.82,386,19822,{"ext":280,"url":3405,"hash":3406,"mime":283,"name":3407,"path":18,"size":3408,"width":206,"height":3409,"sizeInBytes":3410},"/uploads/medium_gerda_023_002_7ddcbb7b70.jpg","medium_gerda_023_002_7ddcbb7b70","medium_gerda-023_(002).jpg",45.65,580,45652,{"ext":280,"url":3412,"hash":3413,"mime":283,"name":3414,"path":18,"size":3415,"width":3416,"height":214,"sizeInBytes":3417},"/uploads/thumbnail_gerda_023_002_7ddcbb7b70.jpg","thumbnail_gerda_023_002_7ddcbb7b70","thumbnail_gerda-023_(002).jpg",4.18,202,4177,"gerda_023_002_7ddcbb7b70",1433.52,"/uploads/gerda_023_002_7ddcbb7b70.jpg","2026-07-28T11:14:06.418Z",{"id":3423,"documentId":3424,"title":3425,"slug":3426,"date":3427,"cardTitle":18,"excerpt":18,"body":3428,"createdAt":3469,"updatedAt":3469,"publishedAt":3470,"cardImage":3471},292,"v92t7w73c9imuhc4lqzy49iu","SensUs Interview: Keita Ito","sensus-interview-keita-ito","2019-06-27",[3429,3433,3437,3441,3445,3449,3453,3457,3461,3465],{"type":152,"children":3430},[3431],{"bold":79,"text":3432,"type":156},"SensUs 2019 focuses on innovative biosensing systems for the treatment of rheumatoid arthritis. Here Keita Ito, full professor in Orthopaedic Biomechanics explains his views on the SensUs competition and this year’s theme.",{"type":152,"children":3434},[3435],{"text":3436,"type":156},"I am Keita Ito and was born in Japan, but I grew up in both the Japanese and American culture. I did my university studies, my graduate school and medical school all in Boston. I am trained as orthopedic surgeon but I also have a doctorate in biomedical engineering. At the moment, I am a full professor and I lead the orthopaedic biomechanics research group in the department of Biomedical Engineering at the Eindhoven University of Technology.",{"type":152,"children":3438},[3439],{"text":3440,"type":156},"My passions are science and engineering, and tend to focus on the things that cross over the line between the two. As a medical doctor, I am passionate about fundamental science and I try to translate the insights to the clinic. In my career I have been flip-flopping between engineering and science. It is only since six years that I have been able to find a balance between these two, as I am now also working at the orthopedics department in Utrecht one day a week. This translates into having more contact with clinicians, also in de region of Eindhoven.",{"type":152,"children":3442},[3443],{"text":3444,"type":156},"Within the orthopaedic biomechanics research group, we focus on biomechanics, because all these tissues have a mechanical function. We study articular cartilage for example. I think the theme of SensUs 2019 is a great theme. I think arthritis is in the top five reasons, if not the number one reason why people visit a doctor. Everybody experiences joint aches and complains about it, especially later in life. Our population is getting older and staying active later in life, thus these joint aches become quite important as it affects your daily activities. There is a saying ‘Movement is life, life is movement’, if your ability to move is taken away, your life is pretty limited.",{"type":152,"children":3446},[3447],{"text":3448,"type":156,"italic":79},"“Movement is life, life is movement.”",{"type":152,"children":3450},[3451],{"text":3452,"type":156},"Point of care testing can be of great value in reumatoïd arthritis. A good argument for why people with rheumatoid arthritis should have access to point of care testing and chemical monitoring, is that most rheumatoid arthritis patients have no idea what the status of their joints is. In the past, the only focus in treating RA was on treating the pain and not on treating the disease. The problem with only treating the pain, is that you can give someone pain killers which relieves the pain, but at the same time, they are damaging their joints.",{"type":152,"children":3454},[3455],{"text":3456,"type":156},"The main problem with rheumatoid arthritis is that cartilage is being worn away slowly. Cartilage is a tissue that does not repair, unless you do something about it. If you allow these patients to be pain free, but also let the disease progress and damage the cartilage, then at some point there is a point of no return. With the points of care and chemical monitoring, you have a chance to not only give the patient feedback about their pain complaints, but also inform them whether the drug is actually modifying the disease.",{"type":152,"children":3458},[3459],{"text":3460,"type":156,"italic":79},"“If you allow patients to be pain free, but also let the disease progress and damage the cartilage, then at some point there is a point of no return.”",{"type":152,"children":3462},[3463],{"text":3464,"type":156},"The SensUs competition gives a purposeful application of the knowledge that you use as a student. Furthermore, it is always fun to achieve this common goal, the development of the best biosensor, as a team. And it is even more fun to compete against the other teams, even though the competition is good-willed. Competitions similar to that of SensUs are also present in other fields of research and often have really surprising outcomes.",{"type":152,"children":3466},[3467],{"text":3468,"type":156},"The advice I would give to the teams has to do with the fact that during the development of these point of care testing systems, there is often a lot of attention paid to the science behind it and care given to the opinion of caregivers, but sometimes not enough attention given to the patients themselves. The opinion of the patients is very important, especially in terms of the impact on their lives, how it is easy to use, how it is easy to understand and the motivation they can get from using these systems. In the end, hardly any of these point of care systems are ‘patient-proof’, in a way that they work independently of the patient, you need the involvement of the patient to get them to work. Only if the patients are happy with the system and see the value it gives to them, the system is going to work. That would be one of the things I have learned in the past about systems that interact with patients and would like to give to the teams as advice.","2026-07-28T11:14:06.991Z","2026-07-28T11:14:06.990Z",{"id":3472,"documentId":3473,"name":3474,"alternativeText":18,"caption":18,"focalPoint":18,"width":3475,"height":3476,"formats":3477,"hash":3506,"ext":280,"mime":283,"size":3507,"url":3508,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":3509,"updatedAt":3509,"publishedAt":3509},1256,"aqyhi6k3xcs3ho3id2ursuuj","BvOF_2015_TUe-BMT_Keita_Ito_-staand-.jpg",933,1159,{"large":3478,"small":3485,"medium":3492,"thumbnail":3499},{"ext":280,"url":3479,"hash":3480,"mime":283,"name":3481,"path":18,"size":3482,"width":3483,"height":190,"sizeInBytes":3484},"/uploads/large_Bv_OF_2015_T_Ue_BMT_Keita_Ito_staand_6cde9ece27.jpg","large_Bv_OF_2015_T_Ue_BMT_Keita_Ito_staand_6cde9ece27","large_BvOF_2015_TUe-BMT_Keita_Ito_-staand-.jpg",122.33,805,122326,{"ext":280,"url":3486,"hash":3487,"mime":283,"name":3488,"path":18,"size":3489,"width":3490,"height":198,"sizeInBytes":3491},"/uploads/small_Bv_OF_2015_T_Ue_BMT_Keita_Ito_staand_6cde9ece27.jpg","small_Bv_OF_2015_T_Ue_BMT_Keita_Ito_staand_6cde9ece27","small_BvOF_2015_TUe-BMT_Keita_Ito_-staand-.jpg",29.7,403,29697,{"ext":280,"url":3493,"hash":3494,"mime":283,"name":3495,"path":18,"size":3496,"width":3497,"height":206,"sizeInBytes":3498},"/uploads/medium_Bv_OF_2015_T_Ue_BMT_Keita_Ito_staand_6cde9ece27.jpg","medium_Bv_OF_2015_T_Ue_BMT_Keita_Ito_staand_6cde9ece27","medium_BvOF_2015_TUe-BMT_Keita_Ito_-staand-.jpg",67.66,604,67657,{"ext":280,"url":3500,"hash":3501,"mime":283,"name":3502,"path":18,"size":3503,"width":3504,"height":214,"sizeInBytes":3505},"/uploads/thumbnail_Bv_OF_2015_T_Ue_BMT_Keita_Ito_staand_6cde9ece27.jpg","thumbnail_Bv_OF_2015_T_Ue_BMT_Keita_Ito_staand_6cde9ece27","thumbnail_BvOF_2015_TUe-BMT_Keita_Ito_-staand-.jpg",4.05,126,4047,"Bv_OF_2015_T_Ue_BMT_Keita_Ito_staand_6cde9ece27",169.26,"/uploads/Bv_OF_2015_T_Ue_BMT_Keita_Ito_staand_6cde9ece27.jpg","2026-07-28T11:14:06.988Z",{"id":3511,"documentId":3512,"title":2790,"slug":3513,"date":3514,"cardTitle":3515,"excerpt":18,"body":3516,"createdAt":3521,"updatedAt":3521,"publishedAt":3522,"cardImage":3523},293,"eok62fx8mge327at0puan6pi","sensus-newsletter-june","2019-06-21","SensUs Newsletter June",[3517],{"type":152,"children":3518},[3519],{"text":3520,"type":156},"Summer vibes means SensUs vibes. The SensUs Innovation Days 2019 will take place in about three months from now and the teams are working hard to show their best biosensors on the event. To keep you updated about the developments, here is our latest news!","2026-07-28T11:14:07.769Z","2026-07-28T11:14:07.766Z",{"id":3524,"documentId":3525,"name":3526,"alternativeText":18,"caption":18,"focalPoint":18,"width":2987,"height":2844,"formats":3527,"hash":3553,"ext":280,"mime":283,"size":3554,"url":3555,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":3556,"updatedAt":3556,"publishedAt":3556},1258,"xf4gryenigrryfb94ukk4a0s","2ABAA.jpg",{"large":3528,"small":3535,"medium":3541,"thumbnail":3547},{"ext":280,"url":3529,"hash":3530,"mime":283,"name":3531,"path":18,"size":3532,"width":190,"height":3533,"sizeInBytes":3534},"/uploads/large_2_ABAA_ada26296a8.jpg","large_2_ABAA_ada26296a8","large_2ABAA.jpg",132.55,562,132548,{"ext":280,"url":3536,"hash":3537,"mime":283,"name":3538,"path":18,"size":3539,"width":198,"height":2557,"sizeInBytes":3540},"/uploads/small_2_ABAA_ada26296a8.jpg","small_2_ABAA_ada26296a8","small_2ABAA.jpg",37.69,37690,{"ext":280,"url":3542,"hash":3543,"mime":283,"name":3544,"path":18,"size":3545,"width":206,"height":2863,"sizeInBytes":3546},"/uploads/medium_2_ABAA_ada26296a8.jpg","medium_2_ABAA_ada26296a8","medium_2ABAA.jpg",79.47,79467,{"ext":280,"url":3548,"hash":3549,"mime":283,"name":3550,"path":18,"size":3551,"width":144,"height":2870,"sizeInBytes":3552},"/uploads/thumbnail_2_ABAA_ada26296a8.jpg","thumbnail_2_ABAA_ada26296a8","thumbnail_2ABAA.jpg",11.35,11351,"2_ABAA_ada26296a8",2749.36,"/uploads/2_ABAA_ada26296a8.jpg","2026-07-28T11:14:07.548Z",{"id":3558,"documentId":3559,"title":3560,"slug":3561,"date":3562,"cardTitle":3563,"excerpt":18,"body":3564,"createdAt":3605,"updatedAt":3605,"publishedAt":3606,"cardImage":3607},294,"r2l6u0akz6sy1p0ddafcw56y","Interview Judith Kreuk: Perspective of an Arthritis Nurse","interview-judith-kreuk","2019-05-23","Interview Judith Kreuk",[3565,3569,3573,3577,3581,3585,3589,3593,3597,3601],{"type":152,"children":3566},[3567],{"bold":79,"text":3568,"type":156},"Judith Kreuk is an arthritis nurse who works at Reade, a center for medical rehabilitation and arthritis, in Amsterdam. SensUs spoke with Judith about her daily activities as an arthritis nurse, trajectories and challenges in treating RA, and her opinion on the SensUs competition.",{"type":152,"children":3570},[3571],{"text":3572,"type":156},"My name is Judith Kreuk, I am an arthritis nurse, and therefore I treat patients with rheumatoid arthritis (RA), but also patients with other forms of arthritis. I run consultation hours where I see many patients who use adalimumab. These consultation hours include information meetings with new patients and meetings with patients who are sent by the rheumatologist to deepen out how the patient is doing. We also conduct meetings to guide and monitor patients in use of biologicals. In this case, we perform a so called ‘visiting moment’ where several tests are performed, like joint examinations, a blood pressure test, weight and length measurement, and filling in a questionnaire.",{"type":152,"children":3574},[3575],{"text":3576,"type":156},"Besides the consultation hours, my daily activities are at the day treatment, where arthritis patients come for the biological treatment through infusion. I perform tests and infusions, and ask patients about their wellbeing. Personal contact with patients is an important part of the job.",{"type":152,"children":3578},[3579],{"text":3580,"type":156,"italic":79},"“We coach and guide patients to regain balance in their daily lives. We are more socially and emotionally involved with patients.”",{"type":152,"children":3582},[3583],{"text":3584,"type":156},"Generally patients first visit the general practitioner with pain in the joints. In case of returning joint inflammations, the patient will go to the rheumatologist. If the results point out that the patient is suffering from RA, the patient will come in the arthritis care path. During the first year after the diagnosis, patients visit the arthritis nurse and the rheumatologist alternately a couple times a year. Over the past years the amount of contact moments with patients has increased. This development is the result of the limited time of the rheumatologists and the new more social focus in the treatment.",{"type":152,"children":3586},[3587],{"text":3588,"type":156,"italic":79},"“Some patients who suffered from RA for many years have said to me that they have never been to an arthritis nurse before, only to consultation moments with rheumatologists in the past.”",{"type":152,"children":3590},[3591],{"text":3592,"type":156},"An important challenge in the treatment of RA is to create a situation where the progress of the disease can be predicted. It is important to know how much adalimumab is needed to inhibit the activity of the disease. Adalimumab is a TNF-alpha inhibitor which blocks the inflammations in the joints. In some cases, the medicine circulates in the blood but does not block TNF-alpha and has no effect. A biosensor can help with fine-tuning the dose to prevent over- or underdosing. Overdosing can lead to side effects such as respiratory tract infections and an increased risk of skin cancer. As adalimumab has not been on the market that long, the long-term side effects are still unsure. Underdosing can lead to more joint damage.",{"type":152,"children":3594},[3595],{"text":3596,"type":156,"italic":79},"“An important challenge in the treatment of RA is to create a situation where the progress of the disease can be predicted.”",{"type":152,"children":3598},[3599],{"text":3600,"type":156},"Furthermore, a biosensor could provide insights for the patients in their own treatment. When a patient measures the adalimumab concentration, concludes that it is good and but still suffers from joint pain, the patient can get insights in the fact that he or she might have done a bit too much and take more control over the treatment.",{"type":152,"children":3602},[3603],{"text":3604,"type":156},"I would like to advise the teams to make sure that the biosensor design is patient-friendly. The teams should determine what extent the patients need to interpret the measurements and take action themselves. For patients who have suffered from RA for a longer period of time and suffer from joint damage, it is important that the device is manageable and patients do not become dependent on their partner to use it. Finally, take into account that not all patients might immediately see the added value of such a monitoring device, as it can be disturbing to be repeatedly confronted with the disease. The SensUs competition can provide added value to healthcare when the interests of the patient are carefully taken into account.","2026-07-28T11:14:08.144Z","2026-07-28T11:14:08.143Z",{"id":3608,"documentId":3609,"name":3610,"alternativeText":18,"caption":18,"focalPoint":18,"width":3611,"height":3612,"formats":3613,"hash":3638,"ext":280,"mime":283,"size":3639,"url":3640,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":3641,"updatedAt":3641,"publishedAt":3641},1265,"nq671o76qc0yakn9t156jhff","IMG_20190311_161415.jpg",4608,3456,{"large":3614,"small":3620,"medium":3626,"thumbnail":3632},{"ext":280,"url":3615,"hash":3616,"mime":283,"name":3617,"path":18,"size":3618,"width":190,"height":206,"sizeInBytes":3619},"/uploads/large_IMG_20190311_161415_241c09d651.jpg","large_IMG_20190311_161415_241c09d651","large_IMG_20190311_161415.jpg",90.03,90029,{"ext":280,"url":3621,"hash":3622,"mime":283,"name":3623,"path":18,"size":3624,"width":198,"height":654,"sizeInBytes":3625},"/uploads/small_IMG_20190311_161415_241c09d651.jpg","small_IMG_20190311_161415_241c09d651","small_IMG_20190311_161415.jpg",30.34,30342,{"ext":280,"url":3627,"hash":3628,"mime":283,"name":3629,"path":18,"size":3630,"width":206,"height":661,"sizeInBytes":3631},"/uploads/medium_IMG_20190311_161415_241c09d651.jpg","medium_IMG_20190311_161415_241c09d651","medium_IMG_20190311_161415.jpg",57.79,57790,{"ext":280,"url":3633,"hash":3634,"mime":283,"name":3635,"path":18,"size":3636,"width":3107,"height":214,"sizeInBytes":3637},"/uploads/thumbnail_IMG_20190311_161415_241c09d651.jpg","thumbnail_IMG_20190311_161415_241c09d651","thumbnail_IMG_20190311_161415.jpg",7.79,7794,"IMG_20190311_161415_241c09d651",1131.7,"/uploads/IMG_20190311_161415_241c09d651.jpg","2026-07-28T11:14:08.142Z",{"id":3643,"documentId":3644,"title":3645,"slug":3646,"date":3647,"cardTitle":3648,"excerpt":18,"body":3649,"createdAt":3792,"updatedAt":3792,"publishedAt":3793,"cardImage":3794},295,"keofmels2ie81rfffkvspux5","Successes of SensUs teams after the SensUs competition","sensus-success-stories","2019-05-22","SensUs Success Stories",[3650,3654,3658,3662,3666,3670,3674,3678,3703,3707,3711,3715,3719,3723,3727,3731,3748,3752,3756,3760,3764,3768,3772,3776,3780,3784,3788],{"type":152,"children":3651},[3652],{"bold":79,"text":3653,"type":156},"In the annual SensUs competition, teams of students strive to make the best possible biosensors and win the SensUs awards. But how are the teams, and their prototypes, doing after the competition? We spoke with six alumni teams who told us about their activities and recognition after the competition.",{"type":152,"children":3655},[3656],{"text":3657,"type":156},"The international SensUs competition challenges multi-disciplinary teams of students to develop innovative biosensors for real-live applications. The teams consist of students with varying age, education and experience. This results in a wide range of creative ideas that are implemented in their prototypes. The SensUs competition is the start of an innovative journey.",{"type":379,"level":106,"children":3659},[3660],{"bold":79,"text":3661,"type":156},"KreaSensa 2016",{"type":152,"children":3663},[3664],{"text":3665,"type":156},"The theme of SensUs 2016 was kidney failure and the teams developed biosensors to detect Creatinine in blood, a biomarker of chronic kidney disease (CKD). KreaSensa, the team form KU Leuven, was the winner of the first edition of SensUs. They won the Analytical Performance award, the Translation Potential award and the Public Inspiration award. KU Leuven filed a patent application on the technology that was part of the KreaSensa prototype. After the competition Francesco Dal Dosso, who was the coach of KreaSensa 2016, and Elena Perez Ruiz enrolled in a training course at the KU Leuven on knowledge and technology transfer and the exploitation of research. In the course they developed a business case based on their SensUs results, and they were the winner in this training course!",{"type":152,"children":3667},[3668],{"text":3669,"type":156},"KeaSensa wrote a scientific paper on their biosensor, that was published in Analytica Chimica Acta in 2018. Their biosensor has not gone unnoticed; KreaSensa was invited to present their biosensor at three recognized events.",{"type":152,"children":3671},[3672],{"text":3673,"type":156},"The first event was the annual event of the Dutch Kidney Foundation and the Association for Kidney Patients on the 13th of January 2017 in Hilversum. The second event was at the MicroTas conference in Savannah, USA, where Kreasensa gave a presentation entitled “Self-powered SIMPLE chip for CKD diagnosis and monitoring using the POC Creasensor”. They presented the CreaSensor, a true point-of-care (POC) biosensor for the detection of creatinine in blood plasma. CreaSensor combines SIMPLE technology, a powerful microfluidics tool that requires no external power for activation or liquid manipulation, with a colorimetric read-out and an enzymatic bio-assay.",{"type":152,"children":3675},[3676],{"text":3677,"type":156},"The third event was a workshop for GPs in Utrecht, The Netherlands, where KreaSensa gave a presentation entitled “SIMPLE, microfluidic devices for POC applications”, by Jolien Breukers and Francesco Dal Dosso.",{"type":152,"children":3679},[3680,3682,3687,3689,3694,3696,3701],{"text":3681,"type":156},"Francesco kept working on the technology during his PhD after the competition. Currently, the Biosensors group in KU Leuven, led by Prof. Jeroen Lammertyn, is further developing the microfluidic technology. The research group received funding to continue working on the microfluidic platform for many applications. The group is looking into different valorization strategies and has published papers in several journals (of ",{"url":3683,"type":236,"children":3684},"https://link.springer.com/article/10.1007%2Fs10544-018-0289-1",[3685],{"text":3686,"type":156},"SpringerLink",{"text":3688,"type":156},", ",{"url":3690,"type":236,"children":3691},"https://www.sciencedirect.com/science/article/abs/pii/S0924424718318910?dgcid=coauthor",[3692],{"text":3693,"type":156},"ScienceDirect ",{"text":3695,"type":156},"and",{"url":3697,"type":236,"children":3698},"https://pubs.acs.org/doi/10.1021/acssensors.8b01555",[3699],{"text":3700,"type":156}," the American Chemical Society",{"text":3702,"type":156},").",{"type":152,"children":3704},[3705],{"text":3706,"type":156,"italic":79},"‘The Biosensors group at KU Leuven is currently exploring all the potential of the SIMPLE technology both in diagnostics and therapeutics applications.’",{"type":379,"level":106,"children":3708},[3709],{"bold":79,"text":3710,"type":156},"Uppsala 2017",{"type":152,"children":3712},[3713],{"text":3714,"type":156},"The theme of SensUs 2017 was heart failure and the teams developed biosensors to detect NT-proBNP in blood, an important biomarker of heart failure. UppSense, the team from Uppsala University, took home the Creativity award. After the competition in 2017, the team received the Swedish Embedded Award at the Annual Scandinavian Embedded Systems Conference. The team won the award for the best newly developed intelligent systems of the year in the student category. They were rewarded with SEK 25000. The Scandinavian Embedded Systems Conference is considered the largest embedded conference of Europe and it attracts a lot of interest from the Swedish industries and academics.",{"type":379,"level":106,"children":3716},[3717],{"bold":79,"text":3718,"type":156},"T.E.S.T 2017",{"type":152,"children":3720},[3721],{"text":3722,"type":156},"Team T.E.S.T, the team from Eindhoven University of Technology, took home three awards in SensUs 2017; they were the winner of the Analytical Performance Award, the Translational Potential Award and the Public Inspiration Award. In the same year, they won the Student Teams Award in the TU/e Contest, worth 5000 euro.",{"type":152,"children":3724},[3725],{"text":3726,"type":156},"After the competition four members of team T.E.S.T kept working on the biosensor. They spoke with marketeers, technology experts, medical doctors and with a large healthcare company to further develop their concept. Unfortunately, the students of team T.E.S.T did not have enough time and resources to continue working on the biosensor and stopped. The technology is being further developed in a research group at Eindhoven University of Technology and a related patent has been extended by a large healthcare company.",{"type":379,"level":106,"children":3728},[3729],{"bold":79,"text":3730,"type":156},"SenSwiss 2018",{"type":152,"children":3732},[3733,3735,3740,3741,3746],{"text":3734,"type":156},"The theme of SensUs 2018 was “Measuring antibiotics for better healthcare’’ and the teams developed biosensors to detect the antibiotic vancomycin in blood. SenSwiss, the team from EPFL (the Swiss Federal Institute of Technology in Lausanne) was the winner of SensUs 2018. They won the Analytical Performance Award and were the runner-up of the Creativity Award and the Translational Potential Award. In Switzerland the success of SenSwiss was on the radio. In an ",{"url":3736,"type":236,"children":3737},"https://youtu.be/MVASUV8_OzI",[3738],{"text":3739,"type":156},"interview with radio channel Couleur 3",{"text":3688,"type":156},{"url":3742,"type":236,"children":3743},"https://www.facebook.com/SenSwissEPFL/?__tn__=K-R&eid=ARCv1HIkP-gIbWS4byFqTMXDIA3P1d_trFCblwjxNevf0iSHv-VGWpMf1dNVfhrhmVmvzJD3ntAzzdvT&fref=mentions&__xts__%5B0%5D=68.ARCalcrGQtc05tO5cBVVZbHVAkx86_mYWBniX6JPQgKO1CtOxJU_B15R5HecBi_p-z2W_26SYkRDTEX54OZaxlSzs60Re1DrWQL6l_VNSaxUjl6CDtrsZ5-b13g96ceIxcw4ddehCbGI7wpLaC3Ai-WZGUuksLPcKNsZC5Ln20TT35iwXwOS0F40bWpYnjS_OGRaiD6Xxf9sC6Mnvt8p5TDTpFiQaZe4DiLZtHwaZzgGT0xn85WoDvTFu0gQpuZcqqu-FQ96P81hxBJ5-xfj6lnFYusAs92KYAm_oiymm4SFo2fW8L8nQaK0r0N73YncWN-DCsr8qUNTR8ImNRLynJNjDahKVAs5IK_rMjU6zKk_6EsU4fG7N---x3tbJ1uxcIhG_VaclrkW45F5RIApKu_arJLBWS-7V0zSzifhnlfGW8tMZ4d87p6rAl8WHffpJ7DMWgg55mjlIoro53WVn6MwDi-FqLGyhNP9Z0BbXfqi6E_5qPzC_lg",[3744],{"text":3745,"type":156},"SenSwiss",{"text":3747,"type":156}," explained that four team members continued to work on the biosensor. They participated in “START Lausanne”, a competition for startups. They competed with 60 other start-ups and made it till the finals!",{"type":152,"children":3749},[3750],{"text":3751,"type":156},"Currently, SenSwiss a start-up company and they are in a support program of the Swiss Federal Institute of Technology in Lausanne to further develop their biosensor.",{"type":152,"children":3753},[3754],{"text":3755,"type":156},"Furthermore, SenSwiss has been invited, together with the SensUs Organization, to give a presentation at EuroMedLab 2019, the large European Congress of Clinical Lab Medicine, which takes place in Barcelona in May 2019. This is an honor for SenSwiss as well as for the SensUs Organization.",{"type":152,"children":3757},[3758],{"text":3759,"type":156,"italic":79},"‘Our SensUs journey was amazing. The opportunity to develop our own prototype was fantastic and even more now that we are still working on it. SensUs was a concrete push into the biosensing field and it opened perspectives that we would not have imagined before the competition. Also, it is a real honour to be invited to EuroMedLab 2019 even though we will not be able to attend it. We are happy that team VanGow has taken the opportunity to speak at the conference.’",{"type":379,"level":106,"children":3761},[3762],{"bold":79,"text":3763,"type":156},"DeTectUs 2018",{"type":152,"children":3765},[3766],{"text":3767,"type":156},"DeTectUs was the team from the Technical University of Denmark in SensUs 2018. The university filed a patent application on the technology that was part of the biosensor prototype. The team continues the development of the vancomycin sensor and plans to create a startup company. Recently DeTectUs received their first funding and they are waiting for on a second source of funding.",{"type":379,"level":106,"children":3769},[3770],{"bold":79,"text":3771,"type":156},"VanGow 2018",{"type":152,"children":3773},[3774],{"text":3775,"type":156},"VanGow, the team from the University of Glasgow, took home two prizes in SensUs 2018: they were the winner of the Creativity Award and the runner-up of the Analytical Performance Award. After the competition, they kept working on their biosensor with the support of their supervisors Dr. Julien Reboud and Dr. Hadi Heidari and the university.",{"type":152,"children":3777},[3778],{"text":3779,"type":156},"VanGow is collaborating with Multi Dimension Technology (MDT) who provided the team with state-of-the-art TMR sensors worth 6000 dollars and EIT health who support the team financially. Currently, VanGow is connecting with the NHS (The National Health Service) and they have been invited to participate in a creativity event at the University of Glasgow.",{"type":152,"children":3781},[3782],{"text":3783,"type":156},"VanGow attended a meeting with the Scottish Minister of Trade, Investment and Innovation, Mr Ivan McKee and several secretaries of the Scottish Government. The minister wrote a letter of recognition to VanGow describing how proud Scotland is of the team and offering help towards taking forward VanGow's biosensor and start-up company.",{"type":152,"children":3785},[3786],{"text":3787,"type":156,"italic":79},"“It was great to receive an invitation to meet with the Scottish Minister and to see the level of support and enthusiasm the Scottish Government has for innovation and healthcare. The importance the Ministry gives to these fields is really praiseworthy!”",{"type":152,"children":3789},[3790],{"text":3791,"type":156},"In conclusion, the teams that participated in the first three editions of the SensUs competition have received external recognition, technologies have been patented, and several teams remained active in making next steps with their biosensor, including development toward startup companies. This underlines the mission of SensUs to stimulate education as well as innovation in the field of biosensing, for a better quality of life. The innovation journey of SensUs has only just started and we are committed to make it grow to its full potential.","2026-07-28T11:14:09.088Z","2026-07-28T11:14:09.087Z",{"id":3795,"documentId":3796,"name":3797,"alternativeText":18,"caption":18,"focalPoint":18,"width":3798,"height":3799,"formats":3800,"hash":3825,"ext":280,"mime":283,"size":3826,"url":3827,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":3828,"updatedAt":3828,"publishedAt":3828},1267,"od3c0x79bst5e8o8rito8a3c","44654578681_683b586ce9_o.jpg",7439,4959,{"large":3801,"small":3807,"medium":3813,"thumbnail":3819},{"ext":280,"url":3802,"hash":3803,"mime":283,"name":3804,"path":18,"size":3805,"width":190,"height":286,"sizeInBytes":3806},"/uploads/large_44654578681_683b586ce9_o_1c1292728c.jpg","large_44654578681_683b586ce9_o_1c1292728c","large_44654578681_683b586ce9_o.jpg",122.78,122782,{"ext":280,"url":3808,"hash":3809,"mime":283,"name":3810,"path":18,"size":3811,"width":198,"height":293,"sizeInBytes":3812},"/uploads/small_44654578681_683b586ce9_o_1c1292728c.jpg","small_44654578681_683b586ce9_o_1c1292728c","small_44654578681_683b586ce9_o.jpg",40.22,40215,{"ext":280,"url":3814,"hash":3815,"mime":283,"name":3816,"path":18,"size":3817,"width":206,"height":198,"sizeInBytes":3818},"/uploads/medium_44654578681_683b586ce9_o_1c1292728c.jpg","medium_44654578681_683b586ce9_o_1c1292728c","medium_44654578681_683b586ce9_o.jpg",75.78,75780,{"ext":280,"url":3820,"hash":3821,"mime":283,"name":3822,"path":18,"size":3823,"width":306,"height":214,"sizeInBytes":3824},"/uploads/thumbnail_44654578681_683b586ce9_o_1c1292728c.jpg","thumbnail_44654578681_683b586ce9_o_1c1292728c","thumbnail_44654578681_683b586ce9_o.jpg",12.02,12019,"44654578681_683b586ce9_o_1c1292728c",4580.3,"/uploads/44654578681_683b586ce9_o_1c1292728c.jpg","2026-07-28T11:14:09.085Z",{"id":3830,"documentId":3831,"title":3832,"slug":3833,"date":3834,"cardTitle":18,"excerpt":18,"body":3835,"createdAt":3880,"updatedAt":3880,"publishedAt":3881,"cardImage":3882},296,"c9yabsp6wfqkps2sodhjv1bo","SensUs Personal Stories: Wendy","sensus-personal-stories-wendy","2019-05-16",[3836,3840,3844,3848,3852,3856,3860,3864,3868,3872,3876],{"type":152,"children":3837},[3838],{"bold":79,"text":3839,"type":156},"SensUs 2019 challenges teams of students to develop biosensors for the detection of adalimumab, an important drug for patients with rheumatoid arthritis (RA). RA is a disease that can strike already at very young age. Wendy got diagnosed with RA before her 18th birthday and tells her story here.",{"type":152,"children":3841},[3842],{"text":3843,"type":156},"My name is Wendy, I am twenty-four years old and I am currently a PhD student at Eindhoven University of Technology. When I was fourteen years old, I started to suffer from symptoms indicative of RA. However, the doctors did not diagnose me with RA because they did not believe it was possible to have the disease at such a young age. Two years later, the doctors discovered that I had a damaged hip and confirmed that I indeed had RA.",{"type":152,"children":3845},[3846],{"text":3847,"type":156},"RA is a chronic inflammatory disease that causes inflammations in the joints, which slowly leads to destruction of the cartilage and damaged joints. The disease causes pain in my joints, mainly in my hip and elbows and it also makes me easily tired. Due to my damaged hip and the irreversible destruction of the cartilage, I had to undergo a hip replacement two years ago.",{"type":152,"children":3849},[3850],{"text":3851,"type":156},"People are often surprised when they find out I have RA. It is an invisible illness and people don’t expect me to have RA because of my age. When I just discovered I had RA, I went up to my PE teacher at high school to tell him that I was not able to join his gym lessons anymore. He was completely surprised and, just like the doctors that examined me when I was fourteen, he did not believe I could suffer from such a disease at my age. Another somewhat funny example is when elderly enter the train and expect me to stand up for them. I often get weird looks when I keep a seat occupied instead of standing up, but they obviously cannot know that my joints are maybe even in a worse state than theirs. The fact that RA is an invisible illness is for me both the best and the worst thing about having the disease. When I am having a good day, I can pretend that nothing is wrong and do anything I want to do. However, when I am having a bad day, people will not immediately see that I could use some help.",{"type":152,"children":3853},[3854],{"text":3855,"type":156,"italic":79},"“I think the best and also the worst thing about having arthritis is that it is an invisible illness.”",{"type":152,"children":3857},[3858],{"text":3859,"type":156},"The disease is very unpredictable, some days are really good, others are not. In general, I can do almost anything I want to do, but I definitely need to do things at my own pace. For instance, it is not possible for me to work 40 hours at the office, so I try to work at home a couple of days. With adjustments here and there, I try to get through the day like anyone else.",{"type":152,"children":3861},[3862],{"text":3863,"type":156,"italic":79},"“Unfortunately, arthritis cannot be cured (yet), but with the current drugs I can reduce the pain and inflammations and I am able to do whatever I want to do.”",{"type":152,"children":3865},[3866],{"text":3867,"type":156},"A short while ago, I started using adalimumab because I reacted badly on other medications. Now, I need to inject myself with adalimumab once every two weeks. The treatment with adalimumab has been effective until now and I have not experienced any side effects as I did with the previous treatments.",{"type":152,"children":3869},[3870],{"text":3871,"type":156},"The main problem with drugs such as adalimumab is that people can experience a lot of side effects and it takes a long time to figure out whether it is effective or not. I am stable now, but last year I had to go to the hospital every six weeks to check if I was responding to the treatment. These periodic check-ups are time consuming, since my hospital is in Groningen, a city at the other side of the country. Therefore, I think that a biosensor could have been a good addition to my treatment, as this device could tell me if the drug dosage is optimal and indicate if the inflammations are indeed controlled or not.",{"type":152,"children":3873},[3874],{"text":3875,"type":156,"italic":79},"“A biosensor could be a good addition to my treatment, as this device tells me if the drug dosage is optimal and indicate if the inflammation is indeed controlled or not.”",{"type":152,"children":3877},[3878],{"text":3879,"type":156},"Besides my job as a PhD student, I am the chair of Youth-R-Well. Youth-R-Well is an organization for young adults with arthritis between 16 and 30 years old. They organize activities and provide information on how to live with the disease. Being a part of Youth-R-Well has made me realize that there are a lot of cool young people with arthritis who can help each other in accepting the disease.","2026-07-28T11:14:09.171Z","2026-07-28T11:14:09.170Z",{"id":3883,"documentId":3884,"name":3885,"alternativeText":18,"caption":18,"focalPoint":18,"width":3886,"height":3887,"formats":3888,"hash":3913,"ext":598,"mime":283,"size":3914,"url":3915,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":3916,"updatedAt":3916,"publishedAt":3916},1269,"vwdgqdhr4tpvunbuqitgg8jv","WhatsApp_Image_2019-05-16_at_11.43.16.jpeg",1600,1066,{"large":3889,"small":3895,"medium":3901,"thumbnail":3907},{"ext":598,"url":3890,"hash":3891,"mime":283,"name":3892,"path":18,"size":3893,"width":190,"height":286,"sizeInBytes":3894},"/uploads/large_Whats_App_Image_2019_05_16_at_11_43_16_d953b85da3.jpeg","large_Whats_App_Image_2019_05_16_at_11_43_16_d953b85da3","large_WhatsApp_Image_2019-05-16_at_11.43.16.jpeg",43.62,43621,{"ext":598,"url":3896,"hash":3897,"mime":283,"name":3898,"path":18,"size":3899,"width":198,"height":293,"sizeInBytes":3900},"/uploads/small_Whats_App_Image_2019_05_16_at_11_43_16_d953b85da3.jpeg","small_Whats_App_Image_2019_05_16_at_11_43_16_d953b85da3","small_WhatsApp_Image_2019-05-16_at_11.43.16.jpeg",15.96,15955,{"ext":598,"url":3902,"hash":3903,"mime":283,"name":3904,"path":18,"size":3905,"width":206,"height":198,"sizeInBytes":3906},"/uploads/medium_Whats_App_Image_2019_05_16_at_11_43_16_d953b85da3.jpeg","medium_Whats_App_Image_2019_05_16_at_11_43_16_d953b85da3","medium_WhatsApp_Image_2019-05-16_at_11.43.16.jpeg",28.55,28548,{"ext":598,"url":3908,"hash":3909,"mime":283,"name":3910,"path":18,"size":3911,"width":617,"height":214,"sizeInBytes":3912},"/uploads/thumbnail_Whats_App_Image_2019_05_16_at_11_43_16_d953b85da3.jpeg","thumbnail_Whats_App_Image_2019_05_16_at_11_43_16_d953b85da3","thumbnail_WhatsApp_Image_2019-05-16_at_11.43.16.jpeg",5.38,5376,"Whats_App_Image_2019_05_16_at_11_43_16_d953b85da3",79.41,"/uploads/Whats_App_Image_2019_05_16_at_11_43_16_d953b85da3.jpeg","2026-07-28T11:14:09.168Z",{"id":3918,"documentId":3919,"title":3920,"slug":3921,"date":3922,"cardTitle":18,"excerpt":18,"body":3923,"createdAt":3932,"updatedAt":3932,"publishedAt":3933,"cardImage":3934},297,"d4qdwanmyt80txh3vpw8rzml","SensUs Newsletter April","sensus-newsletter-april","2019-04-25",[3924,3928],{"type":379,"level":380,"children":3925},[3926],{"text":3927,"type":156},"Making innovation happen!",{"type":152,"children":3929},[3930],{"text":3931,"type":156},"It’s already April and that means that the SensUs Innovation Days are coming closer! The teams are busy working on their prototypes and the preparations for the event are in full swing. Here you find the latest news on our innovative developments!","2026-07-28T11:14:10.695Z","2026-07-28T11:14:10.692Z",{"id":3935,"documentId":3936,"name":3937,"alternativeText":18,"caption":18,"focalPoint":18,"width":3938,"height":3939,"formats":3940,"hash":3965,"ext":280,"mime":283,"size":3966,"url":3967,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":3968,"updatedAt":3968,"publishedAt":3968},1271,"aii48qaamo8e3bic39fvu2yn","BvOF_2018_1011_AUR_-_studententeam_SensUs.jpg",7381,4921,{"large":3941,"small":3947,"medium":3953,"thumbnail":3959},{"ext":280,"url":3942,"hash":3943,"mime":283,"name":3944,"path":18,"size":3945,"width":190,"height":345,"sizeInBytes":3946},"/uploads/large_Bv_OF_2018_1011_AUR_studententeam_Sens_Us_42975f2fc1.jpg","large_Bv_OF_2018_1011_AUR_studententeam_Sens_Us_42975f2fc1","large_BvOF_2018_1011_AUR_-_studententeam_SensUs.jpg",156.12,156115,{"ext":280,"url":3948,"hash":3949,"mime":283,"name":3950,"path":18,"size":3951,"width":198,"height":352,"sizeInBytes":3952},"/uploads/small_Bv_OF_2018_1011_AUR_studententeam_Sens_Us_42975f2fc1.jpg","small_Bv_OF_2018_1011_AUR_studententeam_Sens_Us_42975f2fc1","small_BvOF_2018_1011_AUR_-_studententeam_SensUs.jpg",47.45,47453,{"ext":280,"url":3954,"hash":3955,"mime":283,"name":3956,"path":18,"size":3957,"width":206,"height":198,"sizeInBytes":3958},"/uploads/medium_Bv_OF_2018_1011_AUR_studententeam_Sens_Us_42975f2fc1.jpg","medium_Bv_OF_2018_1011_AUR_studententeam_Sens_Us_42975f2fc1","medium_BvOF_2018_1011_AUR_-_studententeam_SensUs.jpg",93.06,93064,{"ext":280,"url":3960,"hash":3961,"mime":283,"name":3962,"path":18,"size":3963,"width":306,"height":214,"sizeInBytes":3964},"/uploads/thumbnail_Bv_OF_2018_1011_AUR_studententeam_Sens_Us_42975f2fc1.jpg","thumbnail_Bv_OF_2018_1011_AUR_studententeam_Sens_Us_42975f2fc1","thumbnail_BvOF_2018_1011_AUR_-_studententeam_SensUs.jpg",13.18,13183,"Bv_OF_2018_1011_AUR_studententeam_Sens_Us_42975f2fc1",4924.08,"/uploads/Bv_OF_2018_1011_AUR_studententeam_Sens_Us_42975f2fc1.jpg","2026-07-28T11:14:10.115Z",{"id":3970,"documentId":3971,"title":3972,"slug":3973,"date":3974,"cardTitle":18,"excerpt":18,"body":3975,"createdAt":4035,"updatedAt":4035,"publishedAt":4036,"cardImage":4037},298,"n7m5vr6qotgjyc9nj9vzbvx0","Interview: Perspective of a rheumatologist","interview-perspective-rheumatologist","2019-04-23",[3976,3979,3983,3987,3991,3995,3999,4003,4007,4011,4015,4019,4023,4027,4031],{"type":379,"level":106,"children":3977},[3978],{"text":2790,"type":156},{"type":152,"children":3980},[3981],{"text":3982,"type":156},"I am Eric-Jan Kroot, rheumatologist for almost thirteen years in the south of The Netherlands. I studied medicine and wrote my thesis about ‘Therapy and outcome of rheumatoid arthritis’ in Nijmegen, at the Radboud University. The treatment of rheumatoid arthritis has always been important to me. This is one of the reasons why I co-founded the rheumatology clinical practice at the Elkerliek Hospital in Helmond, to ensure that patients living in this area get the best rheumatologic care close to their homes.",{"type":379,"level":106,"children":3984},[3985],{"text":3986,"type":156},"Helping rheumatic patients",{"type":152,"children":3988},[3989],{"text":3990,"type":156},"RA is an invisible disease, some people might not even know that they have RA. This also makes the disease very difficult to treat. Early detection and diagnosis of RA are very important, because early treatment can prevent mechanical problems and the chances to get other diseases, such as cardiovascular diseases. The most difficult symptoms to treat in RA are the fatigue and pain. These discomforts can strongly affect the daily life of a patient. Pain and fatigue have to be reduced, to ensure the patients can still work and have a good life.",{"type":152,"children":3992},[3993],{"text":3994,"type":156,"italic":79},"‘When I just started working as a rheumatologist, patients could end in a wheelchair. Nowadays, this does not happen anymore.’",{"type":152,"children":3996},[3997],{"text":3998,"type":156},"In the past, the rheumatologist would treat the patient and tell him or her what to do. Nowadays, the patient is treated by a team consisting of nurses, rheumatologists, physiotherapists and other specialists. Furthermore, since internet has become available, patients know a lot about the disease and the treatments, and want to be involved in the decision-making and the treatment. In the future, I think patients will get an even bigger role in the treatment of RA. Here, biosensing can play a crucial role. Patients themselves can measure their medication levels and disease activity, which leads to shared decision-making with the patient and improvement of the treatment.",{"type":152,"children":4000},[4001],{"text":4002,"type":156},"We usually see patients two to four times a year, but this could be reduced to fewer appointments per year when patients can measure disease activity themselves. More frequent measurements will result in better individualized care. Furthermore, by reducing hospital visits, more patients can be treated by the same number of doctors and nurses.",{"type":152,"children":4004},[4005],{"text":4006,"type":156},"Diagnosed patients usually start their treatment with classic Disease-Modifying Anti-Rheumatic Drugs (DMARDs) such as methotrexate and prednisolone, which take two or three months before they start working. If the inflammation is not reduced, we increase the prescribed dose. If the disease activity remains high, then a biological drug will be used. About 30% of the patients will use biologicals in their treatment.",{"type":152,"children":4008},[4009],{"text":4010,"type":156},"An example of a biological is adalimumab, the biomarker of SensUs 2019. Adalimumab is one of the first biologicals that were made. It is the most used drug to treat RA and has been used for almost twenty years, also in other diseases. Patients who use adalimumab usually have less fatigue and less pain, they feel a lot better. In the future, I think it will be very helpful to start the treatment with biologicals such as adalimumab in an earlier stage. Adalimumab is very expensive, but it works more quickly and more frequently than the DMARDs, and has almost no side effects.",{"type":152,"children":4012},[4013],{"text":4014,"type":156,"italic":79},"‘Optimized dosing is very important, for the treatment as well as for the physical condition of the patient.’",{"type":152,"children":4016},[4017],{"text":4018,"type":156},"Nowadays, all RA patients who use adalimumab receive the same dose, 40 mg twice a month. This must be optimized since patients do not weigh the same, have differences in the severity of RA and react differently to the same dose, while adalimumab over-dosing reduces the immune system and increases the possibility for having infections. Presently it takes a long time to get measurement results from a laboratory. We would like to know these levels immediately, to be able to change the therapy right away, e.g. when the drug is not effective or when the risk of side effects can be reduced.",{"type":152,"children":4020},[4021],{"text":4022,"type":156},"‘In the future, it is likely that patients will have a more important role in the treatment. Biosensors can allow patients to measure their own disease activity and levels of medication.’",{"type":379,"level":106,"children":4024},[4025],{"text":4026,"type":156},"Biosensors and the SensUs student competition",{"type":152,"children":4028},[4029],{"text":4030,"type":156},"I like the theme ‘Managing rheumatic disease, by measuring with ease’ of SensUs 2019 a lot, as it is of societal relevance and brings attention to the very large group of rheumatic patients. I think it would be very good if patients could measure their medication and inflammation levels at home. It may be difficult for the most senior patients, but the new patients are more involved with technology at home so they are more likely to embrace a biosensor at home. With biosensors becoming available, we would also get better insight into the patient’s blood levels in the months prior to their hospital visits. In a single visit, we can’t check whether the patient did take the medication all the time and if there has been an increase in inflammation.",{"type":152,"children":4032},[4033],{"text":4034,"type":156},"What I really like about the SensUs competition, is that the competition is innovative from the bottom up. The teams want to build the best sensor, without being influenced by other parties. I advise the teams to always stay in contact with physicians, to ensure that the sensors they are building will be useful in the daily clinical practice. The teams have to keep in mind that their sensor should optimize the treatment and the patient care.","2026-07-28T11:14:11.207Z","2026-07-28T11:14:11.206Z",{"id":4038,"documentId":4039,"name":4040,"alternativeText":18,"caption":18,"focalPoint":18,"width":1487,"height":4041,"formats":4042,"hash":4067,"ext":280,"mime":283,"size":4068,"url":4069,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":4070,"updatedAt":4070,"publishedAt":4070},1279,"hbczb3sn25n6h7qn89490wlo","Foto_Eric-Jan_0.jpg",3543,{"large":4043,"small":4049,"medium":4055,"thumbnail":4061},{"ext":280,"url":4044,"hash":4045,"mime":283,"name":4046,"path":18,"size":4047,"width":345,"height":190,"sizeInBytes":4048},"/uploads/large_Foto_Eric_Jan_0_bc8ca7a404.jpg","large_Foto_Eric_Jan_0_bc8ca7a404","large_Foto_Eric-Jan_0.jpg",80.29,80286,{"ext":280,"url":4050,"hash":4051,"mime":283,"name":4052,"path":18,"size":4053,"width":293,"height":198,"sizeInBytes":4054},"/uploads/small_Foto_Eric_Jan_0_bc8ca7a404.jpg","small_Foto_Eric_Jan_0_bc8ca7a404","small_Foto_Eric-Jan_0.jpg",21.22,21217,{"ext":280,"url":4056,"hash":4057,"mime":283,"name":4058,"path":18,"size":4059,"width":198,"height":206,"sizeInBytes":4060},"/uploads/medium_Foto_Eric_Jan_0_bc8ca7a404.jpg","medium_Foto_Eric_Jan_0_bc8ca7a404","medium_Foto_Eric-Jan_0.jpg",45.69,45690,{"ext":280,"url":4062,"hash":4063,"mime":283,"name":4064,"path":18,"size":4065,"width":570,"height":214,"sizeInBytes":4066},"/uploads/thumbnail_Foto_Eric_Jan_0_bc8ca7a404.jpg","thumbnail_Foto_Eric_Jan_0_bc8ca7a404","thumbnail_Foto_Eric-Jan_0.jpg",3.24,3235,"Foto_Eric_Jan_0_bc8ca7a404",943.09,"/uploads/Foto_Eric_Jan_0_bc8ca7a404.jpg","2026-07-28T11:14:11.205Z",{"id":4072,"documentId":4073,"title":4074,"slug":4075,"date":4076,"cardTitle":18,"excerpt":18,"body":4077,"createdAt":4109,"updatedAt":4109,"publishedAt":4110,"cardImage":4111},299,"sgwoij5bng9xuabqhrds77jr","Participating Teams of SensUs 2019","participating-teams-sensus-2019-0","2019-02-19",[4078,4082,4086,4090,4094,4098],{"type":152,"children":4079},[4080],{"text":4081,"type":156},"All fourteen teams of SensUs 2019 have been formed and have started their journey towards the SensUs Innovation Days with the final contest on Friday 30 August!",{"type":152,"children":4083},[4084],{"text":4085,"type":156},"In the public contest event they will demonstrate their biosensors and the knowledge that they have gathered.The teams are highly motivated and want to make a difference by contributing to a higher quality of life.",{"type":152,"children":4087},[4088],{"text":4089,"type":156},"The teams consist of students from several scientific backgrounds. Some teams have students from more than 10 different fields of study and other teams have even members from different universities. This cross-fertilization gives the teams a broad perspective and will lead to innovative solutions.",{"type":152,"children":4091},[4092],{"text":4093,"type":156},"The expectations and dreams of the teams are sky high and each team has its own goals. For instance, team Synosense from KU Leuven wants to “channel their knowledge into a real-life product that contributes directly to a better society”. The BiosensUM team of Montreal consists of students from four different institutions, and aims to develop a device with focus on portability, analytical precision and user-friendliness.",{"type":152,"children":4095},[4096],{"text":4097,"type":156},"Team LxUs of the new participating University of Lisbon aims to develop a viable means of detecting Adalimumab with the best accuracy, time efficiency and affordability possible.",{"type":152,"children":4099},[4100,4102,4107],{"text":4101,"type":156},"To see all the teams, take a look at the ",{"url":4103,"type":236,"children":4104},"https://old.sensus.org/2019/teams",[4105],{"text":4106,"type":156},"team pages",{"text":4108,"type":156},"!","2026-07-28T11:14:12.019Z","2026-07-28T11:14:12.018Z",{"id":4112,"documentId":4113,"name":4114,"alternativeText":18,"caption":18,"focalPoint":18,"width":4115,"height":4116,"formats":4117,"hash":4143,"ext":280,"mime":283,"size":4144,"url":4145,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":4146,"updatedAt":4146,"publishedAt":4146},1281,"ox4q4ynk6j1j4smum3iag8az","6._0.jpg",7979,4487,{"large":4118,"small":4124,"medium":4130,"thumbnail":4137},{"ext":280,"url":4119,"hash":4120,"mime":283,"name":4121,"path":18,"size":4122,"width":190,"height":3533,"sizeInBytes":4123},"/uploads/large_6_0_6d37a68944.jpg","large_6_0_6d37a68944","large_6._0.jpg",139.62,139623,{"ext":280,"url":4125,"hash":4126,"mime":283,"name":4127,"path":18,"size":4128,"width":198,"height":2557,"sizeInBytes":4129},"/uploads/small_6_0_6d37a68944.jpg","small_6_0_6d37a68944","small_6._0.jpg",43.19,43186,{"ext":280,"url":4131,"hash":4132,"mime":283,"name":4133,"path":18,"size":4134,"width":206,"height":4135,"sizeInBytes":4136},"/uploads/medium_6_0_6d37a68944.jpg","medium_6_0_6d37a68944","medium_6._0.jpg",84.37,421,84367,{"ext":280,"url":4138,"hash":4139,"mime":283,"name":4140,"path":18,"size":4141,"width":144,"height":2870,"sizeInBytes":4142},"/uploads/thumbnail_6_0_6d37a68944.jpg","thumbnail_6_0_6d37a68944","thumbnail_6._0.jpg",12.68,12676,"6_0_6d37a68944",3952.36,"/uploads/6_0_6d37a68944.jpg","2026-07-28T11:14:12.004Z",{"id":2131,"documentId":4148,"title":4149,"slug":4150,"date":4151,"cardTitle":18,"excerpt":18,"body":4152,"createdAt":4162,"updatedAt":4162,"publishedAt":4163,"cardImage":4164},"i1qlzumrdbvqnbzc0b8nxsbe","SensUs Newsletter December 2018","sensus-newsletter-december-2018","2019-01-07",[4153,4158],{"type":379,"level":4154,"children":4155},4,[4156],{"text":4157,"type":156},"SensUs is up and running!",{"type":379,"level":106,"children":4159},[4160],{"text":4161,"type":156},"The preperations for SensUs 2019 are in full swing and new initiatives are up and running. The new SensUs organization is settled and is working on a next level edition. To keep you updated, here is our latest news!","2026-07-28T11:14:13.186Z","2026-07-28T11:14:13.181Z",{"id":4165,"documentId":4166,"name":4167,"alternativeText":18,"caption":18,"focalPoint":18,"width":3938,"height":3939,"formats":4168,"hash":4185,"ext":280,"mime":283,"size":3966,"url":4186,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":4187,"updatedAt":4187,"publishedAt":4187},1283,"u45a1thctc08d89u47elkjb4","BvOF_2018_1011_AUR_-_studententeam_SensUs_(1).jpg",{"large":4169,"small":4173,"medium":4177,"thumbnail":4181},{"ext":280,"url":4170,"hash":4171,"mime":283,"name":4172,"path":18,"size":3945,"width":190,"height":345,"sizeInBytes":3946},"/uploads/large_Bv_OF_2018_1011_AUR_studententeam_Sens_Us_1_20f5e82617.jpg","large_Bv_OF_2018_1011_AUR_studententeam_Sens_Us_1_20f5e82617","large_BvOF_2018_1011_AUR_-_studententeam_SensUs_(1).jpg",{"ext":280,"url":4174,"hash":4175,"mime":283,"name":4176,"path":18,"size":3951,"width":198,"height":352,"sizeInBytes":3952},"/uploads/small_Bv_OF_2018_1011_AUR_studententeam_Sens_Us_1_20f5e82617.jpg","small_Bv_OF_2018_1011_AUR_studententeam_Sens_Us_1_20f5e82617","small_BvOF_2018_1011_AUR_-_studententeam_SensUs_(1).jpg",{"ext":280,"url":4178,"hash":4179,"mime":283,"name":4180,"path":18,"size":3957,"width":206,"height":198,"sizeInBytes":3958},"/uploads/medium_Bv_OF_2018_1011_AUR_studententeam_Sens_Us_1_20f5e82617.jpg","medium_Bv_OF_2018_1011_AUR_studententeam_Sens_Us_1_20f5e82617","medium_BvOF_2018_1011_AUR_-_studententeam_SensUs_(1).jpg",{"ext":280,"url":4182,"hash":4183,"mime":283,"name":4184,"path":18,"size":3963,"width":306,"height":214,"sizeInBytes":3964},"/uploads/thumbnail_Bv_OF_2018_1011_AUR_studententeam_Sens_Us_1_20f5e82617.jpg","thumbnail_Bv_OF_2018_1011_AUR_studententeam_Sens_Us_1_20f5e82617","thumbnail_BvOF_2018_1011_AUR_-_studententeam_SensUs_(1).jpg","Bv_OF_2018_1011_AUR_studententeam_Sens_Us_1_20f5e82617","/uploads/Bv_OF_2018_1011_AUR_studententeam_Sens_Us_1_20f5e82617.jpg","2026-07-28T11:14:12.961Z",{"id":4189,"documentId":4190,"title":4191,"slug":4192,"date":4193,"cardTitle":18,"excerpt":18,"body":4194,"createdAt":4211,"updatedAt":4211,"publishedAt":4212,"cardImage":4213},301,"g5ylc00tnpk8cpwfbk1dc64x","Tech & Play Kids Festival","tech-play-kids-festival","2019-01-02",[4195,4199,4203,4207],{"type":152,"children":4196},[4197],{"text":4198,"type":156},"SensUs contributed to the Tech & Play Kids Festival on Friday 28th December. The festival offers a variety of engaging activities for all ages. A place to experiment and learn together.",{"type":152,"children":4200},[4201],{"text":4202,"type":156},"Tech & Play Kids Festival is an annual event organised by the Library of Eindhoven. Together with a lot of partners, they offer a day full of innovation for all ages. Alongside learning programming, making slime and making a luminous badge, we offered kids to join in on a little biosensor experiment.",{"type":152,"children":4204},[4205],{"text":4206,"type":156},"In the SensUs area, children were encouraged to build their own biosensor. Their self-built biosensor compared different kinds of soda. Sodas are all liquid and tasty, but when we have a closer look, they are actually very different. Kids detected the pH values with their biosensor containing a pH paper. For most children, this was the first experiment they ever did, so they were all very excited. With the pH sensor, the children could see that cola, 7-up and water are totally different when it comes to acidity. They were impressed by the results. The experiment shows that looking with our eyes only is not enough, and marks the importance of biosensors.",{"type":152,"children":4208},[4209],{"text":4210,"type":156},"All in all, it was a day full of innovation and we hope we made the visitors enthusiastic about technology.","2026-07-28T11:14:13.534Z","2026-07-28T11:14:13.533Z",{"id":4214,"documentId":4215,"name":4216,"alternativeText":18,"caption":18,"focalPoint":18,"width":641,"height":640,"formats":4217,"hash":4242,"ext":941,"mime":283,"size":4243,"url":4244,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":4245,"updatedAt":4245,"publishedAt":4245},1289,"cy4skslko7enh71lgn7miyyl","IMG_7890_1.JPG",{"large":4218,"small":4224,"medium":4230,"thumbnail":4236},{"ext":941,"url":4219,"hash":4220,"mime":283,"name":4221,"path":18,"size":4222,"width":190,"height":206,"sizeInBytes":4223},"/uploads/large_IMG_7890_1_bf90924cdc.JPG","large_IMG_7890_1_bf90924cdc","large_IMG_7890_1.JPG",133.9,133896,{"ext":941,"url":4225,"hash":4226,"mime":283,"name":4227,"path":18,"size":4228,"width":198,"height":654,"sizeInBytes":4229},"/uploads/small_IMG_7890_1_bf90924cdc.JPG","small_IMG_7890_1_bf90924cdc","small_IMG_7890_1.JPG",46.13,46133,{"ext":941,"url":4231,"hash":4232,"mime":283,"name":4233,"path":18,"size":4234,"width":206,"height":661,"sizeInBytes":4235},"/uploads/medium_IMG_7890_1_bf90924cdc.JPG","medium_IMG_7890_1_bf90924cdc","medium_IMG_7890_1.JPG",84.99,84985,{"ext":941,"url":4237,"hash":4238,"mime":283,"name":4239,"path":18,"size":4240,"width":3107,"height":214,"sizeInBytes":4241},"/uploads/thumbnail_IMG_7890_1_bf90924cdc.JPG","thumbnail_IMG_7890_1_bf90924cdc","thumbnail_IMG_7890_1.JPG",11.06,11062,"IMG_7890_1_bf90924cdc",1485.59,"/uploads/IMG_7890_1_bf90924cdc.JPG","2026-07-28T11:14:13.531Z",{"id":4247,"documentId":4248,"title":4249,"slug":4250,"date":4251,"cardTitle":2798,"excerpt":18,"body":4252,"createdAt":4277,"updatedAt":4277,"publishedAt":4278,"cardImage":4279},302,"e0z5r7lmlt67gst4py7ycsjn","Theme 2019: Rheumatoid Arthritis","theme-2019","2018-11-22",[4253,4261,4265,4269,4273],{"type":152,"children":4254},[4255,4257,4259],{"text":4256,"type":156},"The theme for the upcoming edition of SensUs is Rheumatoid Arthritis",{"text":4258,"type":156,"italic":79},": Managing rheumatic disease by measuring with ease",{"text":4260,"type":156},". This year, the students will work on a biosensor for the detection of the anti-inflammatory drug adalimumab, that is used for treating this autoimmune disease.",{"type":379,"level":111,"children":4262},[4263],{"text":4264,"type":156},"Rheumatoid Arthritis",{"type":152,"children":4266},[4267],{"text":4268,"type":156},"Rheumatoid arthritis is a chronic inflammatory disorder that affects around 1% of the world population every year. The disorder is characterized by inflammation of the synovium of small joints, like hands and feet, which leads to the destruction of cartilage and bone. Patients suffering from rheumatoid arthritis experience constant pain and difficulty with everyday chores.",{"type":379,"level":111,"children":4270},[4271],{"text":4272,"type":156},"Adalimumab",{"type":152,"children":4274},[4275],{"text":4276,"type":156},"Adalimumab relieves the symptoms of rheumatoid arthritis. Adalimumab is a biological drug and is the largest selling pharmaceutical drug worldwide. It binds to TNF-alpha, a pro-inflammatory protein. This represses the body defence system and inhibits inflammation. However, adalimumab is not an adequate treatment for every patient. Patients may not have benefits or may even lose treatment benefits over time. Another problem is that the treatment is very expensive. A biosensor for adalimumab would prevent needless suffering and unnecessary costs by measuring the concentration of adalimumab in the patients blood.","2026-07-28T11:14:13.600Z","2026-07-28T11:14:13.599Z",{"id":4280,"documentId":4281,"name":4282,"alternativeText":18,"caption":18,"focalPoint":18,"width":692,"height":692,"formats":4283,"hash":4308,"ext":280,"mime":283,"size":4309,"url":4310,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":4311,"updatedAt":4311,"publishedAt":4312},1291,"k8m48nwz8bzlqoqvarlp4c0r","drugs_(1).jpg",{"large":4284,"small":4290,"medium":4296,"thumbnail":4302},{"ext":280,"url":4285,"hash":4286,"mime":283,"name":4287,"path":18,"size":4288,"width":190,"height":190,"sizeInBytes":4289},"/uploads/large_drugs_1_e615299c6a.jpg","large_drugs_1_e615299c6a","large_drugs_(1).jpg",33.87,33865,{"ext":280,"url":4291,"hash":4292,"mime":283,"name":4293,"path":18,"size":4294,"width":198,"height":198,"sizeInBytes":4295},"/uploads/small_drugs_1_e615299c6a.jpg","small_drugs_1_e615299c6a","small_drugs_(1).jpg",12.22,12219,{"ext":280,"url":4297,"hash":4298,"mime":283,"name":4299,"path":18,"size":4300,"width":206,"height":206,"sizeInBytes":4301},"/uploads/medium_drugs_1_e615299c6a.jpg","medium_drugs_1_e615299c6a","medium_drugs_(1).jpg",21.88,21877,{"ext":280,"url":4303,"hash":4304,"mime":283,"name":4305,"path":18,"size":4306,"width":214,"height":214,"sizeInBytes":4307},"/uploads/thumbnail_drugs_1_e615299c6a.jpg","thumbnail_drugs_1_e615299c6a","thumbnail_drugs_(1).jpg",2.59,2586,"drugs_1_e615299c6a",41.87,"/uploads/drugs_1_e615299c6a.jpg","2026-07-28T11:14:13.597Z","2026-07-28T11:14:13.598Z",{"id":4314,"documentId":4315,"title":4316,"slug":4317,"date":4318,"cardTitle":18,"excerpt":18,"body":4319,"createdAt":4342,"updatedAt":4342,"publishedAt":4342,"cardImage":4343},303,"fjycxec22pdlz5xk6896dgyi","DDW 2018: Designing for Future Healthcare","ddw-2018-designing-future-healthcare","2018-10-29",[4320,4326,4330,4334,4338],{"type":152,"children":4321},[4322,4324],{"text":4323,"type":156,"italic":79},"“Designing for Future Healthcare”",{"text":4325,"type":156}," - this was the main theme of our story during the Dutch Design Week.",{"type":152,"children":4327},[4328],{"text":4329,"type":156},"SensUs was invited to participate in the Dutch Design Week. This is the biggest design event in Northern Europe with a total of 300.000 visitors and over 2600 designers showing their latest works.",{"type":152,"children":4331},[4332],{"text":4333,"type":156},"We had a stand at the exhibition ‘TU/e Research: Drivers of Change’. The exhibition focused on the translation of new technologies into responsible and innovative solutions for society. The vision of SensUs is that healthcare is developing towards a world wherein care is delivered in a highly personalized manner and that patients can measure their own health with small and precise systems at any time. SensUs supports and stimulates new innovative biosensing solutions for personalized healthcare, so the Dutch Design Week was a perfect place to share our ideas!",{"type":152,"children":4335},[4336],{"text":4337,"type":156},"On the last day of the Dutch Design Week, we closed Mind the Story with a presentation about SensUs and the future of healthcare. ‘Mind the Story’ is part of the ‘Mind the Step’ exhibition where people working on design and innovation share their stories. We explained what the SensUs competition is and how new biosensing technologies are relevant to many of us.",{"type":152,"children":4339},[4340],{"text":4341,"type":156},"To conclude, a week full of interesting conversations on the future of healthcare!","2026-07-28T11:14:13.802Z",{"id":4344,"documentId":4345,"name":4346,"alternativeText":18,"caption":18,"focalPoint":18,"width":4347,"height":4348,"formats":4349,"hash":4377,"ext":280,"mime":283,"size":4378,"url":4379,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":4380,"updatedAt":4380,"publishedAt":4380},1293,"fzl7xijd2g0oqn17jsbwoab1","DDW_klein.jpg",2286,1520,{"large":4350,"small":4357,"medium":4364,"thumbnail":4371},{"ext":280,"url":4351,"hash":4352,"mime":283,"name":4353,"path":18,"size":4354,"width":190,"height":4355,"sizeInBytes":4356},"/uploads/large_DDW_klein_397e8b2e07.jpg","large_DDW_klein_397e8b2e07","large_DDW_klein.jpg",109.57,665,109574,{"ext":280,"url":4358,"hash":4359,"mime":283,"name":4360,"path":18,"size":4361,"width":198,"height":4362,"sizeInBytes":4363},"/uploads/small_DDW_klein_397e8b2e07.jpg","small_DDW_klein_397e8b2e07","small_DDW_klein.jpg",35.21,332,35212,{"ext":280,"url":4365,"hash":4366,"mime":283,"name":4367,"path":18,"size":4368,"width":206,"height":4369,"sizeInBytes":4370},"/uploads/medium_DDW_klein_397e8b2e07.jpg","medium_DDW_klein_397e8b2e07","medium_DDW_klein.jpg",67.85,499,67848,{"ext":280,"url":4372,"hash":4373,"mime":283,"name":4374,"path":18,"size":4375,"width":306,"height":214,"sizeInBytes":4376},"/uploads/thumbnail_DDW_klein_397e8b2e07.jpg","thumbnail_DDW_klein_397e8b2e07","thumbnail_DDW_klein.jpg",10.11,10109,"DDW_klein_397e8b2e07",421.75,"/uploads/DDW_klein_397e8b2e07.jpg","2026-07-28T11:14:13.800Z",{"id":4382,"documentId":4383,"title":4384,"slug":4385,"date":4386,"cardTitle":4387,"excerpt":18,"body":4388,"createdAt":4462,"updatedAt":4462,"publishedAt":4463,"cardImage":4464},304,"q6ppsebcepxjxe5x0bro9mjt","Short summary SensUs 2018","sensus-2018-recap","2018-09-13","SensUs 2018 Recap",[4389],{"type":4390,"format":4391,"children":4392},"list","unordered",[4393,4398,4406,4414,4418,4422,4426,4430,4434,4438,4442,4446,4450,4454,4458],{"type":4394,"children":4395},"list-item",[4396],{"text":4397,"type":156},"13 participating teams from North-America, Asia, Africa and Europe. 150 international students.",{"type":4394,"children":4399},[4400,4402],{"text":4401,"type":156},"Results of the testing event: ",{"url":4403,"type":236,"children":4404},"https://digital.sensus.org/teams",[4405],{"text":4403,"type":156},{"type":4394,"children":4407},[4408,4410],{"text":4409,"type":156},"Impression with photos and videos: ",{"url":4411,"type":236,"children":4412},"https://digital.sensus.org/explore",[4413],{"text":4411,"type":156},{"type":4394,"children":4415},[4416],{"text":4417,"type":156},"Over 10 000 online viewers from over 80 countries. Almost 4000 people casted their votes.",{"type":4394,"children":4419},[4420],{"text":4421,"type":156},"Awards:",{"type":4394,"children":4423},[4424],{"text":4425,"type":156},"Switzerland: 1st Analytical Performance, 2nd Creativity, 2nd Translational Potential",{"type":4394,"children":4427},[4428],{"text":4429,"type":156},"Scotland: 1st Creativity, 2nd Analytical Performance",{"type":4394,"children":4431},[4432],{"text":4433,"type":156},"Belgium: 1st Translational Potential",{"type":4394,"children":4435},[4436],{"text":4437,"type":156},"Egypt: 1st Public Inspiration",{"type":4394,"children":4439},[4440],{"text":4441,"type":156},"Netherlands: 2nd Public Inspiration",{"type":4394,"children":4443},[4444],{"text":4445,"type":156},"High School project: successful pilot with 4 teams from 3 schools. Larger scale competition will be implemented in SensUs 2019.",{"type":4394,"children":4447},[4448],{"text":4449,"type":156},"Meet the Partners: successful pilot with 6 partners and 130 students Will be part of SensUs 2019 with a more diverse portfolio and more partners.",{"type":4394,"children":4451},[4452],{"text":4453,"type":156},"Startup Event: Valuable information was obtained which will be used to further develop SensUs Startups.",{"type":4394,"children":4455},[4456],{"text":4457,"type":156},"SensUs 2019: University of Lisboa, Portugal joins competition",{"type":4394,"children":4459},[4460],{"text":4461,"type":156},"SensUs 2019 Theme is rheumatoid arthritis, biomarker: adalimumab.","2026-07-28T11:14:14.484Z","2026-07-28T11:14:14.482Z",{"id":4465,"documentId":4466,"name":4467,"alternativeText":18,"caption":18,"focalPoint":18,"width":3798,"height":3799,"formats":4468,"hash":4485,"ext":280,"mime":283,"size":3826,"url":4486,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":4487,"updatedAt":4487,"publishedAt":4487},1295,"fkdwjnefn3wr1hojr8ajb33o","BvOF_2018_0908_AWD_-_SensUs_-_awards_groupphoto.jpg",{"large":4469,"small":4473,"medium":4477,"thumbnail":4481},{"ext":280,"url":4470,"hash":4471,"mime":283,"name":4472,"path":18,"size":3805,"width":190,"height":286,"sizeInBytes":3806},"/uploads/large_Bv_OF_2018_0908_AWD_Sens_Us_awards_groupphoto_99fcdfb9f7.jpg","large_Bv_OF_2018_0908_AWD_Sens_Us_awards_groupphoto_99fcdfb9f7","large_BvOF_2018_0908_AWD_-_SensUs_-_awards_groupphoto.jpg",{"ext":280,"url":4474,"hash":4475,"mime":283,"name":4476,"path":18,"size":3811,"width":198,"height":293,"sizeInBytes":3812},"/uploads/small_Bv_OF_2018_0908_AWD_Sens_Us_awards_groupphoto_99fcdfb9f7.jpg","small_Bv_OF_2018_0908_AWD_Sens_Us_awards_groupphoto_99fcdfb9f7","small_BvOF_2018_0908_AWD_-_SensUs_-_awards_groupphoto.jpg",{"ext":280,"url":4478,"hash":4479,"mime":283,"name":4480,"path":18,"size":3817,"width":206,"height":198,"sizeInBytes":3818},"/uploads/medium_Bv_OF_2018_0908_AWD_Sens_Us_awards_groupphoto_99fcdfb9f7.jpg","medium_Bv_OF_2018_0908_AWD_Sens_Us_awards_groupphoto_99fcdfb9f7","medium_BvOF_2018_0908_AWD_-_SensUs_-_awards_groupphoto.jpg",{"ext":280,"url":4482,"hash":4483,"mime":283,"name":4484,"path":18,"size":3823,"width":306,"height":214,"sizeInBytes":3824},"/uploads/thumbnail_Bv_OF_2018_0908_AWD_Sens_Us_awards_groupphoto_99fcdfb9f7.jpg","thumbnail_Bv_OF_2018_0908_AWD_Sens_Us_awards_groupphoto_99fcdfb9f7","thumbnail_BvOF_2018_0908_AWD_-_SensUs_-_awards_groupphoto.jpg","Bv_OF_2018_0908_AWD_Sens_Us_awards_groupphoto_99fcdfb9f7","/uploads/Bv_OF_2018_0908_AWD_Sens_Us_awards_groupphoto_99fcdfb9f7.jpg","2026-07-28T11:14:14.481Z",{"id":4489,"documentId":4490,"title":4491,"slug":4492,"date":4493,"cardTitle":18,"excerpt":18,"body":4494,"createdAt":4507,"updatedAt":4507,"publishedAt":4508,"cardImage":4509},305,"d6g5bi0gp8boc9qe75dzt1zi","Preview SensUs 2018","preview-sensus-2018","2018-09-04",[4495,4499,4503],{"type":152,"children":4496},[4497],{"bold":79,"text":4498,"type":156},"After months of hard work, SensUs 2018 is about to start! On 7 and 8 September, all 13 participating university teams will demonstrate their biosensor to the jury, in the hope to win one of the four prices. We will kick off the event on Friday with the testing event and on Saturday we have an open market. We close the weekend with the award ceremony, the winners of SensUs 2018 and the reveal of the SensUs 2019 theme.",{"type":152,"children":4500},[4501],{"text":4502,"type":156},"This year's theme is ‘Measuring antibiotics for better healthcare”. Antibiotics have transformed medicine and saved millions of lives. Unfortunately, drug-resistant bacteria are appearing and this calls for more precise treatments, including optimal dosing of the drugs. Biosensors can rapidly and easily give feedback to patients and doctors. This is useful to personal dose the right amount of medication creating a more personal treatment. The teams have developed a biosensor for the last resort antibiotic vancomycin. A vancomycin biosensor will help to provide patient continue with the right dose, in order to increase the effectiveness and avoid side effects of drug treatment.",{"type":152,"children":4504},[4505],{"text":4506,"type":156},"The jury has a key role in the SensUs competition, consisting of people from universities, companies, healthcare, and innovation organizations. They will criticize the teams on the analytical performance, creativity and the translational potential of the biosensor during Friday’s testing event. The analytical performance award goes to the team with the biosensor that functions best, in terms of measurement accuracy, speed, and required sample volume. The creativity award relates to the technological novelty of the biosensors and to the way how the teams have worked during their development process. The teams also followed an entrepreneurship training to focus on how to bring their biosensor on the market. This was very useful for the translation potential award, that is about the plans of the teams to bring their biosensor from a prototype to a product that can be used in society. Will the product meet the needs of doctors and patients, and will it be suited for industrial production?","2026-07-28T11:14:15.258Z","2026-07-28T11:14:15.255Z",{"id":4510,"documentId":4511,"name":4512,"alternativeText":18,"caption":18,"focalPoint":18,"width":4513,"height":4514,"formats":4515,"hash":4540,"ext":280,"mime":283,"size":4541,"url":4542,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":4543,"updatedAt":4543,"publishedAt":4543},1297,"qhvvrwvpjky0px4b4hzsbqwn","36509155224_380fe8bd33_o.jpg",5760,3840,{"large":4516,"small":4522,"medium":4528,"thumbnail":4534},{"ext":280,"url":4517,"hash":4518,"mime":283,"name":4519,"path":18,"size":4520,"width":190,"height":345,"sizeInBytes":4521},"/uploads/large_36509155224_380fe8bd33_o_cb63afdd31.jpg","large_36509155224_380fe8bd33_o_cb63afdd31","large_36509155224_380fe8bd33_o.jpg",154.29,154287,{"ext":280,"url":4523,"hash":4524,"mime":283,"name":4525,"path":18,"size":4526,"width":198,"height":293,"sizeInBytes":4527},"/uploads/small_36509155224_380fe8bd33_o_cb63afdd31.jpg","small_36509155224_380fe8bd33_o_cb63afdd31","small_36509155224_380fe8bd33_o.jpg",49.8,49796,{"ext":280,"url":4529,"hash":4530,"mime":283,"name":4531,"path":18,"size":4532,"width":206,"height":198,"sizeInBytes":4533},"/uploads/medium_36509155224_380fe8bd33_o_cb63afdd31.jpg","medium_36509155224_380fe8bd33_o_cb63afdd31","medium_36509155224_380fe8bd33_o.jpg",98.52,98519,{"ext":280,"url":4535,"hash":4536,"mime":283,"name":4537,"path":18,"size":4538,"width":306,"height":214,"sizeInBytes":4539},"/uploads/thumbnail_36509155224_380fe8bd33_o_cb63afdd31.jpg","thumbnail_36509155224_380fe8bd33_o_cb63afdd31","thumbnail_36509155224_380fe8bd33_o.jpg",14.34,14340,"36509155224_380fe8bd33_o_cb63afdd31",2943.48,"/uploads/36509155224_380fe8bd33_o_cb63afdd31.jpg","2026-07-28T11:14:15.079Z",{"id":4545,"documentId":4546,"title":4547,"slug":4548,"date":4549,"cardTitle":18,"excerpt":18,"body":4550,"createdAt":4615,"updatedAt":4615,"publishedAt":4616,"cardImage":4617},306,"c1p3q0j6awmggpacztfoirs7","SensUs interviews: Menno Prins","sensus-interviews-menno-prins-0","2018-09-01",[4551,4555,4559,4563,4567,4571,4575,4579,4583,4587,4591,4595,4599,4603,4607,4611],{"type":152,"children":4552},[4553],{"bold":79,"text":4554,"type":156},"The founder of SensUs is Menno Prins, a professor at Eindhoven University of Technology, working in the field of Molecular Biosensing for Medical Diagnostics. To get an insight in the man behind our mission we interviewed him, revealing his history, his thoughts about antibiotic resistence and his expectations for this year.",{"type":152,"children":4556},[4557],{"text":4558,"type":156,"italic":79},"1. Who are you and what are your daily activities on the TU/e? What is your history with biosensors?",{"type":152,"children":4560},[4561],{"text":4562,"type":156},"I am a professor at Eindhoven University of Technology working in the field of biosensors. Before that, I worked for many years in industry. I am fascinated by new technologies for biochemical sensing and applications in the fields of near-patient testing and patient monitoring, so my thoughts go to fundamental questions as well as to applications and translation to society. SensUs has good synergy with all these aspects, as it stimulates education as well as innovation and entrepreneurship.",{"type":152,"children":4564},[4565],{"text":4566,"type":156},"My main responsibilities are to train and inspire young scientists. Students need to acquire basic knowledge as well as to learn how to become creative with this knowledge. For creativity they need to learn how to think independently and dare to walk new paths. Research is one way to learn such skills, and SensUs is another. Particularly demanding in SensUs is the need to work together as a team and be as effective as possible in reaching a goal. This is what I learned myself when working in the industry, and what I hope that all students learn when they participate in SensUs.",{"type":152,"children":4568},[4569],{"text":4570,"type":156,"italic":79},"2. The theme of SensUs 2018 is “Measuring antibiotics for better healthcare”. Why is this relevant to society?",{"type":152,"children":4572},[4573],{"text":4574,"type":156},"Antibiotics are anti-microbial drugs that have transformed medicine and saved millions of lives. However, due to wide-spread use of the drugs, bacteria are appearing to be less and less sensitive to the available drugs, a problem called Anti-Microbial Resistance (AMR). Therefore, antibiotic treatments should change and should be given in a much more precise way: patients should receive the right drugs at the right dose, at the right time for the right duration. This is where biosensors can help, because they will give accurate and timely data on drug concentrations in the patient. Based on this data, the treatment of the patient can be adapted and will be as effective as possible, with minimal appearance of resistant bacteria.",{"type":152,"children":4576},[4577],{"text":4578,"type":156,"italic":79},"3. Do you see a future for point-of-care testing and biochemical patient-monitoring in the field of antibiotic treatment?",{"type":152,"children":4580},[4581],{"text":4582,"type":156},"Point-of-care testing refers to a sample that is taken from the body, e.g. a finger-prick drop of blood, and that is measured in a small instrument. This can be very useful for testing at the doctor’s office or by the patient at home. However, some infections are acute and lead to hospitalization in the intensive care. Those patients will benefit from being continuously monitored by a biosensor connected to the patient with a catheter, so that drug concentrations as well as indicators of treatment effectiveness and side effects can be monitored continuously.",{"type":152,"children":4584},[4585],{"text":4586,"type":156,"italic":79},"4. What are the technological difficulties in designing a biosensor for an antibiotic? Why don’t we have such a biosensor already?",{"type":152,"children":4588},[4589],{"text":4590,"type":156},"Molecules that are essential for the body, such as proteins, hormones, and drugs, are present in the blood in low concentrations, typically between micromolar down to picomolar concentrations. Such measurements are normally done in a laboratory using large instruments, where blood samples are processed through an elaborate process with multiple steps and biochemical reagents. A biosensor is very different, because the test should be rapid and the device should be small. This demands novel technological approaches in biochemistry, fluid handling, and detection, without compromising on the accuracy of the final measurement result. In addition to the technological challenges, economical challenges play a role as well. The development of a new medical product requires a considerable financial investment, which is made only if there is an attractive business model with clear medical added value and a cost-effective technological solution. So to get back to your question: There is not yet a biosensor for detecting antibiotics on the market because there is not yet a technological solution that meets all medical and business requirements.",{"type":152,"children":4592},[4593],{"text":4594,"type":156,"italic":79},"5. How does SensUs contribute to these developments?",{"type":152,"children":4596},[4597],{"text":4598,"type":156},"SensUs trains students in multidisciplinary technological development and entrepreneurship, and SensUs brings together stakeholders such as university professors, medical professionals, and companies. This generates new ideas and new solutions, some of which will help to close the gaps between technology, medical application and business.",{"type":152,"children":4600},[4601],{"text":4602,"type":156,"italic":79},"6. This year is already the third edition of SensUs. Where do you see the competition in 5-10 years?",{"type":152,"children":4604},[4605],{"text":4606,"type":156},"I see SensUs increasing its impact and scope. First of all, SensUs has every year a different medical theme, so we will address a broad panel of disease areas in the coming 5-10 years. Secondly, I expect that the overall results of the SensUs teams will improve every year due to the collective SensUs learning experience. Furthermore, the SensUs Organization focuses on learning and innovation. Every year we have new ideas on how SensUs can be improved and we run small pilots to test new approaches. For example, this year we have pioneered an entrepreneurship training for the teams. We are eager to see how this will affect the results of the teams, which will steer the design of next year’s entrepreneurship training. In the coming years we plan to develop other new initiatives, for example in the field of student traineeships at companies, and we would like to find ways to stimulate the creation of startup companies or other translational activities. In 5-10 years I think SensUs will be a reputed worldwide competition with impact in several ways, some of which we cannot yet foresee.",{"type":152,"children":4608},[4609],{"text":4610,"type":156,"italic":79},"7. Finally, do you have any advice for the participating teams?",{"type":152,"children":4612},[4613],{"text":4614,"type":156},"Make the best of it and enjoy the SensUs days!","2026-07-28T11:14:15.533Z","2026-07-28T11:14:15.531Z",{"id":4618,"documentId":4619,"name":4620,"alternativeText":18,"caption":18,"focalPoint":18,"width":4621,"height":4622,"formats":4623,"hash":4648,"ext":280,"mime":283,"size":4649,"url":4650,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":4651,"updatedAt":4651,"publishedAt":4652},1302,"sv1lftyd9fwzhzs8gg2mylao","BvOF_2017_1023_CX_-_SensUs.jpg",3600,2400,{"large":4624,"small":4630,"medium":4636,"thumbnail":4642},{"ext":280,"url":4625,"hash":4626,"mime":283,"name":4627,"path":18,"size":4628,"width":190,"height":345,"sizeInBytes":4629},"/uploads/large_Bv_OF_2017_1023_CX_Sens_Us_1a4da4f739.jpg","large_Bv_OF_2017_1023_CX_Sens_Us_1a4da4f739","large_BvOF_2017_1023_CX_-_SensUs.jpg",51.67,51674,{"ext":280,"url":4631,"hash":4632,"mime":283,"name":4633,"path":18,"size":4634,"width":198,"height":293,"sizeInBytes":4635},"/uploads/small_Bv_OF_2017_1023_CX_Sens_Us_1a4da4f739.jpg","small_Bv_OF_2017_1023_CX_Sens_Us_1a4da4f739","small_BvOF_2017_1023_CX_-_SensUs.jpg",17.83,17833,{"ext":280,"url":4637,"hash":4638,"mime":283,"name":4639,"path":18,"size":4640,"width":206,"height":198,"sizeInBytes":4641},"/uploads/medium_Bv_OF_2017_1023_CX_Sens_Us_1a4da4f739.jpg","medium_Bv_OF_2017_1023_CX_Sens_Us_1a4da4f739","medium_BvOF_2017_1023_CX_-_SensUs.jpg",32.97,32966,{"ext":280,"url":4643,"hash":4644,"mime":283,"name":4645,"path":18,"size":4646,"width":306,"height":214,"sizeInBytes":4647},"/uploads/thumbnail_Bv_OF_2017_1023_CX_Sens_Us_1a4da4f739.jpg","thumbnail_Bv_OF_2017_1023_CX_Sens_Us_1a4da4f739","thumbnail_BvOF_2017_1023_CX_-_SensUs.jpg",6.13,6127,"Bv_OF_2017_1023_CX_Sens_Us_1a4da4f739",579.04,"/uploads/Bv_OF_2017_1023_CX_Sens_Us_1a4da4f739.jpg","2026-07-28T11:14:15.475Z","2026-07-28T11:14:15.476Z",{"id":4654,"documentId":4655,"title":4656,"slug":4657,"date":4658,"cardTitle":18,"excerpt":18,"body":4659,"createdAt":4708,"updatedAt":4708,"publishedAt":4709,"cardImage":4710},307,"kdxwmpi4nlar133rtfl2urx7","SensUs Interviews: Amy Yewdall","sensus-interviews-amy-yewdall","2018-08-13",[4660,4664,4668,4672,4676,4680,4684,4688,4692,4696,4700,4704],{"type":152,"children":4661},[4662],{"bold":79,"text":4663,"type":156},"Hereby we proudly announce our Master of Ceremonies of SensUs 2018! Amy Yewdall is a young, talented and enthusiastic postdoctoral researcher at the Technical University of Eindhoven. To introduce her to you, we spoke with her about her role in SensUs 2018, biosensors and the SensUs concept.",{"type":152,"children":4665},[4666],{"text":4667,"type":156,"italic":79},"1. Can you tell us something about yourself?",{"type":152,"children":4669},[4670],{"text":4671,"type":156},"My name is Amy Yewdall and I hail from New Zealand. I am working here at the TU/e, as a postdoctoral researcher with the aim of creating ‘artificial cells’ by harnessing biological and synthetic materials to mimic certain aspects of life. My research provides not only insights into the mechanisms that drive biologically-relevant processes, but also, a platform for the creation of new technologies.",{"type":152,"children":4673},[4674],{"text":4675,"type":156},"Outside of science, I enjoy an active lifestyle involving hiking, cycling and playing Ultimate Frisbee to balance out my primary passion of eating delicious food.",{"type":152,"children":4677},[4678],{"text":4679,"type":156,"italic":79},"2. What is your opinion about biosensors?",{"type":152,"children":4681},[4682],{"text":4683,"type":156},"Biosensors give people the power to answer simple questions about their health without the need for lab tests. This affords people the control and privacy over their own healthcare, and can also connect them to the science behind it. My diabetic or expecting friends have all used some form of biosensor to assess their health. So as a scientist, it is satisfying to see research having an obvious useful impact on society!",{"type":152,"children":4685},[4686],{"text":4687,"type":156,"italic":79},"3. What is your vision about the future of healthcare and biosensors?",{"type":152,"children":4689},[4690],{"text":4691,"type":156},"As healthcare becomes more personalised and specialised, biosensors can fill the niche of providing technologies that answer healthcare questions in a rapid and easy way. Making these devices accessible to underprivileged communities, with innovation being developed in parallel with affordability, can revolutionise global healthcare. I suppose it would be great to see biosensors play a larger role in making healthcare accessible to everyone.",{"type":152,"children":4693},[4694],{"text":4695,"type":156,"italic":79},"4. How are you involved in SensUs?",{"type":152,"children":4697},[4698],{"text":4699,"type":156},"I am excited to represent you as Master of Ceremonies for the event! Entertaining crowds with some Kiwi-flavour is something I have always relished. I especially look forwards to meeting the students and scientists behind the innovations, and am happy to be part of connecting biosensors to the public sphere.",{"type":152,"children":4701},[4702],{"text":4703,"type":156,"italic":79},"5. What is your opinion about SensUs and how do you envision its future?",{"type":152,"children":4705},[4706],{"text":4707,"type":156},"I admire the SensUs concept, especially how it is student driven and for students. You are the future of research and getting students engaged from the bottom-up is a really promising leap for such technologies! This sort of event helps everyone better communicate science and collaborate on new ideas with each other. With the SensUs competition growing each year, it would be fantastic to see teams from even further abroad, such as from New Zealand, participate as well.","2026-07-28T11:14:15.801Z","2026-07-28T11:14:15.799Z",{"id":4711,"documentId":4712,"name":4713,"alternativeText":18,"caption":18,"focalPoint":18,"width":4714,"height":4715,"formats":4716,"hash":4741,"ext":280,"mime":283,"size":4742,"url":4743,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":4744,"updatedAt":4744,"publishedAt":4744},1305,"zlzzzu6vymao5ihdltjkx908","Amy.jpg",2520,1680,{"large":4717,"small":4723,"medium":4729,"thumbnail":4735},{"ext":280,"url":4718,"hash":4719,"mime":283,"name":4720,"path":18,"size":4721,"width":190,"height":345,"sizeInBytes":4722},"/uploads/large_Amy_e85fd142d0.jpg","large_Amy_e85fd142d0","large_Amy.jpg",97.18,97183,{"ext":280,"url":4724,"hash":4725,"mime":283,"name":4726,"path":18,"size":4727,"width":198,"height":293,"sizeInBytes":4728},"/uploads/small_Amy_e85fd142d0.jpg","small_Amy_e85fd142d0","small_Amy.jpg",26.88,26883,{"ext":280,"url":4730,"hash":4731,"mime":283,"name":4732,"path":18,"size":4733,"width":206,"height":198,"sizeInBytes":4734},"/uploads/medium_Amy_e85fd142d0.jpg","medium_Amy_e85fd142d0","medium_Amy.jpg",54.73,54726,{"ext":280,"url":4736,"hash":4737,"mime":283,"name":4738,"path":18,"size":4739,"width":306,"height":214,"sizeInBytes":4740},"/uploads/thumbnail_Amy_e85fd142d0.jpg","thumbnail_Amy_e85fd142d0","thumbnail_Amy.jpg",8.37,8366,"Amy_e85fd142d0",635.6,"/uploads/Amy_e85fd142d0.jpg","2026-07-28T11:14:15.734Z",{"id":4746,"documentId":4747,"title":4748,"slug":4749,"date":4750,"cardTitle":18,"excerpt":18,"body":4751,"createdAt":4804,"updatedAt":4804,"publishedAt":4805,"cardImage":4806},308,"s188t6t1xuv3rotlt1mharzg","SensUs Interviews: Jaap van Dissel","sensus-interviews-jaap-van-dissel","2018-08-06",[4752,4756,4760,4764,4768,4772,4776,4780,4784,4788,4792,4796,4800],{"type":152,"children":4753},[4754],{"bold":79,"text":4755,"type":156},"We spoke with Jaap van Dissel, Director of the Centre for Infectious Disease Control of the Dutch National Institute for Public Health and the Environment (RIVM). He studied Medicine at the University Leiden and he is currently Professor of Internal Medicine at Leiden University Medical Center.",{"type":152,"children":4757},[4758],{"bold":79,"text":4759,"type":156},"RIVM and antibiotics",{"type":152,"children":4761},[4762],{"text":4763,"type":156},"The RIVM is The Dutch National Institute for Public Health and the Environment. It conducts research and provides advice to government bodies and the public. The RIVM is a trusted advisor to the ministries, in particular the ministry of public health, welfare and sports (VWS), and it gives science evidence-based advice in many topics including the field of antibiotics. In this latter field, the RIVM reports on the use of antibiotics and occurrence of antimicrobial resistance across the country, including the fields of both human and animal health.",{"type":152,"children":4765},[4766],{"text":4767,"type":156},"Antibiotic resistance is one of the major threats to society. In the Netherlands, compared to other countries, there are strict policies, good hospital hygiene and good personal hygiene. This results in a relatively low occurrence and spread of antibiotic resistance in the Netherlands. Countries in Southern Europe count up to 3 to 4 times more daily doses of antibiotics per 1000 inhabitants. This higher usage of antimicrobials results is a stronger selective pressure and higher prevalence of antibiotic resistance in health care facilities.",{"type":152,"children":4769},[4770],{"bold":79,"text":4771,"type":156},"Antimicrobial stewardship",{"type":152,"children":4773},[4774],{"text":4775,"type":156},"Antimicrobial stewardship refers to programs that promote the appropriate use of antimicrobials (including antibiotics), in order to improve patient outcomes, reduce microbial resistance, and decrease the spread of infections caused by multidrug-resistant organisms. Part of antibiotic stewardship is to give patients the optimal selection and dose of antibiotics (adjusted to kidney function, site of infection, etc), with the best possible clinical outcome, minimal toxicity and minimal impact on resistance.",{"type":152,"children":4777},[4778],{"text":4779,"type":156},"In this respect, biosensors that can detect precisely the concentration of antibiotics in a patient’s blood or at the site of infection (e.g. urine) will be a most helpful tool to further antibiotic stewardship.",{"type":152,"children":4781},[4782],{"bold":79,"text":4783,"type":156},"Biosensors for antibiotics",{"type":152,"children":4785},[4786],{"text":4787,"type":156},"Currently, when a patient receives antibiotics in a hospital, the dose is based on general parameters like body weight, length, age and gender. In complicated infections, e.g. endocarditis or meningitis, or when specific antibiotics like vancomycin are used, blood from the patient is analyzed to determine the concentration levels of the drug in the blood.",{"type":152,"children":4789},[4790],{"text":4791,"type":156},"This is done in a laboratory and therefore it can take one or two days for the results to get to the doctor. Based on the results, the doctor determines if the concentration is too high or too low and adapts the dose. In the meantime, the patient may have had a non-optimal drug level. A too high concentration may give problems of toxicity, e.g. kidney damage. A concentration that is too low will not have optimal clinical outcome and also increases the risk of antibiotic resistance.",{"type":152,"children":4793},[4794],{"text":4795,"type":156},"With the help of a biosensor, a doctor could rapidly determine the drug concentration in the patient, understand the pharmacokinetics of the drug and immediately act upon the results.",{"type":152,"children":4797},[4798],{"bold":79,"text":4799,"type":156},"Future biosensing with multiple biomarkers",{"type":152,"children":4801},[4802],{"text":4803,"type":156},"The SensUs competition stimulates the field of biosensing. This year teams in 13 international universities are developing biosensors for the rapid detection of vancomycin in blood, which is an important last-resort antibiotic. According to Jaap van Dissel, the real challenge of ideal biosensors of the future is not only to measure antibiotics, but also the effect of the treatment, such as biomarkers that sense the immune status and recovery of the patient. In this way, with the combined results, a very precise picture of a patient’s state can be developed, which will help the doctor to provide the best possible treatment for the patient.","2026-07-28T11:14:15.912Z","2026-07-28T11:14:15.910Z",{"id":4807,"documentId":4808,"name":4809,"alternativeText":18,"caption":18,"focalPoint":18,"width":4810,"height":4811,"formats":4812,"hash":4837,"ext":280,"mime":283,"size":4838,"url":4839,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":4840,"updatedAt":4840,"publishedAt":4840},1308,"syc389t9c1mfbmvzyat57190","foto_JaapVanDissel_0.jpg",1382,922,{"large":4813,"small":4819,"medium":4825,"thumbnail":4831},{"ext":280,"url":4814,"hash":4815,"mime":283,"name":4816,"path":18,"size":4817,"width":190,"height":345,"sizeInBytes":4818},"/uploads/large_foto_Jaap_Van_Dissel_0_bffbe233db.jpg","large_foto_Jaap_Van_Dissel_0_bffbe233db","large_foto_JaapVanDissel_0.jpg",57.81,57808,{"ext":280,"url":4820,"hash":4821,"mime":283,"name":4822,"path":18,"size":4823,"width":198,"height":352,"sizeInBytes":4824},"/uploads/small_foto_Jaap_Van_Dissel_0_bffbe233db.jpg","small_foto_Jaap_Van_Dissel_0_bffbe233db","small_foto_JaapVanDissel_0.jpg",19.34,19340,{"ext":280,"url":4826,"hash":4827,"mime":283,"name":4828,"path":18,"size":4829,"width":206,"height":198,"sizeInBytes":4830},"/uploads/medium_foto_Jaap_Van_Dissel_0_bffbe233db.jpg","medium_foto_Jaap_Van_Dissel_0_bffbe233db","medium_foto_JaapVanDissel_0.jpg",36.73,36726,{"ext":280,"url":4832,"hash":4833,"mime":283,"name":4834,"path":18,"size":4835,"width":306,"height":214,"sizeInBytes":4836},"/uploads/thumbnail_foto_Jaap_Van_Dissel_0_bffbe233db.jpg","thumbnail_foto_Jaap_Van_Dissel_0_bffbe233db","thumbnail_foto_JaapVanDissel_0.jpg",6.32,6323,"foto_Jaap_Van_Dissel_0_bffbe233db",69.05,"/uploads/foto_Jaap_Van_Dissel_0_bffbe233db.jpg","2026-07-28T11:14:15.874Z",{"id":4842,"documentId":4843,"title":4844,"slug":4845,"date":4846,"cardTitle":18,"excerpt":18,"body":4847,"createdAt":4852,"updatedAt":4852,"publishedAt":4853,"cardImage":4854},309,"nrxbbdadhmcjaphcr2ttfekf","Personal stories: Gerard van Bokhorst","personal-stories-gerard-van-bokhorst","2018-07-04",[4848],{"type":152,"children":4849},[4850],{"bold":79,"text":4851,"type":156},"Antibiotic drugs are widely used in society because they are essential to combat infections. However, it is very difficult to give a patient the correct dose. When the dose is too low, the infection will not be resolved; when the dose is too high, the patient can suffer very severe and irreversible side effects. For SensUs Personal Stories, we spoke with Gerard and Anja van Bokhorst about their experiences with Gerard’s treatment with vancomycin, and about the importance of developing biosensors for this last-resort antibiotic drug.","2026-07-28T11:14:16.467Z","2026-07-28T11:14:16.463Z",{"id":4855,"documentId":4856,"name":4857,"alternativeText":18,"caption":18,"focalPoint":18,"width":2987,"height":4858,"formats":4859,"hash":4884,"ext":280,"mime":283,"size":4885,"url":4886,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":4887,"updatedAt":4887,"publishedAt":4887},1311,"iiw5lqwp4haca8jlc5u56dww","Gerard_motor2.jpg",3336,{"large":4860,"small":4866,"medium":4872,"thumbnail":4878},{"ext":280,"url":4861,"hash":4862,"mime":283,"name":4863,"path":18,"size":4864,"width":190,"height":345,"sizeInBytes":4865},"/uploads/large_Gerard_motor2_474989f437.jpg","large_Gerard_motor2_474989f437","large_Gerard_motor2.jpg",118.14,118137,{"ext":280,"url":4867,"hash":4868,"mime":283,"name":4869,"path":18,"size":4870,"width":198,"height":352,"sizeInBytes":4871},"/uploads/small_Gerard_motor2_474989f437.jpg","small_Gerard_motor2_474989f437","small_Gerard_motor2.jpg",38.05,38053,{"ext":280,"url":4873,"hash":4874,"mime":283,"name":4875,"path":18,"size":4876,"width":206,"height":198,"sizeInBytes":4877},"/uploads/medium_Gerard_motor2_474989f437.jpg","medium_Gerard_motor2_474989f437","medium_Gerard_motor2.jpg",73.83,73835,{"ext":280,"url":4879,"hash":4880,"mime":283,"name":4881,"path":18,"size":4882,"width":306,"height":214,"sizeInBytes":4883},"/uploads/thumbnail_Gerard_motor2_474989f437.jpg","thumbnail_Gerard_motor2_474989f437","thumbnail_Gerard_motor2.jpg",11.91,11909,"Gerard_motor2_474989f437",2347.63,"/uploads/Gerard_motor2_474989f437.jpg","2026-07-28T11:14:16.288Z",{"id":4889,"documentId":4890,"title":4891,"slug":4892,"date":4893,"cardTitle":18,"excerpt":18,"body":4894,"createdAt":4915,"updatedAt":4915,"publishedAt":4916,"cardImage":4917},310,"d5d8yr92fplb5smvq3owcxui","Dutch Technology Week","dutch-technology-week","2018-06-06",[4895,4899,4903,4907,4911],{"type":152,"children":4896},[4897],{"bold":79,"text":4898,"type":156},"On 4-9 June the SensUs organization took part in the Dutch Technology Week, a week that exposed the general public to exciting technological developments. This included the Quiz Night XL in the Klokgebouw, the Meetup with student teams on the TU/e campus and the High Tech Discovery Route.",{"type":152,"children":4900},[4901],{"text":4902,"type":156},"SensUs kicked off on Thursday 7 June with the Quiz Night XL. SensUs members and SensUs alumni competed in teams of five with over 1200 other participants in a scientific quiz. This event gave us a fun start to a very nice technical weekend!",{"type":152,"children":4904},[4905],{"text":4906,"type":156},"The Meetup with student teams was held on Friday 8 June. This day was organized for families and professionals to talk with students who are active in student teams. SensUs provided a stand to present the SensUs competition and the field of biosensing. Team T.E.S.T, a participating team of our competition, also deployed a stand. Furthermore, SensUs gave a presentation in the Blauwe Zaal together with team T.E.S.T. Also other student teams were present, e.g. Solar Team Eindhoven presented their new car, team VirTUe presented their high-tech house called LINQ and a medical drone was disclosed by team BlueJay.",{"type":152,"children":4908},[4909],{"text":4910,"type":156},"On Saturday 9 June, the High Tech Discovery Route on the TU/e was opened by Jo van Ham around the sustainable house LINQ. The SensUs Organization and team T.E.S.T. had a stand and spoke about SensUs and developments in the field of biosensing with you.",{"type":152,"children":4912},[4913],{"text":4914,"type":156},"We were very excited to take part in the Dutch Technology Week again and hope to inspire you with our stories in the next edition!","2026-07-28T11:14:16.655Z","2026-07-28T11:14:16.654Z",{"id":4918,"documentId":4919,"name":4920,"alternativeText":18,"caption":18,"focalPoint":18,"width":4921,"height":4922,"formats":4923,"hash":4948,"ext":183,"mime":186,"size":4949,"url":4950,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":4951,"updatedAt":4951,"publishedAt":4951},1316,"e21o9xcyqe9iaymx98f1ksnt","MicrosoftTeams-image.png",1944,1296,{"large":4924,"small":4930,"medium":4936,"thumbnail":4942},{"ext":183,"url":4925,"hash":4926,"mime":186,"name":4927,"path":18,"size":4928,"width":190,"height":345,"sizeInBytes":4929},"/uploads/large_Microsoft_Teams_image_5bc9321538.png","large_Microsoft_Teams_image_5bc9321538","large_MicrosoftTeams-image.png",87.45,87445,{"ext":183,"url":4931,"hash":4932,"mime":186,"name":4933,"path":18,"size":4934,"width":198,"height":293,"sizeInBytes":4935},"/uploads/small_Microsoft_Teams_image_5bc9321538.png","small_Microsoft_Teams_image_5bc9321538","small_MicrosoftTeams-image.png",31.6,31596,{"ext":183,"url":4937,"hash":4938,"mime":186,"name":4939,"path":18,"size":4940,"width":206,"height":198,"sizeInBytes":4941},"/uploads/medium_Microsoft_Teams_image_5bc9321538.png","medium_Microsoft_Teams_image_5bc9321538","medium_MicrosoftTeams-image.png",57.38,57382,{"ext":183,"url":4943,"hash":4944,"mime":186,"name":4945,"path":18,"size":4946,"width":306,"height":214,"sizeInBytes":4947},"/uploads/thumbnail_Microsoft_Teams_image_5bc9321538.png","thumbnail_Microsoft_Teams_image_5bc9321538","thumbnail_MicrosoftTeams-image.png",10.52,10524,"Microsoft_Teams_image_5bc9321538",269.52,"/uploads/Microsoft_Teams_image_5bc9321538.png","2026-07-28T11:14:16.593Z",{"id":4953,"documentId":4954,"title":4955,"slug":4956,"date":4957,"cardTitle":4958,"excerpt":18,"body":4959,"createdAt":4993,"updatedAt":4993,"publishedAt":4994,"cardImage":4995},311,"ytf38a6e8d5wts7jo7dn3ogw","The SensUs High Schools Project: inspiring and stimulating teenagers towards innovation and biosensors","sensus-high-schools-project","2018-05-24","The SensUs High Schools Project",[4960,4964,4968,4972,4976,4980,4984],{"type":152,"children":4961},[4962],{"bold":79,"text":4963,"type":156},"SensUs is an organization consisting of TU/e students and challenges student teams worldwide to develop innovative biosensing systems for the measurement of biomarkers. The aim is to stimulate education, innovation and public awareness and thereby improve the field of healthcare. Currently 13 international student teams are participating in the SensUs student competition which will take place on the 7th and 8th of September 2018 at the TU/e. This year, SensUs organises a brand new competition for high school students to raise the awareness of biosensing even further. We hope to encourage young talents for technology and all the diversity it has to offer by creating a learning environment that stimulates students towards creativity and building real prototypes.",{"type":152,"children":4965},[4966],{"text":4967,"type":156},"Last year, SensUs organized a pilot competition for highschool students: the High Schools Project. This project was a real success, inspiring and stimulating teenagers towards innovation and biosensors. In this competition, 16 students from the ‘Van Maerlantlyceum’, a high school in Eindhoven, worked in small groups on a chosen biomarker related to the SensUs 2017 theme about heart failure. This year, we have grown to 3 different high schools (Stedelijk Gymnasium Breda, Van Maerlant Lyceum, and Frits Philips Lyceum) in the North-Brabant region. In this project, the students will focus on a biosensor that relates to the biosensor the university teams are going to develop for vancomycin.",{"type":152,"children":4969},[4970],{"text":4971,"type":156},"The international university students make a biosensor to directly measure the vancomycin concentration in order to better dose vancomycin to prevent antibiotic resistance and toxicity. The high school students will design a biosensor concept that is able to detect the protein PBP2a. PBP2a is a protein produced by bacteria. When you are able to detect PBP2a you can get an indication whether your bacterial infection is lowering or not. The students will work following the TRIZ-model (Theory of Inventive Problem Solving). This method embodies that societal needs and problems are identified and translated into potentials. Eventually, the students will also present their concepts during the SensUs competition.",{"type":152,"children":4973},[4974],{"text":4975,"type":156},"In March SensUs organized a kick-off lecture for all the participating high schoolers. They were told about SensUs’s visions and goals in general, the TRIZ-model and what the assignment entails. The students believe that SensUs is a great initiative. They especially liked the idea of working together to an overall goal of improving the healthcare industry. The most common biosensor for diabetics to measure their glucose levels was known, but they did not realize that biosensors have an even broader impact on all kind of measurements of syndromes and analysis. The students are thrilled to work on their own biosensor, but realize that it is going to be tough. They hope to learn many new things and are really enthusiastic to start this project and be part of the SensUs Competition! Some of them are even considering studying at an university of technology.",{"type":152,"children":4977},[4978],{"text":4979,"type":156},"That is what we hope to achieve with the High Schools Project: stimulating young talented students towards technology and all the diversity it has to offer. We think it is very important to stimulate students to participate in technical projects such as the High Schools Project, and thereby raise awareness for biosensing. Only then are students able to see what an university of technology really entails. They are not only orientating very well, but also practicing their soft skills such as making posters, working in groups and giving pitch presentations.",{"type":152,"children":4981},[4982],{"text":4983,"type":156},"We are looking forward to all the creativity and new ideas the High Schools Project will bring!",{"type":152,"children":4985},[4986,4988],{"text":4987,"type":156},"Fotografie Bart van Overbeeke - ",{"url":4989,"type":236,"children":4990},"http://www.bvof.nl",[4991],{"text":4992,"type":156},"www.bvof.nl","2026-07-28T11:14:17.196Z","2026-07-28T11:14:17.195Z",{"id":4996,"documentId":4997,"name":4998,"alternativeText":18,"caption":18,"focalPoint":18,"width":4999,"height":5000,"formats":5001,"hash":5025,"ext":280,"mime":283,"size":5026,"url":5027,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":5028,"updatedAt":5028,"publishedAt":5029},1319,"klh2qk22pply2k1dlwno5zz2","Attachment2.jpg",5856,3904,{"large":5002,"small":5008,"medium":5014,"thumbnail":5020},{"ext":280,"url":5003,"hash":5004,"mime":283,"name":5005,"path":18,"size":5006,"width":190,"height":345,"sizeInBytes":5007},"/uploads/large_Attachment2_07b7ff9bfd.jpg","large_Attachment2_07b7ff9bfd","large_Attachment2.jpg",99.72,99721,{"ext":280,"url":5009,"hash":5010,"mime":283,"name":5011,"path":18,"size":5012,"width":198,"height":293,"sizeInBytes":5013},"/uploads/small_Attachment2_07b7ff9bfd.jpg","small_Attachment2_07b7ff9bfd","small_Attachment2.jpg",36.05,36047,{"ext":280,"url":5015,"hash":5016,"mime":283,"name":5017,"path":18,"size":5018,"width":206,"height":198,"sizeInBytes":5019},"/uploads/medium_Attachment2_07b7ff9bfd.jpg","medium_Attachment2_07b7ff9bfd","medium_Attachment2.jpg",66.59,66593,{"ext":280,"url":5021,"hash":5022,"mime":283,"name":5023,"path":18,"size":768,"width":306,"height":214,"sizeInBytes":5024},"/uploads/thumbnail_Attachment2_07b7ff9bfd.jpg","thumbnail_Attachment2_07b7ff9bfd","thumbnail_Attachment2.jpg",11563,"Attachment2_07b7ff9bfd",2244.81,"/uploads/Attachment2_07b7ff9bfd.jpg","2026-07-28T11:14:17.193Z","2026-07-28T11:14:17.194Z",{"id":5031,"documentId":5032,"title":5033,"slug":5034,"date":5035,"cardTitle":18,"excerpt":18,"body":5036,"createdAt":5093,"updatedAt":5093,"publishedAt":5094,"cardImage":5095},312,"aqzyiri6z9qbkp4zq5kjkaz7","SG lecture: Antibiotics, the rise of resistance","sg-lecture-antibiotics-rise-resistance","2018-05-23",[5037,5041,5045,5049,5053,5071,5075,5084],{"type":152,"children":5038},[5039],{"bold":79,"text":5040,"type":156},"Antibiotics are widely used in society, but often misused. Medical microbiologist Kees Verduin discusses the future of antibiotics and the threats of antibiotic resistance.",{"type":152,"children":5042},[5043],{"text":5044,"type":156},"Massive and inefficient use of antibiotic drugs is starting to cause serious problems. Bacteria are becoming less susceptible to drugs and therefore treatments need to be given in the most effective ways possible.",{"type":152,"children":5046},[5047],{"text":5048,"type":156},"During the SensUs 2018 competition, 13 international student teams are developing biosensors to detect and quantify a very important last-resort antibiotic, named vancomycin. These biosensors measure the concentration of the antibiotic in blood plasma, with the aim to enable personalized dosing, and therefore the most effective treatment for every patient.",{"type":152,"children":5050},[5051],{"text":5052,"type":156},"The mission of SensUs is to stimulate education and innovation in biosensing by organizing an international competition for students. This year’s theme is ‘Measuring antibiotics for better healthcare’. To highlight this topic SensUs organizes a lecture, in cooperation with Studium Generale Eindhoven, that will focus on antibiotic resistance and the role of antibiotics in the future.",{"type":152,"children":5054},[5055,5057,5062,5064,5069],{"text":5056,"type":156},"The lecture will be provided by Dr. Kees Verduin, a medical-microbiologist working at ",{"url":5058,"type":236,"children":5059},"http://www.pamm.nl/",[5060],{"text":5061,"type":156},"PAMM laboratories",{"text":5063,"type":156}," in Veldhoven. He advises doctors and hospitals on how to diagnose patients, what antibiotics to use and how to prevent infections. He is also a board member of the ",{"url":5065,"type":236,"children":5066},"http://www.swab.nl/english",[5067],{"text":5068,"type":156},"Dutch Working Group on Antibiotic Policy",{"text":5070,"type":156},"(SWAB).",{"type":152,"children":5072},[5073],{"text":5074,"type":156},"‘Antibiotic resistance is a big problem, and there is no remedy in sight at this moment.’ - Kees Verduin",{"type":152,"children":5076},[5077,5079],{"text":5078,"type":156},"On Wednesday 30th of May at 12:40, this lecture will take place at Eindhoven University of Technology (Blauwe Zaal Auditorium). Are you curious about his lecture? ",{"url":5080,"type":236,"children":5081},"https://studiumgenerale-eindhoven.nl/nl/programma/lezing/antibiotics-the-rise-of-resistance/",[5082],{"text":5083,"type":156},"Click here to reserve your ticket!",{"type":152,"children":5085},[5086,5088,5092],{"text":5087,"type":156},"To learn more about Kees Verduin, his work and his vision on antibiotics, read our interview with him ",{"url":5089,"type":236,"children":5090},"/news/sensus-interviews-kees-verduin",[5091],{"text":2637,"type":156},{"text":4108,"type":156},"2026-07-28T11:14:17.302Z","2026-07-28T11:14:17.300Z",{"id":5096,"documentId":5097,"name":5098,"alternativeText":18,"caption":18,"focalPoint":18,"width":637,"height":5099,"formats":5100,"hash":5129,"ext":280,"mime":283,"size":5130,"url":5131,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":5132,"updatedAt":5132,"publishedAt":5133},1321,"qdunajxhv1akxag3024vth17","header_SG_lezing_groot.jpg",969,{"large":5101,"small":5108,"medium":5115,"thumbnail":5122},{"ext":280,"url":5102,"hash":5103,"mime":283,"name":5104,"path":18,"size":5105,"width":190,"height":5106,"sizeInBytes":5107},"/uploads/large_header_SG_lezing_groot_6fcc6a5042.jpg","large_header_SG_lezing_groot_6fcc6a5042","large_header_SG_lezing_groot.jpg",59,846,59004,{"ext":280,"url":5109,"hash":5110,"mime":283,"name":5111,"path":18,"size":5112,"width":198,"height":5113,"sizeInBytes":5114},"/uploads/small_header_SG_lezing_groot_6fcc6a5042.jpg","small_header_SG_lezing_groot_6fcc6a5042","small_header_SG_lezing_groot.jpg",23.08,423,23083,{"ext":280,"url":5116,"hash":5117,"mime":283,"name":5118,"path":18,"size":5119,"width":206,"height":5120,"sizeInBytes":5121},"/uploads/medium_header_SG_lezing_groot_6fcc6a5042.jpg","medium_header_SG_lezing_groot_6fcc6a5042","medium_header_SG_lezing_groot.jpg",39.93,635,39930,{"ext":280,"url":5123,"hash":5124,"mime":283,"name":5125,"path":18,"size":5126,"width":5127,"height":214,"sizeInBytes":5128},"/uploads/thumbnail_header_SG_lezing_groot_6fcc6a5042.jpg","thumbnail_header_SG_lezing_groot_6fcc6a5042","thumbnail_header_SG_lezing_groot.jpg",5.97,184,5968,"header_SG_lezing_groot_6fcc6a5042",70.22,"/uploads/header_SG_lezing_groot_6fcc6a5042.jpg","2026-07-28T11:14:17.263Z","2026-07-28T11:14:17.264Z",{"id":5135,"documentId":5136,"title":5137,"slug":5138,"date":5139,"cardTitle":18,"excerpt":18,"body":5140,"createdAt":5165,"updatedAt":5165,"publishedAt":5166,"cardImage":5167},313,"ivkg1tqjsuvomzoj4at0gcso","Meet our new organization members!","meet-our-new-organization-members","2018-05-17",[5141,5145,5149,5157,5161],{"type":152,"children":5142},[5143],{"text":5144,"type":156},"Three new teams have joined the SensUs 2018 competition, which gives a total of 13 participating teams this year! With the growth of the SensUs competition, a growth in the SensUs organization was also required. Therefore, we are proud to announce that 14 new members will join the SensUs organization. The enthusiastic new members are already helping in the run-up to the 2018 competition and after that they will take full place in the organization of the 2019 competition.",{"type":152,"children":5146},[5147],{"text":5148,"type":156},"The new members form a very diverse group.The students come from many different study programs, such as Industrial Design, Biomedical Engineering, Industrial Engineering and Psychology & Technology. Diversity is key to a successful organization in which many different viewpoints and skills are considered to find the best solutions.",{"type":152,"children":5150},[5151,5153,5155],{"text":5152,"type":156},"\"",{"text":5154,"type":156,"italic":79},"As an Industrial Design student, I love to be creative and to present new innovations to the world. SensUs gives me the opportunity to develop myself by contributing to the future of health. I'm looking forward to broaden my perspective and to develop my soft skills in the professional and interdisciplinary setting SensUs offers me,",{"text":5156,"type":156},"” explains new member Teun van Acker.",{"type":152,"children":5158},[5159],{"text":5160,"type":156},"The new members are excited to help with the organization of the SensUs event which stimulates the development of new biosensors, an important field in the healthcare industry at the moment. Besides that, an eagerness to explore and expand their professional skills is present in all new members. SensUs creates the perfect platform to broaden both skills and personal development.",{"type":152,"children":5162},[5163],{"text":5164,"type":156},"We hope to see you at the event on the 7th and 8th of September!","2026-07-28T11:14:17.742Z","2026-07-28T11:14:17.740Z",{"id":5168,"documentId":5169,"name":5170,"alternativeText":18,"caption":18,"focalPoint":18,"width":5171,"height":5172,"formats":5173,"hash":5198,"ext":280,"mime":283,"size":5199,"url":5200,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":5201,"updatedAt":5201,"publishedAt":5202},1324,"qi8cvgeloyw4wxuzwii5puam","Nieuwe_leden_artikel.jpg",4000,2667,{"large":5174,"small":5180,"medium":5186,"thumbnail":5192},{"ext":280,"url":5175,"hash":5176,"mime":283,"name":5177,"path":18,"size":5178,"width":190,"height":345,"sizeInBytes":5179},"/uploads/large_Nieuwe_leden_artikel_41e161d4de.jpg","large_Nieuwe_leden_artikel_41e161d4de","large_Nieuwe_leden_artikel.jpg",149.24,149238,{"ext":280,"url":5181,"hash":5182,"mime":283,"name":5183,"path":18,"size":5184,"width":198,"height":293,"sizeInBytes":5185},"/uploads/small_Nieuwe_leden_artikel_41e161d4de.jpg","small_Nieuwe_leden_artikel_41e161d4de","small_Nieuwe_leden_artikel.jpg",43.96,43955,{"ext":280,"url":5187,"hash":5188,"mime":283,"name":5189,"path":18,"size":5190,"width":206,"height":198,"sizeInBytes":5191},"/uploads/medium_Nieuwe_leden_artikel_41e161d4de.jpg","medium_Nieuwe_leden_artikel_41e161d4de","medium_Nieuwe_leden_artikel.jpg",88.94,88939,{"ext":280,"url":5193,"hash":5194,"mime":283,"name":5195,"path":18,"size":5196,"width":306,"height":214,"sizeInBytes":5197},"/uploads/thumbnail_Nieuwe_leden_artikel_41e161d4de.jpg","thumbnail_Nieuwe_leden_artikel_41e161d4de","thumbnail_Nieuwe_leden_artikel.jpg",11.2,11195,"Nieuwe_leden_artikel_41e161d4de",1667.31,"/uploads/Nieuwe_leden_artikel_41e161d4de.jpg","2026-07-28T11:14:17.662Z","2026-07-28T11:14:17.663Z",{"id":5204,"documentId":5205,"title":5206,"slug":5207,"date":5208,"cardTitle":18,"excerpt":18,"body":5209,"createdAt":5318,"updatedAt":5318,"publishedAt":5319,"cardImage":5320},314,"u096s8ukhc07leagl8s9tnxm","Personal stories: Roger Brüggemann and Rob ter Heine","personal-stories-roger-bruggemann-and-rob-ter-heine","2018-04-14",[5210,5214,5218,5222,5226,5230,5234,5238,5242,5246,5250,5254,5258,5262,5266,5270,5274,5278,5282,5286,5290,5294,5298,5302,5306,5310,5314],{"type":152,"children":5211},[5212],{"bold":79,"text":5213,"type":156},"RadboudUMC is the large academic hospital of Radboud University in Nijmegen. We spoke with Rob ter Heine and Roger Brüggemann, pharmacists at RadboudUMC, about the biomarker of SensUs 2018, their vision on biosensing, the importance of personal dosing, and about the future of healthcare and SensUs.",{"type":152,"children":5215},[5216],{"bold":79,"text":5217,"type":156},"Who are we?",{"type":152,"children":5219},[5220],{"text":5221,"type":156},"I am Roger Brüggemann, a hospital pharmacist and clinical pharmacologist at the Radboud University Medical Center in Nijmegen, the Netherlands. My work focuses on antibiotics and the treatment of fungal diseases. In our research group HIV, Hepatitis C and TBC are also researched. I became a hospital pharmacist and clinical pharmacist because it connects chemistry with patients. The interactions with doctors and the complex care of hospitalized patients seemed the most beautiful challenge to me. My main task is to predict the behavior of medicines like antibiotics and to look how we can improve these therapies for individuals.",{"type":152,"children":5223},[5224],{"text":5225,"type":156},"My name is Rob ter Heine, I am specialized in making computer models for the prediction of drug behavior and graduated as a hospital pharmacist and clinical pharmacologist. I have been working at the RadboudUMC Nijmegen for three years to improve the treatment of infectious diseases. In this way, I contribute to improving medical care in a scientific way. Our work can be applied at any moment, i.e. a solution we came up with last week could be used today. At the Radboud UMC Nijmegen I act as an expert for mathematical modelling with applications in multiple medical fields.",{"type":152,"children":5227},[5228],{"text":5229,"type":156},"We look at what happens to patients during their stay in, for example, the Intensive Care and by doing research we try to contribute to an optimal treatment of each individual patient. We work in a so called “stewardship” with our department, which is a collaboration between microbiologists, infectiologists and pharmacists who predict the future of resistance to medicines. We know the drugs, the analytical tools, the patients and the pathogens. An important drug we monitor is for example vancomycin, the antibiotic that SensUs 2018 focuses on.",{"type":152,"children":5231},[5232],{"bold":79,"text":5233,"type":156},"Antibiotic Resistance",{"type":152,"children":5235},[5236],{"text":5237,"type":156,"italic":79},"“The consequence of antibiotic resistance is simply death.”",{"type":152,"children":5239},[5240],{"text":5241,"type":156},"When patients cannot be treated adequately they die, so antibiotic resistance is very dangerous. When penicillin and, later, other antibiotics were discovered and developed, the doctors thought that they had the perfect tool to keep people alive and society stopped investing in the development of new antibiotics.",{"type":152,"children":5243},[5244],{"text":5245,"type":156},"Nowadays, companies do not take the risk anymore to develop new drugs. We believe that good measurements can be part of the solution, in order to give every patient his or her optimal dose. The majority of antibiotic resistance originates from disciplines like livestock farming and agriculture. So in a way eating meat enlarges the problem of antibiotic resistance. Moreover, with increasing global air traffic we foresee a doomsday scenario: micro-organisms travelling between continents without any therapies to counter the diseases that they cause.",{"type":152,"children":5247},[5248],{"text":5249,"type":156,"italic":79},"“We are a bit like Sherlock Holmes.”",{"type":152,"children":5251},[5252],{"text":5253,"type":156},"Nowadays you hear about outbreaks of Vancomycin-Resistant Enterococcus (VRE) and Vancomycin Intermediate Staphylococcus Aureus (VISA) in the Netherlands. These are big problems in many countries. In Nijmegen we prevent such outbreaks in the best possible way: by retaining the transmission of antibiotic resistant strains between individuals and by optimizing the dose of antibiotics.",{"type":152,"children":5255},[5256],{"bold":79,"text":5257,"type":156},"Vancomycin",{"type":152,"children":5259},[5260],{"text":5261,"type":156},"Vancomycin is used in critically ill patients. It is a last-resort drug for which we know the optimum concentration. By measuring drug concentrations we try to give patients the right dose: the dose kills the bacteria but does not damage the kidneys. This right dose depends strongly on the individual patient.",{"type":152,"children":5263},[5264],{"text":5265,"type":156},"The measurement of vancomycin concentrations requires a vast network of trained nurses, professional laboratories and corresponding specialists. In our laboratories we have different machines for different antibiotics, for vancomycin we use immuno-assays and ultrasensitive mass spectrometers. We use these machines at least twice a day to measure vancomycin.",{"type":152,"children":5267},[5268],{"text":5269,"type":156},"Many things can go wrong in this process from sample to answer, so we do have some setbacks from time to time. The time required for the whole dose-adjustment process of general antibiotics of a patient is approximately three days, however, there is a large spread. Treating physicians simply do not have the time to wait for results. Most of the time we look if the patient is doing well and if not we take a blood sample and diagnose the morning after. For vancomycin testing, the turnaround time is about 6 to 12 hours.",{"type":152,"children":5271},[5272],{"bold":79,"text":5273,"type":156},"Treatment of Patients",{"type":152,"children":5275},[5276],{"text":5277,"type":156,"italic":79},"“I just visited a newborn who lies on the intensive care for an infectious disease.”",{"type":152,"children":5279},[5280],{"text":5281,"type":156},"Some people come to the hospital for specific infections that have escalated, while others get infected while being in the hospital. These infections can occur spontaneously, by contact or in the hospital by the environment.",{"type":152,"children":5283},[5284],{"text":5285,"type":156},"As clinical pharmacologists we investigate pharmacokinetics and pharmacodynamics, i.e. the effect of drugs on pathogens, in order to give patients the best possible treatment. We study current practices and have discovered that a lot can be improved. In the intensive care approximately 40% of all patients is not being treated with the adequate exposure. This is something we try to solve.",{"type":152,"children":5287},[5288],{"text":5289,"type":156},"We can only tune vancomycin concentrations using an infusion. If the kidneys of a patient do not function anymore the patient holds a lot of fluid, from which his or her body will literally swell. This affects the distribution of the drug and is important for the calculations we perform. Other difficulties could be human mistakes. An example is a nurse taking blood from the same infusion as where he or she dosed vancomycin in the first place. This could lead to a drug concentration of approximately 180 mg/L while 20 mg/L is the general target concentration. We find it essential that everyone involved in measuring drug concentrations should be qualified in all terrains. Therefore, we try to find optimal therapies for individual patients to prevent these possible problems.",{"type":152,"children":5291},[5292],{"text":5293,"type":156},"The patients’ critical conditions can lead to septic shocks. These shocks block renal perfusion which causes great damage to the kidneys. These patients always get vancomycin, which could result in a downward spiral: first the kidneys stop working, vancomycin will not be cleared anymore by the kidneys, as a result the drug concentration rises and the kidneys get damaged more than before. As pharmacist we see the biggest challenge in the recovery of those critical patients.",{"type":152,"children":5295},[5296],{"bold":79,"text":5297,"type":156},"Biosensing",{"type":152,"children":5299},[5300],{"text":5301,"type":156},"Currently, we have patients in the OPAT (Outpatient Antibiotic Treatment). These patients are treated with vancomycin at home by using elastomeric infusion. However, controlling the vancomycin dose affects patients’ social lives immensely. These patients need to visit the hospital often and therefore have limitations in their daily life. Furthermore, the pharmacokinetic behavior of vancomycin is heavily regulated by hemodynamic changes. It would be very helpful to have a biosensor in order to track these rapid changes.",{"type":152,"children":5303},[5304],{"text":5305,"type":156},"We think that biosensors for vancomycin would be very helpful especially for specific tissue concentration measuring and for critically ill patients. Not only the speed of receiving test results, but also getting direct feedback is beneficial. The biosensors could be helpful as rapid tests, but more ideal would be to integrate the biosensors in catheters and receive online results. If we could measure in specific locations, for example inside an infected knee, that would also be very valuable. Admission to hospitals is getting more and more expensive, and being in a hospital brings the risk of acquiring other infections. So, the ideal situation is to treat patients outside of the hospital rather than by long stays in the hospital.",{"type":152,"children":5307},[5308],{"bold":79,"text":5309,"type":156},"SensUs competition",{"type":152,"children":5311},[5312],{"text":5313,"type":156,"italic":79},"“SensUs could cause a revolution in personalized care.”",{"type":152,"children":5315},[5316],{"text":5317,"type":156},"We think that biosensing is the future of medical care. Measuring drug concentrations could cause major improvements for both patients and medical professionals. We cannot wait until the future of biosensing is here. We think that SensUs can help to realize personalized care and also make it known in society. We are strong supporters of your mission!","2026-07-28T11:14:17.955Z","2026-07-28T11:14:17.953Z",{"id":5321,"documentId":5322,"name":5323,"alternativeText":18,"caption":18,"focalPoint":18,"width":640,"height":5324,"formats":5325,"hash":5353,"ext":280,"mime":283,"size":5354,"url":5355,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":5356,"updatedAt":5356,"publishedAt":5356},1327,"clj3efzz5ut8d7skzay1xbqg","R&R_vierkant.jpg",2274,{"large":5326,"small":5333,"medium":5340,"thumbnail":5347},{"ext":280,"url":5327,"hash":5328,"mime":283,"name":5329,"path":18,"size":5330,"width":190,"height":5331,"sizeInBytes":5332},"/uploads/large_R_and_R_vierkant_558a1a4d6b.jpg","large_R_and_R_vierkant_558a1a4d6b","large_R&R_vierkant.jpg",52.69,752,52689,{"ext":280,"url":5334,"hash":5335,"mime":283,"name":5336,"path":18,"size":5337,"width":198,"height":5338,"sizeInBytes":5339},"/uploads/small_R_and_R_vierkant_558a1a4d6b.jpg","small_R_and_R_vierkant_558a1a4d6b","small_R&R_vierkant.jpg",19.11,376,19105,{"ext":280,"url":5341,"hash":5342,"mime":283,"name":5343,"path":18,"size":5344,"width":206,"height":5345,"sizeInBytes":5346},"/uploads/medium_R_and_R_vierkant_558a1a4d6b.jpg","medium_R_and_R_vierkant_558a1a4d6b","medium_R&R_vierkant.jpg",34.73,564,34726,{"ext":280,"url":5348,"hash":5349,"mime":283,"name":5350,"path":18,"size":5351,"width":3107,"height":214,"sizeInBytes":5352},"/uploads/thumbnail_R_and_R_vierkant_558a1a4d6b.jpg","thumbnail_R_and_R_vierkant_558a1a4d6b","thumbnail_R&R_vierkant.jpg",5.26,5261,"R_and_R_vierkant_558a1a4d6b",373.17,"/uploads/R_and_R_vierkant_558a1a4d6b.jpg","2026-07-28T11:14:17.868Z",{"id":5358,"documentId":5359,"title":5360,"slug":5361,"date":5362,"cardTitle":18,"excerpt":18,"body":5363,"createdAt":5380,"updatedAt":5380,"publishedAt":5381,"cardImage":5382},315,"hq9vr7jvscce6zwqjgmkz0sc","SensUs visits: Puls 2018","sensus-visits-puls-2018","2018-02-27",[5364,5368,5372,5376],{"type":152,"children":5365},[5366],{"bold":79,"text":5367,"type":156},"The SensUs Organization hosted interactive discussions at Puls, a biannual event of the Dutch Heart Foundation where patients, professionals and the industry meet to discuss progress in the field of cardiovascular research.",{"type":152,"children":5369},[5370],{"text":5371,"type":156},"Puls consists of a range of activities such as lectures, workshops and so called interactive points. On Thursday the 8th of February, the SensUs Organization hosted one of the interactive points in order to engage visitors and ourselves in a discussion about the ethical aspects that come with a biosensor.",{"type":152,"children":5373},[5374],{"text":5375,"type":156},"The main question was: ‘How do we deal with the data measured by biosensors?’ What to do with the data that is becoming available with novel devices? Do we want to know everything that is ongoing in our bodies? Who has access to what information? And when is someone or something to be trusted? Some participants stated that they do not want to know all that is going on in their bodies. Another remarkable comment was that relying completely on sensors could even be dangerous, as such measurements could potentially miss a harmful condition. Therefore, it remains very important to take one’s own natural body signals seriously.",{"type":152,"children":5377},[5378],{"text":5379,"type":156},"We noticed that many organizations are working on mobile applications to either support a healthy lifestyle or to track body measurements, like heart rate and daily steps. Instead of remedying cardiovascular disease, they often focus on prevention. In the future, biosensors can also become a source of data to realize that prospective.","2026-07-28T11:14:18.315Z","2026-07-28T11:14:18.314Z",{"id":5383,"documentId":5384,"name":5385,"alternativeText":18,"caption":18,"focalPoint":18,"width":641,"height":640,"formats":5386,"hash":5411,"ext":280,"mime":283,"size":5412,"url":5413,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":5414,"updatedAt":5414,"publishedAt":5414},1330,"wqvx4124nl88xeuibttfw162","Puls.jpg",{"large":5387,"small":5393,"medium":5399,"thumbnail":5405},{"ext":280,"url":5388,"hash":5389,"mime":283,"name":5390,"path":18,"size":5391,"width":190,"height":206,"sizeInBytes":5392},"/uploads/large_Puls_4361618cb2.jpg","large_Puls_4361618cb2","large_Puls.jpg",126.83,126834,{"ext":280,"url":5394,"hash":5395,"mime":283,"name":5396,"path":18,"size":5397,"width":198,"height":654,"sizeInBytes":5398},"/uploads/small_Puls_4361618cb2.jpg","small_Puls_4361618cb2","small_Puls.jpg",41.71,41705,{"ext":280,"url":5400,"hash":5401,"mime":283,"name":5402,"path":18,"size":5403,"width":206,"height":661,"sizeInBytes":5404},"/uploads/medium_Puls_4361618cb2.jpg","medium_Puls_4361618cb2","medium_Puls.jpg",78.86,78858,{"ext":280,"url":5406,"hash":5407,"mime":283,"name":5408,"path":18,"size":5409,"width":3107,"height":214,"sizeInBytes":5410},"/uploads/thumbnail_Puls_4361618cb2.jpg","thumbnail_Puls_4361618cb2","thumbnail_Puls.jpg",10.15,10150,"Puls_4361618cb2",1357.6,"/uploads/Puls_4361618cb2.jpg","2026-07-28T11:14:18.311Z",{"id":5416,"documentId":5417,"title":5418,"slug":5419,"date":5420,"cardTitle":18,"excerpt":18,"body":5421,"createdAt":5494,"updatedAt":5494,"publishedAt":5495,"cardImage":5496},316,"im7j67tntdbkxyh6hdfje3ab","SensUs interviews: Kees Verduin","sensus-interviews-kees-verduin","2018-02-19",[5422,5426,5430,5434,5438,5442,5446,5450,5454,5458,5462,5466,5470,5474,5478,5482,5486,5490],{"type":152,"children":5423},[5424],{"bold":79,"text":5425,"type":156},"Have you ever taken a blood test in a hospital and wondered how they measure what’s inside your blood? We spoke with Kees Verduin, a medical microbiologist and the right person to ask this question. He tells us about his job, how they measure samples in the lab and why we really need to be concerned about the problem of antibiotic resistance.",{"type":152,"children":5427},[5428],{"bold":79,"text":5429,"type":156},"Can you tell something about yourself and your job as a medical microbiologist?",{"type":152,"children":5431},[5432],{"text":5433,"type":156},"My name is Kees Verduin and I studied microbiology at the University hospital of Utrecht. In my professional life I have worked for different Dutch hospitals, e.g. Erasmus Medical Center Rotterdam, St. Anna Hospital Geldrop, Maxima Medical Center Veldhoven, Elkerliek Hospital Helmond and Amphia Hospital, Breda. Nowadays I work as a medical-microbiology consultant at PAMM laboratories in Veldhoven. My role within PAMM is to advise doctors and hospitals how to diagnose patients, what antibiotics to use and how to prevent infections. Together with 8 other medical microbiologists, I supervise and support more than 70 laboratory technicians in their daily job to analyse thousands of medical samples coming from our region in the south of the Netherlands.",{"type":152,"children":5435},[5436],{"bold":79,"text":5437,"type":156},"How did the role of medical-microbiologists evolve over the years?",{"type":152,"children":5439},[5440],{"text":5441,"type":156},"Medical microbiologists have been around for more than 100 years. Well-known founders of the field are Anthony van Leeuwenhoek, Louis Pasteur and Robert Koch. Alexander Fleming, also known as the man who discovered benzylpenicillin (first penicillin antibiotic), is a good example of how medical-microbiologists worked in the past. Besides diagnosing patients, they used to do the laboratory analysis themselves as well, often in an improvised home laboratory. Nowadays, a team of technicians does this job in high-tech laboratories. The current role of medical-microbiologists is to supervise the laboratory and take decisions regarding test results and thereby advising treating physicians.",{"type":152,"children":5443},[5444],{"bold":79,"text":5445,"type":156},"Does the widespread use of antibiotics affect your work as a medical-microbiologist?",{"type":152,"children":5447},[5448],{"text":5449,"type":156},"Since antibiotics work very effectively in most cases, doctors tend to prescribe them often, many times even too often. You see this happening in many healthcare settings all over the world. However, there are big differences in usage of antibiotics: In some countries the use is very high while in others, for example in the Netherlands, the use is much lower. What one forgets is that many infections will heal without antibiotic therapy, yet we often prescribe antibiotics just to be sure or to reassure the doctor and the patient. A common thought is that as long as we use antibiotics to fight infections, we will be able to cure everybody. Unfortunately, that is not true. If we continue to prescribe too much antibiotics, we will have no cure for many serious infections in 30-40 years due to antibiotic resistance. So, my job as a medical-microbiologist gets harder with the day, because millions of people use antibiotics around the world and resistance is rising rapidly. For this reason we need to find new ways to fight infections, in a world where antibiotics are becoming almost useless in many cases.",{"type":152,"children":5451},[5452],{"bold":79,"text":5453,"type":156},"Regarding the general problem of antibiotic resistance, what is in your opinion the main challenge and what is necessary in order to tackle it?",{"type":152,"children":5455},[5456],{"text":5457,"type":156},"Antibiotic resistance is a big problem in the Netherlands, however it is not so bad in comparison with other countries in Europe or in the rest of the world. Together with Scandinavia, the Netherlands is one of the countries with the least deaths per year due to antibiotic resistance. Some people think that the biggest challenge is to convince big pharmaceutical companies to develop new antibiotics, however, I am afraid that there are things that money cannot buy. When looking at drug development, the most effective antibiotics that we use nowadays were discovered over 40 years ago. Unfortunately, it seems that we cannot successfully continue antibiotic development. I am an optimistic person, however I am afraid that humans might never find new revolutionary antimicrobial drugs ever again. So, antibiotic resistance is a big problem, and there is no remedy in sight at this moment.",{"type":152,"children":5459},[5460],{"text":5461,"type":156},"As I stated before, antibiotic resistance is a huge problem worldwide. When looking at the numbers, we see that there are rising numbers of death due to antimicrobial resistance. Although this is still rare in the Netherlands, the situation in other countries is much worse. Greece and Italy have very serious problems with patients that can no longer be effectively treated with antibiotics.",{"type":152,"children":5463},[5464],{"bold":79,"text":5465,"type":156},"The theme of SensUs 2018 is “Measuring antibiotics for better healthcare”. What is its relevance to society?",{"type":152,"children":5467},[5468],{"text":5469,"type":156},"When giving an antibiotic one wants to be sure that the dose is right and the concentrations in the blood are high enough to be effective. In addition, some antibiotics are toxic and measuring concentrations in the blood can prevent serious complications, such as kidney failure or liver toxicity. Therefore, measuring antibiotic concentrations in blood is very important. Nowadays measuring concentrations is difficult and takes a long time, making it less useful for optimization of treatment.",{"type":152,"children":5471},[5472],{"bold":79,"text":5473,"type":156},"The biomarker of SensUs 2018 is vancomycin. Can you tell something about it? Why is it important and what are the clinical problems?",{"type":152,"children":5475},[5476],{"text":5477,"type":156},"Vancomycin is a last resort antibiotic, that we only prescribe when patients show resistance for other antibiotics. Unfortunately, vancomycin has a very small therapeutic window. For this reason, the administered dose should be precisely controlled to prevent resistance and toxicity. One clinical problem is that it is hard to determine the best treatment dose. A second problem is that it often takes days before vancomycin reaches the optimal concentration in the blood and works properly. If you are lucky, it will start working effectively after 2 days and that is considered to be really fast. However, some people need to wait much longer, which is in some cases too late.",{"type":152,"children":5479},[5480],{"bold":79,"text":5481,"type":156},"How do you see the future for sensing technologies in the field of healthcare?",{"type":152,"children":5483},[5484],{"text":5485,"type":156},"Here, at PAMM laboratories, we have the right equipment and medical staff to run almost every measurement one can dream of. However, when looking at hospitals in rural areas or hospitals in third world countries, there is a huge difference in what they can measure due to lack of medical equipment and medical staff. I really think that sensing technologies can close that gap. I dream of a world where people from Africa can be tested in the same way as people in the western world and biosensing might be the answer. Some sceptics say that biosensors cannot replace expensive medical measuring equipment, to them I say that people used to be sceptical about the first mobile phone and look how far we have come since then. So, I think that sensing technologies will help to further improve our healthcare.",{"type":152,"children":5487},[5488],{"bold":79,"text":5489,"type":156},"What do you think about the SensUs competition? Do you have any advice for the teams and/or for the SensUs organization?",{"type":152,"children":5491},[5492],{"text":5493,"type":156},"I really like the idea behind the SensUs competition, because it stimulates young talented students to look at socially relevant medical problems and seek for creative solutions. I hope that this competition will lead to novel ideas, which might change the way we analyse, work and think in the world of microbiology. My advice for the teams is to focus on ease-of-use and measuring speed. Do not hesitate to build an expensive biosensor, as long as it is easy-to-use and applicable to every person.","2026-07-28T11:14:18.647Z","2026-07-28T11:14:18.645Z",{"id":5497,"documentId":5498,"name":5499,"alternativeText":18,"caption":18,"focalPoint":18,"width":5500,"height":5501,"formats":5502,"hash":5527,"ext":280,"mime":283,"size":5528,"url":5529,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":5530,"updatedAt":5530,"publishedAt":5530},1332,"icqqmcb1dhv0gid75syyz0qj","Kees_Verduin_rechthoek.jpg",3240,4855,{"large":5503,"small":5509,"medium":5515,"thumbnail":5521},{"ext":280,"url":5504,"hash":5505,"mime":283,"name":5506,"path":18,"size":5507,"width":345,"height":190,"sizeInBytes":5508},"/uploads/large_Kees_Verduin_rechthoek_ee40c46bce.jpg","large_Kees_Verduin_rechthoek_ee40c46bce","large_Kees_Verduin_rechthoek.jpg",89.53,89528,{"ext":280,"url":5510,"hash":5511,"mime":283,"name":5512,"path":18,"size":5513,"width":352,"height":198,"sizeInBytes":5514},"/uploads/small_Kees_Verduin_rechthoek_ee40c46bce.jpg","small_Kees_Verduin_rechthoek_ee40c46bce","small_Kees_Verduin_rechthoek.jpg",22.77,22774,{"ext":280,"url":5516,"hash":5517,"mime":283,"name":5518,"path":18,"size":5519,"width":359,"height":206,"sizeInBytes":5520},"/uploads/medium_Kees_Verduin_rechthoek_ee40c46bce.jpg","medium_Kees_Verduin_rechthoek_ee40c46bce","medium_Kees_Verduin_rechthoek.jpg",47.98,47978,{"ext":280,"url":5522,"hash":5523,"mime":283,"name":5524,"path":18,"size":5525,"width":570,"height":214,"sizeInBytes":5526},"/uploads/thumbnail_Kees_Verduin_rechthoek_ee40c46bce.jpg","thumbnail_Kees_Verduin_rechthoek_ee40c46bce","thumbnail_Kees_Verduin_rechthoek.jpg",3.63,3630,"Kees_Verduin_rechthoek_ee40c46bce",2542.05,"/uploads/Kees_Verduin_rechthoek_ee40c46bce.jpg","2026-07-28T11:14:18.610Z",{"id":5532,"documentId":5533,"title":5534,"slug":5535,"date":5536,"cardTitle":18,"excerpt":18,"body":5537,"createdAt":5594,"updatedAt":5594,"publishedAt":5595,"cardImage":5596},317,"id4an7ey8j5x027q2qevutz5","SensUs interviews: Ursula Mühle","sensus-interviews-ursula-muhle","2018-01-27",[5538,5542,5546,5550,5554,5558,5562,5566,5570,5574,5578,5582,5586,5590],{"type":152,"children":5539},[5540],{"bold":79,"text":5541,"type":156},"EIT Health is a Knowledge and Innovation Community established by EIT. They promote healthy living, support active ageing and improve healthcare for citizens. We spoke with Dr. Ursula Mühle, Director of Education, about healthcare technology and about SensUs.",{"type":152,"children":5543},[5544],{"bold":79,"text":5545,"type":156},"Can you tell something about yourself? Who are you and what is your role in EIT Health?",{"type":152,"children":5547},[5548],{"text":5549,"type":156},"I am Ursula Mühle and I work as Director of Education for EIT Health. EIT Health is one of the largest initiatives in healthcare innovation worldwide. We collaborate with approximately 150 leading partner organisations in the mission to create novel healthcare products and services and accelerate start-ups and trainings to support the European citizen towards better health. As my title says, I am responsible for overseeing and sparking the Education Portfolio of our partners. This includes training for students, entrepreneurs, professionals and citizens. I am very happy to have SensUs as part of our portfolio to combine novel teaching methodologies with innovations in healthcare.",{"type":152,"children":5551},[5552],{"bold":79,"text":5553,"type":156},"How is EIT Health involved in healthcare technology innovation?",{"type":152,"children":5555},[5556],{"text":5557,"type":156},"EIT Health is the dynamic, integrated network for talent, innovation and entrepreneurship, empowering citizens to lead healthier and more productive lives. Our mission is to accelerate innovation and entrepreneurship for active ageing and healthy living. As the Director of Education, I lead and am responsible for developing EIT Health CAMPUS. Our goal is to educate for better health. Through innovative education programmes, we empower Europe’s top talents, leaders and citizens with new opportunities and resources to create novel solutions and achieve transformations in healthcare that make healthy lives a reality for all.",{"type":152,"children":5559},[5560],{"bold":79,"text":5561,"type":156},"What do you think of the SensUs concept and vision?",{"type":152,"children":5563},[5564],{"text":5565,"type":156},"We decided to let SensUs become part of our EIT Health CAMPUS portfolio in 2017 already. The EIT Health CAMPUS Training for Students projects focuses on stimulating students to improve their knowledge, skills and attitudes in a way that enhances their health-related innovation and entrepreneurial capabilities. SensUs contributes very nicely to this aim by using innovative learning approaches combined with a competition where students have a unique training experience with goal-oriented multidisciplinary teamwork and in health innovations.",{"type":152,"children":5567},[5568],{"bold":79,"text":5569,"type":156},"What is your long term expectation of SensUs?",{"type":152,"children":5571},[5572],{"text":5573,"type":156},"For the next three years, EIT Health CAMPUS aims to expand its support for innovation within education itself by using innovative education models, methods and formats. Based on the successes of previous student competitions such as SensUs, we would like to see SensUs become part of an international EIT Health network of international competitions for teams of students.",{"type":152,"children":5575},[5576],{"bold":79,"text":5577,"type":156},"The theme of SensUs 2018 is “Measuring antibiotics for better healthcare”. What is your opinion about this theme and its relevance?",{"type":152,"children":5579},[5580],{"text":5581,"type":156},"In my opinion this theme is highly relevant. According to the World Health Organization, antibiotic resistance is rising to dangerously high levels in all parts of the world. New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases. A growing list of infections, some of them which have almost been eliminated, such as tuberculosis, are becoming harder or even impossible to treat as antibiotics become less effective. Within EIT Health we have taken up this challenge already at several places, and within the EIT Health CAMPUS portfolio there will also be a PhD School being developed to train students from all scientific disciplines addressing the problems of infections and anti-microbial resistance. The aim is to develop implementations and interventions of new and better antibiotics, diagnostic methods, rational economic models for drug development, political incentives and to increase overall awareness of the use of antibiotics and spread of pathogens.",{"type":152,"children":5583},[5584],{"text":5585,"type":156},"EIT Health recently launched a call for applications for its wild card initiative, to build innovative solutions that tackle the growing problem of antibiotic resistance, both in terms of raising awareness and enabling new processes and methodologies across EU healthcare.",{"type":152,"children":5587},[5588],{"bold":79,"text":5589,"type":156},"Do you have an advice for the student teams and for the SensUs organization?",{"type":152,"children":5591},[5592],{"text":5593,"type":156},"Believe in your own ideas and always be open to your team-members, as this can lift you up massively. Develop an entrepreneurial mindset: try out new things, enjoy the unexpected and always have a big mission in mind. Then you can change the world!","2026-07-28T11:14:18.925Z","2026-07-28T11:14:18.923Z",{"id":5597,"documentId":5598,"name":5599,"alternativeText":18,"caption":18,"focalPoint":18,"width":3612,"height":5600,"formats":5601,"hash":5626,"ext":280,"mime":283,"size":5627,"url":5628,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":5629,"updatedAt":5629,"publishedAt":5629},1335,"dsa16e19jzu0uxmwqmlskli6","Ursula.jpg",5184,{"large":5602,"small":5608,"medium":5614,"thumbnail":5620},{"ext":280,"url":5603,"hash":5604,"mime":283,"name":5605,"path":18,"size":5606,"width":345,"height":190,"sizeInBytes":5607},"/uploads/large_Ursula_89d6582975.jpg","large_Ursula_89d6582975","large_Ursula.jpg",50.18,50177,{"ext":280,"url":5609,"hash":5610,"mime":283,"name":5611,"path":18,"size":5612,"width":293,"height":198,"sizeInBytes":5613},"/uploads/small_Ursula_89d6582975.jpg","small_Ursula_89d6582975","small_Ursula.jpg",17.64,17638,{"ext":280,"url":5615,"hash":5616,"mime":283,"name":5617,"path":18,"size":5618,"width":198,"height":206,"sizeInBytes":5619},"/uploads/medium_Ursula_89d6582975.jpg","medium_Ursula_89d6582975","medium_Ursula.jpg",32.46,32457,{"ext":280,"url":5621,"hash":5622,"mime":283,"name":5623,"path":18,"size":5624,"width":570,"height":214,"sizeInBytes":5625},"/uploads/thumbnail_Ursula_89d6582975.jpg","thumbnail_Ursula_89d6582975","thumbnail_Ursula.jpg",3.57,3565,"Ursula_89d6582975",559.85,"/uploads/Ursula_89d6582975.jpg","2026-07-28T11:14:18.870Z",{"id":5631,"documentId":5632,"title":5633,"slug":5634,"date":5635,"cardTitle":18,"excerpt":18,"body":5636,"createdAt":5711,"updatedAt":5711,"publishedAt":5712,"cardImage":5713},318,"zwunqvv23c3onzk2ozeiehew","Personal stories: Stijn Konings","personal-stories-stijn-konings","2018-01-07",[5637,5641,5652,5656,5660,5664,5668,5672,5675,5679,5683,5687,5691,5695,5699,5703,5707],{"type":379,"level":106,"children":5638},[5639],{"bold":79,"text":5640,"type":156,"italic":79},"A biosensor for vancomycin would be really helpful",{"type":379,"level":111,"children":5642},[5643,5645,5650],{"bold":79,"text":5644,"type":156},"We spoke with Stijn Konings, an internist-nephrologist from the ",{"url":5646,"type":236,"children":5647},"https://www.facebook.com/CatharinaZiekenhuis/?fref=mentions",[5648],{"bold":79,"text":5649,"type":156},"Catharina Hospital in Eindhoven",{"bold":79,"text":5651,"type":156},", about the benefits that biosensors can bring in healthcare and how a biosensor for antibiotics can help patients.",{"type":152,"children":5653},[5654],{"text":5655,"type":156},"My name is Stijn Konings, I have been working as an internist-nephrologist at the Catharina Hospital in Eindhoven since 2002. Most of the time I work at the dialysis department, together in a broad team, to provide the best care for the patient. I am especially concerned with cardiovascular diseases in patients with renal insufficiencies. Furthermore I focus on the self management and home treatment of patients having renal function replacement therapy.",{"type":152,"children":5657},[5658],{"text":5659,"type":156},"Sometimes I find it difficult to see people having a disease, especially young kidney patients, because it is hardly possible to completely cure these patients for the rest of their lives. Additional therapies will always be needed. At the same time, one of the pros of this work is that there is a good treatment available for these diseases, like replacement of the whole organ or replacement therapies. This brings a positive perspective for the patients. We try to involve the patients as much as possible in their treatment, and we also stimulate treatment at home. When patients have more control, they feel less sick. They are more stimulated to stay positive and can function in the society. It is always a nice challenge to work as a team in order to come up with the best treatment for the patient. But of course, preferably we want to prevent kidney diseases in the first place.",{"type":152,"children":5661},[5662],{"bold":79,"text":5663,"type":156},"Antibiotic resistance",{"type":152,"children":5665},[5666],{"text":5667,"type":156},"I think that antibiotic resistance is a massive problem. Antibiotics are excessively used and in the wrong way, especially in the south of Europe. This wrong use can cause resistance against the antibiotic, causing massive problems for society. In my opinion, doctors and microbiologists should consider whether to give a patient antibiotics or not. This should also be done on worldwide level to prevent the spread of antibiotic resistant bacteria from other countries.",{"type":152,"children":5669},[5670],{"text":5671,"type":156},"In practice, the treatment of patients can be negatively influenced by resistant bacteria. When patients return form their holiday, they are investigated thoroughly for antibiotic resistant bacteria before hospitalization. This is done to prevent possible spreading of antibiotic resistant bacteria that the patients might be carrying. Because when they carry such bacterium they have to be treated in an isolated room. This not only costs a lot of money, but also brings a lot of waste, like the use of extra prevention tools, which all is very inefficient.",{"type":152,"children":5673},[5674],{"bold":79,"text":5257,"type":156},{"type":152,"children":5676},[5677],{"text":5678,"type":156},"As nephrologists, we work a lot with vancomycin. We mainly prescribe it when patients show resistance for certain antibiotics. It is also used in patients that undergo peritoneal dialysis, because it can easily be administered with the peritoneal liquid. Since vancomycin has a small therapeutic window, the administered dose should be precisely controlled to prevent resistance and toxicity, and thereby more damage to the kidneys. When we treat patients intravenously with vancomycin, we measure trough levels, i.e. the lowest concentration reached before the next dose is administered. This is done after dialysis to prevent washing of vancomycin. Based on the results, the patient will be dosed again with the right dose of vancomycin to reach the right level in the blood.",{"type":152,"children":5680},[5681],{"text":5682,"type":156},"A biosensor would be really helpful. We would no longer have to measure trough levels, which takes a lot of time and has a certain delay. Nowadays it takes 12-24 hours to receive the results from the lab and we are not able to rapidly adapt the medication. When we are able to directly measure the vancomycin concentration after dialysis with a biosensor, we can directly give the next dose to prevent any resistance or possible toxicities.",{"type":152,"children":5684},[5685],{"bold":79,"text":5686,"type":156},"Biosensors",{"type":152,"children":5688},[5689],{"text":5690,"type":156},"In general, the use of biosensors would be very beneficial in healthcare. Not only could we measure very fast, but it is also more patient friendly. It can really be an enabler for treatment at home. Nowadays blood has to be taken from the patients at home and the samples are sent to the lab. This gives transportation costs and the lab is not always available to directly analyse the blood. It would be wonderful to measure all of this with a biosensor. Of course, the development of a biosensor would require an investment, but I think this will be earned back over time. Furthermore, a biosensor would make treatment so much more personal. The patient or the caregiver would be able to adapt the medication at any time. This all provides a better quality of life.",{"type":152,"children":5692},[5693],{"bold":79,"text":5694,"type":156},"Biosensors of the future",{"type":152,"children":5696},[5697],{"text":5698,"type":156},"I think that biosensors will especially be helpful for patients with a chronic disease. We would for example like to measure hydration levels and urine markers. Also a biosensor to measure the antibiotic gentamicin would be important. Gentamicin is nephrotoxic, so needs to be carefully dosed in order to avoid kidney damage.",{"type":152,"children":5700},[5701],{"text":5702,"type":156},"People often think that the hospital is the ‘holy place’. What they do not realize is that the hospital is a place where many people come together and therefore also a lot of bacteria circulate, including bacteria that could be resistant. Treatment at home would be safer because of a lower chance of getting infected by bacteria. Biosensors could enable treatment at home. In short, home therapy is the future!",{"type":152,"children":5704},[5705],{"bold":79,"text":5706,"type":156},"SensUs Competition",{"type":152,"children":5708},[5709],{"text":5710,"type":156},"Young researchers working on societal problems will lead to novel ideas. These might seem weird at first sight, but we need new startups to work on those new ideas. I think we should really stimulate young people and give innovation a chance. They are the new generation and the clever ones of the future. SensUs is a good example of stimulating young students to develop new ideas. Keep it up!","2026-07-28T11:14:19.094Z","2026-07-28T11:14:19.092Z",{"id":5714,"documentId":5715,"name":5716,"alternativeText":18,"caption":18,"focalPoint":18,"width":5717,"height":5718,"formats":5719,"hash":5747,"ext":280,"mime":283,"size":5748,"url":5749,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":5750,"updatedAt":5750,"publishedAt":5750},1338,"iix1hr31z47clxyrap19dut0","Konings_C.J.A.M_highres_(002)_0.jpg",2083,1917,{"large":5720,"small":5727,"medium":5734,"thumbnail":5741},{"ext":280,"url":5721,"hash":5722,"mime":283,"name":5723,"path":18,"size":5724,"width":190,"height":5725,"sizeInBytes":5726},"/uploads/large_Konings_C_J_A_M_highres_002_0_a7a49c9901.jpg","large_Konings_C_J_A_M_highres_002_0_a7a49c9901","large_Konings_C.J.A.M_highres_(002)_0.jpg",66.11,920,66114,{"ext":280,"url":5728,"hash":5729,"mime":283,"name":5730,"path":18,"size":5731,"width":198,"height":5732,"sizeInBytes":5733},"/uploads/small_Konings_C_J_A_M_highres_002_0_a7a49c9901.jpg","small_Konings_C_J_A_M_highres_002_0_a7a49c9901","small_Konings_C.J.A.M_highres_(002)_0.jpg",20.77,460,20766,{"ext":280,"url":5735,"hash":5736,"mime":283,"name":5737,"path":18,"size":5738,"width":206,"height":5739,"sizeInBytes":5740},"/uploads/medium_Konings_C_J_A_M_highres_002_0_a7a49c9901.jpg","medium_Konings_C_J_A_M_highres_002_0_a7a49c9901","medium_Konings_C.J.A.M_highres_(002)_0.jpg",40.75,690,40747,{"ext":280,"url":5742,"hash":5743,"mime":283,"name":5744,"path":18,"size":4154,"width":5745,"height":214,"sizeInBytes":5746},"/uploads/thumbnail_Konings_C_J_A_M_highres_002_0_a7a49c9901.jpg","thumbnail_Konings_C_J_A_M_highres_002_0_a7a49c9901","thumbnail_Konings_C.J.A.M_highres_(002)_0.jpg",170,4001,"Konings_C_J_A_M_highres_002_0_a7a49c9901",232.11,"/uploads/Konings_C_J_A_M_highres_002_0_a7a49c9901.jpg","2026-07-28T11:14:19.028Z",{"id":5752,"documentId":5753,"title":5754,"slug":5755,"date":5756,"cardTitle":18,"excerpt":18,"body":5757,"createdAt":5774,"updatedAt":5774,"publishedAt":5775,"cardImage":5776},319,"r9zt4orl4f8v6j3uhr118u1d","Tech & Play Kids festival: Build your own biosensor","tech-play-kids-festival-build-your-own-biosensor","2017-12-29",[5758,5762,5766,5770],{"type":152,"children":5759},[5760],{"text":5761,"type":156},"On Thursday 28th of December the SensUs Organization contributed to the Tech & Play Kids Festival in Eindhoven. A day full of technical innovations where children could experiment, collaborate, and learn.",{"type":152,"children":5763},[5764],{"text":5765,"type":156},"The event, organized by the Eindhoven library, offered a large range of activities for children and families: fly a drone, build your own musical instrument, build a robot, learn to program, hop on the Sustainable Discover-bus, bring your own drawing to life, and many more!",{"type":152,"children":5767},[5768],{"text":5769,"type":156},"In the SensUs area the kids and parents were invited to build their own biosensor. In this way they could become familiar with the concept of biosensors. Their self-built biosensor compared different kinds of soda. Sodas are all liquid and tasty, but when we have a closer look, they are actually very different. Kids detected the pH values with their biosensor containing pH paper. Most of the children thought that water and 7-up would be the same, according to color. But with the pH sensor, the children could see that cola, 7-up and water are totally different when it comes to acidity. They were impressed by the results of the experiment. It shows that looking with our eyes is not enough, and marks the importance of a biosensor.",{"type":152,"children":5771},[5772],{"text":5773,"type":156},"It was an exciting day where many biosensors were built and used! We hope that you all got inspired by the world of science, technology and biosensing!","2026-07-28T11:14:19.235Z","2026-07-28T11:14:19.233Z",{"id":5777,"documentId":5778,"name":5779,"alternativeText":18,"caption":18,"focalPoint":18,"width":5780,"height":5781,"formats":5782,"hash":5807,"ext":280,"mime":283,"size":5808,"url":5809,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":5810,"updatedAt":5810,"publishedAt":5810},1341,"ztjeqn42a3vimsso2lvne0pa","Snapchat-941803646.jpg",1280,720,{"large":5783,"small":5789,"medium":5795,"thumbnail":5801},{"ext":280,"url":5784,"hash":5785,"mime":283,"name":5786,"path":18,"size":5787,"width":190,"height":661,"sizeInBytes":5788},"/uploads/large_Snapchat_941803646_476e0c24eb.jpg","large_Snapchat_941803646_476e0c24eb","large_Snapchat-941803646.jpg",96.39,96385,{"ext":280,"url":5790,"hash":5791,"mime":283,"name":5792,"path":18,"size":5793,"width":198,"height":2557,"sizeInBytes":5794},"/uploads/small_Snapchat_941803646_476e0c24eb.jpg","small_Snapchat_941803646_476e0c24eb","small_Snapchat-941803646.jpg",31.45,31453,{"ext":280,"url":5796,"hash":5797,"mime":283,"name":5798,"path":18,"size":5799,"width":206,"height":2863,"sizeInBytes":5800},"/uploads/medium_Snapchat_941803646_476e0c24eb.jpg","medium_Snapchat_941803646_476e0c24eb","medium_Snapchat-941803646.jpg",60.24,60237,{"ext":280,"url":5802,"hash":5803,"mime":283,"name":5804,"path":18,"size":5805,"width":144,"height":2870,"sizeInBytes":5806},"/uploads/thumbnail_Snapchat_941803646_476e0c24eb.jpg","thumbnail_Snapchat_941803646_476e0c24eb","thumbnail_Snapchat-941803646.jpg",9.51,9510,"Snapchat_941803646_476e0c24eb",154.47,"/uploads/Snapchat_941803646_476e0c24eb.jpg","2026-07-28T11:14:19.179Z",{"id":5812,"documentId":5813,"title":5814,"slug":5815,"date":5816,"cardTitle":18,"excerpt":18,"body":5817,"createdAt":5870,"updatedAt":5870,"publishedAt":5871,"cardImage":5872},320,"eutxglnmn2064l08bppwj4ud","SensUs interviews: Pekka Hildén","sensus-interviews-pekka-hilden","2017-12-03",[5818,5822,5826,5830,5834,5838,5842,5846,5850,5854,5858,5862,5866],{"type":152,"children":5819},[5820],{"bold":79,"text":5821,"type":156},"HyTest is a biotechnology company that sponsored the biomaterials used in SensUs 2017. We spoke with Pekka Hildén, business development manager of HyTest, about innovations in biosensing, developments in healthcare, and about his experiences with SensUs.",{"type":152,"children":5823},[5824],{"bold":79,"text":5825,"type":156},"Can you tell something about yourself? Who are you and what is your role in HyTest?",{"type":152,"children":5827},[5828],{"text":5829,"type":156},"I am Pekka Hildén and I work as a business development manager. As the title hints, my tasks are very much related in finding new business opportunities for HyTest in different areas. The different areas can be anything, from new biomarkers and technologies to new business contacts. In addition, one of my main tasks is to supervise our operations in China where we have a wholly owned subsidiary. I am also participating in our new product development process.",{"type":152,"children":5831},[5832],{"bold":79,"text":5833,"type":156},"How is your company involved in the field of diagnostics and biosensing?",{"type":152,"children":5835},[5836],{"text":5837,"type":156},"We provide antibodies, antigens and other raw materials mainly for the In Vitro Diagnostics industry (IVD). As a diagnostics raw material provider we deal with very different companies of which some use quite basic technologies while others might use high-end biosensors. We have been in this business more than 20 years and this has offered us an excellent opportunity to see the evolution of IVD-industry.",{"type":152,"children":5839},[5840],{"bold":79,"text":5841,"type":156},"How do you see the future for biosensing? Which innovations are needed and which long-term developments do you foresee?",{"type":152,"children":5843},[5844],{"text":5845,"type":156},"Near patient testing, or point-of-care testing (PoC), is the future of diagnostics. For quite a few years, PoC was like an unkept promise as it was very much discussed and its advantages were promoted, but most of the companies could not meet the requirements. PoC has largely been based on low-technology lateral flow devices which, in most cases, do not deliver the needed sensitivity and accuracy. Now the scene is changing as more robust and sensitive sensors are brought to the market and with these new devices healthcare providers can obtain laboratory quality results in field settings. This is an important driver as the current paradigm of healthcare is still very much dependent on centralized testing and care and there is a need for change. Global healthcare challenges, like obesity and diabetes are rising healthcare costs in almost all countries and aging is becoming another major hurdle. Because of these, healthcare providers need to think of new ways to provide their services and the need for prevention and home-testing is getting a bigger role. This is the main area where miniaturized biosensors are going to have a major role but what is needed is quality of results, ease of use and most importantly rethinking of the current paradigm of healthcare.",{"type":152,"children":5847},[5848],{"bold":79,"text":5849,"type":156},"Your company has strongly contributed to SensUs 2017. What has been your motivation for becoming a partner of SensUs?",{"type":152,"children":5851},[5852],{"text":5853,"type":156},"For the 2017 SensUs contest, HyTest provided antibodies for the target molecule that was NT-proBNP. In addition, our R&D people helped the competitors to understand how the target molecule should be measured and how to select correct antibodies. In addition, we provided the antigen that was measured and also the plasma so that the samples mimicked patient samples as well as possible. We wanted to be the partner for SensUs 2017 as HyTest has been in frontline of cardiac diseases’ diagnostics for over 20 years and NT-proBNP is very much one of our core areas, so it was quite natural for us.",{"type":152,"children":5855},[5856],{"bold":79,"text":5857,"type":156},"What is your opinion about SensUs?",{"type":152,"children":5859},[5860],{"text":5861,"type":156},"I think that the best part of SensUs is that it brings together young talented students with very different backgrounds and skills to think how to meet the challenge. To me, this is more important than the quality of the results – of course the quality of results is important – but even more important is how the results were obtained. I hope this drives young people to think differently and bring them to this industry that has been quite conservative quite a few years. “Thinking out of the box” is very much what this industry and healthcare needs and hopefully it is the younger generation that can bring on the change.",{"type":152,"children":5863},[5864],{"bold":79,"text":5865,"type":156},"The theme of SensUs 2018 is “Measuring antibiotics for better healthcare”. Do you have an advice for the teams and for SensUs in general?",{"type":152,"children":5867},[5868],{"text":5869,"type":156},"Do not start thinking from the technology perspective. Think about the challenge and customer’s needs and only after you have defined that, think about what would be the best tools to provide that solution. If you start from technology, you will lock yourself in that “box”. This is also what I would like to see from SensUs in long term: tight combination of technology, business and more general problem solving skills.","2026-07-28T11:14:19.302Z","2026-07-28T11:14:19.301Z",{"id":5873,"documentId":5874,"name":5875,"alternativeText":18,"caption":18,"focalPoint":18,"width":637,"height":5876,"formats":5877,"hash":5905,"ext":280,"mime":283,"size":5906,"url":5907,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":5908,"updatedAt":5908,"publishedAt":5908},1344,"gpvcc9pc5rsxolrun05e7pvm","HyTest_Pekka_LR2.jpg",594,{"large":5878,"small":5885,"medium":5891,"thumbnail":5898},{"ext":280,"url":5879,"hash":5880,"mime":283,"name":5881,"path":18,"size":5882,"width":190,"height":5883,"sizeInBytes":5884},"/uploads/large_Hy_Test_Pekka_LR_2_54d2f85166.jpg","large_Hy_Test_Pekka_LR_2_54d2f85166","large_HyTest_Pekka_LR2.jpg",49.45,519,49449,{"ext":280,"url":5886,"hash":5887,"mime":283,"name":5888,"path":18,"size":5889,"width":198,"height":971,"sizeInBytes":5890},"/uploads/small_Hy_Test_Pekka_LR_2_54d2f85166.jpg","small_Hy_Test_Pekka_LR_2_54d2f85166","small_HyTest_Pekka_LR2.jpg",12.6,12595,{"ext":280,"url":5892,"hash":5893,"mime":283,"name":5894,"path":18,"size":5895,"width":206,"height":5896,"sizeInBytes":5897},"/uploads/medium_Hy_Test_Pekka_LR_2_54d2f85166.jpg","medium_Hy_Test_Pekka_LR_2_54d2f85166","medium_HyTest_Pekka_LR2.jpg",28.17,389,28168,{"ext":280,"url":5899,"hash":5900,"mime":283,"name":5901,"path":18,"size":5902,"width":144,"height":5903,"sizeInBytes":5904},"/uploads/thumbnail_Hy_Test_Pekka_LR_2_54d2f85166.jpg","thumbnail_Hy_Test_Pekka_LR_2_54d2f85166","thumbnail_HyTest_Pekka_LR2.jpg",4.59,127,4585,"Hy_Test_Pekka_LR_2_54d2f85166",65.51,"/uploads/Hy_Test_Pekka_LR_2_54d2f85166.jpg","2026-07-28T11:14:19.299Z",{"id":5910,"documentId":5911,"title":5912,"slug":5913,"date":5914,"cardTitle":18,"excerpt":18,"body":5915,"createdAt":5943,"updatedAt":5943,"publishedAt":5944,"cardImage":5945},321,"txm01tawt3prpwump8970izk","Vancomycin - A last-resort antibiotic","vancomycin-last-resort-antibiotic","2017-11-30",[5916,5920,5923,5927,5931,5935,5939],{"type":152,"children":5917},[5918],{"text":5919,"type":156},"The biomarker of SensUs 2018 is the antibiotic drug vancomycin, for which student teams from 13 universities will design, build and test their new biosensors. Currently, there are no rapid biosensors available for measuring vancomycin. So how will a biosensor change the future? What will be the benefits of a biosensor for measuring vancomycin?",{"type":152,"children":5921},[5922],{"bold":79,"text":5257,"type":156},{"type":152,"children":5924},[5925],{"text":5926,"type":156},"Vancomycin is a very powerful antibiotic, however, it is difficult to dose correctly. A too low dose makes vancomycin ineffective and a too high dose gives side effects such as kidney damage. Dosing needs to be optimized to obtain a therapeutic and non-toxic exposure, while pathogens are very different from one another. One pathogen might need a high exposure to be killed, while another might need a low dosing. As all patients are different and respond differently, it is important to regularly check the drug level in the body, which is called Therapeutic Drug Monitoring (TDM). This is particularly the case for vulnerable patients, for example patients in the intensive care.",{"type":152,"children":5928},[5929],{"bold":79,"text":5930,"type":156},"What benefits could a biosensor give?",{"type":152,"children":5932},[5933],{"text":5934,"type":156},"Vancomycin is presently measured by taking blood samples of patients and testing these in a laboratory. This is a slow process of a day waiting time and is therefore not used often in medical practice. A rapid biosensor can be a solution, as it would give a direct individualized result and ensure that the antibiotic treatment is as effective and safe as possible.",{"type":152,"children":5936},[5937],{"text":5938,"type":156},"The increasing problem of antibiotic resistance makes it crucial to use a drug like vancomycin as efficiently and effectively as possible. The pathogen should be completely driven away, without causing irreversible toxic effects to the patient. A biosensor can help to deliver the optimal treatment.",{"type":152,"children":5940},[5941],{"text":5942,"type":156},"We look forward to the biosensors that the teams will develop, to improve healthcare in the field of antibiotics treatment!","2026-07-28T11:14:19.432Z","2026-07-28T11:14:19.431Z",{"id":5946,"documentId":5947,"name":5948,"alternativeText":18,"caption":18,"focalPoint":18,"width":5949,"height":5950,"formats":5951,"hash":5976,"ext":280,"mime":283,"size":5977,"url":5978,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":5979,"updatedAt":5979,"publishedAt":5979},1346,"yd3dkz3281yxk3bntrnv1hjx","moleculen_vanco.jpg",2498,1665,{"large":5952,"small":5958,"medium":5964,"thumbnail":5970},{"ext":280,"url":5953,"hash":5954,"mime":283,"name":5955,"path":18,"size":5956,"width":190,"height":345,"sizeInBytes":5957},"/uploads/large_moleculen_vanco_29a6850e16.jpg","large_moleculen_vanco_29a6850e16","large_moleculen_vanco.jpg",37.23,37226,{"ext":280,"url":5959,"hash":5960,"mime":283,"name":5961,"path":18,"size":5962,"width":198,"height":293,"sizeInBytes":5963},"/uploads/small_moleculen_vanco_29a6850e16.jpg","small_moleculen_vanco_29a6850e16","small_moleculen_vanco.jpg",14.16,14164,{"ext":280,"url":5965,"hash":5966,"mime":283,"name":5967,"path":18,"size":5968,"width":206,"height":198,"sizeInBytes":5969},"/uploads/medium_moleculen_vanco_29a6850e16.jpg","medium_moleculen_vanco_29a6850e16","medium_moleculen_vanco.jpg",24.63,24626,{"ext":280,"url":5971,"hash":5972,"mime":283,"name":5973,"path":18,"size":5974,"width":306,"height":214,"sizeInBytes":5975},"/uploads/thumbnail_moleculen_vanco_29a6850e16.jpg","thumbnail_moleculen_vanco_29a6850e16","thumbnail_moleculen_vanco.jpg",5.19,5193,"moleculen_vanco_29a6850e16",142.76,"/uploads/moleculen_vanco_29a6850e16.jpg","2026-07-28T11:14:19.429Z",{"id":5981,"documentId":5982,"title":5983,"slug":5984,"date":5985,"cardTitle":5986,"excerpt":18,"body":5987,"createdAt":6015,"updatedAt":6015,"publishedAt":6016,"cardImage":6017},322,"dtcrjqsihh8wfksx234g6ama","SensUs visits: Symposium on antibiotic resistance and care for the elderly","sensus-visits-symposium","2017-11-15","Sensus visits: symposium",[5988,5992,5996,6007,6011],{"type":152,"children":5989},[5990],{"text":5991,"type":156},"Seek advice from a qualified healthcare professional before taking antibiotics. That’s the theme of the World Antibiotics Awareness Week 2018.",{"type":152,"children":5993},[5994],{"text":5995,"type":156},"This week, 13-19 November, the World Health Organization (WHO) wants to raise awareness about the problem of antibiotic resistance and the importance of proper usage of antibiotics. All around the world, countries organize events to give attention to this global threat.",{"type":152,"children":5997},[5998,6000,6005],{"text":5999,"type":156},"In the Netherlands, the Ministry of Health, Welfare and Sports and the National Institute for Public Health and the Environment (RIVM) organized a ",{"url":6001,"type":236,"children":6002},"http://www.rivm.nl/Onderwerpen/A/Antibioticaresistentie/Antibioticaresistentie/Nieuws_en_agenda_antibioticaresistentie",[6003],{"text":6004,"type":156},"symposium",{"text":6006,"type":156}," on antibiotic resistance and care for the elderly, in cooperation with Vilans, centre of expertise for long-term care. During this symposium, held on the 14th of November, visitors could learn and discuss about new developments in the prevention of antibiotic resistance and proper usage of antibiotics.",{"type":152,"children":6008},[6009],{"text":6010,"type":156},"The SensUs Organization grasped this opportunity to learn more about the problems around antibiotics and about how measurement devices might be of help. We went to the event and had a stand there to inform visitors about SensUs, to hear opinions about antibiotics, and to learn how biosensors can help contribute to better healthcare.",{"type":152,"children":6012},[6013],{"text":6014,"type":156},"We learned a lot from this thought-provoking symposium, for example about the importance of hygiene in preventing antibiotics resistance. We want to thank the symposium organization for inviting SensUs and for giving us the opportunity to present our competition and speak with experts in the field.","2026-07-28T11:14:19.696Z","2026-07-28T11:14:19.694Z",{"id":6018,"documentId":6019,"name":6020,"alternativeText":18,"caption":18,"focalPoint":18,"width":641,"height":640,"formats":6021,"hash":6046,"ext":941,"mime":283,"size":6047,"url":6048,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":6049,"updatedAt":6049,"publishedAt":6049},1348,"s8qw6py32hobtc5irvqt8w8m","IMG_4159.JPG",{"large":6022,"small":6028,"medium":6034,"thumbnail":6040},{"ext":941,"url":6023,"hash":6024,"mime":283,"name":6025,"path":18,"size":6026,"width":190,"height":206,"sizeInBytes":6027},"/uploads/large_IMG_4159_f7886b2414.JPG","large_IMG_4159_f7886b2414","large_IMG_4159.JPG",61.17,61173,{"ext":941,"url":6029,"hash":6030,"mime":283,"name":6031,"path":18,"size":6032,"width":198,"height":654,"sizeInBytes":6033},"/uploads/small_IMG_4159_f7886b2414.JPG","small_IMG_4159_f7886b2414","small_IMG_4159.JPG",20.63,20632,{"ext":941,"url":6035,"hash":6036,"mime":283,"name":6037,"path":18,"size":6038,"width":206,"height":661,"sizeInBytes":6039},"/uploads/medium_IMG_4159_f7886b2414.JPG","medium_IMG_4159_f7886b2414","medium_IMG_4159.JPG",38.38,38377,{"ext":941,"url":6041,"hash":6042,"mime":283,"name":6043,"path":18,"size":6044,"width":3107,"height":214,"sizeInBytes":6045},"/uploads/thumbnail_IMG_4159_f7886b2414.JPG","thumbnail_IMG_4159_f7886b2414","thumbnail_IMG_4159.JPG",5.42,5423,"IMG_4159_f7886b2414",561.45,"/uploads/IMG_4159_f7886b2414.JPG","2026-07-28T11:14:19.692Z",{"id":6051,"documentId":6052,"title":6053,"slug":6054,"date":6055,"cardTitle":18,"excerpt":18,"body":6056,"createdAt":6082,"updatedAt":6082,"publishedAt":6083,"cardImage":6084},323,"zbsgoi32cdb17n3t1fl7kq8n","DDW 2017: SensUs shares its story","ddw-2017-sensus-shares-its-story","2017-10-30",[6057,6070,6074,6078],{"type":152,"children":6058},[6059,6061,6063,6068],{"text":6060,"type":156,"italic":79},"A world in which healthcare will be all about personalized medicine",{"text":6062,"type":156}," - this was our message during the ",{"url":6064,"type":236,"children":6065},"https://www.ddw.nl",[6066],{"text":6067,"type":156},"Dutch Design Week",{"text":6069,"type":156},", a week about design, technology and research.",{"type":152,"children":6071},[6072],{"text":6073,"type":156},"We were invited to present during the “Mind the Story” event, which focuses on discussions with the general public. We spoke about biosensors in our everyday lives and about the SensUs competition. Afterwards the public asked us questions related to biosensors and the future of healthcare.",{"type":152,"children":6075},[6076],{"text":6077,"type":156},"We also presented in an event about Superheroes, organized by Barry Fitzgerald, our master of ceremony during the previous SensUs editions. It was a magical evening about superheroes, alien forces and the universe of Marvel. In our presentation we focused on how superheroes can use biosensors in order to protect themselves and humanity against villains. For instance, did you know that the iron man would not have existed without his futuristic suit full of sensors? At the end we had a discussion with the audience about the role of biosensors in superhero movies.",{"type":152,"children":6079},[6080],{"text":6081,"type":156},"All together it was a very interesting week for the SensUs organization. We enjoyed the Dutch Design Week and it was a pleasure to share our story about biosensors!","2026-07-28T11:14:19.828Z","2026-07-28T11:14:19.827Z",{"id":6085,"documentId":6086,"name":6087,"alternativeText":18,"caption":18,"focalPoint":18,"width":6088,"height":6089,"formats":6090,"hash":6114,"ext":941,"mime":283,"size":6115,"url":6116,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":6117,"updatedAt":6117,"publishedAt":6117},1350,"gne7hc35c5kxv43gbwcghrp5","IMG_9678.JPG",2016,1512,{"large":6091,"small":6097,"medium":6103,"thumbnail":6109},{"ext":941,"url":6092,"hash":6093,"mime":283,"name":6094,"path":18,"size":6095,"width":190,"height":206,"sizeInBytes":6096},"/uploads/large_IMG_9678_bd591e4071.JPG","large_IMG_9678_bd591e4071","large_IMG_9678.JPG",60.25,60245,{"ext":941,"url":6098,"hash":6099,"mime":283,"name":6100,"path":18,"size":6101,"width":198,"height":654,"sizeInBytes":6102},"/uploads/small_IMG_9678_bd591e4071.JPG","small_IMG_9678_bd591e4071","small_IMG_9678.JPG",20.97,20969,{"ext":941,"url":6104,"hash":6105,"mime":283,"name":6106,"path":18,"size":6107,"width":206,"height":661,"sizeInBytes":6108},"/uploads/medium_IMG_9678_bd591e4071.JPG","medium_IMG_9678_bd591e4071","medium_IMG_9678.JPG",38.6,38597,{"ext":941,"url":6110,"hash":6111,"mime":283,"name":6112,"path":18,"size":6113,"width":3107,"height":214,"sizeInBytes":1035},"/uploads/thumbnail_IMG_9678_bd591e4071.JPG","thumbnail_IMG_9678_bd591e4071","thumbnail_IMG_9678.JPG",5.5,"IMG_9678_bd591e4071",210.4,"/uploads/IMG_9678_bd591e4071.JPG","2026-07-28T11:14:19.825Z",{"id":6119,"documentId":6120,"title":6121,"slug":6122,"date":6123,"cardTitle":18,"excerpt":18,"body":6124,"createdAt":6149,"updatedAt":6149,"publishedAt":6150,"cardImage":6151},324,"mpmei5pzxucjhn9tuhe9j3kk","Theme 2018: Measuring antibiotics for better healthcare","theme-2018-measuring-antibiotics-better-healthcare","2017-10-25",[6125,6129,6133,6137,6141,6145],{"type":152,"children":6126},[6127],{"text":6128,"type":156},"In this News Item we are happy to announce the theme of SensUs 2018: Measuring antibiotics for better healthcare. This year the SensUs teams will develop innovative biosensors for the detection of vancomycin, which is an important antibiotic drug. The biosensors can have impact in several ways:",{"type":152,"children":6130},[6131],{"bold":79,"text":6132,"type":156},"Antibiotics",{"type":152,"children":6134},[6135],{"text":6136,"type":156},"Antibiotic drugs are widely used in society. Unfortunately, the massive use of the drugs causes Anti-Microbial Resistance (AMR), which has become a serious global threat. It is important that last-resort antibiotics, such as vancomycin, are used as efficiently and effectively as possible, which is where antibiotics measurements can play a role.",{"type":152,"children":6138},[6139],{"bold":79,"text":6140,"type":156},"Drug monitoring",{"type":152,"children":6142},[6143],{"text":6144,"type":156},"The monitoring of drug levels helps for providing patients always with the right therapeutic dose, thereby increasing the effectiveness and reducing side effects of drug treatment. This Therapeutic Drug Monitoring (TDM) falls in the scope of personalized medicine and precision medicine, which aim to perfectly tune medical treatment to the needs of individual people.",{"type":152,"children":6146},[6147],{"text":6148,"type":156},"We are looking forward to see what the teams will develop this year and how their biosensors will help patients to receive the best possible treatments and help society in its fight against antimicrobial resistance.","2026-07-28T11:14:20.177Z","2026-07-28T11:14:20.176Z",{"id":6152,"documentId":6153,"name":6154,"alternativeText":18,"caption":18,"focalPoint":18,"width":6155,"height":6156,"formats":6157,"hash":6182,"ext":280,"mime":283,"size":6183,"url":6184,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":6185,"updatedAt":6185,"publishedAt":6185},1352,"rmwqcyhart0kd4lygbyzbxnk","thermometer-temperature-fever-flu.jpg",5276,3517,{"large":6158,"small":6164,"medium":6170,"thumbnail":6176},{"ext":280,"url":6159,"hash":6160,"mime":283,"name":6161,"path":18,"size":6162,"width":190,"height":286,"sizeInBytes":6163},"/uploads/large_thermometer_temperature_fever_flu_1b0e532791.jpg","large_thermometer_temperature_fever_flu_1b0e532791","large_thermometer-temperature-fever-flu.jpg",53.01,53014,{"ext":280,"url":6165,"hash":6166,"mime":283,"name":6167,"path":18,"size":6168,"width":198,"height":293,"sizeInBytes":6169},"/uploads/small_thermometer_temperature_fever_flu_1b0e532791.jpg","small_thermometer_temperature_fever_flu_1b0e532791","small_thermometer-temperature-fever-flu.jpg",20.36,20362,{"ext":280,"url":6171,"hash":6172,"mime":283,"name":6173,"path":18,"size":6174,"width":206,"height":198,"sizeInBytes":6175},"/uploads/medium_thermometer_temperature_fever_flu_1b0e532791.jpg","medium_thermometer_temperature_fever_flu_1b0e532791","medium_thermometer-temperature-fever-flu.jpg",35.83,35831,{"ext":280,"url":6177,"hash":6178,"mime":283,"name":6179,"path":18,"size":6180,"width":306,"height":214,"sizeInBytes":6181},"/uploads/thumbnail_thermometer_temperature_fever_flu_1b0e532791.jpg","thumbnail_thermometer_temperature_fever_flu_1b0e532791","thumbnail_thermometer-temperature-fever-flu.jpg",7.17,7171,"thermometer_temperature_fever_flu_1b0e532791",612.17,"/uploads/thermometer_temperature_fever_flu_1b0e532791.jpg","2026-07-28T11:14:20.174Z",{"id":6187,"documentId":6188,"title":6189,"slug":6190,"date":6191,"cardTitle":18,"excerpt":18,"body":6192,"createdAt":6213,"updatedAt":6213,"publishedAt":6214,"cardImage":6215},325,"lr860c0uquvwhzev90q8itnj","The Science Festival: We are biosensors ourselves!","science-festival-we-are-biosensors-ourselves","2017-10-09",[6193,6197,6201,6205,6209],{"type":152,"children":6194},[6195],{"text":6196,"type":156},"The SensUs Organization contributed to the TU/e Science Festival on Sunday 8th of October. It was an exciting day for young and old, with presentations about research being done at the University and the Science Show hosted by Valerio Zeno!",{"type":152,"children":6198},[6199],{"text":6200,"type":156},"We invited visitors to look upon themselves in a new way, namely as a biosensor! We organized two interesting experiments so that especially kids could become familiar with the concept of biosensors.",{"type":152,"children":6202},[6203],{"text":6204,"type":156},"Actually, the human body is one big sensor. The body can sense for example temperature, touch and also taste. During the event, visitors were able to test their own tongue as a biosensor. The kids could taste bitter, sweet and sour food. They were thrilled by the fact that they are a biosensor themselves!",{"type":152,"children":6206},[6207],{"text":6208,"type":156},"In a second experiment, we compared different kinds of soda. Sodas are all liquid and tasty. But when we have a closer look, they are actually very different from each other. Kids detected the pH values of different sodas with pH paper. Children all thought that water and 7-up are the same, according to color. But with the pH sensor, the children could see that cola, 7-up and water are totally different when it comes to acidity. They were impressed by the results of the experiment.",{"type":152,"children":6210},[6211],{"text":6212,"type":156},"It was a very interesting day with curious visitors who all learned about biosensors and the SensUs competition. We hope that you all got inspired by the world of science, technology and biosensing!","2026-07-28T11:14:20.557Z","2026-07-28T11:14:20.555Z",{"id":6216,"documentId":6217,"name":6218,"alternativeText":18,"caption":18,"focalPoint":18,"width":641,"height":640,"formats":6219,"hash":6244,"ext":280,"mime":283,"size":6245,"url":6246,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":6247,"updatedAt":6247,"publishedAt":6247},1354,"axtu8l9jxrnkrc7cjojs7j52","20171008_144744.jpg",{"large":6220,"small":6226,"medium":6232,"thumbnail":6238},{"ext":280,"url":6221,"hash":6222,"mime":283,"name":6223,"path":18,"size":6224,"width":190,"height":206,"sizeInBytes":6225},"/uploads/large_20171008_144744_2cc8a4ca26.jpg","large_20171008_144744_2cc8a4ca26","large_20171008_144744.jpg",178.45,178453,{"ext":280,"url":6227,"hash":6228,"mime":283,"name":6229,"path":18,"size":6230,"width":198,"height":654,"sizeInBytes":6231},"/uploads/small_20171008_144744_2cc8a4ca26.jpg","small_20171008_144744_2cc8a4ca26","small_20171008_144744.jpg",52.53,52533,{"ext":280,"url":6233,"hash":6234,"mime":283,"name":6235,"path":18,"size":6236,"width":206,"height":661,"sizeInBytes":6237},"/uploads/medium_20171008_144744_2cc8a4ca26.jpg","medium_20171008_144744_2cc8a4ca26","medium_20171008_144744.jpg",106.18,106175,{"ext":280,"url":6239,"hash":6240,"mime":283,"name":6241,"path":18,"size":6242,"width":3107,"height":214,"sizeInBytes":6243},"/uploads/thumbnail_20171008_144744_2cc8a4ca26.jpg","thumbnail_20171008_144744_2cc8a4ca26","thumbnail_20171008_144744.jpg",11.66,11658,"20171008_144744_2cc8a4ca26",1935.89,"/uploads/20171008_144744_2cc8a4ca26.jpg","2026-07-28T11:14:20.553Z",{"id":6249,"documentId":6250,"title":6251,"slug":6252,"date":6253,"cardTitle":18,"excerpt":18,"body":6254,"createdAt":6298,"updatedAt":6298,"publishedAt":6299,"cardImage":6300},326,"naotcii43k6yo7cwby4hh5d7","SensUs 2017 ― Visitors, votes and winners","sensus-2017-visitors-votes-and-winners","2017-09-17",[6255,6259,6275,6279,6283,6287,6291],{"type":152,"children":6256},[6257],{"text":6258,"type":156},"The exciting finals of SensUs 2017 took place at Eindhoven University of Technology on the 8th and 9th of September. Ten teams came together from Sweden, Denmark, Scotland, England, Belgium, Netherlands, Germany, Switzerland, Egypt, and the USA. The teams competed to inspire the public and convince the jury of their biosensors for the detection of heart failure.",{"type":152,"children":6260},[6261,6263,6267,6269,6273],{"text":6262,"type":156},"The biosensors were tested by measuring NT-proBNP in blood plasma. The measurement results are available ",{"url":6264,"type":236,"children":6265},"https://sensus.icts.tue.nl/teams",[6266],{"text":2637,"type":156},{"text":6268,"type":156}," and ",{"url":6270,"type":236,"children":6271},"https://www.sensus2017.org/teamresults",[6272],{"text":2637,"type":156},{"text":6274,"type":156},". Visitors from all over the world watched the tests live on the online SensUs Digital platform, featuring livestreams, pictures, Q&As, and live data. Furthermore, all could cast votes on their favourite teams for winning the Public Inspiration Award. A total of 1500 people voted and the cumulative visitor count was 5000, from 74 countries.",{"type":152,"children":6276},[6277],{"text":6278,"type":156},"The teams showed their biosensors and presented several lively pitches. They were judged by an international multidisciplinary jury on Analytical Performance (the best measurement of NT-proBNP in blood plasma), Translation Potential (probability that the concepts will make it into society), and Creativity (novelty of approach).",{"type":152,"children":6280},[6281],{"text":6282,"type":156},"This year’s winner was team T.E.S.T. from Eindhoven. They won the 1st prize in Analytical Performance, the 1st prize in Translation Potential and the 1st prize in Public Inspiration. Sweden (Uppsala) won the 1st prize in Creativity. Denmark (DTU) won the 2nd prize in Creativity and the 2nd prize in Public Inspiration. And Belgium (Leuven) won the 2nd prize in Analytical Performance and the 2nd prize in Translation Potential.",{"type":152,"children":6284},[6285],{"text":6286,"type":156},"It was an amazing weekend and we are thrilled that next year 13 universities will participate: all universities of SensUs 2017, and 3 new ones from Canada (Montreal), China (Zhejiang), and Spain (Barcelona). The theme of SensUs 2018 is “Measuring antibiotics for better healthcare” and the teams will develop biosensors for the measurement of Vancomycin, a very important antibiotic.",{"type":152,"children":6288},[6289],{"text":6290,"type":156},"We thank all universities, companies, healthcare professionals, and global citizens for contributing to SensUs 2017 and we look forward to a great competition in 2018!",{"type":152,"children":6292},[6293],{"url":6294,"type":236,"children":6295},"https://www.youtube.com/watch?v=XwY57zFU9z4&feature=youtu.be",[6296],{"text":6297,"type":156},"Watch the aftermovie here!","2026-07-28T11:14:21.290Z","2026-07-28T11:14:21.288Z",{"id":1303,"documentId":6301,"name":6302,"alternativeText":18,"caption":18,"focalPoint":18,"width":937,"height":938,"formats":6303,"hash":6328,"ext":280,"mime":283,"size":6329,"url":6330,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":6331,"updatedAt":6331,"publishedAt":6331},"vvokpi9bapiqxag1dp72xu6p","BvOF_2017_0909_AOV_-_SensUs_-_market.jpg",{"large":6304,"small":6310,"medium":6316,"thumbnail":6322},{"ext":280,"url":6305,"hash":6306,"mime":283,"name":6307,"path":18,"size":6308,"width":190,"height":946,"sizeInBytes":6309},"/uploads/large_Bv_OF_2017_0909_AOV_Sens_Us_market_05f5e12b2d.jpg","large_Bv_OF_2017_0909_AOV_Sens_Us_market_05f5e12b2d","large_BvOF_2017_0909_AOV_-_SensUs_-_market.jpg",160.75,160746,{"ext":280,"url":6311,"hash":6312,"mime":283,"name":6313,"path":18,"size":6314,"width":198,"height":352,"sizeInBytes":6315},"/uploads/small_Bv_OF_2017_0909_AOV_Sens_Us_market_05f5e12b2d.jpg","small_Bv_OF_2017_0909_AOV_Sens_Us_market_05f5e12b2d","small_BvOF_2017_0909_AOV_-_SensUs_-_market.jpg",51.05,51049,{"ext":280,"url":6317,"hash":6318,"mime":283,"name":6319,"path":18,"size":6320,"width":206,"height":359,"sizeInBytes":6321},"/uploads/medium_Bv_OF_2017_0909_AOV_Sens_Us_market_05f5e12b2d.jpg","medium_Bv_OF_2017_0909_AOV_Sens_Us_market_05f5e12b2d","medium_BvOF_2017_0909_AOV_-_SensUs_-_market.jpg",101.14,101144,{"ext":280,"url":6323,"hash":6324,"mime":283,"name":6325,"path":18,"size":6326,"width":306,"height":214,"sizeInBytes":6327},"/uploads/thumbnail_Bv_OF_2017_0909_AOV_Sens_Us_market_05f5e12b2d.jpg","thumbnail_Bv_OF_2017_0909_AOV_Sens_Us_market_05f5e12b2d","thumbnail_BvOF_2017_0909_AOV_-_SensUs_-_market.jpg",14.58,14582,"Bv_OF_2017_0909_AOV_Sens_Us_market_05f5e12b2d",3633.81,"/uploads/Bv_OF_2017_0909_AOV_Sens_Us_market_05f5e12b2d.jpg","2026-07-28T11:14:21.226Z",{"id":6333,"documentId":6334,"title":6335,"slug":6336,"date":6337,"cardTitle":18,"excerpt":18,"body":6338,"createdAt":6376,"updatedAt":6376,"publishedAt":6377,"cardImage":6378},327,"umfm8efsa1y7o1pn4qlj2oj2","SensUs has started!","sensus-has-started","2017-09-08",[6339,6343,6347,6351,6355,6359,6366,6370],{"type":152,"children":6340},[6341],{"text":6342,"type":156},"The day of the SensUs event has finally arrived! Yesterday, all the teams have arrived in Eindhoven and got the chance to get to know each other.",{"type":152,"children":6344},[6345],{"text":6346,"type":156},"Today they will finally test their biosensors live! During the Testing Event the teams will test their biosensors and receive samples in different time intervals.",{"type":152,"children":6348},[6349],{"text":6350,"type":156},"There will also be pitches and afterwards a social network drink.",{"type":152,"children":6352},[6353],{"text":6354,"type":156},"From Friday 12:30 till Saturday 15:00, the voting for the public inspiration award will start.",{"type":152,"children":6356},[6357],{"text":6358,"type":156},"To experience SensUs online:",{"type":152,"children":6360},[6361],{"url":6362,"type":236,"children":6363},"https://www.digital.sensus.org",[6364],{"text":6365,"type":156},"Visit SensUs Digital",{"type":152,"children":6367},[6368],{"text":6369,"type":156},"Do you want to learn more about the biosensors of the teams?",{"type":152,"children":6371},[6372],{"url":6270,"type":236,"children":6373},[6374],{"text":6375,"type":156},"Read about the biosensors of the teams here!","2026-07-28T11:14:21.765Z","2026-07-28T11:14:21.764Z",{"id":6379,"documentId":6380,"name":6381,"alternativeText":18,"caption":18,"focalPoint":18,"width":6382,"height":6383,"formats":6384,"hash":6408,"ext":280,"mime":283,"size":6409,"url":6410,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":6411,"updatedAt":6411,"publishedAt":6411},1359,"c8tysgt75mk5flscl7x9h30t","BvOF_2017_0907_AC_-_SensUs_-_opening.jpg",5712,3808,{"large":6385,"small":6391,"medium":6397,"thumbnail":6403},{"ext":280,"url":6386,"hash":6387,"mime":283,"name":6388,"path":18,"size":6389,"width":190,"height":345,"sizeInBytes":6390},"/uploads/large_Bv_OF_2017_0907_AC_Sens_Us_opening_c38b16b86e.jpg","large_Bv_OF_2017_0907_AC_Sens_Us_opening_c38b16b86e","large_BvOF_2017_0907_AC_-_SensUs_-_opening.jpg",67.33,67333,{"ext":280,"url":6392,"hash":6393,"mime":283,"name":6394,"path":18,"size":6395,"width":198,"height":293,"sizeInBytes":6396},"/uploads/small_Bv_OF_2017_0907_AC_Sens_Us_opening_c38b16b86e.jpg","small_Bv_OF_2017_0907_AC_Sens_Us_opening_c38b16b86e","small_BvOF_2017_0907_AC_-_SensUs_-_opening.jpg",25.3,25302,{"ext":280,"url":6398,"hash":6399,"mime":283,"name":6400,"path":18,"size":6401,"width":206,"height":198,"sizeInBytes":6402},"/uploads/medium_Bv_OF_2017_0907_AC_Sens_Us_opening_c38b16b86e.jpg","medium_Bv_OF_2017_0907_AC_Sens_Us_opening_c38b16b86e","medium_BvOF_2017_0907_AC_-_SensUs_-_opening.jpg",45.08,45079,{"ext":280,"url":6404,"hash":6405,"mime":283,"name":6406,"path":18,"size":1907,"width":306,"height":214,"sizeInBytes":6407},"/uploads/thumbnail_Bv_OF_2017_0907_AC_Sens_Us_opening_c38b16b86e.jpg","thumbnail_Bv_OF_2017_0907_AC_Sens_Us_opening_c38b16b86e","thumbnail_BvOF_2017_0907_AC_-_SensUs_-_opening.jpg",8719,"Bv_OF_2017_0907_AC_Sens_Us_opening_c38b16b86e",1760.08,"/uploads/Bv_OF_2017_0907_AC_Sens_Us_opening_c38b16b86e.jpg","2026-07-28T11:14:21.761Z",{"id":6413,"documentId":6414,"title":6415,"slug":6416,"date":6417,"cardTitle":6418,"excerpt":18,"body":6419,"createdAt":6491,"updatedAt":6491,"publishedAt":6492,"cardImage":6493},328,"y1fd3eoinrat308z9jxb35s8","Keeping heart failure under control","personal-stories-gp-eefke-baggen","2017-09-04","Personal Stories: GP Eefke Baggen",[6420,6423,6427,6431,6435,6439,6443,6447,6451,6455,6459,6463,6467,6471,6475,6479,6483,6487],{"type":152,"children":6421},[6422],{"bold":79,"text":2790,"type":156},{"type":152,"children":6424},[6425],{"text":6426,"type":156},"My name is Eefke Baggen and I have been a general practitioner (GP) for over five years. I knew that I wanted to become a GP ever since I started studying medicine. As the end of my education approached, I wandered away of the path towards becoming a general practitioner for a short time, and I dedicated my time to working at the emergency department and intensive care. However, after a while I decided to go back to becoming a GP. My motivation for becoming a GP is that the problems of patients are very diverse, so that I get to deal with a wide variety of health issues. Another reason is that I can be very close to people. I can be involved with them, in their daily life, with their family, and I see them regularly. That is what I especially like about being a GP.",{"type":152,"children":6428},[6429],{"text":6430,"type":156},"Of course, sometimes doing my job can be hard, because people pass away. Over time one learns how to cope with this. Some people live on in my thoughts, and they stay with me. That is difficult sometimes. On the other hand, it is great that I have helped these people in being as comfortable as possible during their last days. That is what is beautiful about being a GP, and fortunately these aspects overweigh the sometimes difficult side of it.",{"type":152,"children":6432},[6433],{"bold":79,"text":6434,"type":156},"Seeing people with heart failure",{"type":152,"children":6436},[6437],{"text":6438,"type":156},"While I was working in the intensive care at the hospital, I witnessed cases where people suffered from severe heart failure. Nowadays, I regularly see people with heart failure, but mostly less acute. Most of these patients are elderly, and after many issues with their heart they have eventually ended up with heart failure. But also relatively young people can have heart failure.",{"type":152,"children":6440},[6441],{"text":6442,"type":156},"It is difficult for patients to recognize the symptoms of heart failure, since these are often very vague and can also be caused by other diseases. Most of the time patients come with various complaints that together form the picture that we as GPs eventually recognize as heart failure.",{"type":152,"children":6444},[6445],{"text":6446,"type":156},"There are multiple possible origins of heart failure. It may be caused by a prior heart infarction, but can also be caused by a continuously high blood pressure, congenital disease or lung problems. Heart failure is often a problem that adds to already existing health issues. It is generally hard for patients to deal with, because there is no hope for full recovery. I try to help the patient to keep the disease under control, by means of medication and diet for example.",{"type":152,"children":6448},[6449],{"bold":79,"text":6450,"type":156},"Living with heart failure",{"type":152,"children":6452},[6453],{"text":6454,"type":156},"The effect of living with heart failure depends on the patient and his/her lifestyle. When having an active lifestyle, living with heart failure can be seen as a great obstacle. In addition to this, to stay in control, patients should see their GPs regularly and visit the hospital one or two times a year. These visits are really necessary. Furthermore, the patients see general practice nurses, who monitor for instance blood pressure, glucose levels, kidney markers, cholesterol and so on. When any of these tests gives an uncertain outcome, the GP is seen and if necessary the medication is adapted.",{"type":152,"children":6456},[6457],{"text":6458,"type":156},"In some cases a patient’s life can drastically change when having heart failure. For example in some cases immobile elderly people continue their lives with little adaptation, but young people, who are in the prime of their lives, suffer a considerable handicap. In some cases dreams should be adjusted since living the life you were used to is simply not possible anymore. You can become short of breath, have little air and feel anxious by that feeling. I think it is most important to avoid this feeling of discomfort. This can only be achieved by trying to live as comfortable as possible with as few risks as possible.",{"type":152,"children":6460},[6461],{"bold":79,"text":6462,"type":156},"Detection of heart failure",{"type":152,"children":6464},[6465],{"text":6466,"type":156},"In order to detect a possible heart failure, a GP has to think of several test that can be done. The way I see it, one of the best ways is to test for NT-proBNP. The NT-proBNP level gives information about the vehement of heart failure. Briefly you can say that it indicates the strain of the heart and therefore NT-proBNP tests are widely used by GPs. When a patient walks in with all sorts of complaints that refer to lung problems and heart failure, frequently I also decide to test for NT-proBNP. Just to be sure if the complaints result from the lungs or the heart.",{"type":152,"children":6468},[6469],{"text":6470,"type":156},"If I suspect heart failure and we test the patient for NT-proBNP, we will know the results of the test four days later. This delay can be too long, definitely if a patient walks in with shortness of breath problems or with already known heart problems. It is also possible to send the blood to the laboratory with high urgency, then the results are known by the end of the day. Unfortunately there is not always someone available to take some blood, then a visit to the hospital is necessary. I think this can be a obstacle when the condition of the patient is already very low due to the heart failure.",{"type":152,"children":6472},[6473],{"bold":79,"text":6474,"type":156},"The advantages of a biosensor",{"type":152,"children":6476},[6477],{"text":6478,"type":156},"Like all other diseases, early detection is best for the health of the patient. I often see patients who are short of breath and have all sorts of other vague complaints. It is very difficult to diagnose the disease of which the patient is suffering in this case, because the complaints may refer to all kind of physical failures. Therefore it would be easy if GPs could just test for NT-proBNP and directly monitor the results. With a positive outcome we can start treatment right away, and with a negative outcome we can exclude heart failure. It may also rapidly indicate if a treatment is effective.",{"type":152,"children":6480},[6481],{"text":6482,"type":156},"A biosensor is also advantageous for the patient. When being able to test fast at the general practice, hospitalization might be prevented. Maybe in the future it would even be possible that a patient tests at home. But this can also lead to problems and we should think carefully about who has the possibilities and responsibilities to test for NT-proBNP and cope with the consequences of the result. Another possibility would be to test NT-proBNP at home and send the results to the GP who can directly monitor the outcome of the test. In that way it is possible to relieve the work of the home carers and give the patient a certain control of the disease.",{"type":152,"children":6484},[6485],{"bold":79,"text":6486,"type":156},"The SensUs Competition",{"type":152,"children":6488},[6489],{"text":6490,"type":156},"In my opinion the SensUs Student Competition is a very nice initiative and may lead to a working biosensor. I like the idea that there are teams from all over the world working on something that I might be using in the future. If there would be a good biosensor for indicating NT-proBNP, then I would use this biosensor for testing. I would test for NT-proBNP more frequently because it is fast and easy in use. I am very curious about the outcome of the competition!","2026-07-28T11:14:22.264Z","2026-07-28T11:14:22.262Z",{"id":6494,"documentId":6495,"name":6496,"alternativeText":18,"caption":18,"focalPoint":18,"width":6497,"height":6498,"formats":6499,"hash":6524,"ext":280,"mime":283,"size":6525,"url":6526,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":6527,"updatedAt":6527,"publishedAt":6527},1361,"gbus01pj5ndm0yoqfeuf9do0","BvOF_2017_0901_DD_-_Eefke_Baggen.jpg",5152,3864,{"large":6500,"small":6506,"medium":6512,"thumbnail":6518},{"ext":280,"url":6501,"hash":6502,"mime":283,"name":6503,"path":18,"size":6504,"width":190,"height":206,"sizeInBytes":6505},"/uploads/large_Bv_OF_2017_0901_DD_Eefke_Baggen_4465f49c3a.jpg","large_Bv_OF_2017_0901_DD_Eefke_Baggen_4465f49c3a","large_BvOF_2017_0901_DD_-_Eefke_Baggen.jpg",114.15,114150,{"ext":280,"url":6507,"hash":6508,"mime":283,"name":6509,"path":18,"size":6510,"width":198,"height":654,"sizeInBytes":6511},"/uploads/small_Bv_OF_2017_0901_DD_Eefke_Baggen_4465f49c3a.jpg","small_Bv_OF_2017_0901_DD_Eefke_Baggen_4465f49c3a","small_BvOF_2017_0901_DD_-_Eefke_Baggen.jpg",37.39,37391,{"ext":280,"url":6513,"hash":6514,"mime":283,"name":6515,"path":18,"size":6516,"width":206,"height":661,"sizeInBytes":6517},"/uploads/medium_Bv_OF_2017_0901_DD_Eefke_Baggen_4465f49c3a.jpg","medium_Bv_OF_2017_0901_DD_Eefke_Baggen_4465f49c3a","medium_BvOF_2017_0901_DD_-_Eefke_Baggen.jpg",72.85,72850,{"ext":280,"url":6519,"hash":6520,"mime":283,"name":6521,"path":18,"size":6522,"width":3107,"height":214,"sizeInBytes":6523},"/uploads/thumbnail_Bv_OF_2017_0901_DD_Eefke_Baggen_4465f49c3a.jpg","thumbnail_Bv_OF_2017_0901_DD_Eefke_Baggen_4465f49c3a","thumbnail_BvOF_2017_0901_DD_-_Eefke_Baggen.jpg",9.31,9311,"Bv_OF_2017_0901_DD_Eefke_Baggen_4465f49c3a",1654.41,"/uploads/Bv_OF_2017_0901_DD_Eefke_Baggen_4465f49c3a.jpg","2026-07-28T11:14:22.198Z",{"id":6529,"documentId":6530,"title":6531,"slug":6532,"date":6533,"cardTitle":18,"excerpt":18,"body":6534,"createdAt":6633,"updatedAt":6633,"publishedAt":6634,"cardImage":6635},329,"gue4bifz66by1hm2nyvu3h4s","SensUs Interviews: Barry Fitzgerald","sensus-interviews-barry-fitzgerald","2017-08-23",[6535,6539,6543,6547,6551,6555,6559,6563,6567,6571,6575,6583,6587,6591,6595,6601,6605,6609,6617,6621,6625,6629],{"type":152,"children":6536},[6537],{"bold":79,"text":6538,"type":156},"Question 1: Can you tell something about yourself? How are you involved with SensUs?",{"type":152,"children":6540},[6541],{"text":6542,"type":156},"My name is Barry Fitzgerald and I'm a postdoctoral researcher based in the Process & Energy department of the 3mE faculty at TU Delft. My main research at TU Delft is focussed on the simulation of fluidized bed reactors containing non-spherical particles, which is of relevance for biomass energy production. I'm also interested in studying polymeric systems, collective motion in active systems such as birds and people, fluid dynamics and granular materials.",{"type":152,"children":6544},[6545],{"text":6546,"type":156},"In 2016 I was asked to be the MC (Master of Ceremonies) for the 1st SensUs competition. For the 2017 I will once again be the MC. I'm delighted to have been asked to be a part of the event once again and I'm very much looking forward to the 2017 final.",{"type":152,"children":6548},[6549],{"bold":79,"text":6550,"type":156},"Question 2: Can you tell something about your activities, such as your popular book: \"Secrets of Superhero Science\".",{"type":152,"children":6552},[6553],{"text":6554,"type":156},"In addition to being a research scientist I'm a superhero enthusiast. I'm quite active in the area of scientific communication and outreach through my company BW Science, which I established in 2014. I've given hundreds of talks on superhero science at schools, universities, conferences, companies and public events such as Dutch Comic Con, Xmas Comic Con, Science Week Ireland, the Galway International Arts Festival, Delft International Festival of Technology and Studium Generale.",{"type":152,"children":6556},[6557],{"text":6558,"type":156},"In 2016 I self-published my first book \"Secrets of Superhero Science\" in which I describe the fundamental science and advanced scientific research that could yield the superpowers of characters such as the Invisible Woman, Iron Man and Spider-Man in the future. I have also written a book about the science behind Santa Claus entitled \"Secret Science of Santa Claus\", which was published in October 2016.",{"type":152,"children":6560},[6561],{"text":6562,"type":156},"In June 2017 I arranged and hosted the first ever symposium on superhero science for the Delft International Festival of Technology. The symposium was entitled \"Secrets of Superhero Science\". Speakers on genetic editing, regenerative medicine, exoskeletons, bio-art, bulletproof spider silk human skin and ethics spoke about how their work could lead to superpowers in the future.",{"type":152,"children":6564},[6565],{"text":6566,"type":156},"Finally in June 2017 I established a brand new open access journal - \"Superhero Science and Technology\". The aim of the journal is to publish scientific papers from researchers who motivate their work by making reference to superheroes, supervillains, superpowers, the superhero films or the comic book stories. The first issue will be published in October 2017.",{"type":152,"children":6568},[6569],{"bold":79,"text":6570,"type":156},"Question 3: How do you see your findings in the future?",{"type":152,"children":6572},[6573],{"text":6574,"type":156},"In terms of scientific research at TU Delft my work on fluidized bed reactors has important implications for energy production in the future. With a greater emphasis now being placed on green and renewable energies it is imperative that we optimise the processes behind energy production. At TU Delft we are developing computer models to study how biomass particles, which are non-spherical, behave when fluidized by air. The more we know about the particle dynamics within a fluidized bed reactor the better as we can aim to optimise fluidization technologies to make them more efficient for energy production. Associate Professor Johan Padding of Process & Energy, 3mE, TU Delft, leads the research project and it is funded by a research grant from the European Research Council (ERC).",{"type":152,"children":6576},[6577,6579,6581],{"text":6578,"type":156},"Superheroes are a huge part of my life and I'm very passionate about superhero science. I use superheroes as a platform to communicate complicated scientific concepts and theories.",{"bold":79,"text":6580,"type":156}," My aim is make science and engineering accessible, fun, interactive and interesting to everyone. It is essential that we as scientists and engineers communicate our findings to not only the academic community but also to the world at large.",{"text":6582,"type":156}," I hope that my books, talks, presentations, workshops and open access journal can help bridge this gap in communication.",{"type":152,"children":6584},[6585],{"bold":79,"text":6586,"type":156},"Question 4: What is your vision about the future of healthcare?",{"type":152,"children":6588},[6589],{"text":6590,"type":156},"The majority of scientists and engineers around the world are striving to design and develop technologies that will change our world for the better. These innovations could lead to improved transport systems, environmentally friendly energy production devices/methods, and of course, advancements in healthcare. I've spoken to a lot of researchers from varying disciplines based here in the Netherlands and abroad over the past year or so. In my opinion, each and every one of them is working on a research topic that could improve our society and make the world a healthier and safer place.",{"type":152,"children":6592},[6593],{"text":6594,"type":156},"Using the superhero analogy, the real superheroes are those in medicine and science fighting diseases and developing solutions to help people deal with medical conditions. They should be commended for their effort and I have the utmost respect for them. However, like any superhero, they can't do it alone. With an ever increasing population and the resulting demands placed on the healthcare system, we need technologies or devices that allow the patient to help the medical practitioner.",{"type":152,"children":6596},[6597,6599],{"bold":79,"text":6598,"type":156},"Imagine a future where every household has an Iron Man-like suit in their homes. Instead of flying in the suit you step into the suit and it immediately performs a full analysis of your body and its functions thanks to a suite of non-invasive sensors. ",{"text":6600,"type":156},"This data is instantly sent to your doctor, thus allowing your doctor to instantly make a diagnosis using the data while you remain at home. In effect the doctor can use the data to decide if you need any medication or if you need to travel to a hospital for more involved treatments.",{"type":152,"children":6602},[6603],{"bold":79,"text":6604,"type":156},"Question 5: How can SensUs contribute in these developments?",{"type":152,"children":6606},[6607],{"text":6608,"type":156},"Tony Stark's Iron Man suit contains a plethora of biosensors that monitor his body. These sensors have been called into action in films such as Iron Man 3 and Captain America: Civil War. The Iron Man suit represents the pinnacle of personalised medicine.",{"type":152,"children":6610},[6611,6613,6615],{"text":6612,"type":156},"The development of biosensors for personalised use such as those used in the Iron Man suit needs a strong foundation and beginning.",{"bold":79,"text":6614,"type":156}," In my opinion a competitions like SensUs provides the perfect platform for the future generation of scientists and technology developers to innovate, create and think differently about solutions in molecular health sensing technologies. ",{"text":6616,"type":156},"The demand for functional and purposeful wearable technologies is self-evident in modern society. While many of these technologies focus on providing the wearer with heart rate or blood pressure information, the possibility of advancing these wearable devices to provide practical measurements regarding other bodily functions is a highly attractive prospect. SensUs is excellently placed to provide an arena for the future pioneers and inventors of these technologies.",{"type":152,"children":6618},[6619],{"bold":79,"text":6620,"type":156},"Question 6: What do you think of the SensUs concept and vision?",{"type":152,"children":6622},[6623],{"text":6624,"type":156},"From the moment I heard about the SensUs competition I was impressed. After some students from the 2016 competition committee attended one of my \"Secrets of Superhero Science\" presentations I was approached by the students about the role of MC for the first competition. In our first meeting the students explained their idea for the event and the overall concept and vision for SensUs. After hearing the details of the event and SensUs I had no hesitation in accepting the role of MC, a role that I thoroughly enjoyed I might add.",{"type":152,"children":6626},[6627],{"text":6628,"type":156},"Since that first competition in September 2016 I have actively promoted the competition and the importance of developing molecular biosensor technologies in my Superhero workshops throughout Ireland and the Netherlands. I use the Iron Man suit as a paradigm for the ultimate biosensor and highlight that the SensUs teams are walking the same path that Tony Stark would have walked in developing the sensors in the Iron Man suit. In addition to promoting SensUs at schools I've also spoken about the SensUs competition at Studium Generale, Dutch Comic Con, Xmas Comic Con, Dutch Science Week and Irish Science Week.",{"type":152,"children":6630},[6631],{"bold":79,"text":6632,"type":156},"Put simply SensUs takes innovation and creativity to a new level by motivating the next generation of scientists, engineers and inventors to think differently about approaches towards health diagnostics. SensUs will undoubtedly make a difference, SensUs will inspire.","2026-07-28T11:14:22.346Z","2026-07-28T11:14:22.345Z",{"id":6636,"documentId":6637,"name":6638,"alternativeText":18,"caption":18,"focalPoint":18,"width":6639,"height":6640,"formats":6641,"hash":6666,"ext":280,"mime":283,"size":6667,"url":6668,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":6669,"updatedAt":6669,"publishedAt":6669},1364,"o91jgnqiez61wi4bny07dtoi","event16.jpg",1443,962,{"large":6642,"small":6648,"medium":6654,"thumbnail":6660},{"ext":280,"url":6643,"hash":6644,"mime":283,"name":6645,"path":18,"size":6646,"width":190,"height":345,"sizeInBytes":6647},"/uploads/large_event16_eee02918fc.jpg","large_event16_eee02918fc","large_event16.jpg",74.92,74923,{"ext":280,"url":6649,"hash":6650,"mime":283,"name":6651,"path":18,"size":6652,"width":198,"height":293,"sizeInBytes":6653},"/uploads/small_event16_eee02918fc.jpg","small_event16_eee02918fc","small_event16.jpg",23.54,23538,{"ext":280,"url":6655,"hash":6656,"mime":283,"name":6657,"path":18,"size":6658,"width":206,"height":198,"sizeInBytes":6659},"/uploads/medium_event16_eee02918fc.jpg","medium_event16_eee02918fc","medium_event16.jpg",44.18,44179,{"ext":280,"url":6661,"hash":6662,"mime":283,"name":6663,"path":18,"size":6664,"width":306,"height":214,"sizeInBytes":6665},"/uploads/thumbnail_event16_eee02918fc.jpg","thumbnail_event16_eee02918fc","thumbnail_event16.jpg",8.02,8021,"event16_eee02918fc",165.01,"/uploads/event16_eee02918fc.jpg","2026-07-28T11:14:22.344Z",{"id":6671,"documentId":6672,"title":6673,"slug":6674,"date":6675,"cardTitle":6676,"excerpt":18,"body":6677,"createdAt":6737,"updatedAt":6737,"publishedAt":6737,"cardImage":6738},330,"i7gf4g62pkxenjp3k7z1gtgm","Easing the life of heart failure patients","personal-stories-hans-post","2017-08-07","Personal Stories: Hans Post",[6678,6682,6686,6690,6694,6698,6702,6706,6710,6714,6717,6721,6725,6729],{"type":152,"children":6679},[6680],{"text":6681,"type":156},"My name is Hans Post. I have been a cardiologist for the past fifteen years at the Catharina Hospital in Eindhoven. While I was studying medicine I became fascinated with the functioning and possible dysfunctioning of the heart. The knowledge and skills required to become a cardiologist are very broad. The complexity of the heart and the detailed knowledge required of the mechanics and physiology of this organ, make the profession of a cadiologist very intellectually challenging. I used to focus on cardiovascular imaging, but during the past few years I have specialized in heart failure.",{"type":152,"children":6683},[6684],{"bold":79,"text":6685,"type":156},"What is heart failure?",{"type":152,"children":6687},[6688],{"text":6689,"type":156},"Heart failure is hard to define specifically. It is known as a problem where the pump function of the heart falls short in providing sufficient blood circulation, which comes with various consequences. Firstly, it results in the congestion of blood in the vascular system, which causes fluid to exit veins and accumulate in other areas of the body, such as the lungs for example, which leads to shortness of breath. The fluid can also accumulate in the lowest areas of the body, for instance in the feet and legs. Secondly, it can become dangerous when an insufficient amount of blood reaches vital organs. The liver, kidneys and even the brain can be affected. Furthermore, people can feel tired very quickly as low blood circulation causes a low amount of oxygen and nutrients to reach the muscles.",{"type":152,"children":6691},[6692],{"text":6693,"type":156},"Heart failure can have many origins, but grossly has two patterns of appearance. The first is acute heart failure. This is the case when something happens that immediately affects the functioning of the heart, for example when a heart infarction strikes. The people suffering from this type of heart failure could have been in perfect health right up to the point of the infarction, after which they suddenly became heart failure patient. The second form of heart failure develops gradually. It can, for example, arise after having lived with high blood pressure for several years/decades .",{"type":152,"children":6695},[6696],{"bold":79,"text":6697,"type":156},"Consequences",{"type":152,"children":6699},[6700],{"text":6701,"type":156},"Heart failure is a chronic condition. Once someone has it, in many cases there is little hope for a full recovery. Most heart failure patients will have to learn to live with the disease for the rest of their lives.",{"type":152,"children":6703},[6704],{"text":6705,"type":156},"Problems that often arise as a result of heart failure are, among others, fatigue and fluid accumulation. Some patients find having to swallow five or six pills per day the most trying aspect of their condition. Moreover, patients with heart failure have an increased chance of acquiring further (e.g. electrical) heart problems. Even small issues can cause a patient to have to go back to the hospital regularly and most heart failure patients are in and out of hospital many times for treatment and control.",{"type":152,"children":6707},[6708],{"bold":79,"text":6709,"type":156},"Detecting heart failure",{"type":152,"children":6711},[6712],{"text":6713,"type":156},"Detecting heart failure at an early stage is difficult. The problem is that heart failure causes symptoms which are similar to those of various other diseases. It is hard for General Practitioners to determine if a patient is suffering from heart failure or from something else on the basis of their complaints alone, which leads to relatively late detections for many patients. To confirm whether a patient has heart failure or not, often NT-proBNP is measured. This is a biomarker of which the concentration in blood can indicate heart failure. Measuring NT-proBNP is currently an important aspect of both the diagnosis and the monitoring of patients. NT-proBNP is the most useful indicator for heart failure today, as it has a very trustworthy negative predictive value, which entails that whenever the NT-proBNP level in the blood is normal, you can be almost 100% certain that the patient does not have heart failure.",{"type":152,"children":6715},[6716],{"bold":79,"text":5686,"type":156},{"type":152,"children":6718},[6719],{"text":6720,"type":156},"A biosensor can provide a faster and easier way to measure NT-proBNP. This could play a significant role in monitoring the progression of the patient's condition. The advantages of monitoring patient data are currently thoroughly being investigated. It might prevent re-hospitalization or even help patients to live longer. Regular measurements with a biosensor could provide more accurate information to help monitor the patient's condition. My hope for the future is that on the basis of the data provided by a biosensor, patients will be able to adjust their medication to better fit their needs at a particular moment in time.",{"type":152,"children":6722},[6723],{"text":6724,"type":156},"When it becomes possible to measure important indicators of heart failure at home, patients will not have to go to the hospital as much and will receive quicker results, which will drastically improve their quality of life. Biosensors are also very cost-effective as blood samples do not have to be sent to a laboratory anymore. Furthermore, with the use of these sensors heart failure can be detected earlier, or excluded from the possible diagnoses, even at the GP's office as NT-proBNP can be tested quickly and efficiently. Thus biosensors could reduce the time patients are uncertain about their disease, as the measurement is executed earlier in the diagnostic process. With the current method, measuring NT-proBNP levels takes some time, depending on the laboratory you send the results to. With a sensor like the ones that are being developed in the SensUs competition, a patient would see the results within five minutes.",{"type":152,"children":6726},[6727],{"bold":79,"text":6728,"type":156},"SensUs",{"type":152,"children":6730},[6731,6733,6735],{"text":6732,"type":156},"Even if the prototypes that the teams are developing do not work perfectly, the SensUs competition is very important. The effort and research that is put into the process of creating a biosensor will result in new knowledge. However, I do think that the teams ",{"text":6734,"type":156,"italic":79},"will",{"text":6736,"type":156}," manage to produce a working biosensor. The devices that will be developed will be very useful in the healthcare domain. I look forward to seeing something beautiful created by SensUs.","2026-07-28T11:14:22.787Z",{"id":6739,"documentId":6740,"name":6741,"alternativeText":18,"caption":18,"focalPoint":18,"width":6742,"height":6743,"formats":6744,"hash":6769,"ext":280,"mime":283,"size":6770,"url":6771,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":6772,"updatedAt":6772,"publishedAt":6772},1366,"qpbd8rueoq170vqixsv6zqk4","hanspost_2.jpg",5630,3753,{"large":6745,"small":6751,"medium":6757,"thumbnail":6763},{"ext":280,"url":6746,"hash":6747,"mime":283,"name":6748,"path":18,"size":6749,"width":190,"height":345,"sizeInBytes":6750},"/uploads/large_hanspost_2_448993e9e4.jpg","large_hanspost_2_448993e9e4","large_hanspost_2.jpg",71.62,71621,{"ext":280,"url":6752,"hash":6753,"mime":283,"name":6754,"path":18,"size":6755,"width":198,"height":352,"sizeInBytes":6756},"/uploads/small_hanspost_2_448993e9e4.jpg","small_hanspost_2_448993e9e4","small_hanspost_2.jpg",25.35,25348,{"ext":280,"url":6758,"hash":6759,"mime":283,"name":6760,"path":18,"size":6761,"width":206,"height":198,"sizeInBytes":6762},"/uploads/medium_hanspost_2_448993e9e4.jpg","medium_hanspost_2_448993e9e4","medium_hanspost_2.jpg",47.37,47366,{"ext":280,"url":6764,"hash":6765,"mime":283,"name":6766,"path":18,"size":6767,"width":306,"height":214,"sizeInBytes":6768},"/uploads/thumbnail_hanspost_2_448993e9e4.jpg","thumbnail_hanspost_2_448993e9e4","thumbnail_hanspost_2.jpg",8.12,8119,"hanspost_2_448993e9e4",1375.38,"/uploads/hanspost_2_448993e9e4.jpg","2026-07-28T11:14:22.785Z",{"id":603,"documentId":6774,"title":6775,"slug":6776,"date":6777,"cardTitle":6778,"excerpt":18,"body":6779,"createdAt":6836,"updatedAt":6836,"publishedAt":6837,"cardImage":6838},"ola3mcbot6oh4rphkitcjvtv","Keeping the quality of life as high as possible","personal-stories-cindy-verstappen","2017-07-04","Personal Stories: Cindy Verstappen",[6780,6784,6788,6792,6796,6800,6804,6808,6812,6816,6820,6824,6828,6832],{"type":152,"children":6781},[6782],{"text":6783,"type":156},"My name is Cindy Verstappen and I have been a nurse in in the field of cardiology since 1999. In 2003 I became a nurse practitioner, which means that I integrate tasks typically performed by a cardiologist with those of a nurse. I map case histories, do physical examinations, treat, and guide patients at the heart failure clinic. I also educate cardiology nurses and nurse practitioners. I work closely with cardiologists, other nurse practitioners, general practitioners, the dietitian, the physiotherapist, personal carers in private homes, and heart patients and their families.",{"type":152,"children":6785},[6786],{"bold":79,"text":6787,"type":156},"Contact with heart failure every day",{"type":152,"children":6789},[6790],{"text":6791,"type":156},"I see heart failure patients on a daily basis. I ensure that everything goes smoothly for the patients and that they see all their other caretakers. We try to keep the patients' quality of life as high as possible, so they can stay at home, in their own environment, for as long as possible. Yet despite our best efforts, many patients with heart failure need to be rehospitalized multiple times. Either because their heart is too weak, or due to other factors that can provoke a deterioration of the condition of the patient.",{"type":152,"children":6793},[6794],{"bold":79,"text":6795,"type":156},"Struggles every day",{"type":152,"children":6797},[6798],{"text":6799,"type":156},"Living with heart failure comes with a lot of everyday struggles. Heart patients have to weigh themselves every day, meaning that they are confronted with their disease on a daily basis. Furthermore, heart patients need to keep a very strict diet, because they can only consume a limited amount of salt and water. The exact amount differs per patient, but following such strict guidelines takes a lot of discipline and determination, as does following the numerous edicts relating to the correct use and dosage of their medication. Finally, all these difficulties are compounded by frequent interruptions in the lives of these patients by visits to the hospital and the GP's office to monitor drug use, heart rate, blood pressure, and several molecular parameters.",{"type":152,"children":6801},[6802],{"text":6803,"type":156},"There are also the societal issues to take into consideration. Heart patients usually get tired very easily and have other physical restrictions that make it hard for them to find a job. This sometimes gives rise to financial problems. Furthermore, because heart failure is invisible from the outside, people don't usually notice the condition of the patient. It is very visible if you break your arm and people will ask you how you are doing all the time, but when you have heart disease people don't notice the problem. This causes a lot of struggles in social interactions.",{"type":152,"children":6805},[6806],{"bold":79,"text":6807,"type":156},"NT-proBNP",{"type":152,"children":6809},[6810],{"text":6811,"type":156},"One of the molecular parameters we monitor is NT-proBNP, the target biomarker of SensUs 2017. (NT-pro)BNP maintains the blood pressure. We currently use this to test if there is an increase of heart failure in a patient. When someone suffers from heart failure, the pressure on the heart increases, and more (NT-pro)BNP is secreted into the blood. Therefore, a higher NT-proBNP value could be an indication for heart failure.",{"type":152,"children":6813},[6814],{"text":6815,"type":156},"When we want to test for the amount of NT-proBNP, we draw blood and it takes at least a day before we have the results. If I request an urgent test in the morning, the laboratory is most of the time able to provide me the results at the end of the afternoon. However, it is currently impossible to have the result within an hour, which would be useful when I need them as supporting information to an examination.",{"type":152,"children":6817},[6818],{"bold":79,"text":6819,"type":156},"Point-of-care testing",{"type":152,"children":6821},[6822],{"text":6823,"type":156},"It would be a great help to have a device for point-of-care testing. Not only for use in the clinic, but also for patients to use at home. If patients had a biosensor for the monitoring of kidney function and NT-proBNP, that could really help to keep the patients out of the hospital. It would also be a great help if these devices were synched with the electronic record of the patient. That way I could monitor patients from a distance and only have to help them if their blood values or other parameters were off. Collecting all this information in their online electronic records would be a great help for the patients and for the healthcare professionals.",{"type":152,"children":6825},[6826],{"text":6827,"type":156},"Furthermore, a biosensor could also give the patient more control over his or her own health. This is beneficial for the mental health state of the patient and will contribute greatly to their quality of life.",{"type":152,"children":6829},[6830],{"bold":79,"text":6831,"type":156},"The SensUs competition",{"type":152,"children":6833},[6834],{"text":6835,"type":156},"I believe the SensUs competition is a great initiative. Personally I have always been fascinated by innovations in health care and SensUs can contribute to that. I think the fact that the competition has so much contact with different stakeholders from hospitals and healthcare environments is amazing. This can provide a lot of useful information, since these people are going to be the ones that use the sensors once they become available. Having teams of students work on innovative solutions for point-of-care biosensing is really good. You can challenge each other and that stimulates even bigger and more innovative thinking.","2026-07-28T11:14:23.090Z","2026-07-28T11:14:23.088Z",{"id":6839,"documentId":6840,"name":6841,"alternativeText":18,"caption":18,"focalPoint":18,"width":6842,"height":6843,"formats":6844,"hash":6869,"ext":280,"mime":283,"size":6870,"url":6871,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":6872,"updatedAt":6872,"publishedAt":6872},1368,"c7hlkarp5llrmg59buu2i9af","cindy2.jpg",4200,2804,{"large":6845,"small":6851,"medium":6857,"thumbnail":6863},{"ext":280,"url":6846,"hash":6847,"mime":283,"name":6848,"path":18,"size":6849,"width":190,"height":946,"sizeInBytes":6850},"/uploads/large_cindy2_899f880aef.jpg","large_cindy2_899f880aef","large_cindy2.jpg",59.46,59457,{"ext":280,"url":6852,"hash":6853,"mime":283,"name":6854,"path":18,"size":6855,"width":198,"height":352,"sizeInBytes":6856},"/uploads/small_cindy2_899f880aef.jpg","small_cindy2_899f880aef","small_cindy2.jpg",21.46,21458,{"ext":280,"url":6858,"hash":6859,"mime":283,"name":6860,"path":18,"size":6861,"width":206,"height":359,"sizeInBytes":6862},"/uploads/medium_cindy2_899f880aef.jpg","medium_cindy2_899f880aef","medium_cindy2.jpg",38.64,38636,{"ext":280,"url":6864,"hash":6865,"mime":283,"name":6866,"path":18,"size":6867,"width":306,"height":214,"sizeInBytes":6868},"/uploads/thumbnail_cindy2_899f880aef.jpg","thumbnail_cindy2_899f880aef","thumbnail_cindy2.jpg",6.88,6879,"cindy2_899f880aef",574.51,"/uploads/cindy2_899f880aef.jpg","2026-07-28T11:14:23.036Z",{"id":4362,"documentId":6874,"title":6875,"slug":6876,"date":6877,"cardTitle":18,"excerpt":18,"body":6878,"createdAt":6887,"updatedAt":6887,"publishedAt":6888,"cardImage":6889},"rmzyzs3n00x003fbf3fygku0","Teams update video 2017","teams-update-video-2017","2017-06-30",[6879,6883],{"type":152,"children":6880},[6881],{"text":6882,"type":156},"The competition is nearing and the teams are working hard to design, build and test their biosensors. In approximately three months from now the contest event will take place in Eindhoven, on the 8th and 9th of September.",{"type":152,"children":6884},[6885],{"text":6886,"type":156},"But how far are the teams now? Let's take a look! The teams have sent in small video fragments of some daily work to give you an impression of what developing a biosensor looks like.","2026-07-28T11:14:23.615Z","2026-07-28T11:14:23.613Z",{"id":6890,"documentId":6891,"name":6892,"alternativeText":18,"caption":18,"focalPoint":18,"width":6893,"height":5171,"formats":6894,"hash":6919,"ext":280,"mime":283,"size":6920,"url":6921,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":6922,"updatedAt":6922,"publishedAt":6922},1371,"lbsvu6qbtoowi84zwa61zfqr","teamsvideo2017.jpg",6000,{"large":6895,"small":6901,"medium":6907,"thumbnail":6913},{"ext":280,"url":6896,"hash":6897,"mime":283,"name":6898,"path":18,"size":6899,"width":190,"height":345,"sizeInBytes":6900},"/uploads/large_teamsvideo2017_c2c039b211.jpg","large_teamsvideo2017_c2c039b211","large_teamsvideo2017.jpg",100.17,100173,{"ext":280,"url":6902,"hash":6903,"mime":283,"name":6904,"path":18,"size":6905,"width":198,"height":293,"sizeInBytes":6906},"/uploads/small_teamsvideo2017_c2c039b211.jpg","small_teamsvideo2017_c2c039b211","small_teamsvideo2017.jpg",35.26,35262,{"ext":280,"url":6908,"hash":6909,"mime":283,"name":6910,"path":18,"size":6911,"width":206,"height":198,"sizeInBytes":6912},"/uploads/medium_teamsvideo2017_c2c039b211.jpg","medium_teamsvideo2017_c2c039b211","medium_teamsvideo2017.jpg",65.92,65923,{"ext":280,"url":6914,"hash":6915,"mime":283,"name":6916,"path":18,"size":6917,"width":306,"height":214,"sizeInBytes":6918},"/uploads/thumbnail_teamsvideo2017_c2c039b211.jpg","thumbnail_teamsvideo2017_c2c039b211","thumbnail_teamsvideo2017.jpg",11.01,11008,"teamsvideo2017_c2c039b211",1704.76,"/uploads/teamsvideo2017_c2c039b211.jpg","2026-07-28T11:14:23.611Z",{"id":293,"documentId":6924,"title":6925,"slug":6926,"date":6927,"cardTitle":18,"excerpt":18,"body":6928,"createdAt":6957,"updatedAt":6957,"publishedAt":6958,"cardImage":6959},"xjt7ctetvg9kedlx16eiwj1v","Meet our new members!","meet-our-new-members","2017-05-30",[6929,6933,6937,6941,6945,6949,6953],{"type":152,"children":6930},[6931],{"text":6932,"type":156},"The SensUs Student Competition is getting bigger and bigger. In the 2017 event, there are 10 teams taking part in the competition and in the 2018 contest the number of participating teams will grow up to 15 teams.",{"type":152,"children":6934},[6935],{"text":6936,"type":156},"As the number of SensUs teams grows, we also need more people in the organization. We are happy to announce that 14 new members are going to join the SensUs organization. These students now already play an active role and eventually they will take on the responsibility to organize the 2018 event.",{"type":152,"children":6938},[6939],{"text":6940,"type":156},"The new members originate from different studies and have different interests. Therefore the organization is broadly oriented which helps to look at subjects in many different ways. This is what makes the organization so powerful.",{"type":152,"children":6942},[6943],{"text":6944,"type":156},"Also, the students participating in the organization have different motivations why they want to join the organization. Either they love to delve into the uses and users of biosensors, or they want to develop themselves professionally by taking on opportunities that SensUs can offer them..",{"type":152,"children":6946},[6947],{"text":6948,"type":156},"\"What I really like about the SensUs organization is that it gives me the freedom to improve many professional skills, which I do not encounter during my regular study. Furthermore, the organization stands for something I believe in, namely keeping people healthy as long as possible by means of promoting biomedical sensors that can be used anytime and everywhere.\", confirms Ido Golan.",{"type":152,"children":6950},[6951],{"text":6952,"type":156},"All the new members agree that biosensors are an essential new development in the healthcare industry. SensUs raises awareness and stimulates development in this field and we all like being part of an organization that has the power to achieve this.",{"type":152,"children":6954},[6955],{"text":6956,"type":156},"We hope to see you all at the contest at the 8th and 9th of September!","2026-07-28T11:14:23.751Z","2026-07-28T11:14:23.749Z",{"id":6960,"documentId":6961,"name":6962,"alternativeText":18,"caption":18,"focalPoint":18,"width":3886,"height":497,"formats":6963,"hash":6988,"ext":280,"mime":283,"size":6989,"url":6990,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":6991,"updatedAt":6991,"publishedAt":6991},1373,"ivocst0pnsv7tt7hu2sfanpu","imgnewmembers201720181.jpg",{"large":6964,"small":6970,"medium":6976,"thumbnail":6982},{"ext":280,"url":6965,"hash":6966,"mime":283,"name":6967,"path":18,"size":6968,"width":190,"height":206,"sizeInBytes":6969},"/uploads/large_imgnewmembers201720181_a9afe3c553.jpg","large_imgnewmembers201720181_a9afe3c553","large_imgnewmembers201720181.jpg",99.65,99646,{"ext":280,"url":6971,"hash":6972,"mime":283,"name":6973,"path":18,"size":6974,"width":198,"height":654,"sizeInBytes":6975},"/uploads/small_imgnewmembers201720181_a9afe3c553.jpg","small_imgnewmembers201720181_a9afe3c553","small_imgnewmembers201720181.jpg",33.29,33286,{"ext":280,"url":6977,"hash":6978,"mime":283,"name":6979,"path":18,"size":6980,"width":206,"height":661,"sizeInBytes":6981},"/uploads/medium_imgnewmembers201720181_a9afe3c553.jpg","medium_imgnewmembers201720181_a9afe3c553","medium_imgnewmembers201720181.jpg",63.41,63406,{"ext":280,"url":6983,"hash":6984,"mime":283,"name":6985,"path":18,"size":6986,"width":3107,"height":214,"sizeInBytes":6987},"/uploads/thumbnail_imgnewmembers201720181_a9afe3c553.jpg","thumbnail_imgnewmembers201720181_a9afe3c553","thumbnail_imgnewmembers201720181.jpg",8.3,8297,"imgnewmembers201720181_a9afe3c553",185.74,"/uploads/imgnewmembers201720181_a9afe3c553.jpg","2026-07-28T11:14:23.703Z",{"id":352,"documentId":6993,"title":6994,"slug":6995,"date":6996,"cardTitle":18,"excerpt":18,"body":6997,"createdAt":7006,"updatedAt":7006,"publishedAt":7007,"cardImage":7008},"dwgp2fe7xkq5gctepv1thgrq","Personal Stories: Paula","personal-stories-paula","2017-05-29",[6998,7002],{"type":152,"children":6999},[7000],{"text":7001,"type":156},"If you looked at me a few years ago, you would have seen a strong and fit middle-aged woman. I have one passion: sports, especially mountaineering. If it was up to me, I would be in the mountains twenty-four-seven. I have always wanted to be a strong and independent woman, who is capable of everything. I was the one people would contact if they wanted a tree to be cut down. I always push myself to the limit and strive to go beyond.",{"type":152,"children":7003},[7004],{"text":7005,"type":156},"If you look at me now, outsiders still see the same Paula. A middle-aged woman with two children and a husband, who still looks quite fit. However, I am not the same anymore. Inside I have an invisible disability that affects me and numerous other people: heart failure.","2026-07-28T11:14:24.464Z","2026-07-28T11:14:24.461Z",{"id":7009,"documentId":7010,"name":7011,"alternativeText":18,"caption":18,"focalPoint":18,"width":937,"height":938,"formats":7012,"hash":7037,"ext":280,"mime":283,"size":7038,"url":7039,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":7040,"updatedAt":7040,"publishedAt":7040},1376,"evboa85ten8rc42ts2avp8lo","paula2.jpg",{"large":7013,"small":7019,"medium":7025,"thumbnail":7031},{"ext":280,"url":7014,"hash":7015,"mime":283,"name":7016,"path":18,"size":7017,"width":190,"height":946,"sizeInBytes":7018},"/uploads/large_paula2_83e1e19400.jpg","large_paula2_83e1e19400","large_paula2.jpg",84.33,84332,{"ext":280,"url":7020,"hash":7021,"mime":283,"name":7022,"path":18,"size":7023,"width":198,"height":352,"sizeInBytes":7024},"/uploads/small_paula2_83e1e19400.jpg","small_paula2_83e1e19400","small_paula2.jpg",29.07,29073,{"ext":280,"url":7026,"hash":7027,"mime":283,"name":7028,"path":18,"size":7029,"width":206,"height":359,"sizeInBytes":7030},"/uploads/medium_paula2_83e1e19400.jpg","medium_paula2_83e1e19400","medium_paula2.jpg",54.53,54533,{"ext":280,"url":7032,"hash":7033,"mime":283,"name":7034,"path":18,"size":7035,"width":306,"height":214,"sizeInBytes":7036},"/uploads/thumbnail_paula2_83e1e19400.jpg","thumbnail_paula2_83e1e19400","thumbnail_paula2.jpg",9.39,9387,"paula2_83e1e19400",1680.93,"/uploads/paula2_83e1e19400.jpg","2026-07-28T11:14:24.247Z",{"id":7042,"documentId":7043,"title":7044,"slug":7045,"date":7046,"cardTitle":18,"excerpt":18,"body":7047,"createdAt":7085,"updatedAt":7085,"publishedAt":7086,"cardImage":7087},335,"bn33ki0zndm5ovy2xx1m3c3l","Detecting tumors at home","detecting-tumors-home","2017-05-26",[7048,7052,7056,7060,7064,7068,7072,7076],{"type":152,"children":7049},[7050],{"bold":79,"text":7051,"type":156},"Personalized health care at home is becoming more relevant than ever before. Biosensors play a key role in this, since they can check your health with ease of use. Science journalist Diederik Jekel will give a lecture about this innovative research field: the future of personalized healthcare.",{"type":152,"children":7053},[7054],{"text":7055,"type":156},"An important aim in healthcare is to let people live high-quality lives in their own environments. Miniaturized and easy to use biochemical sensing devices will become increasingly important for monitoring, treating and coaching of patients. Consequently, the coming decades the need for biochemical sensing technologies will increase.",{"type":152,"children":7057},[7058],{"text":7059,"type":156},"The mission of SensUs is to stimulate education and innovation in molecular health sensing by organizing an international competition for students. Next to this, the SensUs organization aims to raise awareness and discussion about the role of biosensors in society",{"type":152,"children":7061},[7062],{"text":7063,"type":156},"That is why SensUs organizes, in cooperation with Studium Generale Eindhoven, a lecture that will focus on the future of healthcare, personalized and at home.",{"type":152,"children":7065},[7066],{"text":7067,"type":156},"Diederik Jekel, science journalist and writer, will provide this lecture. He has a big passion for the natural sciences and is regularly seen on television in programs such as \"De Wereld Draait Door\" to explain new scientific developments. Next to this Diederik presents the program \"De Kennis van Nu\".",{"type":152,"children":7069},[7070],{"text":7071,"type":156},"Diederik Jekel is not unfamiliar with biosensing. When he was 17 years old, he was diagnosed with diabetes type 1.",{"type":152,"children":7073},[7074],{"text":7075,"type":156},"The lecture will be given at Technical University Eindhoven, Wednesday 31st of May.",{"type":152,"children":7077},[7078,7080],{"text":7079,"type":156},"Are you also curious about his lecture? ",{"url":7081,"type":236,"children":7082},"http://www.studiumgenerale-eindhoven.nl/nl/agenda/overzicht/tumoren-opsporen-doe-je-thuis/0/1070/",[7083],{"text":7084,"type":156}," Click here to reserve your ticket!","2026-07-28T11:14:24.739Z","2026-07-28T11:14:24.738Z",{"id":4810,"documentId":7088,"name":7089,"alternativeText":18,"caption":18,"focalPoint":18,"width":7090,"height":7091,"formats":7092,"hash":7117,"ext":280,"mime":283,"size":7118,"url":7119,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":7120,"updatedAt":7120,"publishedAt":7120},"u5q7a4dv9agbe3ofqflq2itd","DIEDERIK_130320_74-PA3.jpg",2443,3665,{"large":7093,"small":7099,"medium":7105,"thumbnail":7111},{"ext":280,"url":7094,"hash":7095,"mime":283,"name":7096,"path":18,"size":7097,"width":286,"height":190,"sizeInBytes":7098},"/uploads/large_DIEDERIK_130320_74_PA_3_b3abc689d3.jpg","large_DIEDERIK_130320_74_PA_3_b3abc689d3","large_DIEDERIK_130320_74-PA3.jpg",52.26,52256,{"ext":280,"url":7100,"hash":7101,"mime":283,"name":7102,"path":18,"size":7103,"width":293,"height":198,"sizeInBytes":7104},"/uploads/small_DIEDERIK_130320_74_PA_3_b3abc689d3.jpg","small_DIEDERIK_130320_74_PA_3_b3abc689d3","small_DIEDERIK_130320_74-PA3.jpg",17.71,17707,{"ext":280,"url":7106,"hash":7107,"mime":283,"name":7108,"path":18,"size":7109,"width":198,"height":206,"sizeInBytes":7110},"/uploads/medium_DIEDERIK_130320_74_PA_3_b3abc689d3.jpg","medium_DIEDERIK_130320_74_PA_3_b3abc689d3","medium_DIEDERIK_130320_74-PA3.jpg",33.17,33174,{"ext":280,"url":7112,"hash":7113,"mime":283,"name":7114,"path":18,"size":7115,"width":570,"height":214,"sizeInBytes":7116},"/uploads/thumbnail_DIEDERIK_130320_74_PA_3_b3abc689d3.jpg","thumbnail_DIEDERIK_130320_74_PA_3_b3abc689d3","thumbnail_DIEDERIK_130320_74-PA3.jpg",3.29,3287,"DIEDERIK_130320_74_PA_3_b3abc689d3",477.01,"/uploads/DIEDERIK_130320_74_PA_3_b3abc689d3.jpg","2026-07-28T11:14:24.736Z",{"id":7122,"documentId":7123,"title":7124,"slug":7125,"date":7126,"cardTitle":18,"excerpt":18,"body":7127,"createdAt":7136,"updatedAt":7136,"publishedAt":7137,"cardImage":7138},336,"umunx8say59kvbggk8s9csim","Dutch Technology Week 2017","dutch-technology-week-2017","2017-05-22",[7128,7132],{"type":152,"children":7129},[7130],{"bold":79,"text":7131,"type":156},"From May 15 till May 20 the Dutch Technology Week took place in Eindhoven and its surroundings. During this week the latest innovations in the field of technology are being shown in different ways. SensUs had the special opportunity to be present at four occasions.",{"type":152,"children":7133},[7134],{"text":7135,"type":156},"Technology connects and so do the visitors of the Dutch Technology week. It all started at monday morning where topics related to technology were discussed. We had the honor to pitch our technological dream for the future; biosensors for countless different diseases that are easily available, simple to use and not too expensive. Next to ours, other inspiring pitches and talks were held that gave the public insight in the importance of connections and of course, technology. At eleven o'clock the mayor of Eindhoven officially opened the Dutch Technology Week.","2026-07-28T11:14:25.270Z","2026-07-28T11:14:25.267Z",{"id":7139,"documentId":7140,"name":7141,"alternativeText":18,"caption":18,"focalPoint":18,"width":3611,"height":7142,"formats":7143,"hash":7168,"ext":280,"mime":283,"size":7169,"url":7170,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":7171,"updatedAt":7171,"publishedAt":7171},1384,"gioio107dcg2bzba42mvbmrp","dtw2017.jpg",3072,{"large":7144,"small":7150,"medium":7156,"thumbnail":7162},{"ext":280,"url":7145,"hash":7146,"mime":283,"name":7147,"path":18,"size":7148,"width":190,"height":345,"sizeInBytes":7149},"/uploads/large_dtw2017_f209828779.jpg","large_dtw2017_f209828779","large_dtw2017.jpg",135.52,135520,{"ext":280,"url":7151,"hash":7152,"mime":283,"name":7153,"path":18,"size":7154,"width":198,"height":293,"sizeInBytes":7155},"/uploads/small_dtw2017_f209828779.jpg","small_dtw2017_f209828779","small_dtw2017.jpg",41.86,41861,{"ext":280,"url":7157,"hash":7158,"mime":283,"name":7159,"path":18,"size":7160,"width":206,"height":198,"sizeInBytes":7161},"/uploads/medium_dtw2017_f209828779.jpg","medium_dtw2017_f209828779","medium_dtw2017.jpg",83.36,83361,{"ext":280,"url":7163,"hash":7164,"mime":283,"name":7165,"path":18,"size":7166,"width":306,"height":214,"sizeInBytes":7167},"/uploads/thumbnail_dtw2017_f209828779.jpg","thumbnail_dtw2017_f209828779","thumbnail_dtw2017.jpg",12.13,12129,"dtw2017_f209828779",1569.71,"/uploads/dtw2017_f209828779.jpg","2026-07-28T11:14:25.111Z",{"id":7173,"documentId":7174,"title":7175,"slug":7176,"date":7177,"cardTitle":18,"excerpt":18,"body":7178,"createdAt":7200,"updatedAt":7200,"publishedAt":7201,"cardImage":7202},337,"sipgk6h45wkuee3n8rfmgoik","Keynote speaker SensUs 2017","keynote-speaker-sensus-2017","2017-05-17",[7179,7183,7192],{"type":152,"children":7180},[7181],{"text":7182,"type":156},"We are proud to announce that dr. Zayna Khayat will give a keynote presentation during the upcoming SensUs event on 8-9 September 2017. Dr. Khayat completed a PhD in biochemistry from the University of Toronto and thereafter specialized in consultancy for healthcare innovation. She is currently on secondment from Toronto (Canada) to the REshape Health Innovation Centre at Radboud University Medical Centre in Nijmegen. We look forward to Dr. Zayna's presentation on exciting developments in the field of sensors for health!",{"type":152,"children":7184},[7185,7190],{"url":7186,"type":236,"children":7187},"https://www.facebook.com/events/706596226189178/?acontext=%7B%22source%22%3A5%2C%22page_id_source%22%3A123481758002187%2C%22action_history%22%3A[%7B%22surface%22%3A%22page%22%2C%22mechanism%22%3A%22main_list%22%2C%22extra_data%22%3A%22%7B%5C%22page_id%5C%22%3A123481758002187%2C%5C%22tour_id%5C%22%3Anull%7D%22%7D]%2C%22has_source%22%3Atrue%7D",[7188],{"text":7189,"type":156},"Click here",{"text":7191,"type":156}," to register for the Facebook event!",{"type":152,"children":7193},[7194,7198],{"url":7195,"type":236,"children":7196},"https://old.sensus.org/2017.php",[7197],{"text":7189,"type":156},{"text":7199,"type":156}," for more information about the program on 8-9 September 2017.","2026-07-28T11:14:25.644Z","2026-07-28T11:14:25.642Z",{"id":7203,"documentId":7204,"name":7205,"alternativeText":18,"caption":18,"focalPoint":18,"width":190,"height":190,"formats":7206,"hash":7224,"ext":280,"mime":283,"size":7225,"url":7226,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":7227,"updatedAt":7227,"publishedAt":7227},1389,"jm4yvx6qdmwhfgy5rafxdjdw","zayna.jpg",{"small":7207,"medium":7213,"thumbnail":7219},{"ext":280,"url":7208,"hash":7209,"mime":283,"name":7210,"path":18,"size":7211,"width":198,"height":198,"sizeInBytes":7212},"/uploads/small_zayna_1df78e7fa5.jpg","small_zayna_1df78e7fa5","small_zayna.jpg",30.59,30590,{"ext":280,"url":7214,"hash":7215,"mime":283,"name":7216,"path":18,"size":7217,"width":206,"height":206,"sizeInBytes":7218},"/uploads/medium_zayna_1df78e7fa5.jpg","medium_zayna_1df78e7fa5","medium_zayna.jpg",58.67,58674,{"ext":280,"url":7220,"hash":7221,"mime":283,"name":7222,"path":18,"size":5974,"width":214,"height":214,"sizeInBytes":7223},"/uploads/thumbnail_zayna_1df78e7fa5.jpg","thumbnail_zayna_1df78e7fa5","thumbnail_zayna.jpg",5192,"zayna_1df78e7fa5",93.09,"/uploads/zayna_1df78e7fa5.jpg","2026-07-28T11:14:25.592Z",{"id":7229,"documentId":7230,"title":7231,"slug":7232,"date":7233,"cardTitle":18,"excerpt":18,"body":7234,"createdAt":7254,"updatedAt":7254,"publishedAt":7255,"cardImage":7256},338,"h5rjxjgkah42tdviyc65z7yj","SensUs at Biomedica 2017","sensus-biomedica-2017","2017-05-15",[7235,7246,7250],{"type":152,"children":7236},[7237,7239,7244],{"text":7238,"type":156},"This week the SensUs Organization visited ",{"url":7240,"type":236,"children":7241},"http://www.biomedicasummit.com/program-2017.html",[7242],{"text":7243,"type":156},"Biomedica, the Euregional LifeSciences summit",{"text":7245,"type":156},". Biomedica is an event visited by over 800 participants of 20 different nationalities. With nearly 2500 m2 exhibition space, there was plenty to see, such as new innovations, interesting projects and revolutionary products. This year Biomedica was held in the Auditorium building at TU Eindhoven, the same location where the SensUs contest is held.",{"type":152,"children":7247},[7248],{"text":7249,"type":156},"SensUs Organization had an oral presentation and a stand with information about SensUs. The presentation was part of a session about smart diagnostics. SensUs was asked to give a presentation about biosensing and the goal of SensUs. Tamar van Asch gave this presentation together with team T.E.S.T. from the TU Eindhoven. They explained some interesting things about the biosensor for heart failure detection they are developing at this moment.",{"type":152,"children":7251},[7252],{"text":7253,"type":156},"We are very happy to have been a part of this interesting and innovative LifeScience summit and to have had the chance to speak with lots of fascinating people.","2026-07-28T11:14:25.843Z","2026-07-28T11:14:25.842Z",{"id":7257,"documentId":7258,"name":7259,"alternativeText":18,"caption":18,"focalPoint":18,"width":3886,"height":7260,"formats":7261,"hash":7286,"ext":598,"mime":283,"size":7287,"url":7288,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":7289,"updatedAt":7289,"publishedAt":7290},1392,"cop3dm771ei9o67cbtwgbh6e","biomedica2.jpeg",900,{"large":7262,"small":7268,"medium":7274,"thumbnail":7280},{"ext":598,"url":7263,"hash":7264,"mime":283,"name":7265,"path":18,"size":7266,"width":190,"height":661,"sizeInBytes":7267},"/uploads/large_biomedica2_9ab404190c.jpeg","large_biomedica2_9ab404190c","large_biomedica2.jpeg",108.96,108964,{"ext":598,"url":7269,"hash":7270,"mime":283,"name":7271,"path":18,"size":7272,"width":198,"height":2557,"sizeInBytes":7273},"/uploads/small_biomedica2_9ab404190c.jpeg","small_biomedica2_9ab404190c","small_biomedica2.jpeg",35.15,35148,{"ext":598,"url":7275,"hash":7276,"mime":283,"name":7277,"path":18,"size":7278,"width":206,"height":2863,"sizeInBytes":7279},"/uploads/medium_biomedica2_9ab404190c.jpeg","medium_biomedica2_9ab404190c","medium_biomedica2.jpeg",68.78,68777,{"ext":598,"url":7281,"hash":7282,"mime":283,"name":7283,"path":18,"size":7284,"width":144,"height":2870,"sizeInBytes":7285},"/uploads/thumbnail_biomedica2_9ab404190c.jpeg","thumbnail_biomedica2_9ab404190c","thumbnail_biomedica2.jpeg",10.67,10667,"biomedica2_9ab404190c",227.52,"/uploads/biomedica2_9ab404190c.jpeg","2026-07-28T11:14:25.741Z","2026-07-28T11:14:25.742Z",{"id":7292,"documentId":7293,"title":7294,"slug":7295,"date":7296,"cardTitle":18,"excerpt":18,"body":7297,"createdAt":7326,"updatedAt":7326,"publishedAt":7327,"cardImage":7328},339,"jt499uzb6n7t5x33gbm1vqdc","New initiative: SensUs Digital","new-initiative-sensus-digital","2017-05-08",[7298,7302,7306,7310,7314,7318,7322],{"type":152,"children":7299},[7300],{"text":7301,"type":156},"SensUs is growing: this year ten teams from three different continents are working on their biosensors to detect heart failure. The students come from all over the world, and so do the people who would like to see their achievements.",{"type":152,"children":7303},[7304],{"bold":79,"text":7305,"type":156},"Therefore, we want to give everybody, from any place in the world, the opportunity to be part of the SensUs experience on the 8th & 9th of September.",{"type":152,"children":7307},[7308],{"text":7309,"type":156},"We have taken the initiative to build a platform called SensUs Digital. With this platform we want to provide an online experience similar to physical attendance on the 8th and 9th of September. We want to accomplish this by providing multiple live streams, webcams, real-time data, Q&A and more.",{"type":152,"children":7311},[7312],{"bold":79,"text":7313,"type":156},"Everyone interested in SensUs is welcome to attend our event online or physically. Viewers will have the chance to vote and ask questions to the teams about their work.",{"type":152,"children":7315},[7316],{"text":7317,"type":156},"This will give SensUs a bigger reach and will allow people all over the globe to learn about new biosensors for health care.",{"type":152,"children":7319},[7320],{"text":7321,"type":156},"We are presently working with ten bachelor students from the Eindhoven University of Technology Software Science department to build a first version of this online platform. The SensUs organization is delighted that the SensUs Digital project has now really started.",{"type":152,"children":7323},[7324],{"text":7325,"type":156},"We will keep you updated about this project!","2026-07-28T11:14:26.016Z","2026-07-28T11:14:26.014Z",{"id":7329,"documentId":7330,"name":7331,"alternativeText":18,"caption":18,"focalPoint":18,"width":7332,"height":7333,"formats":7334,"hash":7359,"ext":280,"mime":283,"size":7360,"url":7361,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":7362,"updatedAt":7362,"publishedAt":7362},1396,"d39qix2a5y1tygi8m5g2mg4w","digital1.jpg",1599,899,{"large":7335,"small":7341,"medium":7347,"thumbnail":7353},{"ext":280,"url":7336,"hash":7337,"mime":283,"name":7338,"path":18,"size":7339,"width":190,"height":3533,"sizeInBytes":7340},"/uploads/large_digital1_45e239ba00.jpg","large_digital1_45e239ba00","large_digital1.jpg",61.58,61582,{"ext":280,"url":7342,"hash":7343,"mime":283,"name":7344,"path":18,"size":7345,"width":198,"height":2557,"sizeInBytes":7346},"/uploads/small_digital1_45e239ba00.jpg","small_digital1_45e239ba00","small_digital1.jpg",21.95,21954,{"ext":280,"url":7348,"hash":7349,"mime":283,"name":7350,"path":18,"size":7351,"width":206,"height":2863,"sizeInBytes":7352},"/uploads/medium_digital1_45e239ba00.jpg","medium_digital1_45e239ba00","medium_digital1.jpg",40.49,40490,{"ext":280,"url":7354,"hash":7355,"mime":283,"name":7356,"path":18,"size":7357,"width":144,"height":2870,"sizeInBytes":7358},"/uploads/thumbnail_digital1_45e239ba00.jpg","thumbnail_digital1_45e239ba00","thumbnail_digital1.jpg",7.58,7582,"digital1_45e239ba00",119.34,"/uploads/digital1_45e239ba00.jpg","2026-07-28T11:14:25.923Z",{"id":7364,"documentId":7365,"title":7366,"slug":7367,"date":7368,"cardTitle":18,"excerpt":18,"body":7369,"createdAt":7382,"updatedAt":7382,"publishedAt":7382,"cardImage":7383},340,"gg9s92jcdkszbklynkuebf33","The High School Project","high-school-project","2017-03-24",[7370,7374,7378],{"type":152,"children":7371},[7372],{"text":7373,"type":156},"We are pleased to announce to you a new project for involving High School students in SensUs!",{"type":152,"children":7375},[7376],{"text":7377,"type":156},"The SensUs Organization has designed a project with a few High Schools in the Eindhoven region. In small groups, the high school students will choose a biomarker and conceive a biosensor using the TRIZ-model, which is a Russian acronym for \"Theory of Inventive Problem Solving\". The societal needs will be identified and the translation potential will be considered. The students will be invited to present their results by means of a poster and a pitch during the SensUs contest days in September!",{"type":152,"children":7379},[7380],{"text":7381,"type":156},"With this High School project, we hope to inspire teenagers toward technology and biosensors in particular. The first groups are about to start, so we are looking forward to see their results!","2026-07-28T11:14:26.089Z",{"id":7384,"documentId":7385,"name":7386,"alternativeText":18,"caption":18,"focalPoint":18,"width":5780,"height":7387,"formats":7388,"hash":7416,"ext":280,"mime":283,"size":7417,"url":7418,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":7419,"updatedAt":7419,"publishedAt":7419},1400,"h7b1u6wypoc72685f53a2zf7","highschoolstart2.jpg",807,{"large":7389,"small":7396,"medium":7402,"thumbnail":7409},{"ext":280,"url":7390,"hash":7391,"mime":283,"name":7392,"path":18,"size":7393,"width":190,"height":7394,"sizeInBytes":7395},"/uploads/large_highschoolstart2_69d3353c90.jpg","large_highschoolstart2_69d3353c90","large_highschoolstart2.jpg",44.39,630,44393,{"ext":280,"url":7397,"hash":7398,"mime":283,"name":7399,"path":18,"size":7400,"width":198,"height":5358,"sizeInBytes":7401},"/uploads/small_highschoolstart2_69d3353c90.jpg","small_highschoolstart2_69d3353c90","small_highschoolstart2.jpg",16.6,16596,{"ext":280,"url":7403,"hash":7404,"mime":283,"name":7405,"path":18,"size":7406,"width":206,"height":7407,"sizeInBytes":7408},"/uploads/medium_highschoolstart2_69d3353c90.jpg","medium_highschoolstart2_69d3353c90","medium_highschoolstart2.jpg",29.34,473,29341,{"ext":280,"url":7410,"hash":7411,"mime":283,"name":7412,"path":18,"size":7413,"width":144,"height":7414,"sizeInBytes":7415},"/uploads/thumbnail_highschoolstart2_69d3353c90.jpg","thumbnail_highschoolstart2_69d3353c90","thumbnail_highschoolstart2.jpg",5.98,154,5981,"highschoolstart2_69d3353c90",64.87,"/uploads/highschoolstart2_69d3353c90.jpg","2026-07-28T11:14:26.087Z",{"id":7421,"documentId":7422,"title":7423,"slug":7424,"date":7425,"cardTitle":7426,"excerpt":18,"body":7427,"createdAt":7448,"updatedAt":7448,"publishedAt":7449,"cardImage":7450},341,"ubqywcn45f5awbxiyfix9mvj","New addition Committee of Recommendation","new-addition-cor","2017-03-18","New addition CoR",[7428,7439],{"type":152,"children":7429},[7430,7432,7437],{"text":7431,"type":156},"We are proud to announce that Floris Italianer has joined our committee of recommendation. Floris Italianer is the CEO of the ",{"url":7433,"type":236,"children":7434},"https://www.hartstichting.nl/",[7435],{"text":7436,"type":156},"Dutch Heart Foundation",{"text":7438,"type":156},", which is an important partner for SensUs because of the relevance of biosensing for the field of heart disease. This year, the focus of SensUs is on heart failure, so we are very happy to work with the Dutch Heart Foundation and have the recognition of Floris Italianer!",{"type":152,"children":7440},[7441,7443,7447],{"text":7442,"type":156},"Read the interview of Floris Italianer ",{"url":7444,"type":236,"children":7445},"https://old.sensus.org/article.php?l=interview-floris-italianer",[7446],{"text":2637,"type":156},{"text":887,"type":156},"2026-07-28T11:14:26.166Z","2026-07-28T11:14:26.165Z",{"id":7451,"documentId":7452,"name":7453,"alternativeText":18,"caption":18,"focalPoint":18,"width":5780,"height":7454,"formats":7455,"hash":7483,"ext":280,"mime":283,"size":7484,"url":7485,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":7486,"updatedAt":7486,"publishedAt":7486},1402,"kvp0v804q0q2kwc0qhy17aal","florisEditedCropped.jpg",946,{"large":7456,"small":7463,"medium":7470,"thumbnail":7477},{"ext":280,"url":7457,"hash":7458,"mime":283,"name":7459,"path":18,"size":7460,"width":190,"height":7461,"sizeInBytes":7462},"/uploads/large_floris_Edited_Cropped_d31a7a40bc.jpg","large_floris_Edited_Cropped_d31a7a40bc","large_florisEditedCropped.jpg",77.84,739,77843,{"ext":280,"url":7464,"hash":7465,"mime":283,"name":7466,"path":18,"size":7467,"width":198,"height":7468,"sizeInBytes":7469},"/uploads/small_floris_Edited_Cropped_d31a7a40bc.jpg","small_floris_Edited_Cropped_d31a7a40bc","small_florisEditedCropped.jpg",25.52,370,25524,{"ext":280,"url":7471,"hash":7472,"mime":283,"name":7473,"path":18,"size":7474,"width":206,"height":7475,"sizeInBytes":7476},"/uploads/medium_floris_Edited_Cropped_d31a7a40bc.jpg","medium_floris_Edited_Cropped_d31a7a40bc","medium_florisEditedCropped.jpg",48.05,554,48046,{"ext":280,"url":7478,"hash":7479,"mime":283,"name":7480,"path":18,"size":6867,"width":7481,"height":214,"sizeInBytes":7482},"/uploads/thumbnail_floris_Edited_Cropped_d31a7a40bc.jpg","thumbnail_floris_Edited_Cropped_d31a7a40bc","thumbnail_florisEditedCropped.jpg",212,6877,"floris_Edited_Cropped_d31a7a40bc",118.92,"/uploads/floris_Edited_Cropped_d31a7a40bc.jpg","2026-07-28T11:14:26.163Z",{"id":7488,"documentId":7489,"title":7490,"slug":7491,"date":7492,"cardTitle":18,"excerpt":18,"body":7493,"createdAt":7510,"updatedAt":7510,"publishedAt":7510,"cardImage":7511},342,"tgjvpe1gymsvafve27s6o9zs","SensUs receives grant from EIT Health","sensus-receives-grant-eit-health","2016-12-23",[7494,7498,7502,7506],{"type":152,"children":7495},[7496],{"bold":79,"text":7497,"type":156},"We are proud to inform you that SensUs has received a grant from EIT Health, the Health division of the European Institute of Innovation and Technology, for the development of the SensUs competition.",{"type":152,"children":7499},[7500],{"text":7501,"type":156},"The subsidy has been granted by the EIT Health Campus programme, which supports the development of education initiatives that train new generations of entrepreneurial professionals.",{"type":152,"children":7503},[7504],{"text":7505,"type":156},"The grant supports the education programs in the 10 universities that participate in SensUs 2017 as well as the honors program of TU/e that organizes the competition. The funding will be used amongst others for multidisciplinary prototype development by teams of students in the 10 universities, integrating biomolecular and physical engineering technologies, and for mobility to allow the teams to convene in the contest week, when they will demonstrate their prototype systems and compete for several awards in a public contest event.",{"type":152,"children":7507},[7508],{"text":7509,"type":156},"The recognition by EIT Health is an important validation of the SensUs educational concept and will help us to realize our mission: To stimulate education and innovation in biosensing, with a worldwide scope.","2026-07-28T11:14:26.244Z",{"id":7512,"documentId":7513,"name":7514,"alternativeText":18,"caption":18,"focalPoint":18,"width":7515,"height":190,"formats":7516,"hash":7544,"ext":280,"mime":283,"size":7545,"url":7546,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":7547,"updatedAt":7547,"publishedAt":7547},1404,"tek0tjduhsobkqnzncy5iuys","EITHealth2.jpg",1900,{"large":7517,"small":7524,"medium":7530,"thumbnail":7537},{"ext":280,"url":7518,"hash":7519,"mime":283,"name":7520,"path":18,"size":7521,"width":190,"height":7522,"sizeInBytes":7523},"/uploads/large_EIT_Health2_2f20dc3aa0.jpg","large_EIT_Health2_2f20dc3aa0","large_EITHealth2.jpg",18.42,526,18424,{"ext":280,"url":7525,"hash":7526,"mime":283,"name":7527,"path":18,"size":7528,"width":198,"height":1286,"sizeInBytes":7529},"/uploads/small_EIT_Health2_2f20dc3aa0.jpg","small_EIT_Health2_2f20dc3aa0","small_EITHealth2.jpg",7.06,7060,{"ext":280,"url":7531,"hash":7532,"mime":283,"name":7533,"path":18,"size":7534,"width":206,"height":7535,"sizeInBytes":7536},"/uploads/medium_EIT_Health2_2f20dc3aa0.jpg","medium_EIT_Health2_2f20dc3aa0","medium_EITHealth2.jpg",12.38,395,12382,{"ext":280,"url":7538,"hash":7539,"mime":283,"name":7540,"path":18,"size":7541,"width":144,"height":7542,"sizeInBytes":7543},"/uploads/thumbnail_EIT_Health2_2f20dc3aa0.jpg","thumbnail_EIT_Health2_2f20dc3aa0","thumbnail_EITHealth2.jpg",2.74,129,2742,"EIT_Health2_2f20dc3aa0",36.79,"/uploads/EIT_Health2_2f20dc3aa0.jpg","2026-07-28T11:14:26.242Z",{"id":7549,"documentId":7550,"title":7551,"slug":7552,"date":7553,"cardTitle":18,"excerpt":18,"body":7554,"createdAt":7623,"updatedAt":7623,"publishedAt":7624,"cardImage":7625},343,"isazjnngkykfbllpj9txxrid","SensUs Interviews: Floris Italianer","sensus-interviews-floris-italianer","2016-12-21",[7555,7559,7563,7567,7571,7575,7579,7583,7587,7591,7595,7604,7607,7611,7615,7619],{"type":152,"children":7556},[7557],{"bold":79,"text":7558,"type":156},"For our first edition of SensUs interviews for SensUs 2017, we spoke with Floris Italianer, the CEO of the Dutch Heart Foundation. The goal of SensUs 2017 is to make working prototypes to detect heart failure. We spoke with Floris Italianer about the benefits of future biosensors for patients and about research supported by the Dutch Heart Foundation.",{"type":152,"children":7560},[7561],{"bold":79,"text":7562,"type":156},"Can you tell something about yourself, and about your role as director of the Heart Foundation?",{"type":152,"children":7564},[7565],{"text":7566,"type":156},"FI: Before joining the Dutch Heart Foundation, three years ago, I have been working in the healthcare industry for ten years. Originally, as a CEO of a private eye laser clinic, later on in advising and financing roles for smaller Dutch hospitals and finally, as CEO of a public foundation that was responsible for the financing system for hospitals in The Netherlands. Those experiences in private and public healthcare, combined with my background in private industry, help me tremendously in my work for the Dutch Heart Foundation. Within the Dutch Heart Foundation we combine marketing, science and advocacy. Consequently, a background in these areas helps a lot.",{"type":152,"children":7568},[7569],{"bold":79,"text":7570,"type":156},"Why do you like working in the medical sector?",{"type":152,"children":7572},[7573],{"text":7574,"type":156},"FI: It is much broader than the medical sector. For instance, we are also involved in health programs in schools and in various anti-tobacco programs. Health encompasses all people on this planet. That is why our work is so relevant and interesting. I am also board member of the European Heart Network and of the World Heart Federation. Globally, 17 mln people and in Europe, 4 mln people die of cardiovascular disease, every year. These numbers are growing every year, so measures are severely needed to stop this threat. It is a privilege to be able to contribute to this fight.",{"type":152,"children":7576},[7577],{"bold":79,"text":7578,"type":156},"How are you involved with TU Eindhoven?",{"type":152,"children":7580},[7581],{"text":7582,"type":156},"FI: I have been asked to join the Advisory Board of the Strategic Area Health of TU/e. For me it is important to stay in touch with the academic world and to stay involved in the plans and activities of universities such as the TU/e. It is very inspiring to be among people with different backgrounds, such as from the insurance world and from Philips and to discuss how academic work translates in applications and solutions in healthcare.",{"type":152,"children":7584},[7585],{"bold":79,"text":7586,"type":156},"Might patients benefit from biosensing in the future?",{"type":152,"children":7588},[7589],{"text":7590,"type":156},"FI: Technology opens new roads to monitoring and curing patients and should be explored as much as possible. Equally important is to innovate in how different healthcare providers cooperate and exchange patient information for the benefit of the patient and for scientists to exchange scientific data. For these developments, smart and experienced people need to sit and work together. The center point should be the patient, for which reason we are involved in many of these discussions.",{"type":152,"children":7592},[7593],{"bold":79,"text":7594,"type":156},"How is the Heart Foundation involved in research?",{"type":152,"children":7596},[7597,7599],{"text":7598,"type":156},"FI: The biggest part of our spending is in research. Since 2011, we have committed almost 100 mln euro in research. This is between 10-20% of all research spend in cardiovascular diseases, in The Netherlands. In addition to large, multi-university consortia, we provide grants for individual talented researchers. This year, we have developed a crowdfunding platform for innovation, where young researchers and the Dutch Heart Foundation jointly attract financing for research. If a researcher gets 25.000 euro financed through this platform, the Dutch Heart Foundation doubles it. This proves to be very successful. ",{"url":7600,"type":236,"children":7601},"https://steunmijnonderzoek.hartstichting.nl/",[7602],{"text":7603,"type":156}," To read more about the subsidies click here.",{"type":152,"children":7605},[7606],{"bold":79,"text":5561,"type":156},{"type":152,"children":7608},[7609],{"text":7610,"type":156},"The Dutch Heart Foundation wants to realise scientific breakthroughs that society needs and that will have a major impact on the lives of patients with cardiovascular problems and their loved ones. We strongly believe in using the creative and innovative power of multidisciplinary student teams to develop new technological solutions for preventing and curing cardiovascular diseases. Therefore we are establishing different forms of collaboration with the TU/e. In 2014, together with scientists, patients, care providers, donors and volunteers, we set our research agenda for the coming years. Earlier recognition of cardiovascular disease is top priority on this list. We strongly believe biomarkers can play an important role in identifying cardiovascular health risks at an earlier stage as well as in treatment of cardiovascular diseases.",{"type":152,"children":7612},[7613],{"text":7614,"type":156},"Hence, we are looking forward to the results of this initiative.",{"type":152,"children":7616},[7617],{"bold":79,"text":7618,"type":156},"The teams of SensUs 2017 will build biosensor prototypes that can detect NT-proBNP in blood. Can you explain how heart patients can benefit from these biosensors?",{"type":152,"children":7620},[7621],{"text":7622,"type":156},"NT-proBNP is a marker for damage of the heart muscle. In combination with other tests, it is used for the diagnosis of heart failure. It is also used to monitor disease progression and effect of therapy. There are about 142.000 patients with heart failure in the Netherlands. Cardiologists, GPs and specialised nurses are working together in the care for these patients. A validated NT-proBNP point-of-care biosensor that would make the testing of this marker faster, more efficient, more accurate, less complicated or require less blood could improve care for heart failure patients. It would for example mean that they would have to go to hospital less often, that they don’t have to wait long for the results of the test and that their treatment could be adjusted more precisely. Overall, it would make the burden of the disease a little less and it would allow patients to better live the life they want. And this is what the Hartstichting and the Hart&Vaatgroep are working for.","2026-07-28T11:14:26.684Z","2026-07-28T11:14:26.682Z",{"id":7626,"documentId":7627,"name":7628,"alternativeText":18,"caption":18,"focalPoint":18,"width":4513,"height":4514,"formats":7629,"hash":7653,"ext":280,"mime":283,"size":7654,"url":7655,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":7656,"updatedAt":7656,"publishedAt":7656},1406,"kvb7kun28bufo9x2egc3f2u9","floris3.jpg",{"large":7630,"small":7636,"medium":7642,"thumbnail":7648},{"ext":280,"url":7631,"hash":7632,"mime":283,"name":7633,"path":18,"size":7634,"width":190,"height":345,"sizeInBytes":7635},"/uploads/large_floris3_daa468b604.jpg","large_floris3_daa468b604","large_floris3.jpg",53.36,53364,{"ext":280,"url":7637,"hash":7638,"mime":283,"name":7639,"path":18,"size":7640,"width":198,"height":293,"sizeInBytes":7641},"/uploads/small_floris3_daa468b604.jpg","small_floris3_daa468b604","small_floris3.jpg",18.05,18047,{"ext":280,"url":7643,"hash":7644,"mime":283,"name":7645,"path":18,"size":7646,"width":206,"height":198,"sizeInBytes":7647},"/uploads/medium_floris3_daa468b604.jpg","medium_floris3_daa468b604","medium_floris3.jpg",33.71,33711,{"ext":280,"url":7649,"hash":7650,"mime":283,"name":7651,"path":18,"size":4835,"width":306,"height":214,"sizeInBytes":7652},"/uploads/thumbnail_floris3_daa468b604.jpg","thumbnail_floris3_daa468b604","thumbnail_floris3.jpg",6315,"floris3_daa468b604",607.58,"/uploads/floris3_daa468b604.jpg","2026-07-28T11:14:26.668Z",{"id":7658,"documentId":7659,"title":7660,"slug":7661,"date":7662,"cardTitle":18,"excerpt":18,"body":7663,"createdAt":7676,"updatedAt":7676,"publishedAt":7677,"cardImage":7678},344,"xw1hyqqwfbcrdvf541lor9ux","New SensUs 2017 Organization","new-sensus-2017-organization","2016-12-01",[7664,7668,7672],{"type":152,"children":7665},[7666],{"text":7667,"type":156},"Hereby we proudly present to you our new SensUs 2017 organization. After some members of the 2016 organization have left and new members have joined, the new organization is ready to go.",{"type":152,"children":7669},[7670],{"text":7671,"type":156},"We have organized ourselves as follows: Chair, Vice-Chair, Secretary, Treasurer, External relations, and groups focusing on Technology, Event and Media. Our new email addresses can be found in contact.",{"type":152,"children":7673},[7674],{"text":7675,"type":156},"We are very excited to work on SensUs 2017. We are full of new ideas and plans, aiming to make SensUs bigger and better, in order to stimulate education and innovation in the field of biosensing, worldwide.","2026-07-28T11:14:27.346Z","2026-07-28T11:14:27.345Z",{"id":7679,"documentId":7680,"name":7681,"alternativeText":18,"caption":18,"focalPoint":18,"width":937,"height":938,"formats":7682,"hash":7707,"ext":280,"mime":283,"size":7708,"url":7709,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":7710,"updatedAt":7710,"publishedAt":7710},1408,"vuz81eckf7cn3ncrm6jxl8ac","group1-min.jpg",{"large":7683,"small":7689,"medium":7695,"thumbnail":7701},{"ext":280,"url":7684,"hash":7685,"mime":283,"name":7686,"path":18,"size":7687,"width":190,"height":946,"sizeInBytes":7688},"/uploads/large_group1_min_9bb8ea886d.jpg","large_group1_min_9bb8ea886d","large_group1-min.jpg",155.59,155585,{"ext":280,"url":7690,"hash":7691,"mime":283,"name":7692,"path":18,"size":7693,"width":198,"height":352,"sizeInBytes":7694},"/uploads/small_group1_min_9bb8ea886d.jpg","small_group1_min_9bb8ea886d","small_group1-min.jpg",43.23,43231,{"ext":280,"url":7696,"hash":7697,"mime":283,"name":7698,"path":18,"size":7699,"width":206,"height":359,"sizeInBytes":7700},"/uploads/medium_group1_min_9bb8ea886d.jpg","medium_group1_min_9bb8ea886d","medium_group1-min.jpg",92.45,92450,{"ext":280,"url":7702,"hash":7703,"mime":283,"name":7704,"path":18,"size":7705,"width":306,"height":214,"sizeInBytes":7706},"/uploads/thumbnail_group1_min_9bb8ea886d.jpg","thumbnail_group1_min_9bb8ea886d","thumbnail_group1-min.jpg",11.59,11586,"group1_min_9bb8ea886d",2622.92,"/uploads/group1_min_9bb8ea886d.jpg","2026-07-28T11:14:27.343Z",{"id":7712,"documentId":7713,"title":7714,"slug":7715,"date":7716,"cardTitle":18,"excerpt":18,"body":7717,"createdAt":7726,"updatedAt":7726,"publishedAt":7727,"cardImage":7728},345,"wp7ya8ikm87x1ik2ew5my36o","SensUs Promotion Movie","sensus-promotion-movie","2016-10-14",[7718,7722],{"type":152,"children":7719},[7720],{"text":7721,"type":156},"We have made a SensUs promotion movie. The movie shows what SensUs is, with footage of the contest days of 9-10 September 2016, and with quotes of companies, students, and other participants.",{"type":152,"children":7723},[7724],{"text":7725,"type":156},"Enjoy !","2026-07-28T11:14:28.211Z","2026-07-28T11:14:28.210Z",{"id":7729,"documentId":7730,"name":7731,"alternativeText":18,"caption":18,"focalPoint":18,"width":7732,"height":7733,"formats":7734,"hash":7759,"ext":280,"mime":283,"size":7760,"url":7761,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":7762,"updatedAt":7762,"publishedAt":7762},1410,"bwwbbrgz70qbpwwkcyh5rxz7","groupphoto_sky.jpg",4911,7346,{"large":7735,"small":7741,"medium":7747,"thumbnail":7753},{"ext":280,"url":7736,"hash":7737,"mime":283,"name":7738,"path":18,"size":7739,"width":946,"height":190,"sizeInBytes":7740},"/uploads/large_groupphoto_sky_f2d334ca3d.jpg","large_groupphoto_sky_f2d334ca3d","large_groupphoto_sky.jpg",192.95,192951,{"ext":280,"url":7742,"hash":7743,"mime":283,"name":7744,"path":18,"size":7745,"width":352,"height":198,"sizeInBytes":7746},"/uploads/small_groupphoto_sky_f2d334ca3d.jpg","small_groupphoto_sky_f2d334ca3d","small_groupphoto_sky.jpg",53.02,53018,{"ext":280,"url":7748,"hash":7749,"mime":283,"name":7750,"path":18,"size":7751,"width":359,"height":206,"sizeInBytes":7752},"/uploads/medium_groupphoto_sky_f2d334ca3d.jpg","medium_groupphoto_sky_f2d334ca3d","medium_groupphoto_sky.jpg",111,110995,{"ext":280,"url":7754,"hash":7755,"mime":283,"name":7756,"path":18,"size":7757,"width":570,"height":214,"sizeInBytes":7758},"/uploads/thumbnail_groupphoto_sky_f2d334ca3d.jpg","thumbnail_groupphoto_sky_f2d334ca3d","thumbnail_groupphoto_sky.jpg",6.73,6734,"groupphoto_sky_f2d334ca3d",2546.22,"/uploads/groupphoto_sky_f2d334ca3d.jpg","2026-07-28T11:14:28.208Z",{"id":7764,"documentId":7765,"title":7766,"slug":7767,"date":7768,"cardTitle":18,"excerpt":18,"body":7769,"createdAt":7774,"updatedAt":7774,"publishedAt":7775,"cardImage":7776},346,"o06elwl5xhp9vgzupi0pljrv","Official start of the event","official-start-event","2016-09-08",[7770],{"type":152,"children":7771},[7772],{"bold":79,"text":7773,"type":156},"We've had the opening for the five participating teams on campus. Today, we have officially started the SensUs event!","2026-07-28T11:14:28.481Z","2026-07-28T11:14:28.479Z",{"id":7777,"documentId":7778,"name":7779,"alternativeText":18,"caption":18,"focalPoint":18,"width":4622,"height":3886,"formats":7780,"hash":7805,"ext":280,"mime":283,"size":7806,"url":7807,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":7808,"updatedAt":7808,"publishedAt":7809},1412,"fyuxik89h65zyc4z0ayd498u","opening1.jpg",{"large":7781,"small":7787,"medium":7793,"thumbnail":7799},{"ext":280,"url":7782,"hash":7783,"mime":283,"name":7784,"path":18,"size":7785,"width":190,"height":345,"sizeInBytes":7786},"/uploads/large_opening1_4652996d6a.jpg","large_opening1_4652996d6a","large_opening1.jpg",50.71,50705,{"ext":280,"url":7788,"hash":7789,"mime":283,"name":7790,"path":18,"size":7791,"width":198,"height":293,"sizeInBytes":7792},"/uploads/small_opening1_4652996d6a.jpg","small_opening1_4652996d6a","small_opening1.jpg",18.79,18785,{"ext":280,"url":7794,"hash":7795,"mime":283,"name":7796,"path":18,"size":7797,"width":206,"height":198,"sizeInBytes":7798},"/uploads/medium_opening1_4652996d6a.jpg","medium_opening1_4652996d6a","medium_opening1.jpg",33.38,33375,{"ext":280,"url":7800,"hash":7801,"mime":283,"name":7802,"path":18,"size":7803,"width":306,"height":214,"sizeInBytes":7804},"/uploads/thumbnail_opening1_4652996d6a.jpg","thumbnail_opening1_4652996d6a","thumbnail_opening1.jpg",6.28,6280,"opening1_4652996d6a",227.33,"/uploads/opening1_4652996d6a.jpg","2026-07-28T11:14:28.364Z","2026-07-28T11:14:28.365Z",{"id":7811,"documentId":7812,"title":7813,"slug":7814,"date":7815,"cardTitle":18,"excerpt":18,"body":7816,"createdAt":7907,"updatedAt":7907,"publishedAt":7908,"cardImage":7909},347,"z5rnuloz2hcol1m6cfhn5prg","SensUs Interviews: Brenda and Margot","sensus-interviews-brenda-and-margot","2016-08-19",[7817,7821,7825,7831,7837,7841,7846,7851,7855,7860,7865,7869,7874,7879,7883,7888,7893,7897,7902],{"type":152,"children":7818},[7819],{"bold":79,"text":7820,"type":156},"For this edition of SensUs Interviews, we have interviewed Brenda de Coninck and Margot Linden, who are both members of the Dutch Association for Kidney Patients. The goal of SensUs 2016 is to make a biosensor that measures creatinine, which is of great importance for kidney patients. In this interview they explain the great impact that kidney disease has in their lives, and what it would mean for them if they could have a biosensor to monitor their kidney status.",{"type":152,"children":7822},[7823],{"text":7824,"type":156,"italic":79},"Can you tell something about yourself?",{"type":152,"children":7826},[7827,7829],{"text":7828,"type":156,"italic":79},"Brenda:",{"text":7830,"type":156}," \"I am 53 years old and work as a hypnotherapist. I perform volunteer work for the Dutch Association for Kidney Patients and wrote a book entitled 'I am not a car?!' with a series of columns that I wrote for a kidney news internet site. I am a member of the European ADPKD (Autosomal Dominant Polycystic Kidney Disease) patient steering group, and a member of the European ADPKD Forum, which is a group of medical professionals who aim to raise awareness about ADPKD.\"",{"type":152,"children":7832},[7833,7835],{"text":7834,"type":156,"italic":79},"Margot:",{"text":7836,"type":156}," \"I am 48 years old and I had to stop working due to my illness 15 years ago. I have performed volunteer work for the Dutch Association for Kidney Patients for many years, which is enormously rewarding and which compensates for the loss of a normal job. I suffer from a rare form of Nephrotic Syndrome. The disease leads to a strong loss of proteins; this gives low protein levels in the blood and retention of water in soft tissues (edema). Secondary complications are for example high cholesterol levels and risk of thrombosis. \"",{"type":152,"children":7838},[7839],{"text":7840,"type":156,"italic":79},"Can you tell something about your medical condition and how it affects your life(style)?",{"type":152,"children":7842},[7843,7844],{"text":7828,"type":156,"italic":79},{"text":7845,"type":156}," \"I am diagnosed with Autosomal Dominant Polycystic Kidney Disease (ADPKD). This is a genetic disease involving the development of renal cysts. Half of the patients with this disease develop end-stage kidney disease and need dialysis or an organ transplant. My kidneys are enlarged to 18 and 16 cm, filling up my torso from my back to my belly, pushing all other organs aside. Hence, I feel 'full' quite often. I try to eat organic food, with low sodium, low potassium, low protein and low phosphate. I make sure to have a high fluid intake.\"",{"type":152,"children":7847},[7848,7849],{"text":7834,"type":156,"italic":79},{"text":7850,"type":156}," \"My illness has had a huge impact on my life: I lost my job, I am not able to practise active sports, lost my relationship, and the possibility to ever become a mother. My kidney function has gradually declined to a level of about 15%. I am mentally young and vital, but physically I feel like an 80-year-old. Every step back in physical condition requires an enormous adaptive power, because with every step I can do less myself and become more and more dependent on the help of others. I am currently in the middle of investigations to receive a kidney from my mother.\"",{"type":152,"children":7852},[7853],{"text":7854,"type":156,"italic":79},"How could a biosensor be useful for you? Could you have benefit from a biosensor for creatinine?",{"type":152,"children":7856},[7857,7858],{"text":7828,"type":156,"italic":79},{"text":7859,"type":156}," \"I would certainly benefit from a biosensor for creatinine. It would enable me to easily and regularly monitor my kidney function, instead of having to go to the hospital all the time. It would give me a feeling of 'control' too.\"",{"type":152,"children":7861},[7862,7863],{"text":7834,"type":156,"italic":79},{"text":7864,"type":156}," \"This would give several advantages for kidney patients. For patients without a transplant, it would be beneficial to check at home if certain complaints or symptoms arise from a decrease in kidney function or not. For patients with a transplant, it would be an easy way to detect the starting rejection of the transplanted organ. It is cumbersome and very time-consuming to do creatinine testing via the GP and central lab. A biosensor would give less trouble and a quicker result.\"",{"type":152,"children":7866},[7867],{"text":7868,"type":156,"italic":79},"In the field of point-of-care testing and biosensing, what would be on your wish list, or on the wish list of other people that you know of?",{"type":152,"children":7870},[7871,7872],{"text":7828,"type":156,"italic":79},{"text":7873,"type":156}," \"To be able to monitor my potassium level at home.\"",{"type":152,"children":7875},[7876,7877],{"text":7834,"type":156,"italic":79},{"text":7878,"type":156}," \"That it would be simple and easy to do. As simple as present-day glucose testing: one tiny finger prick, one drop of blood on a test strip, and the device shows the result.\"",{"type":152,"children":7880},[7881],{"text":7882,"type":156,"italic":79},"What do you think of the SensUs concept and vision? How are you involved in SensUs?",{"type":152,"children":7884},[7885,7886],{"text":7828,"type":156,"italic":79},{"text":7887,"type":156}," \"It is good to see that young students are making biosensors and are asked to think about translation into products that can make a world of a difference for patients. I am happy that I was asked to be part of the jury at the SensUs competition and to represent the interests of kidney patients.\"",{"type":152,"children":7889},[7890,7891],{"text":7834,"type":156,"italic":79},{"text":7892,"type":156}," \"I like the idea of challenging students to think of technological concepts which could be useful for mankind. I feel honoured and privileged to be asked for de SensUs jury. Unfortunately my physical condition has worsened too much to be able to visit Eindhoven.\"",{"type":152,"children":7894},[7895],{"text":7896,"type":156,"italic":79},"Finally, do you have an advice for the SensUs students and stakeholders?",{"type":152,"children":7898},[7899,7900],{"text":7828,"type":156,"italic":79},{"text":7901,"type":156}," \"Please make biosensors easy to use. I would like to have only an on-off switch and an easy to read display, that's all. What is a normal range? Can the device warn me if my values are too high or too low? Furthermore, is it possible that my nephrologist also gets the results, so that he or she can intervene when it is necessary? \"",{"type":152,"children":7903},[7904,7905],{"text":7834,"type":156,"italic":79},{"text":7906,"type":156}," \"Make sure the biosensor is very practical, as mentioned above. Also make sure that the test is affordable, since many kidney patients receive unemployment benefits only. Preferably the test is reimbursed by the insurance companies, so also involve them in your developments.\"","2026-07-28T11:14:28.617Z","2026-07-28T11:14:28.615Z",{"id":7910,"documentId":7911,"name":7912,"alternativeText":18,"caption":18,"focalPoint":18,"width":1543,"height":595,"formats":7913,"hash":7926,"ext":183,"mime":186,"size":7927,"url":7928,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":7929,"updatedAt":7929,"publishedAt":7929},1416,"bedx1e8zf9s0r4ytusihmhab","Brenda-Margot-small.png",{"small":7914,"thumbnail":7920},{"ext":183,"url":7915,"hash":7916,"mime":186,"name":7917,"path":18,"size":7918,"width":198,"height":1550,"sizeInBytes":7919},"/uploads/small_Brenda_Margot_small_e4418d239d.png","small_Brenda_Margot_small_e4418d239d","small_Brenda-Margot-small.png",255.65,255651,{"ext":183,"url":7921,"hash":7922,"mime":186,"name":7923,"path":18,"size":7924,"width":1557,"height":214,"sizeInBytes":7925},"/uploads/thumbnail_Brenda_Margot_small_e4418d239d.png","thumbnail_Brenda_Margot_small_e4418d239d","thumbnail_Brenda-Margot-small.png",46.39,46387,"Brenda_Margot_small_e4418d239d",132.17,"/uploads/Brenda_Margot_small_e4418d239d.png","2026-07-28T11:14:28.613Z",{"id":7931,"documentId":7932,"title":7933,"slug":7934,"date":7935,"cardTitle":18,"excerpt":18,"body":7936,"createdAt":7989,"updatedAt":7989,"publishedAt":7990,"cardImage":7991},348,"ccvozbv7ufeaamiuypfpwmsh","SensUs Interviews: Jesper Svenning Kristensen","sensus-interviews-jesper-svenning-kristensen","2016-08-13",[7937,7941,7945,7949,7953,7957,7961,7965,7969,7973,7977,7981,7985],{"type":152,"children":7938},[7939],{"bold":79,"text":7940,"type":156},"Medtronic is a large medical technology company and one of our major sponsors. We spoke with Jesper Svenning Kristensen, Principal R&D Engineer, about the long-term developments in the field of biosensing and the role that SensUs can play.",{"type":152,"children":7942},[7943],{"text":7944,"type":156,"italic":79},"Can you tell something about yourself? Who are you and what is your role in Medtronic?",{"type":152,"children":7946},[7947],{"text":7948,"type":156},"\"I have a background in physics and organic chemistry from the University of Aarhus. Since 1991 I have been working in industrial research on sensors and biosensors for medical applications, first as a research chemist at Radiometer Medical doing in vitro electrochemical and biochemical sensors for the ICU segment (ICU=Intensive Care Unit), later in a start-up (PreciSense) where we developed an optical sensor for continuous glucose monitoring for type one diabetes patients. This technology was acquired by Medtronic Diabetes in 2009. My current role in Medtronic is Principal R&D Engineer at the Bakken Research Center in Maastricht working on developing sensors for biochemical parameters that are useful in creating a deeper picture of the condition in heart failure patients.\"",{"type":152,"children":7950},[7951],{"text":7952,"type":156,"italic":79},"How is your company involved in the field of biosensing?",{"type":152,"children":7954},[7955],{"text":7956,"type":156},"\"Medtronic believes in sensing in many of its business fields and acts accordingly. Naturally the most well-known and acknowledged product is the Medtronic Diabetes continuous glucose monitoring system, the Enlite sensor, that builds on the traditional electrochemical glucose oxidase based glucose sensor, but being very advanced using internal sensor diagnostics and algorithms allowing it to partially control the insulin dosage of the insulin pump.\"",{"type":152,"children":7958},[7959],{"text":7960,"type":156,"italic":79},"How do you see the future for biochemical patient monitoring? Which innovations are needed and which long-term developments do you foresee?",{"type":152,"children":7962},[7963],{"text":7964,"type":156},"\"The ability to determine, interpret and act on information obtained from biochemical sensors will be key in future patient care. Whether it being in vitro or in vivo sensing will depend on the need of the patient and the caretakers, whatever creates most value. In order to provide meaningful information, sensor results have to be reliable and hence focus in sensor research should always include repeatability and robustness of the sensing system. Also the need for implantable sensors calls for solution to challenges like sterility, always a huge task to solve.\"",{"type":152,"children":7966},[7967],{"text":7968,"type":156,"italic":79},"Which patient groups will benefit most from developments in biosensing? Can you give examples?",{"type":152,"children":7970},[7971],{"text":7972,"type":156},"\"I think all patients potentially can benefit from biosensors. Look to GPs office, small devices giving fast glucose, HbA1c, cholesterol or other analytical answers in the nick of time; some of those devices are based on biosensing, also disposable OTC pregnancy tests are biosensors (OTC=Over The Counter). To me the entire population benefits already but naturally the diabetic patient population is most likely the single patient group right now benefitting the most. However future sensing devices needs to address the frequency of answers needed in each condition targeted, in order to develop the most suitable device and sensing principle for that particular patient group. One of my key worries is that we sense without looking at the actual need and over-interpret answers and diagnose everybody. There is a risk that we drown ourselves in data overload, hence also data presentation needs to be considered.\"",{"type":152,"children":7974},[7975],{"text":7976,"type":156,"italic":79},"What do you think of the SensUs concept and vision? How is SensUs of interest for Medtronic? What is your motivation for becoming a partner of SensUs?",{"type":152,"children":7978},[7979],{"text":7980,"type":156},"\"The SensUs contest is for me an opportunity to observe groups of students from diverse disciplines collectively solve a task. It is highly likely that the future of these (engineering) students will be working in project groups where compromise is the best solution. When working in the minefield between biology/physiology, chemistry, physics, math and computer science, no discipline can determine everything, hence compromises are needed, and good data and experience will choose where the compromise ends. In Medtronic we are always interested in identifying talent and the SensUs contest lets us get close to talents in five different countries in one go and this has been a great motivation for us.\"",{"type":152,"children":7982},[7983],{"text":7984,"type":156,"italic":79},"Finally, do you have an advice and/or a question for the SensUs students and stakeholders?",{"type":152,"children":7986},[7987],{"text":7988,"type":156},"\"I hope the SensUs contest will continue and expand to more universities. To the students: maintain focus on the overall objective and be constructive when compromises are needed. The good project participant will always be able to see a way forward when problems are faced if the rest of the team is equally flexible. The compromises needed may impact the specifications of the end product, which in some cases may be perfectly OK. Remember that the perfect solution can be the worst enemy of the good solution.\"","2026-07-28T11:14:28.915Z","2026-07-28T11:14:28.914Z",{"id":7992,"documentId":7993,"name":7994,"alternativeText":18,"caption":18,"focalPoint":18,"width":7995,"height":7996,"formats":7997,"hash":8025,"ext":280,"mime":283,"size":8026,"url":8027,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":8028,"updatedAt":8028,"publishedAt":8028},1418,"h3otb6ffg3hld1n1ov0sluym","jesper.jpg",3000,1618,{"large":7998,"small":8005,"medium":8011,"thumbnail":8018},{"ext":280,"url":7999,"hash":8000,"mime":283,"name":8001,"path":18,"size":8002,"width":190,"height":8003,"sizeInBytes":8004},"/uploads/large_jesper_c2fd22c63c.jpg","large_jesper_c2fd22c63c","large_jesper.jpg",31.85,539,31846,{"ext":280,"url":8006,"hash":8007,"mime":283,"name":8008,"path":18,"size":8009,"width":198,"height":1618,"sizeInBytes":8010},"/uploads/small_jesper_c2fd22c63c.jpg","small_jesper_c2fd22c63c","small_jesper.jpg",9.11,9111,{"ext":280,"url":8012,"hash":8013,"mime":283,"name":8014,"path":18,"size":8015,"width":206,"height":8016,"sizeInBytes":8017},"/uploads/medium_jesper_c2fd22c63c.jpg","medium_jesper_c2fd22c63c","medium_jesper.jpg",18.28,405,18282,{"ext":280,"url":8019,"hash":8020,"mime":283,"name":8021,"path":18,"size":8022,"width":144,"height":8023,"sizeInBytes":8024},"/uploads/thumbnail_jesper_c2fd22c63c.jpg","thumbnail_jesper_c2fd22c63c","thumbnail_jesper.jpg",2.99,132,2991,"jesper_c2fd22c63c",230.39,"/uploads/jesper_c2fd22c63c.jpg","2026-07-28T11:14:28.912Z",{"id":8030,"documentId":8031,"title":8032,"slug":8033,"date":8034,"cardTitle":18,"excerpt":18,"body":8035,"createdAt":8057,"updatedAt":8057,"publishedAt":8058,"cardImage":8059},349,"t2hokopa5oa9r6erxitriym1","The start of WikiSensUs: Creatinine!","start-wikisensus-creatinine","2016-07-16",[8036,8040,8051],{"type":152,"children":8037},[8038],{"text":8039,"type":156},"The choice of biomarker is a crucial one for SensUs. For SensUs 2016 we reached out to various experts and eventually decided on creatinine, because of the challenges involved in biosensing technology and the high relevance for kidney disease.",{"type":152,"children":8041},[8042,8044,8049],{"text":8043,"type":156},"As of today we have created ",{"url":8045,"type":236,"children":8046},"https://old.sensus.org/wiki",[8047],{"text":8048,"type":156},"WikiSensUs",{"text":8050,"type":156},"! The purpose of WikiSensUs is to share chemical, medical-biological, and analytical information about the SensUs biomarker. The first entry is this year's biomarker; creatinine. On this new webpage the teams, experts and other stakeholders can find and share information about molecular biomarkers. We aim that the wiki will grow and become a database and roadmap for the field of molecular biosensing. Read WikiSensUs and let us know what you think about it!",{"type":152,"children":8052},[8053],{"url":8045,"type":236,"children":8054},[8055],{"text":8056,"type":156},"Visit WikiSensUs","2026-07-28T11:14:29.161Z","2026-07-28T11:14:29.160Z",{"id":8060,"documentId":8061,"name":8062,"alternativeText":18,"caption":18,"focalPoint":18,"width":8063,"height":8064,"formats":8065,"hash":8090,"ext":280,"mime":283,"size":8091,"url":8092,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":8093,"updatedAt":8093,"publishedAt":8093},1420,"ebyi62e5k080w3yugbia4v3s","Wikipedia_mini_globe_handheld.jpg",4368,2912,{"large":8066,"small":8072,"medium":8078,"thumbnail":8084},{"ext":280,"url":8067,"hash":8068,"mime":283,"name":8069,"path":18,"size":8070,"width":190,"height":345,"sizeInBytes":8071},"/uploads/large_Wikipedia_mini_globe_handheld_5b3bea6690.jpg","large_Wikipedia_mini_globe_handheld_5b3bea6690","large_Wikipedia_mini_globe_handheld.jpg",50.7,50696,{"ext":280,"url":8073,"hash":8074,"mime":283,"name":8075,"path":18,"size":8076,"width":198,"height":293,"sizeInBytes":8077},"/uploads/small_Wikipedia_mini_globe_handheld_5b3bea6690.jpg","small_Wikipedia_mini_globe_handheld_5b3bea6690","small_Wikipedia_mini_globe_handheld.jpg",17.62,17617,{"ext":280,"url":8079,"hash":8080,"mime":283,"name":8081,"path":18,"size":8082,"width":206,"height":198,"sizeInBytes":8083},"/uploads/medium_Wikipedia_mini_globe_handheld_5b3bea6690.jpg","medium_Wikipedia_mini_globe_handheld_5b3bea6690","medium_Wikipedia_mini_globe_handheld.jpg",32.05,32050,{"ext":280,"url":8085,"hash":8086,"mime":283,"name":8087,"path":18,"size":8088,"width":306,"height":214,"sizeInBytes":8089},"/uploads/thumbnail_Wikipedia_mini_globe_handheld_5b3bea6690.jpg","thumbnail_Wikipedia_mini_globe_handheld_5b3bea6690","thumbnail_Wikipedia_mini_globe_handheld.jpg",6.02,6017,"Wikipedia_mini_globe_handheld_5b3bea6690",491.62,"/uploads/Wikipedia_mini_globe_handheld_5b3bea6690.jpg","2026-07-28T11:14:29.158Z",{"id":8095,"documentId":8096,"title":8097,"slug":8098,"date":8099,"cardTitle":18,"excerpt":18,"body":8100,"createdAt":8160,"updatedAt":8160,"publishedAt":8161,"cardImage":8162},350,"pjy4cpezwyc2i7n5zfo0p2fy","SensUs Interviews: Mike Martens","sensus-interviews-mike-martens","2016-07-15",[8101,8105,8109,8113,8116,8120,8124,8128,8132,8136,8140,8144,8148,8152,8156],{"type":152,"children":8102},[8103],{"bold":79,"text":8104,"type":156},"In this edition of SensUs Interviews, we spoke with the managing director of Future Diagnostics, Mike Martens. Future Diagnostics is an assay development company and the first sponsor of SensUs. We spoke with Mike Martens about the future of biosensing and how SensUs can make a difference.",{"type":152,"children":8106},[8107],{"text":8108,"type":156,"italic":79},"Can you tell something about yourself? Who are you and what is your role within Future Diagnostics?",{"type":152,"children":8110},[8111],{"text":8112,"type":156},"\"My name is Mike Martens and I have been managing director of Future Diagnostics for four years now. Before that, I have been the Chief Technology Officer of Future Diagnostics and I was one of the founders of the company. I studied Biomedical Sciences at the University of Amsterdam. Then I moved to the Radboud University, where I performed my PhD research in the lab of the Department of Surgery, which I finished in '91. Thereafter I started working as a scientist in the industry at Nichols Institute Diagnostics, where I developed an EPO immunoassay, which is now used as a doping agent. Within that organization I later became R&D manager. In 1996, the R&D facility in the Netherlands was fully moved to the USA, leaving only a sales organization. At that time, five of my colleagues from that R&D department and I started Future Diagnostics in May '97. Right now, there are 105 employees at Future Diagnostics, of which most joined in the last three years.\"",{"type":152,"children":8114},[8115],{"text":7952,"type":156,"italic":79},{"type":152,"children":8117},[8118],{"text":8119,"type":156},"\"That actually started in 2005 when I met Menno Prins. He approached us and asked whether we could be of help in developing reagents for a new biosensor technology. From that time, we have been involved in the Minicare of Philips that launched their first assay last month.\"",{"type":152,"children":8121},[8122],{"text":8123,"type":156,"italic":79},"Have you had more projects within the biosensing field?",{"type":152,"children":8125},[8126],{"text":8127,"type":156},"\"Yes, we have had other projects concerning different detection technologies. We have done several proofs of concept related to other devices that used innovative technologies for detection, also related to microfluidic devices. We have had two Marie Curie fellows that worked here on a microfluidic device with a Eureka subsidy.\"",{"type":152,"children":8129},[8130],{"text":8131,"type":156,"italic":79},"How do you see the future of biosensing? Which innovations are needed and which long-term developments do you foresee?",{"type":152,"children":8133},[8134],{"text":8135,"type":156},"\"I think within a certain time period – let's say 25 years – everybody will have a device at home to measure a certain condition. Obviously, this would initially only be the case for patients who have had certain treatments or have some type of disease that requires monitoring on a regular basis. This would for example be a device that you could take out of your refrigerator, put a drop of blood in a cartridge, and the results will be sent via WiFi to the doctor that is treating the patient. He or she will consequently ask the patient to come in or not, depending on the result.\"",{"type":152,"children":8137},[8138],{"text":8139,"type":156,"italic":79},"Which patient groups will benefit the most from these developments? Could you give some examples of patient groups?",{"type":152,"children":8141},[8142],{"text":8143,"type":156},"\"Candidates could be patients who have survived cancer, or patients with a cardiovascular disease. Basically everyone of whom you would like to monitor either the progression or recurrence of the disease will benefit from these developments. And with this benefit, I mean the fact that the current logistics that is needed – a blood draw, the waiting for the result et cetera – will disappear. Biosensing should be made so easy that it is goof-proof and that everybody can do it.\"",{"type":152,"children":8145},[8146],{"text":8147,"type":156,"italic":79},"What do you think of the SensUs concept and its vision? What is the interest for Future Diagnostics?",{"type":152,"children":8149},[8150],{"text":8151,"type":156},"\"When I heard of SensUs for the first time, I was very intrigued. It reminded me of competitions that are ongoing in other areas, like the Robocup and the World Solar Challenge. That is a very nice way to involve young students with a lot of ideas, focused on a certain area. I think it will generate new ideas from which the industry can learn. Hence we were very interested in sponsoring the event, because as a company we are innovative and we want to know what is happening in the world of biosensing. Consequently, we as Future Diagnostics want to be positioned so that we can do something with the new ideas that will be generated.\"",{"type":152,"children":8153},[8154],{"text":8155,"type":156,"italic":79},"Do you have an advice or a question for SensUs students and stakeholders?",{"type":152,"children":8157},[8158],{"text":8159,"type":156},"\"I am very much looking forward to the results and I really like the initiative. On paper, it may seem like a very simple thing to do, but in practice it takes a lot of perseverance to build a working biosensor. SensUs can be a very good way to make the young generation come up with new ideas and technologies. I think that students may have completely different views than companies. Students are usually very open and their thinking is not limited to already established ideas. They can stimulate each other to go to high levels and may generate new insights. Therefore, I am very much looking forward to the public event on the 10th of September and to the discussions with the student teams!\"","2026-07-28T11:14:29.242Z","2026-07-28T11:14:29.241Z",{"id":8163,"documentId":8164,"name":8165,"alternativeText":18,"caption":18,"focalPoint":18,"width":180,"height":8166,"formats":8167,"hash":8195,"ext":280,"mime":283,"size":8196,"url":8197,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":8198,"updatedAt":8198,"publishedAt":8198},1422,"kh84xk7dxoeksd1l5k4sthwv","mike.jpg",894,{"large":8168,"small":8175,"medium":8182,"thumbnail":8188},{"ext":280,"url":8169,"hash":8170,"mime":283,"name":8171,"path":18,"size":8172,"width":190,"height":8173,"sizeInBytes":8174},"/uploads/large_mike_65c5d377c2.jpg","large_mike_65c5d377c2","large_mike.jpg",34.56,447,34561,{"ext":280,"url":8176,"hash":8177,"mime":283,"name":8178,"path":18,"size":8179,"width":198,"height":8180,"sizeInBytes":8181},"/uploads/small_mike_65c5d377c2.jpg","small_mike_65c5d377c2","small_mike.jpg",10.12,224,10120,{"ext":280,"url":8183,"hash":8184,"mime":283,"name":8185,"path":18,"size":8186,"width":206,"height":7042,"sizeInBytes":8187},"/uploads/medium_mike_65c5d377c2.jpg","medium_mike_65c5d377c2","medium_mike.jpg",20.52,20519,{"ext":280,"url":8189,"hash":8190,"mime":283,"name":8191,"path":18,"size":8192,"width":144,"height":8193,"sizeInBytes":8194},"/uploads/thumbnail_mike_65c5d377c2.jpg","thumbnail_mike_65c5d377c2","thumbnail_mike.jpg",3.34,109,3340,"mike_65c5d377c2",104.88,"/uploads/mike_65c5d377c2.jpg","2026-07-28T11:14:29.239Z",{"id":8200,"documentId":8201,"title":8202,"slug":8203,"date":8204,"cardTitle":18,"excerpt":18,"body":8205,"createdAt":8271,"updatedAt":8271,"publishedAt":8272,"cardImage":8273},351,"f7hrgrfksg33gxz7ki632uk7","SensUs Interviews: Jeroen Nieuwenhuis","sensus-interviews-jeroen-nieuwenhuis","2016-07-08",[8206,8210,8214,8218,8221,8225,8229,8233,8237,8241,8244,8248,8252,8256,8260,8264,8267],{"type":152,"children":8207},[8208],{"bold":79,"text":8209,"type":156},"As one of our first and largest sponsors we proudly present our partner Philips in this edition of SensUs Interviews. We spoke with Jeroen Nieuwenhuis who is the head of the research and development organisation of Philips Handheld Diagnostics and one of the jury members of SensUs 2016.",{"type":152,"children":8211},[8212],{"text":8213,"type":156,"italic":79},"Can you tell something about yourself? Who are you and what is your role in Philips Handheld Diagnostics?",{"type":152,"children":8215},[8216],{"text":8217,"type":156},"\"I obtained a MSc in electrical engineering from the Delft University of Technology and during my PhD studies I developed a lab-on-a-chip device at the Vienna University of Technology. After spending some time in R&D roles in the US I joined Philips Research in 2005 to work on magnetic biosensors. Since 2009 I have worked at Philips Handheld Diagnostics where I current head the R&D organization.\"",{"type":152,"children":8219},[8220],{"text":7952,"type":156,"italic":79},{"type":152,"children":8222},[8223],{"text":8224,"type":156},"\"At Philips Handheld Diagnostics we have developed a point-of-care immunoassay platform called the Minicare I-20 for which we have developed the Minicare cTnI test as an aid in the diagnosis of acute coronary syndrome. Currently we are working on adding more tests to the menu. In other departments in Philips we are working on additional point-of-care biosensor modalities such as hematology and molecular diagnostics.\"",{"type":152,"children":8226},[8227],{"text":8228,"type":156,"italic":79},"How do you see the future for point-of-care testing and biochemical patient monitoring? Which innovations are needed and which long-term developments do you foresee?",{"type":152,"children":8230},[8231],{"text":8232,"type":156},"\"Point-of-care test testing will become easier to use, enabling non-professional operators to use these devices not only for diagnosis but increasingly for prevention and monitoring of disease state as well. For certain applications continuous monitoring may even be desirable; innovations will be needed in the long-term stability of these sensors.\"",{"type":152,"children":8234},[8235],{"text":8236,"type":156,"italic":79},"Which patient groups will benefit most from developments in molecular biosensing?",{"type":152,"children":8238},[8239],{"text":8240,"type":156},"\"With aging populations and increased life expectancies in many countries the prevalence of chronic disease will increase; unless we find more cost-effective solutions to manage these diseases, healthcare systems will struggle to cope with these patient groups. An example of such a disease state would be chronic heart failure, where the patient could measure BNP, creatinine and potassium to manage his/her health state.\"",{"type":152,"children":8242},[8243],{"text":5561,"type":156,"italic":79},{"type":152,"children":8245},[8246],{"text":8247,"type":156},"\"In-vitro diagnostic measurements play a major role in clinical decision making; it is important to stimulate innovation to develop better biosensors capable of identifying potential health risks at an earlier state such that these can be treated before they become severe.\"",{"type":152,"children":8249},[8250],{"text":8251,"type":156,"italic":79},"How is SensUs of interest for Philips Handheld Diagnostics?",{"type":152,"children":8253},[8254],{"text":8255,"type":156},"\"Innovative diagnostics solutions are at the heart of what we do at Philips Handheld Diagnostics. We support SensUs because it raises interest in the field of innovative diagnostics and inspires students to join this rewarding field.\"",{"type":152,"children":8257},[8258],{"text":8259,"type":156,"italic":79},"How are you involved in SensUs 2016?",{"type":152,"children":8261},[8262],{"text":8263,"type":156},"\"As Philips we sponsor the SensUs 2016 competition and personally I will be a jury member.\"",{"type":152,"children":8265},[8266],{"text":7896,"type":156,"italic":79},{"type":152,"children":8268},[8269],{"text":8270,"type":156},"\"Developing a good biosensor is a multi-disciplinary team effort; embrace diversity to form successful teams.\"","2026-07-28T11:14:29.370Z","2026-07-28T11:14:29.369Z",{"id":8274,"documentId":8275,"name":8276,"alternativeText":18,"caption":18,"focalPoint":18,"width":180,"height":8277,"formats":8278,"hash":8302,"ext":280,"mime":283,"size":8303,"url":8304,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":8305,"updatedAt":8305,"publishedAt":8305},1424,"isakv0mtk1ek6wnbnmr5gwq7","jeroennieuwenhuis.jpg",1187,{"large":8279,"small":8285,"medium":8291,"thumbnail":8296},{"ext":280,"url":8280,"hash":8281,"mime":283,"name":8282,"path":18,"size":8283,"width":190,"height":5876,"sizeInBytes":8284},"/uploads/large_jeroennieuwenhuis_eb58d45158.jpg","large_jeroennieuwenhuis_eb58d45158","large_jeroennieuwenhuis.jpg",54.05,54050,{"ext":280,"url":8286,"hash":8287,"mime":283,"name":8288,"path":18,"size":8289,"width":198,"height":3918,"sizeInBytes":8290},"/uploads/small_jeroennieuwenhuis_eb58d45158.jpg","small_jeroennieuwenhuis_eb58d45158","small_jeroennieuwenhuis.jpg",17.06,17064,{"ext":280,"url":8292,"hash":8293,"mime":283,"name":8294,"path":18,"size":4640,"width":206,"height":8295,"sizeInBytes":4641},"/uploads/medium_jeroennieuwenhuis_eb58d45158.jpg","medium_jeroennieuwenhuis_eb58d45158","medium_jeroennieuwenhuis.jpg",445,{"ext":280,"url":8297,"hash":8298,"mime":283,"name":8299,"path":18,"size":5126,"width":144,"height":8300,"sizeInBytes":8301},"/uploads/thumbnail_jeroennieuwenhuis_eb58d45158.jpg","thumbnail_jeroennieuwenhuis_eb58d45158","thumbnail_jeroennieuwenhuis.jpg",145,5965,"jeroennieuwenhuis_eb58d45158",169.21,"/uploads/jeroennieuwenhuis_eb58d45158.jpg","2026-07-28T11:14:29.367Z",{"id":8307,"documentId":8308,"title":8309,"slug":8310,"date":8311,"cardTitle":18,"excerpt":18,"body":8312,"createdAt":8329,"updatedAt":8329,"publishedAt":8330,"cardImage":8331},352,"dcmbosfb4t1uh4so4cychev3","SensUs team update: T.E.S.T.","sensus-team-update-test","2016-06-16",[8313,8317,8321,8325],{"type":152,"children":8314},[8315],{"bold":79,"text":8316,"type":156},"This is the fifth edition of a series of updates from the SensUs student teams. In this series, the teams summarize what they have been doing recently. This week is the update from T.E.S.T., the TU/e SensUs Team.",{"type":152,"children":8318},[8319],{"text":8320,"type":156},"TU/e SensUs Team (T.E.S.T.) worked hard to test the two concepts they found and all the different facets of the biosensor. After months of hard work on both concepts, one concept has been chosen.",{"type":152,"children":8322},[8323],{"text":8324,"type":156},"For now we've decided upon a system that uses optical detection to determine the concentration of creatinine in blood plasma. We have already seen that this system shows a measurable response to creatinine, although not in the right concentration range yet.",{"type":152,"children":8326},[8327],{"text":8328,"type":156},"In the coming period we will focus on implementing the system into an easy to use device, optimizing the sensitivity of the system and general optimization. With only two-and-a-half months to go, we know this is going to be a challenge. However, we are confident that we will present a working biosensor during the competition days in September.","2026-07-28T11:14:29.555Z","2026-07-28T11:14:29.554Z",{"id":8332,"documentId":8333,"name":8334,"alternativeText":18,"caption":18,"focalPoint":18,"width":8335,"height":5383,"formats":8336,"hash":8362,"ext":280,"mime":283,"size":8363,"url":8364,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":8365,"updatedAt":8365,"publishedAt":8366},1426,"u22wsltstwfbthob7yn9ythl","eindhoven3_0.jpg",2843,{"large":8337,"small":8344,"medium":8350,"thumbnail":8356},{"ext":280,"url":8338,"hash":8339,"mime":283,"name":8340,"path":18,"size":8341,"width":190,"height":8342,"sizeInBytes":8343},"/uploads/large_eindhoven3_0_d05f5aa2ff.jpg","large_eindhoven3_0_d05f5aa2ff","large_eindhoven3_0.jpg",97.3,468,97303,{"ext":280,"url":8345,"hash":8346,"mime":283,"name":8347,"path":18,"size":8348,"width":198,"height":306,"sizeInBytes":8349},"/uploads/small_eindhoven3_0_d05f5aa2ff.jpg","small_eindhoven3_0_d05f5aa2ff","small_eindhoven3_0.jpg",29.84,29839,{"ext":280,"url":8351,"hash":8352,"mime":283,"name":8353,"path":18,"size":8354,"width":206,"height":8200,"sizeInBytes":8355},"/uploads/medium_eindhoven3_0_d05f5aa2ff.jpg","medium_eindhoven3_0_d05f5aa2ff","medium_eindhoven3_0.jpg",59.03,59026,{"ext":280,"url":8357,"hash":8358,"mime":283,"name":8359,"path":18,"size":8360,"width":144,"height":1383,"sizeInBytes":8361},"/uploads/thumbnail_eindhoven3_0_d05f5aa2ff.jpg","thumbnail_eindhoven3_0_d05f5aa2ff","thumbnail_eindhoven3_0.jpg",9.47,9468,"eindhoven3_0_d05f5aa2ff",534.52,"/uploads/eindhoven3_0_d05f5aa2ff.jpg","2026-07-28T11:14:29.534Z","2026-07-28T11:14:29.535Z",{"id":1376,"documentId":8368,"title":8369,"slug":8370,"date":8371,"cardTitle":18,"excerpt":18,"body":8372,"createdAt":8381,"updatedAt":8381,"publishedAt":8382,"cardImage":8383},"lhip6yggqvx5zy5jx5x32o1p","SensUs at Dutch Technology Week","sensus-dutch-technology-week","2016-06-09",[8373,8377],{"type":152,"children":8374},[8375],{"text":8376,"type":156},"On Saturday 28th of May, the High Tech Discovery Route Hotspot ASML/MMC of the Dutch Technology Week took place at the ASML Plaza. ASML is an international technology company and MMC is a large medical center. Around 3000 visitors experienced the future possibilities of healthcare and technology.",{"type":152,"children":8378},[8379],{"text":8380,"type":156},"We were present at the event with our own stand, talking to people about biosensors and about our new student competition.","2026-07-28T11:14:29.823Z","2026-07-28T11:14:29.820Z",{"id":8384,"documentId":8385,"name":8386,"alternativeText":18,"caption":18,"focalPoint":18,"width":180,"height":8387,"formats":8388,"hash":8413,"ext":941,"mime":283,"size":8414,"url":8415,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":8416,"updatedAt":8416,"publishedAt":8416},1428,"l4iofckdqinxhd35bh2bn7ri","dtw2.JPG",1333,{"large":8389,"small":8395,"medium":8401,"thumbnail":8407},{"ext":941,"url":8390,"hash":8391,"mime":283,"name":8392,"path":18,"size":8393,"width":190,"height":345,"sizeInBytes":8394},"/uploads/large_dtw2_e0e71d7bb9.JPG","large_dtw2_e0e71d7bb9","large_dtw2.JPG",100.73,100733,{"ext":941,"url":8396,"hash":8397,"mime":283,"name":8398,"path":18,"size":8399,"width":198,"height":293,"sizeInBytes":8400},"/uploads/small_dtw2_e0e71d7bb9.JPG","small_dtw2_e0e71d7bb9","small_dtw2.JPG",33.74,33739,{"ext":941,"url":8402,"hash":8403,"mime":283,"name":8404,"path":18,"size":8405,"width":206,"height":198,"sizeInBytes":8406},"/uploads/medium_dtw2_e0e71d7bb9.JPG","medium_dtw2_e0e71d7bb9","medium_dtw2.JPG",64.53,64529,{"ext":941,"url":8408,"hash":8409,"mime":283,"name":8410,"path":18,"size":8411,"width":306,"height":214,"sizeInBytes":8412},"/uploads/thumbnail_dtw2_e0e71d7bb9.JPG","thumbnail_dtw2_e0e71d7bb9","thumbnail_dtw2.JPG",10.06,10059,"dtw2_e0e71d7bb9",279.55,"/uploads/dtw2_e0e71d7bb9.JPG","2026-07-28T11:14:29.687Z",{"id":197,"documentId":8418,"title":8419,"slug":8420,"date":8421,"cardTitle":18,"excerpt":18,"body":8422,"createdAt":8451,"updatedAt":8451,"publishedAt":8452,"cardImage":8453},"an54v6kzsyi0c8fc3xelglxc","SensUs team update: Creative9","sensus-team-update-creative9","2016-05-17",[8423,8427,8431,8435,8439,8443,8447],{"type":152,"children":8424},[8425],{"bold":79,"text":8426,"type":156},"This is the fourth edition of a series of updates from the SensUs student teams. In this series, the teams summarize what they have been doing, recently. This week is the update from the Creative9, the Copenhagen SensUs Student Team:",{"type":152,"children":8428},[8429],{"text":8430,"type":156},"During this month, we have been spending a lot of time in the lab, as well as in meetings, to keep ourselves updated of every thing that was going on experimentally.",{"type":152,"children":8432},[8433],{"text":8434,"type":156},"The molecular biology team has synthesized the first imprinted (MIPs) and non imprinted (NIPs) polymers. Some variables as the kind of organic solvent used and the polymerization time have been tested. After obtaining the first polymer particles, a more optimal protcol with the variables that, so far, worked better, has been elaborated. These particles are meant to be embedded to the electrode, once this has been coated with a light-sensitive polymer.",{"type":152,"children":8436},[8437],{"text":8438,"type":156},"The physics team has measured the impedance of the blood plasma using the micrux interdigitated electrodes using a 3 electrode setup. On visual inspection, the results looked similar to the ones obtained in the experiment carried on by Pradhan, R. et al. (2012). Next, the team wants try out the MIPs as well as anti-creatinine antibodies. In parallel, the physics team started reading about the Jaffe method to see if we can use it as an alternative.",{"type":152,"children":8440},[8441],{"text":8442,"type":156},"Currently, the team is looking forward to see how the MIP-based sensor performs once the electrodes are functionalized, and also how the second sensor is going to finally be built.",{"type":152,"children":8444},[8445],{"text":8446,"type":156},"Best regards,",{"type":152,"children":8448},[8449],{"text":8450,"type":156},"Creative9, the Copenhagen SensUs Student Team","2026-07-28T11:14:30.078Z","2026-07-28T11:14:30.077Z",{"id":8454,"documentId":8455,"name":8456,"alternativeText":18,"caption":18,"focalPoint":18,"width":4514,"height":8457,"formats":8458,"hash":8483,"ext":280,"mime":283,"size":8484,"url":8485,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":8486,"updatedAt":8486,"publishedAt":8486},1432,"jw7mtnnaxxsgawj0qwhx19um","dtu.jpg",2160,{"large":8459,"small":8465,"medium":8471,"thumbnail":8477},{"ext":280,"url":8460,"hash":8461,"mime":283,"name":8462,"path":18,"size":8463,"width":190,"height":661,"sizeInBytes":8464},"/uploads/large_dtu_7ef0ab6f9b.jpg","large_dtu_7ef0ab6f9b","large_dtu.jpg",59.16,59160,{"ext":280,"url":8466,"hash":8467,"mime":283,"name":8468,"path":18,"size":8469,"width":198,"height":2557,"sizeInBytes":8470},"/uploads/small_dtu_7ef0ab6f9b.jpg","small_dtu_7ef0ab6f9b","small_dtu.jpg",19.19,19191,{"ext":280,"url":8472,"hash":8473,"mime":283,"name":8474,"path":18,"size":8475,"width":206,"height":2863,"sizeInBytes":8476},"/uploads/medium_dtu_7ef0ab6f9b.jpg","medium_dtu_7ef0ab6f9b","medium_dtu.jpg",36.02,36015,{"ext":280,"url":8478,"hash":8479,"mime":283,"name":8480,"path":18,"size":8481,"width":144,"height":2870,"sizeInBytes":8482},"/uploads/thumbnail_dtu_7ef0ab6f9b.jpg","thumbnail_dtu_7ef0ab6f9b","thumbnail_dtu.jpg",6.41,6409,"dtu_7ef0ab6f9b",794.19,"/uploads/dtu_7ef0ab6f9b.jpg","2026-07-28T11:14:30.075Z",{"id":8488,"documentId":8489,"title":8490,"slug":8491,"date":8492,"cardTitle":8493,"excerpt":18,"body":8494,"createdAt":8511,"updatedAt":8511,"publishedAt":8512,"cardImage":8513},355,"fdsifr2gw7zgkvhibuwfw0pz","Dream & Dare: TU/e's 60th year anniversary","tues-60th-year-anniversary","2016-04-26","TU/e's 60th year anniversary",[8495,8499,8503,8507],{"type":152,"children":8496},[8497],{"text":8498,"type":156},"Last weekend the Technical University of Eindhoven celebrated her 60th anniversary. On Saturday, the festival day, artists entertained the visitors till midnight, but Sunday was a day for the whole family. On this day the SensUs organization arranged an activity in the Kids Science Lab. Children could make their own 'biosensor'; test different fluids on acidity with pH detection and visitors could indicate for which purpose they would like to have a biosensor.",{"type":152,"children":8500},[8501],{"text":8502,"type":156},"We did a special demonstration called 'the rainbow connection'.",{"type":152,"children":8504},[8505],{"text":8506,"type":156},"Also, Anne de Dreu represented SensUs at TU/e Talks. Here she gave a talk about biosensors, the future of health care, and the concept of SensUs.",{"type":152,"children":8508},[8509],{"text":8510,"type":156},"A lot of (young) people learned about biosensors and the first edition of SensUs Student Competition. On top of that, the SensUs organization had fun as well ツ.","2026-07-28T11:14:30.270Z","2026-07-28T11:14:30.268Z",{"id":8514,"documentId":8515,"name":8516,"alternativeText":18,"caption":18,"focalPoint":18,"width":180,"height":8387,"formats":8517,"hash":8542,"ext":280,"mime":283,"size":8543,"url":8544,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":8545,"updatedAt":8545,"publishedAt":8545},1434,"qt63bre7gfphn9vlmu5p1u5g","ddheader.jpg",{"large":8518,"small":8524,"medium":8530,"thumbnail":8536},{"ext":280,"url":8519,"hash":8520,"mime":283,"name":8521,"path":18,"size":8522,"width":190,"height":345,"sizeInBytes":8523},"/uploads/large_ddheader_b46a6a6de8.jpg","large_ddheader_b46a6a6de8","large_ddheader.jpg",102.82,102822,{"ext":280,"url":8525,"hash":8526,"mime":283,"name":8527,"path":18,"size":8528,"width":198,"height":293,"sizeInBytes":8529},"/uploads/small_ddheader_b46a6a6de8.jpg","small_ddheader_b46a6a6de8","small_ddheader.jpg",36.12,36120,{"ext":280,"url":8531,"hash":8532,"mime":283,"name":8533,"path":18,"size":8534,"width":206,"height":198,"sizeInBytes":8535},"/uploads/medium_ddheader_b46a6a6de8.jpg","medium_ddheader_b46a6a6de8","medium_ddheader.jpg",67.29,67292,{"ext":280,"url":8537,"hash":8538,"mime":283,"name":8539,"path":18,"size":8540,"width":306,"height":214,"sizeInBytes":8541},"/uploads/thumbnail_ddheader_b46a6a6de8.jpg","thumbnail_ddheader_b46a6a6de8","thumbnail_ddheader.jpg",11.12,11115,"ddheader_b46a6a6de8",281.01,"/uploads/ddheader_b46a6a6de8.jpg","2026-07-28T11:14:30.205Z",{"id":8547,"documentId":8548,"title":8549,"slug":8550,"date":8551,"cardTitle":18,"excerpt":18,"body":8552,"createdAt":8597,"updatedAt":8597,"publishedAt":8598,"cardImage":8599},356,"ukbprny0fyxmfba5gcvwmzbz","SensUs team update: SensUpp","sensus-team-update-sensupp","2016-04-19",[8553,8557,8561,8565,8569,8573,8577,8581,8585,8589,8593],{"type":152,"children":8554},[8555],{"bold":79,"text":8556,"type":156},"This is the third edition of a series of updates from the SensUs student teams. In this series, the teams summarize what they have been doing, recently. This week is the update from the SensUpp - Uppsala SensUs team:",{"type":152,"children":8558},[8559],{"text":8560,"type":156},"The SensUpp - Uppsala SensUs team is very happy to share the news and developments from the first three months of the competition.",{"type":152,"children":8562},[8563],{"text":8564,"type":156},"Our first goal was to make a comprehensive literature search and with that, understand how the current biomedical devices that measure creatinine work, thus finding where improvement is needed.",{"type":152,"children":8566},[8567],{"text":8568,"type":156},"The team came across many bureaucratic problems, such as creating a legal student organization to open a bank account, finding an insurance for us to work in the laboratory and finding a laboratory to work in, but luckily we are a group of motivated students, we managed to get all the work done by splitting up in groups. We would like to acknowledge Prof. Helena Danielson for the immense help in regard to the insurance and the search for a laboratory!",{"type":152,"children":8570},[8571],{"text":8572,"type":156},"The team also had the chance to participate in a science fair, called SciFest, that occurred in Uppsala in the beginning of March. In SciFest we presented our SensUs project to the public, that consisted of primary and high school students, their parents and surprisingly many researchers and entrepreneurs that were visiting the fair. SciFest allowed us to make some interesting contacts and promote awareness of kidney disease.",{"type":152,"children":8574},[8575],{"text":8576,"type":156},"After these first three months, the team decided that it was time to decide which technology we are using. By the beginning of March, we had two research groups within Uppsala University that were willing to help us with microfluidics (Professor Klas Hjort) and solid state electronics (Professor Zhen Zhang), two essential areas of expertise that are necessary for the development of a biosensor.",{"type":152,"children":8578},[8579],{"text":8580,"type":156},"The microfluidic will be a crucial piece of our biosensor that will allow the transport of the plasma into the sensor and enable a dilution step if necessary. The group of Zhen will allow the design of innovative electrodes to detect signals generated from enzymes or molecular imprinted polymers (MIPs), which are the sensing technologies that we will use. Enzymes and MIPs will interact directly with the creatinine molecule and produce a signal that will be read by the electrodes. In addition to this, we also received assistance from the chemistry department from which Professor Helena Danielson belongs.",{"type":152,"children":8582},[8583],{"text":8584,"type":156},"The MIPs are extensively described in the literature, and may be a feasible and innovative way to measure creatinine. The development of the MIPs will originate from a partnership of the SensUpp with a visiting professor in Uppsala University, Ian Nichols. For that reason, as mentioned above, we will start with both sensing technologies: MIPs and enzymes, deciding later for one of them, depending on the sensitivity and specificity of each method.",{"type":152,"children":8586},[8587],{"text":8588,"type":156},"The team is very excited for the next developments, stay tuned to our Facebook page and contact us for support or more information!",{"type":152,"children":8590},[8591],{"text":8592,"type":156},"Sincerely,",{"type":152,"children":8594},[8595],{"text":8596,"type":156},"SensUpp - the Uppsala University SensUs team.","2026-07-28T11:14:31.455Z","2026-07-28T11:14:31.454Z",{"id":8600,"documentId":8601,"name":8602,"alternativeText":18,"caption":18,"focalPoint":18,"width":1543,"height":595,"formats":8603,"hash":8616,"ext":183,"mime":186,"size":8617,"url":8618,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":8619,"updatedAt":8619,"publishedAt":8620},1438,"a7ecrxev6pbmboebxapf42fp","Untitled-5.png",{"small":8604,"thumbnail":8610},{"ext":183,"url":8605,"hash":8606,"mime":186,"name":8607,"path":18,"size":8608,"width":198,"height":1550,"sizeInBytes":8609},"/uploads/small_Untitled_5_0e6f874ddb.png","small_Untitled_5_0e6f874ddb","small_Untitled-5.png",482.87,482866,{"ext":183,"url":8611,"hash":8612,"mime":186,"name":8613,"path":18,"size":8614,"width":1557,"height":214,"sizeInBytes":8615},"/uploads/thumbnail_Untitled_5_0e6f874ddb.png","thumbnail_Untitled_5_0e6f874ddb","thumbnail_Untitled-5.png",74.88,74879,"Untitled_5_0e6f874ddb",241.6,"/uploads/Untitled_5_0e6f874ddb.png","2026-07-28T11:14:31.452Z","2026-07-28T11:14:31.453Z",{"id":8622,"documentId":8623,"title":8624,"slug":8625,"date":8626,"cardTitle":18,"excerpt":18,"body":8627,"createdAt":8707,"updatedAt":8707,"publishedAt":8708,"cardImage":8709},357,"iumkd2dybpf8cpdzdem69iva","SensUs Interviews: Tom Oostrom","sensus-interviews-tom-oostrom","2016-04-08",[8628,8632,8636,8640,8644,8648,8652,8656,8660,8664,8668,8671,8675,8679,8683,8687,8691,8695,8699,8703],{"type":152,"children":8629},[8630],{"bold":79,"text":8631,"type":156},"Recently we had the honour to welcome the Dutch Kidney Foundation (DKF) as an affiliate of SensUs. For this edition of SensUs Interviews we speak with Tom Oostrom. He is the managing director of the DKF and the newest member of our committee of recommendation. His answers introduce the DKF and give insight in the applications of the future creatinine sensors.",{"type":152,"children":8633},[8634],{"text":8635,"type":156,"italic":79},"Can you tell something about yourself, and about your role as director of the Kidney Foundation?",{"type":152,"children":8637},[8638],{"text":8639,"type":156},"I started my career as a nurse, later I studied health management and policy. I worked in different organizations and positions as policy advisor and management consultant. From 2005 I work for the DKF, and now as the director. Being a director is the best job I have ever had.",{"type":152,"children":8641},[8642],{"text":8643,"type":156},"The DKF is independent of the government and has to arrange for its own income. This creates a dynamic environment with highly motivated employees. We are the third largest health foundation of the Netherlands with a turnover of 20 million euros in 2015. The money raised through collecting door to door was 3,5 million euros last year. We receive a lot of money from estates (6 million last year), financial donors (6 million), major donors, events and we are sponsored by the Vriendenloterij and the Lotto.",{"type":152,"children":8645},[8646],{"text":8647,"type":156},"The money is spent on research and non-research activities, e.g. in the field of kidney failure and prevention. How can we detect a kidney failure as soon as possible? The salt campaign is an element of this program. Furthermore, we strive for more organ donations, and there is a travel program that enables dialysis patients to go on holiday.",{"type":152,"children":8649},[8650],{"text":8651,"type":156},"My goal as the director of the Kidney Foundation is to make sure that the organisation runs smoothly. I have many conversations with partners, funds, insurance companies, etc. We try to stimulate collaborations on important topics, such as the portable artificial kidney.",{"type":152,"children":8653},[8654],{"text":8655,"type":156,"italic":79},"How does the Kidney Foundation stimulate innovation?",{"type":152,"children":8657},[8658],{"text":8659,"type":156},"We find it important that research results lead to tangible benefits for the patients. This requires that research results are translated into prototypes and products, which requires the involvement of companies for example. We try to stimulate such translation and collaboration.",{"type":152,"children":8661},[8662],{"text":8663,"type":156,"italic":79},"What is your view on the role of patients in innovation?",{"type":152,"children":8665},[8666],{"text":8667,"type":156},"There are three levels of innovation: Technological innovation, social innovation (relating to the behaviour of patients and health professionals), and healthcare innovation (relating to the overall healthcare system). We think that patients should already be involved in the early stages of research. Take the example of the portable artificial kidney. First we focused on a device that patients could carry 24 hours per day. After some time we asked patients what they thought about the concept and their responses were not all positive. They answered that they did not want to carry a machine for 24 hours per day. They did not want to be constantly reminded of the device. They preferred a device that they could connect to when they wanted. Therefore, we decided to develop a device that could be placed on a bedside table. This also relieved an important technical problem, because it is extremely difficult to achieve 24 hour blood vessel access. This example shows that involving patients at an early stage can accelerate innovation. We were actually late, because we had been working for some time on a concept that the patients did not like.",{"type":152,"children":8669},[8670],{"text":5561,"type":156,"italic":79},{"type":152,"children":8672},[8673],{"text":8674,"type":156},"We definitely see the added value of pocket biosensors and in-vivo sensors. Early detection is very important. Furthermore, the concept of having a competition is fantastic. A few years ago we participated in a Battle of the Universities where student teams where challenged for only 24 hours, but even in such a short time they came up with surprising results.",{"type":152,"children":8676},[8677],{"text":8678,"type":156,"italic":79},"Do you see a future for point-of-care testing and biochemical patient monitoring in the field of kidney disease?",{"type":152,"children":8680},[8681],{"text":8682,"type":156},"Point-of-care testing is important for early detection, disease self-management, and personalized healthcare. Albumin and creatinine testing can assist in early detection of kidney failure. An albumin test helps the GP to refer patients to a specialist. Creatinine testing is important to determine if medication can be safely taken.",{"type":152,"children":8684},[8685],{"text":8686,"type":156},"Patients with kidney failure have a badly regulated water and electrolyte balance. Such patients are on a diet with minimal potassium and sodium intake. With a sodium and potassium measurement, immediate feedback can be given on the diet, so that they can better manage their own disease.",{"type":152,"children":8688},[8689],{"text":8690,"type":156},"Finally, in-vivo sensing is very important for patients with chronic kidney failure. Every patient is different. With biosensors one could personalize the treatment and maximize treatment effectiveness.",{"type":152,"children":8692},[8693],{"text":8694,"type":156,"italic":79},"How might patients benefit from a creatinine biosensor in the future?",{"type":152,"children":8696},[8697],{"text":8698,"type":156},"A patient on dialysis costs around 90 000 euros annually, so preventing dialysis saves an incredible amount of money. Early detection and the personalization of treatment may delay the need for dialysis or organ transplantation, or may even prevent it. Dialysis has an enormous impact on the lives of our patients, so there is a large potential to enhance the quality of life of patients.",{"type":152,"children":8700},[8701],{"text":8702,"type":156,"italic":79},"Do you have an advice and/or a question for the SensUs students and stakeholders?",{"type":152,"children":8704},[8705],{"text":8706,"type":156},"General Practitioners will prefer a sensor that measures more than creatinine. The sensing systems must be a relief for doctors and patients. So carefully analyse how your sensor concepts can have the biggest impact in the healthcare system.","2026-07-28T11:14:32.254Z","2026-07-28T11:14:32.253Z",{"id":8710,"documentId":8711,"name":8712,"alternativeText":18,"caption":18,"focalPoint":18,"width":1543,"height":595,"formats":8713,"hash":8726,"ext":183,"mime":186,"size":8727,"url":8728,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":8729,"updatedAt":8729,"publishedAt":8729},1440,"yzue2lmavyh913kynwuj0dc7","oostrum.png",{"small":8714,"thumbnail":8720},{"ext":183,"url":8715,"hash":8716,"mime":186,"name":8717,"path":18,"size":8718,"width":198,"height":1550,"sizeInBytes":8719},"/uploads/small_oostrum_e4c38890c4.png","small_oostrum_e4c38890c4","small_oostrum.png",416.25,416245,{"ext":183,"url":8721,"hash":8722,"mime":186,"name":8723,"path":18,"size":8724,"width":1557,"height":214,"sizeInBytes":8725},"/uploads/thumbnail_oostrum_e4c38890c4.png","thumbnail_oostrum_e4c38890c4","thumbnail_oostrum.png",68.47,68466,"oostrum_e4c38890c4",187.49,"/uploads/oostrum_e4c38890c4.png","2026-07-28T11:14:32.251Z",{"id":8731,"documentId":8732,"title":8733,"slug":8734,"date":8735,"cardTitle":18,"excerpt":18,"body":8736,"createdAt":8782,"updatedAt":8782,"publishedAt":8782,"cardImage":8783},358,"ueme3alf9hvy21wmmalmjpyg","SensUs team update: Imperial College London","sensus-team-update-imperial-college-london","2016-04-04",[8737,8741,8745,8749,8753,8757,8761,8765],{"type":152,"children":8738},[8739],{"bold":79,"text":8740,"type":156},"This is the second edition of a series of updates from the SensUs student teams. In this series, the teams summarize what they have been doing, recently. This week is the update from the Imperial College London SensUs Team:",{"type":152,"children":8742},[8743],{"text":8744,"type":156},"With the second term at Imperial drawing to a close we are happy to inform SensUs of all our advancements. The weekly meetings of the team and divisions within the team have allowed us to make significant progress.",{"type":152,"children":8746},[8747],{"text":8748,"type":156},"The Imperial Team began by conducting Market Research, contacting various experts in the field of biosensors from clinicians to GP's and Professors, by sending out emails which contained an online survey which can be found on our website. We managed to get in touch with some very useful contacts including Professor Pusey, Head of Renal & Vascular Inflammation Research in the Department of Medicine at Imperial. He offered to circulate our survey throughout his department as well as potentially distributing it via the renal association which has the capacity to reach nephrologists nationwide. This opened up our Market Research potential and meant we had the ability to gain lots of valuable information. The Market Research continues and we hope that by summer we have detailed information of the areas of our biosensor that we should focus on.",{"type":152,"children":8750},[8751],{"text":8752,"type":156},"Whilst the market research was being undertaken, predominantly by the designated Market Researchers within the team, the rest of the team were researching all the existing creatinine sensors as well as potential other systems that could be used, these included Molecularly Imprinted Polymers (MIP's), Enzyme based systems, Aptomers and Antibodies. From the research, we decided to home in on MIP's and Enzyme based systems. The team is likely going to be split up in to two with each sub team focusing on one of the options.",{"type":152,"children":8754},[8755],{"text":8756,"type":156},"The two webmasters of the Imperial Team also began to develop a website, which was completed just over a month in to the competition and alongside various emails being sent out, this has helped us to secure the team sponsorship, from Orion High Technologies S.L. who have kindly offered to supply screen printed electrodes free of charge. We also have other companies who may be interested.",{"type":152,"children":8758},[8759],{"text":8760,"type":156},"Fortunately, we have also had access to data from the potentiostats we could potentially be using and so our Head of Data Analysis has been hard at work producing a program which effectively works through the text files produced and plots a graph. This will allow us to efficiently test sensors.",{"type":152,"children":8762},[8763],{"text":8764,"type":156},"In the upcoming weeks each team member is to propose which enzymes they think should be used. From this we will vote on the which enzymes we think should be used in the system. After this we hope to develop a protocol for both the MIP and Enzyme systems so that in summer we can immediately begin testing. During the Easter holidays we hope to get in to the labs to learn some basic techniques and understand how to handle the bovine plasma that we have recently ordered. Alongside this we are also developing a Gantt chart so that we have deadlines to keep to so that we maximize our progress.",{"type":152,"children":8766},[8767,8769,8774,8776,8781],{"text":8768,"type":156},"To follow the team's progress like us on ",{"url":8770,"type":236,"children":8771},"https://www.facebook.com/imperialcollegesensus",[8772],{"text":8773,"type":156},"Facebook",{"text":8775,"type":156},": or visit our ",{"url":8777,"type":236,"children":8778},"http://imperialcollege.sensus.org/",[8779],{"text":8780,"type":156},"website",{"text":887,"type":156},"2026-07-28T11:14:32.363Z",{"id":8784,"documentId":8785,"name":8786,"alternativeText":18,"caption":18,"focalPoint":18,"width":180,"height":497,"formats":8787,"hash":8812,"ext":280,"mime":283,"size":8813,"url":8814,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":8815,"updatedAt":8815,"publishedAt":8815},1442,"ala65ktq7rrl3dlrz8emi0dn","cropped-imperial-building.jpg",{"large":8788,"small":8794,"medium":8800,"thumbnail":8806},{"ext":280,"url":8789,"hash":8790,"mime":283,"name":8791,"path":18,"size":8792,"width":190,"height":2124,"sizeInBytes":8793},"/uploads/large_cropped_imperial_building_fbc127bfd5.jpg","large_cropped_imperial_building_fbc127bfd5","large_cropped-imperial-building.jpg",108.99,108985,{"ext":280,"url":8795,"hash":8796,"mime":283,"name":8797,"path":18,"size":8798,"width":198,"height":2131,"sizeInBytes":8799},"/uploads/small_cropped_imperial_building_fbc127bfd5.jpg","small_cropped_imperial_building_fbc127bfd5","small_cropped-imperial-building.jpg",35.05,35048,{"ext":280,"url":8801,"hash":8802,"mime":283,"name":8803,"path":18,"size":8804,"width":206,"height":2138,"sizeInBytes":8805},"/uploads/medium_cropped_imperial_building_fbc127bfd5.jpg","medium_cropped_imperial_building_fbc127bfd5","medium_cropped-imperial-building.jpg",69.6,69603,{"ext":280,"url":8807,"hash":8808,"mime":283,"name":8809,"path":18,"size":8810,"width":144,"height":2145,"sizeInBytes":8811},"/uploads/thumbnail_cropped_imperial_building_fbc127bfd5.jpg","thumbnail_cropped_imperial_building_fbc127bfd5","thumbnail_cropped-imperial-building.jpg",10.19,10187,"cropped_imperial_building_fbc127bfd5",330.4,"/uploads/cropped_imperial_building_fbc127bfd5.jpg","2026-07-28T11:14:32.361Z",{"id":8817,"documentId":8818,"title":8819,"slug":8820,"date":8821,"cardTitle":18,"excerpt":18,"body":8822,"createdAt":8827,"updatedAt":8827,"publishedAt":8828,"cardImage":8829},359,"wwt84bc66zx0gpvi796uewik","SensUs team update: KreaSensa","sensus-team-update-kreasensa","2016-03-09",[8823],{"type":152,"children":8824},[8825],{"bold":79,"text":8826,"type":156},"This is the beginning of a series of updates from the SensUs student teams. In this series, the teams summarize what they have been doing, recently. This week is the first update and it is from KreaSensa, the KU Leuven SensUs team:","2026-07-28T11:14:33.102Z","2026-07-28T11:14:33.099Z",{"id":8830,"documentId":8831,"name":8832,"alternativeText":18,"caption":18,"focalPoint":18,"width":8833,"height":8834,"formats":8835,"hash":8860,"ext":280,"mime":283,"size":8861,"url":8862,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":8863,"updatedAt":8863,"publishedAt":8863},1444,"qjb27or2c9jwwav7zqld1su2","6393_central_library_KU_Leuven_cRob_Stevens.jpg",4267,2846,{"large":8836,"small":8842,"medium":8848,"thumbnail":8854},{"ext":280,"url":8837,"hash":8838,"mime":283,"name":8839,"path":18,"size":8840,"width":190,"height":345,"sizeInBytes":8841},"/uploads/large_6393_central_library_KU_Leuven_c_Rob_Stevens_2d6388bae0.jpg","large_6393_central_library_KU_Leuven_c_Rob_Stevens_2d6388bae0","large_6393_central_library_KU_Leuven_cRob_Stevens.jpg",111.52,111524,{"ext":280,"url":8843,"hash":8844,"mime":283,"name":8845,"path":18,"size":8846,"width":198,"height":293,"sizeInBytes":8847},"/uploads/small_6393_central_library_KU_Leuven_c_Rob_Stevens_2d6388bae0.jpg","small_6393_central_library_KU_Leuven_c_Rob_Stevens_2d6388bae0","small_6393_central_library_KU_Leuven_cRob_Stevens.jpg",32.01,32011,{"ext":280,"url":8849,"hash":8850,"mime":283,"name":8851,"path":18,"size":8852,"width":206,"height":198,"sizeInBytes":8853},"/uploads/medium_6393_central_library_KU_Leuven_c_Rob_Stevens_2d6388bae0.jpg","medium_6393_central_library_KU_Leuven_c_Rob_Stevens_2d6388bae0","medium_6393_central_library_KU_Leuven_cRob_Stevens.jpg",65.31,65308,{"ext":280,"url":8855,"hash":8856,"mime":283,"name":8857,"path":18,"size":8858,"width":306,"height":214,"sizeInBytes":8859},"/uploads/thumbnail_6393_central_library_KU_Leuven_c_Rob_Stevens_2d6388bae0.jpg","thumbnail_6393_central_library_KU_Leuven_c_Rob_Stevens_2d6388bae0","thumbnail_6393_central_library_KU_Leuven_cRob_Stevens.jpg",8.76,8758,"6393_central_library_KU_Leuven_c_Rob_Stevens_2d6388bae0",1423.93,"/uploads/6393_central_library_KU_Leuven_c_Rob_Stevens_2d6388bae0.jpg","2026-07-28T11:14:32.740Z",{"id":8865,"documentId":8866,"title":8867,"slug":8868,"date":8869,"cardTitle":8870,"excerpt":18,"body":8871,"createdAt":8908,"updatedAt":8908,"publishedAt":8909,"cardImage":8910},360,"m5o3i3mq4hao15wzserto89l","Going from Lab to Life! - Puls 2016","sensus-pulse-2016-0","2016-03-03","SensUs at: Pulse 2016",[8872,8878,8889,8904],{"type":152,"children":8873},[8874,8876],{"text":8875,"type":156,"italic":79},"\"Going from Lab to Life\"",{"text":8877,"type":156}," was the slogan of the Puls Event on 18 February 2016, a national event by the Dutch Heart Foundation and the Heart & Vascular Patient Group, with the purpose of enhancing patient participation in scientific research. In the age of mass communication and automization, the voice of consumers is often not taken into account, and healthcare is no different. During the Puls Event patients, researchers, companies and medical professionals were all actively discussing the future course of healthcare in the field of cardiovascular disease.",{"type":152,"children":8879},[8880,8882,8884,8885,8887],{"text":8881,"type":156},"The SensUs organisation was invited to organize and lead one of the workshops at the Puls Event. In this workshop patients, researchers, companies and medical professionals could give their opinion about biosensing. In small groups several questions were discussed such as ",{"text":8883,"type":156,"italic":79},"\"Can a patient perform a diagnostic test on his/her own body for the first time?\"",{"text":6268,"type":156},{"text":8886,"type":156,"italic":79},"\"Would patients like to wear a biosensor implant?\"",{"text":8888,"type":156},", which evoked many lively responses.",{"type":152,"children":8890},[8891,8893,8895,8896,8898,8900,8902],{"text":8892,"type":156},"Among those were remarks such as ",{"text":8894,"type":156,"italic":79},"\"I wouldn't know what to do with all those numbers or if the test would show a worrisome result\"",{"text":3688,"type":156},{"text":8897,"type":156,"italic":79},"\"I know many heart failure patients who are afraid of potential disease exacerbations and who would love to be carefully monitored\"",{"text":8899,"type":156}," and, much to the surprise of some researchers, ",{"text":8901,"type":156,"italic":79},"\"I would love an implant so that I don't have to think about having to test myself every several hours\"",{"text":8903,"type":156},". All in all a very fruitful discussion with many valid points throughout the entire workshop.",{"type":152,"children":8905},[8906],{"text":8907,"type":156},"The results from the workshop will aid us in developing a multi-year roadmap for the SensUs competition. With SensUs, just like Puls, we hope to stimulate and facilitate the involvement of patients and the general public in healthcare developments. We therefore hope to continue our collaboration with the Puls Event in the coming years.","2026-07-28T11:14:33.215Z","2026-07-28T11:14:33.214Z",{"id":8911,"documentId":8912,"name":8913,"alternativeText":18,"caption":18,"focalPoint":18,"width":180,"height":8387,"formats":8914,"hash":8939,"ext":280,"mime":283,"size":8940,"url":8941,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":8942,"updatedAt":8942,"publishedAt":8942},1450,"di0mlqfw5ebk1odsjyasgz3i","puls3.jpg",{"large":8915,"small":8921,"medium":8927,"thumbnail":8933},{"ext":280,"url":8916,"hash":8917,"mime":283,"name":8918,"path":18,"size":8919,"width":190,"height":345,"sizeInBytes":8920},"/uploads/large_puls3_007ff9cce6.jpg","large_puls3_007ff9cce6","large_puls3.jpg",72.11,72113,{"ext":280,"url":8922,"hash":8923,"mime":283,"name":8924,"path":18,"size":8925,"width":198,"height":293,"sizeInBytes":8926},"/uploads/small_puls3_007ff9cce6.jpg","small_puls3_007ff9cce6","small_puls3.jpg",25.48,25482,{"ext":280,"url":8928,"hash":8929,"mime":283,"name":8930,"path":18,"size":8931,"width":206,"height":198,"sizeInBytes":8932},"/uploads/medium_puls3_007ff9cce6.jpg","medium_puls3_007ff9cce6","medium_puls3.jpg",46.62,46615,{"ext":280,"url":8934,"hash":8935,"mime":283,"name":8936,"path":18,"size":8937,"width":306,"height":214,"sizeInBytes":8938},"/uploads/thumbnail_puls3_007ff9cce6.jpg","thumbnail_puls3_007ff9cce6","thumbnail_puls3.jpg",8.22,8219,"puls3_007ff9cce6",214.59,"/uploads/puls3_007ff9cce6.jpg","2026-07-28T11:14:33.213Z",{"id":8944,"documentId":8945,"title":8946,"slug":8947,"date":8948,"cardTitle":18,"excerpt":8949,"body":8950,"createdAt":9026,"updatedAt":9026,"publishedAt":9027,"cardImage":9028},361,"xmpqceatm2ll6vd6jz7h7d1w","SensUs Interviews: Rogier Hopstaken","sensus-interviews-rogier-hopstaken","2016-02-12","The first SensUs interview",[8951,8962,8966,8970,8974,8978,8982,8986,8990,8994,8998,9002,9006,9010,9014,9018,9022],{"type":152,"children":8952},[8953,8955,8960],{"bold":79,"text":8954,"type":156},"For this edition of SensUs Interviews, we spoke with Rogier Hopstaken, member of our committee of recommendation. Rogier has the unique position to be both a general practitioner (GP) for 14 years and an expert on point-of-care testing (POCT). POCT is an important process in the diagnostics of patients, which SensUs wants to stimulate. Moreover, he works at ",{"url":8956,"type":236,"children":8957},"http://saltro.nl/",[8958],{"bold":79,"text":8959,"type":156},"Saltro",{"bold":79,"text":8961,"type":156},", one of SensUs's first sponsors.",{"type":152,"children":8963},[8964],{"text":8965,"type":156,"italic":79},"1. Who are you and what are your daily activities in Saltro?",{"type":152,"children":8967},[8968],{"text":8969,"type":156},"I am a general practitioner who combined his GP training program with research at Maastricht University. While working as a GP at Meerhoven Primary Health Care Center in Eindhoven I have continued research, innovation and implemention activities, mainly in the fields of diagnostic testing, respiratory tract infections, antibiotics, and point-of-care testing. Currently, I am Head of Innovation and the Medical Staff and member of the Management Team of Saltro Diagnostic Center in Utrecht. I am active in various commissions at the Dutch College of GPs (NHG) and author of the Dutch guideline on POCT in general practice.",{"type":152,"children":8971},[8972],{"text":8973,"type":156,"italic":79},"2. What exactly is Point of Care testing?",{"type":152,"children":8975},[8976],{"text":8977,"type":156},"Nobody knows. ツ That means, literally, it is any test performed at the point of care (e.g. at the bedside of a patient). Generally, the term POCT is mainly used for tests that otherwise require a central laboratory. To underline the fact that POCT is not 'a rapid test', but a process, including a chain of elements that need to be taken into account, we have developed a specific definition for the Dutch guideline on POCT in general practice.[1]",{"type":152,"children":8979},[8980],{"text":8981,"type":156,"italic":79},"3. What is the added value of POCT for patients and GPs?",{"type":152,"children":8983},[8984],{"text":8985,"type":156},"The result of POCT is available during the same consultation with the medical professional. This has several advantages. It helps the doctor to reduce diagnostic uncertainty, so a more accurate diagnosis will be made. Particularly in primary care, diagnosing illnesses with the doctor's 'eyes and ears' can be difficult, because the patient presents symptoms and signs that are often less explicit ('grey') than learned from medical textbooks ('black and white') or when presented in a hospital setting (later stage of illness, more severe illness). Therefore, additional, high-quality, diagnostic tools are of great importance.",{"type":152,"children":8987},[8988],{"text":8989,"type":156},"The added value of POCT is considered largest for acute illnesses, mainly for safely excluding a particular serious illness. But patients, particularly, also greatly value the service aspects. Other advantages of POCT include the possibility of serial testing and (home) monitoring. Self-testing is of course closely related, and may be the result of the same, or similar, technical developments.",{"type":152,"children":8991},[8992],{"text":8993,"type":156,"italic":79},"4. Can you give examples of diseases of which diagnosis and/or treatment has improved through molecular biosensors?",{"type":152,"children":8995},[8996],{"text":8997,"type":156},"In 2005 I have defended my thesis on lower respiratory tract infections in general practice. An important finding was the great difficulty for GPs to correctly diagnose pneumonia. The added value of a blood test, C-reactive protein, was immense. If this test is performed at the point of care, patients profit from much better management decisions, including less unjustified antibiotic prescribing. We have proven this after introduction of a CRP POCT test device in general practice. Our results were validated in larger, European studies. Patients, nurses and doctors were very satisfied with the use of these devices and with the collaboration with the diagnostic center that facilitated this introduction (training, logistics, quality assurance, follow-up). After our studies, CRP POCT was introduced in various guidelines, and is now routinely used by 60% of the GPs in the Netherlands. Other examples include D-dimer POCT, but also 'classical' tests like glucose, urine testing and hemoglobin POCT.",{"type":152,"children":8999},[9000],{"text":9001,"type":156,"italic":79},"5. Which diseases can be improved in the future in terms of diagnosis and/or treatments thanks to molecular biosensors?",{"type":152,"children":9003},[9004],{"text":9005,"type":156},"Possibly many and, again, particularly for use in primary care, where additional testing is mostly not possible. I expect that early detection of illnesses (cancer, infections) and prevention of illnesses (cardiovascular, genetic) with new biomarkers and genetic profiling will reveal many opportunities with direct impact for healthcare.",{"type":152,"children":9007},[9008],{"text":9009,"type":156,"italic":79},"6. How can SensUs contribute in these developments?",{"type":152,"children":9011},[9012],{"text":9013,"type":156},"This is a great initiative. The international competition and international focus will enhance learning processes and may result in great collaborations, soon after the competition, or in the future. SensUs will definitely stimulate the development of new solutions for the - so many - opportunities to improve patient care and service, particularly when initiatives like these are aligned with the needs in health care.",{"type":152,"children":9015},[9016],{"bold":79,"text":9017,"type":156},"Notes",{"type":152,"children":9019},[9020],{"text":9021,"type":156},"[1]",{"type":152,"children":9023},[9024],{"text":9025,"type":156},"The process of indicating, executing, processing, interpreting, documenting, reporting and following a laboratory test, performed by a health care collaborator during the act of providing health care to and in the proximity of the patient.","2026-07-28T11:14:33.337Z","2026-07-28T11:14:33.336Z",{"id":9029,"documentId":9030,"name":9031,"alternativeText":18,"caption":18,"focalPoint":18,"width":180,"height":8387,"formats":9032,"hash":9057,"ext":598,"mime":283,"size":9058,"url":9059,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":9060,"updatedAt":9060,"publishedAt":9060},1452,"q2luz0blgz8xbshdj70ut9mm","rogierhopstaken.jpeg",{"large":9033,"small":9039,"medium":9045,"thumbnail":9051},{"ext":598,"url":9034,"hash":9035,"mime":283,"name":9036,"path":18,"size":9037,"width":190,"height":345,"sizeInBytes":9038},"/uploads/large_rogierhopstaken_eb41252ec9.jpeg","large_rogierhopstaken_eb41252ec9","large_rogierhopstaken.jpeg",65.3,65304,{"ext":598,"url":9040,"hash":9041,"mime":283,"name":9042,"path":18,"size":9043,"width":198,"height":293,"sizeInBytes":9044},"/uploads/small_rogierhopstaken_eb41252ec9.jpeg","small_rogierhopstaken_eb41252ec9","small_rogierhopstaken.jpeg",18.07,18070,{"ext":598,"url":9046,"hash":9047,"mime":283,"name":9048,"path":18,"size":9049,"width":206,"height":198,"sizeInBytes":9050},"/uploads/medium_rogierhopstaken_eb41252ec9.jpeg","medium_rogierhopstaken_eb41252ec9","medium_rogierhopstaken.jpeg",38.42,38422,{"ext":598,"url":9052,"hash":9053,"mime":283,"name":9054,"path":18,"size":9055,"width":306,"height":214,"sizeInBytes":9056},"/uploads/thumbnail_rogierhopstaken_eb41252ec9.jpeg","thumbnail_rogierhopstaken_eb41252ec9","thumbnail_rogierhopstaken.jpeg",4.99,4992,"rogierhopstaken_eb41252ec9",270.61,"/uploads/rogierhopstaken_eb41252ec9.jpeg","2026-07-28T11:14:33.334Z",{"id":9062,"documentId":9063,"title":9064,"slug":9065,"date":9066,"cardTitle":9067,"excerpt":18,"body":9068,"createdAt":9104,"updatedAt":9104,"publishedAt":9105,"cardImage":9106},362,"uz2hh1qqiod78181xbfct04a","TU Eindhoven: Easy test for early detection kidney failure","meet-teams-tu-eindhoven","2016-02-05","Meet the Teams: TU Eindhoven",[9069,9079,9083,9087,9091,9094,9100],{"type":152,"children":9070},[9071,9073,9077],{"text":9072,"type":156},"A team of TU/e students, fifteen strong, wants to develop an easy-to-use test this year to detect kidney failure in an early stage.",{"url":9074,"type":236,"children":9075},"https://old.sensus.org/article.php?l=eindhoven-easy-test-early-detection-kidney-failure#notes",[9076],{"text":9021,"type":156},{"text":9078,"type":156}," They will be creating a biosensor as part of the 2016 SensUs student competition, in which multi-disciplinary student teams of five European universities will all be working toward designing, building, and testing a biosensor prototype.",{"type":152,"children":9080},[9081],{"text":9082,"type":156},"The sooner kidney failure can be detected, the greater the chance of successful treatment to inhibit the damage. Diabetes, high blood pressure and age come with a higher risk of kidney failure, so the Dutch Kidney Foundation urges people aged sixty and over to have their kidney function checked every year to expose possible kidney damage.",{"type":152,"children":9084},[9085],{"text":9086,"type":156},"Right now, these checks often involve laboratory tests in hospitals. The easy-to-use test the TU/e students plan on developing should reduce the burden for both patients and caregivers. Patients could do the easy, quick, and cost-effective test at their GP or even at home. It's a biosensor: a device that measures a certain substance, a so-called biomarker, in blood, urine, sweat or saliva, indicating whether someone is sick or not. SensUs 2016 focuses on the measurement of creatinine in blood plasma.",{"type":152,"children":9088},[9089],{"text":9090,"type":156},"The Eindhoven student team will take on teams from England, Sweden, Belgium, and Denmark on September 9 and 10. The protoypes will then be tested and assessed for aspects such as precision, user-friendliness, and innovation.",{"type":152,"children":9092},[9093],{"bold":79,"text":9017,"type":156},{"type":152,"children":9095},[9096],{"url":9097,"type":236,"children":9098},"https://old.sensus.org/article.php?l=eindhoven-easy-test-early-detection-kidney-failure#note-1",[9099],{"text":9021,"type":156},{"type":152,"children":9101},[9102],{"text":9103,"type":156},"This text is a translation of a Dutch press release that has been prepared by the TU Eindhoven SensUs Team.","2026-07-28T11:14:33.510Z","2026-07-28T11:14:33.508Z",{"id":9107,"documentId":9108,"name":9109,"alternativeText":18,"caption":18,"focalPoint":18,"width":8335,"height":5383,"formats":9110,"hash":9127,"ext":280,"mime":283,"size":8363,"url":9128,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":9129,"updatedAt":9129,"publishedAt":9129},1454,"b6pz25ypf8axoth6m0aetitk","eindhoven3.jpg",{"large":9111,"small":9115,"medium":9119,"thumbnail":9123},{"ext":280,"url":9112,"hash":9113,"mime":283,"name":9114,"path":18,"size":8341,"width":190,"height":8342,"sizeInBytes":8343},"/uploads/large_eindhoven3_a9f60ce93f.jpg","large_eindhoven3_a9f60ce93f","large_eindhoven3.jpg",{"ext":280,"url":9116,"hash":9117,"mime":283,"name":9118,"path":18,"size":8348,"width":198,"height":306,"sizeInBytes":8349},"/uploads/small_eindhoven3_a9f60ce93f.jpg","small_eindhoven3_a9f60ce93f","small_eindhoven3.jpg",{"ext":280,"url":9120,"hash":9121,"mime":283,"name":9122,"path":18,"size":8354,"width":206,"height":8200,"sizeInBytes":8355},"/uploads/medium_eindhoven3_a9f60ce93f.jpg","medium_eindhoven3_a9f60ce93f","medium_eindhoven3.jpg",{"ext":280,"url":9124,"hash":9125,"mime":283,"name":9126,"path":18,"size":8360,"width":144,"height":1383,"sizeInBytes":8361},"/uploads/thumbnail_eindhoven3_a9f60ce93f.jpg","thumbnail_eindhoven3_a9f60ce93f","thumbnail_eindhoven3.jpg","eindhoven3_a9f60ce93f","/uploads/eindhoven3_a9f60ce93f.jpg","2026-07-28T11:14:33.507Z",{"id":9131,"documentId":9132,"title":9133,"slug":9134,"date":9135,"cardTitle":8870,"excerpt":9136,"body":9137,"createdAt":9146,"updatedAt":9146,"publishedAt":9147,"cardImage":9148},363,"k1xat0szdseue45t88ns77tb","Puls 2016","sensus-pulse-2016","2016-01-28","SensUs visited Pulse 2016",[9138,9142],{"type":152,"children":9139},[9140],{"text":9141,"type":156},"On the 18th of February the Dutch Heart Foundation organizes Puls 2016, the largest event in the Netherlands on cardiovascular research. Patients, scientists and industry are involved.",{"type":152,"children":9143},[9144],{"text":9145,"type":156},"SensUs will present a workshop on biosensors. During the session we will discuss the use and purpose of biosensors. Furthermore, participants will get hands-on experience with current medical home tests.","2026-07-28T11:14:33.850Z","2026-07-28T11:14:33.849Z",{"id":9149,"documentId":9150,"name":9151,"alternativeText":18,"caption":18,"focalPoint":18,"width":9152,"height":9153,"formats":9154,"hash":9179,"ext":280,"mime":283,"size":9180,"url":9181,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":9182,"updatedAt":9182,"publishedAt":9182},1456,"utmbirybcp378lig960k9hh1","0d1ab3887f884ff03aed41a43c07aa24.jpg",4256,2832,{"large":9155,"small":9161,"medium":9167,"thumbnail":9173},{"ext":280,"url":9156,"hash":9157,"mime":283,"name":9158,"path":18,"size":9159,"width":190,"height":4355,"sizeInBytes":9160},"/uploads/large_0d1ab3887f884ff03aed41a43c07aa24_1b25dd2ae1.jpg","large_0d1ab3887f884ff03aed41a43c07aa24_1b25dd2ae1","large_0d1ab3887f884ff03aed41a43c07aa24.jpg",119.28,119284,{"ext":280,"url":9162,"hash":9163,"mime":283,"name":9164,"path":18,"size":9165,"width":198,"height":293,"sizeInBytes":9166},"/uploads/small_0d1ab3887f884ff03aed41a43c07aa24_1b25dd2ae1.jpg","small_0d1ab3887f884ff03aed41a43c07aa24_1b25dd2ae1","small_0d1ab3887f884ff03aed41a43c07aa24.jpg",35.9,35904,{"ext":280,"url":9168,"hash":9169,"mime":283,"name":9170,"path":18,"size":9171,"width":206,"height":4369,"sizeInBytes":9172},"/uploads/medium_0d1ab3887f884ff03aed41a43c07aa24_1b25dd2ae1.jpg","medium_0d1ab3887f884ff03aed41a43c07aa24_1b25dd2ae1","medium_0d1ab3887f884ff03aed41a43c07aa24.jpg",70.78,70775,{"ext":280,"url":9174,"hash":9175,"mime":283,"name":9176,"path":18,"size":9177,"width":306,"height":214,"sizeInBytes":9178},"/uploads/thumbnail_0d1ab3887f884ff03aed41a43c07aa24_1b25dd2ae1.jpg","thumbnail_0d1ab3887f884ff03aed41a43c07aa24_1b25dd2ae1","thumbnail_0d1ab3887f884ff03aed41a43c07aa24.jpg",10.03,10027,"0d1ab3887f884ff03aed41a43c07aa24_1b25dd2ae1",1495.58,"/uploads/0d1ab3887f884ff03aed41a43c07aa24_1b25dd2ae1.jpg","2026-07-28T11:14:33.846Z",{"id":9184,"documentId":9185,"title":9186,"slug":9187,"date":9188,"cardTitle":4547,"excerpt":9189,"body":9190,"createdAt":9235,"updatedAt":9235,"publishedAt":9236,"cardImage":9237},364,"va3d53g1wwrvv6fdwqetgpil","The man behind the mission","sensus-interviews-menno-prins","2015-12-13","The start of SensUs",[9191,9195,9199,9203,9207,9211,9215,9219,9223,9227,9231],{"type":152,"children":9192},[9193],{"bold":79,"text":9194,"type":156},"This interview marks the beginning of a series of interviews with people involved in SensUs. The founder of the first international student competition SensUs is Menno Prins, a professor at Eindhoven University of Technology, working in the field of Molecular Biosensing for Medical Diagnostics. To get an insight in the man behind the mission we interviewed professor Prins, revealing his history, his first thoughts about SensUs and his expectations.",{"type":152,"children":9196},[9197],{"text":9198,"type":156,"italic":79},"Who are you and what are your daily activities on the TU/e?",{"type":152,"children":9200},[9201],{"text":9202,"type":156},"\"I am fascinated by new technologies for biochemical sensing and by applications in the fields of near-patient testing and patient monitoring. My mission is to train and inspire young scientists and engineers by involving them in top-level biosensing research, and to lay the foundations for sensing technologies that will in the future improve the quality of life of patients.\"",{"type":152,"children":9204},[9205],{"text":9206,"type":156,"italic":79},"What is your history with biosensors?",{"type":152,"children":9208},[9209],{"text":9210,"type":156},"\"I have been working in the field of biosensing for 15 years now. While working at Philips Research, I initiated and then developed with a team a point-of-care biosensing platform based on magnetic nanoparticles. I became a fulltime professor at Eindhoven University of Technology in 2014, and my aim is again to develop innovative biosensing technologies, starting from novel basic concepts, and then translate the results to society.\"",{"type":152,"children":9212},[9213],{"text":9214,"type":156,"italic":79},"How did you come up with the idea of SensUs?",{"type":152,"children":9216},[9217],{"text":9218,"type":156},"\"I was thinking about a novel way to stimulate the development of technologies and applications in the field of molecular biosensing. A way that should bring together talented young people from different scientific disciplines and from different countries, and that should nurture collaborations between universities, companies, patient organizations, and other stakeholders. A way that would be fun to watch for a very broad audience. That's how the idea to start an international student competition was born, which we named SensUs.\"",{"type":152,"children":9220},[9221],{"text":9222,"type":156,"italic":79},"Why do you think that those five universities are promising participants?",{"type":152,"children":9224},[9225],{"text":9226,"type":156},"\"The five universities that participate in SensUs 2016 do research at high level across a broad range of scientific disciplines. Students should have access to these resources for the development of new biosensing systems, in particular biochemistry, chemistry, physics, electrical and mechanical engineering, and software science. I think that the student teams will generate highly creative ideas and will build systems that work. They are going to surprise themselves and the world. SensUs 2016 is a pilot year; next year more universities are welcome to join the SensUs competition.\"",{"type":152,"children":9228},[9229],{"text":9230,"type":156,"italic":79},"In what way do you think that SensUs can be relevant for the society?",{"type":152,"children":9232},[9233],{"text":9234,"type":156},"\"SensUs has a roadmap philosophy. With the stakeholders we will plan a series of challenges in the coming years. Every year, a meaningful challenge will be addressed by the teams, insights will be gained, and solutions will be generated. The involvement of stakeholders such as patient organizations and companies will enhance the chance that promising solutions will be carried to next levels, with translation to society as the end goal.\"","2026-07-28T11:14:33.994Z","2026-07-28T11:14:33.992Z",{"id":9238,"documentId":9239,"name":9240,"alternativeText":18,"caption":18,"focalPoint":18,"width":180,"height":190,"formats":9241,"hash":9266,"ext":280,"mime":283,"size":9267,"url":9268,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":9269,"updatedAt":9269,"publishedAt":9269},1458,"rfo4vy957p73pjrs1279jmal","menno.jpg",{"large":9242,"small":9248,"medium":9254,"thumbnail":9260},{"ext":280,"url":9243,"hash":9244,"mime":283,"name":9245,"path":18,"size":9246,"width":190,"height":198,"sizeInBytes":9247},"/uploads/large_menno_abc20dd7be.jpg","large_menno_abc20dd7be","large_menno.jpg",31.25,31253,{"ext":280,"url":9249,"hash":9250,"mime":283,"name":9251,"path":18,"size":9252,"width":198,"height":481,"sizeInBytes":9253},"/uploads/small_menno_abc20dd7be.jpg","small_menno_abc20dd7be","small_menno.jpg",9.21,9211,{"ext":280,"url":9255,"hash":9256,"mime":283,"name":9257,"path":18,"size":9258,"width":206,"height":654,"sizeInBytes":9259},"/uploads/medium_menno_abc20dd7be.jpg","medium_menno_abc20dd7be","medium_menno.jpg",18.16,18163,{"ext":280,"url":9261,"hash":9262,"mime":283,"name":9263,"path":18,"size":9264,"width":144,"height":132,"sizeInBytes":9265},"/uploads/thumbnail_menno_abc20dd7be.jpg","thumbnail_menno_abc20dd7be","thumbnail_menno.jpg",3.06,3058,"menno_abc20dd7be",100.67,"/uploads/menno_abc20dd7be.jpg","2026-07-28T11:14:33.943Z",{"id":9271,"documentId":9272,"title":9273,"slug":9274,"date":9275,"cardTitle":9276,"excerpt":18,"body":9277,"createdAt":9317,"updatedAt":9317,"publishedAt":9318,"cardImage":9319},365,"usa6ysxl86u02tltfvdgqfb0","What is a molecular biosensor?","molecular-biosensor","2015-09-22","Molecular Biosensor",[9278,9288,9292,9296,9300,9304,9307,9313],{"type":152,"children":9279},[9280,9282,9286],{"bold":79,"text":9281,"type":156},"The field of molecular biosensing",{"url":9283,"type":236,"children":9284},"https://old.sensus.org/article.php?l=what-is-a-biosensor#notes",[9285],{"bold":79,"text":9021,"type":156},{"bold":79,"text":9287,"type":156}," started in the last century with the development of compact devices for enzymatic metabolite detection - mainly blood glucose sensing for patients with diabetes - and with devices for antibody-based detection of small molecules and proteins, e.g. detection of the hCG hormone as a biomarker for pregnancy. In recent years molecular biosensors have also become available for in-vivo monitoring of glucose in skin.",{"type":152,"children":9289},[9290],{"text":9291,"type":156},"In spite of these advances, most medical biomarkers can still only be measured on large laboratory instruments, and near-patient tests - let alone devices for real-time monitoring - are not yet available. An important reason is that biomolecular measurements are intrinsically difficult: most biomarkers have low concentrations, biological samples contain a lot of substances that can interfere with measurements, samples can vary strongly between patients, measurements are sensitive to environmental conditions, etc. Therefore, mostly laboratory conditions, complex sample preparation procedures and large sophisticated instruments are needed to perform reliable biomarker measurements.",{"type":152,"children":9293},[9294],{"text":9295,"type":156},"However science and technology are developing steadily and strongly, in areas such as micro- and nanotechnologies, biomolecular engineering and biochemistry, high-tech instrumentation and computational methods. New recognition and detection molecules are being designed, new ways to incorporate molecules in devices, new ways to transduce biomolecular interactions into chemical and physical signals, and new ways to detect these signals using miniaturized optics, electronics, mechanics, etc.",{"type":152,"children":9297},[9298],{"text":9299,"type":156},"The increase of understanding and control enable steps to be made in analytical performance and miniaturization, driven by multidisciplinary teams that combine the required scientific and engineering skills. Many new technological concepts are being and will be developed. Over time, biosensor technologies will become more sensitive, more accurate, faster, more integrated, more user-friendly, available for more biomarkers, and more cost-effective.",{"type":152,"children":9301},[9302],{"text":9303,"type":156},"We foresee a roadmap of challenges that need to and will be addressed in the coming years. The approach of SensUs is to select every year a well-defined technological goal that is to be targeted by the international teams. With the same functional end goal, the teams will develop their unique solutions and creative technological embodiments. At the contest all solutions will be shown, shared, appreciated, and discussed. In this way, SensUs will become a platform for learning, for the generation of novel solutions and for innovation in the field of molecular biosensors for healthcare applications.",{"type":152,"children":9305},[9306],{"bold":79,"text":9017,"type":156},{"type":152,"children":9308},[9309],{"url":9310,"type":236,"children":9311},"https://old.sensus.org/article.php?l=what-is-a-biosensor#note-1",[9312],{"text":9021,"type":156},{"type":152,"children":9314},[9315],{"text":9316,"type":156},"A biosensor is a compact device that interacts with a biological system to acquire a signal for diagnostic or monitoring purposes. A molecular biosensor is a biosensor with a molecular interaction as a central aspect. It is an analytical device with a molecular recognition element and with a transduction principle that turns the biomolecular interaction into a measurable signal. Molecular biosensors operate on samples taken from the body (in-vitro testing e.g. using a drop of blood) or are worn on or inside the body (for real-time in-vivo sensing).","2026-07-28T11:14:34.354Z","2026-07-28T11:14:34.353Z",{"id":9320,"documentId":9321,"name":9322,"alternativeText":18,"caption":18,"focalPoint":18,"width":1643,"height":9323,"formats":9324,"hash":9347,"ext":280,"mime":283,"size":9348,"url":9349,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":9350,"updatedAt":9350,"publishedAt":9350},1461,"dxplah46hwet0k0zigagm7pg","2872482711_7c735a6b1e_b.jpg",768,{"large":9325,"small":9331,"medium":9337,"thumbnail":9342},{"ext":280,"url":9326,"hash":9327,"mime":283,"name":9328,"path":18,"size":9329,"width":190,"height":206,"sizeInBytes":9330},"/uploads/large_2872482711_7c735a6b1e_b_2698ead4a4.jpg","large_2872482711_7c735a6b1e_b_2698ead4a4","large_2872482711_7c735a6b1e_b.jpg",79.06,79055,{"ext":280,"url":9332,"hash":9333,"mime":283,"name":9334,"path":18,"size":9335,"width":198,"height":654,"sizeInBytes":9336},"/uploads/small_2872482711_7c735a6b1e_b_2698ead4a4.jpg","small_2872482711_7c735a6b1e_b_2698ead4a4","small_2872482711_7c735a6b1e_b.jpg",27.3,27297,{"ext":280,"url":9338,"hash":9339,"mime":283,"name":9340,"path":18,"size":8070,"width":206,"height":661,"sizeInBytes":9341},"/uploads/medium_2872482711_7c735a6b1e_b_2698ead4a4.jpg","medium_2872482711_7c735a6b1e_b_2698ead4a4","medium_2872482711_7c735a6b1e_b.jpg",50700,{"ext":280,"url":9343,"hash":9344,"mime":283,"name":9345,"path":18,"size":13,"width":3107,"height":214,"sizeInBytes":9346},"/uploads/thumbnail_2872482711_7c735a6b1e_b_2698ead4a4.jpg","thumbnail_2872482711_7c735a6b1e_b_2698ead4a4","thumbnail_2872482711_7c735a6b1e_b.jpg",6999,"2872482711_7c735a6b1e_b_2698ead4a4",80.95,"/uploads/2872482711_7c735a6b1e_b_2698ead4a4.jpg","2026-07-28T11:14:34.351Z",{"id":9352,"documentId":9353,"title":9354,"slug":9355,"date":9356,"cardTitle":18,"excerpt":9357,"body":9358,"createdAt":9391,"updatedAt":9391,"publishedAt":9392,"cardImage":9393},366,"rs2nr6mlhxem1h9ghh4byzjv","SensUs goes live!","sensus-goes-live","2015-09-13","Announcement: SensUs website is online",[9359,9363,9367,9371,9375,9379,9383,9387],{"type":152,"children":9360},[9361],{"bold":79,"text":9362,"type":156},"Finally, after months of hard work, including the summer holidays, we can proudly say that our website is in the air. We are very excited to present SensUs to the world, the first international student competition on molecular biosensors for healthcare applications.",{"type":152,"children":9364},[9365],{"text":9366,"type":156},"Early 2015 professor Prins was looking for people to work out his idea: \"I was thinking about a novel way to stimulate the development of technologies in the field of molecular biosensing. A way that should bring together talented young people from different scientific disciplines and from different countries. That's how the idea to start an international student competition was born, which we named SensUs.\"",{"type":152,"children":9368},[9369],{"text":9370,"type":156},"An enthusiastic team of students gathered to work on SensUs as part of their Honors Track in the TU/e Honors Academy. We organized ourselves with Chair, Vice-Chair, and groups focussing on Technology, Logistics and Communications. We are very happy to see the ideas taking shape, behind the curtains and now also in public.",{"type":152,"children":9372},[9373],{"text":9374,"type":156},"The Technology group works out the technical challenge that is to be addressed by the participating teams, in particular the biomarker that is to be measured and the sample matrix. Potential challenges are being discussed with professors and other stakeholders, and we will announce the selected challenge at the latest on the first working day of 2016. The Logistics group is developing an interesting program for the contest days in September 2016, when all participating teams will convene in Eindhoven and will demonstrate their biosensing systems.",{"type":152,"children":9376},[9377],{"text":9378,"type":156},"In the coming months, students from University of Leuven, Imperial College London, Uppsala University, Danish Technical University and Eindhoven University of Technology can apply via their local contact person (see apply). SensUs 2016 is a pilot year with still a limited number of universities; more universities will be able to join in 2017.",{"type":152,"children":9380},[9381],{"text":9382,"type":156},"We expect to see great things from the participating teams. Professor Prins: \"I strongly believe in the creativity of people and the power of teamwork. Molecular biosensing technologies are difficult to develop because a broad set of scientific and engineering skills are required. The competition will result in novel ideas, novel technologies, and in novel collaborations between universities, companies, and other stakeholders in the field of healthcare.\"",{"type":152,"children":9384},[9385],{"text":9386,"type":156},"We are looking forward to November 2015 when the teams will have been formed at the five universities, which will kick-start the first edition of the SensUs competition. Professor Prins: \"We hope to develop a scalable multi-year contest wherein students will address challenges of increasing complexity in a focused manner, across several countries, for the benefit of healthcare.\" There is still a lot of work to do for the SensUs organizing team, but we are already looking forward to September 2016. We expect to meet awesome teams, see inspiring projects, interesting technologies, and have fun along the way!",{"type":152,"children":9388},[9389],{"text":9390,"type":156},"If you would like to learn more about SensUs, click here.","2026-07-28T11:14:34.687Z","2026-07-28T11:14:34.686Z",{"id":9394,"documentId":9395,"name":9396,"alternativeText":18,"caption":18,"focalPoint":18,"width":180,"height":180,"formats":9397,"hash":9421,"ext":280,"mime":283,"size":9422,"url":9423,"previewUrl":18,"provider":219,"provider_metadata":18,"createdAt":9424,"updatedAt":9424,"publishedAt":9424},1463,"tlsm5d2ex2apblylglxsneff","HemoglobinPIC.jpg",{"large":9398,"small":9404,"medium":9409,"thumbnail":9415},{"ext":280,"url":9399,"hash":9400,"mime":283,"name":9401,"path":18,"size":9402,"width":190,"height":190,"sizeInBytes":9403},"/uploads/large_Hemoglobin_PIC_8664a1e3f5.jpg","large_Hemoglobin_PIC_8664a1e3f5","large_HemoglobinPIC.jpg",118.17,118167,{"ext":280,"url":9405,"hash":9406,"mime":283,"name":9407,"path":18,"size":4228,"width":198,"height":198,"sizeInBytes":9408},"/uploads/small_Hemoglobin_PIC_8664a1e3f5.jpg","small_Hemoglobin_PIC_8664a1e3f5","small_HemoglobinPIC.jpg",46131,{"ext":280,"url":9410,"hash":9411,"mime":283,"name":9412,"path":18,"size":9413,"width":206,"height":206,"sizeInBytes":9414},"/uploads/medium_Hemoglobin_PIC_8664a1e3f5.jpg","medium_Hemoglobin_PIC_8664a1e3f5","medium_HemoglobinPIC.jpg",80.59,80586,{"ext":280,"url":9416,"hash":9417,"mime":283,"name":9418,"path":18,"size":9419,"width":214,"height":214,"sizeInBytes":9420},"/uploads/thumbnail_Hemoglobin_PIC_8664a1e3f5.jpg","thumbnail_Hemoglobin_PIC_8664a1e3f5","thumbnail_HemoglobinPIC.jpg",7.89,7891,"Hemoglobin_PIC_8664a1e3f5",312.98,"/uploads/Hemoglobin_PIC_8664a1e3f5.jpg","2026-07-28T11:14:34.684Z"]